<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="generate">
            <roleset id="generate.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#x09;&#x09;//gene, process//&#x0A;" />
                    <role n="1" descr="thing created&#x09;&#x09;&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>21-23 nt of long mature RNAs (carot, and permease from DcuB to motor, carot and aspartate) were generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>21-23 nt of long mature RNAs (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>21-23 nt of long mature RNAs (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>21-23 nt of long mature RNAs (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>21-23 nt of long mature RNAs are generated by biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>21-23 nt of long mature RNAs are generated by biceps RNase III Dicer .</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>21-23 nt of long mature RNAs are generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>21-23 nt of long mature RNAs can be generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>21-23 nt of long mature RNAs is generated by biceps RNase III Dicer whose deletion removes the FHL2 binding.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>21-23 nt of long mature RNAs is generated by biceps RNase III Dicer whose elimination removes the FHL2 link.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>21-23 nt of long mature RNAs is generated by biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>21-23 nt of long mature RNAs is generated by biceps RNase III Dicer within the recombinant synapses.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>21-23 nt of long mature RNAs is generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>21-23 nt of long mature RNAs was generated by biceps RNase III Dicer (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>21-23 nt of long mature RNAs was generated by biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>21-23 nt of long mature RNAs was generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>21-23 nt of long mature RNAs were generated by biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>21-23 nt of long mature RNAs were generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>21-23 nt of long mature RNAs will be generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and 21-23 nt of long mature RNAs was generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and 21-23 nt of long mature RNAs will be generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Abeta peptides was generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Abeta peptides will be generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Abeta peptides will be generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Bydented RNase III dyce generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA was generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA was generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA was generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA was generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA will be generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA will be generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA will be generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA will be generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and L723 in H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and L723 to H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and NNOS generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Prnd generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant was generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant will be generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA will be generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and The biceps RNase III Dicer generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and The biceps RNase III Dicer generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface was generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface will be generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a high-order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher DNA complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher-order protein&#x13;DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher-order protein DNA complex was generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher-order protein DNA complex will be generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher-order protein-DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive DNase I will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive chromatin I remodeling complex will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I will be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a monoclonal antibody vs. FHL2 was generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a monoclonal antibody vs. FHL2 will be generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and biceps RNase III Dicer generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and degradation generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and ens generates a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat B generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat was generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat was generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat will be generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumatase B generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and high-order DNA protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and high-order DNA protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and high-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and high-order protein-DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and hypersensitive to DNase I will be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and intergenic slicing with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and intergenic slicing with Prnp generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and intergenic slicing with Prnp generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and intergenic spike with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and large transcriptions of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and large transcriptions of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt was generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt will be generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mRNA of mature HeLa cells will be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb was generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb will be generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb will be generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and matur HeLa cell mRNA will be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt was generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt will be generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt will be generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature heLa cell mRNA will be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature hela cell mRNA will be generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and moker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and moker will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and motor will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and nodes generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and nodes generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and proteolysis of amyloid precursor proteins (APP) generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and proteolysis of amyloid precursor proteins generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sequential fragment overlapping was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sequential fragment overlapping will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sequential overlapping fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sequential superposition fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoke B generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoke was generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoke will be generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoker B generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoker B generates smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoker will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions was generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions will be generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chimeric transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chimeric transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and specific fragments will be generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex will be generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex was generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex will be generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex will be generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex will be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and superoxide was generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and superoxide was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and superoxide will be generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and superoxide will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and superposed sequential defects was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and superposed sequential defects will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and suspected was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and suspected will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the 21-23 nt of long mature RNAs will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the N-terminal AR generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the TBC method generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the bidentate RNase III Dicer generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface was generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface will be generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface will be generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the term N-AR generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the term N-AR generates a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this binding generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this binding generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this binding generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this binding generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this binding generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this union generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this union generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this union generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and us generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and us generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and L723 in H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and L723 to H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and NNOS generated superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and PRnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and Prnd generated large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and Prnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generated overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generated sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and The biceps RNase III Dicer generated long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and The biceps RNase III Dicer generated long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of primary gene transcription generated HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of primary genetic transcription generated HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of primary transcription of the gene generated HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of the primary transcription of the gene generated HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and biceps RNase III Dicer generated 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and bidentate RNase III generated mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and degradation generated specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and ens generated a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and fumat B generated fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and fumatase B generated fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and intergenic slicing with Prnp generated some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and intergenic slicing with Prnp generated some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and nNOS generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and nNOS generated suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and nodes generated monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and nodes generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and prnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and proteolysis of amyloid precursor proteins (APP) generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and proteolysis of amyloid precursor proteins generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and smoke B generated smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and smoker B generated moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and smoker B generated motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and smoker B generated smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the N-terminal AR generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the N-terminal RA generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the TBC method generated overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the TBC method generated superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the bidentate RNase III Dicer generated mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the term N-AR generated a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the term N-AR generated a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this binding generated a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this binding generated a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this binding generated a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this binding generated a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this junction generated a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this union generated a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this union generated a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and us generated monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and 21-23 nt of long mature RNAs is generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and 21-23 nt of long mature RNAs was generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and 21-23 nt of long mature RNAs will be generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Abeta peptides is generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Abeta peptides was generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Abeta peptides will be generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Abeta peptides will be generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Bydented RNase III dyce generated long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Bydented RNase III dyce generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA is generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA is generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA is generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA was generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA was generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA will be generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA will be generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA will be generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and L723 in H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and L723 in H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and L723 to H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and NNOS generated superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and NNOS generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and PRnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and PRnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Prnd generated large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Prnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Prnd generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA DNA-binding mutant was generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA DNA-binding mutant will be generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA will be generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generated overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generated sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generated sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and The biceps RNase III Dicer generated long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and The biceps RNase III Dicer generated long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface is generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface was generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface will be generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a high-order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher DNA complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein&#x13;DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein&#x13;DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein DNA complex is generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein DNA complex was generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein DNA complex will be generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive chromatin I remodeling complex will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I will be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a monoclonal antibody vs. FHL2 is generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a monoclonal antibody vs. FHL2 was generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a monoclonal antibody vs. FHL2 will be generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of primary gene transcription generated HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of primary genetic transcription generated HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of the primary transcription of the gene generated HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of the primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and biceps RNase III Dicer generated 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and biceps RNase III Dicer generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and bidentate RNase III generated mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and bidentate RNase III generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and degradation generated specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and degradation generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and ens generated a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and ens generates a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat B generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat is generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat is generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat was generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat was generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat will be generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat will be generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumatase B generated fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumatase B generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order DNA protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order DNA protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order DNA protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order protein-DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic slicing with Prnp generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic slicing with Prnp generated some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic slicing with Prnp generated some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic slicing with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic slicing with Prnp generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic spike with Prnp generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and large transcriptions of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and large transcriptions of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long RNAs of 21-23 nt was generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long RNAs of 21-23 nt will be generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long RNAs of 21-23 nt will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long mature RNAs of 21-23 nt will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mRNA of heLa cells will be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mRNA of mature HeLa cells will be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb is generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb was generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb will be generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb will be generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature RNA 21-23 nt is generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature RNA 21-23 nt is generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature RNA 21-23 nt was generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature RNA 21-23 nt was generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature RNA 21-23 nt will be generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature heLa cell mRNA will be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature hela cell mRNA will be generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and moker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and moker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and moker will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody against FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody against FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody against FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody against FHL2 will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody against FHL2 will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody vs. FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody vs. FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody vs. FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody vs. FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody vs. FHL2 will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody vs. FHL2 will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and motor is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and motor was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and motor will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nNOS generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nNOS generated suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nNOS generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nNOS generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nodes generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and overlapping sequential fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and overlapping sequential fragments is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and overlapping sequential fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and overlapping sequential fragments was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and overlapping sequential fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and overlapping sequential fragments will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and proteolysis of amyloid precursor proteins (APP) generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and proteolysis of amyloid precursor proteins generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential fragment overlapping is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential fragment overlapping will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential overlapping fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential overlapping fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential superposition fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential superposition fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoke B generated smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoke B generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoke is generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoke was generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoke will be generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker B generated motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker B generated smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker B generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker B generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker B generates smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemical transcriptions is generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemical transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemical transcriptions will be generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chimeric transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chimeric transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chimeric transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and specific fragments is generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and specific fragments was generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and specific fragments will be generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex will be generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex was generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex will be generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex will be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superoxide is generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superoxide was generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superoxide was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superoxide will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superposed sequential defects is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superposed sequential defects will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and suspected is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the 21-23 nt of long mature RNAs will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-terminal AR generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-terminal AR generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-terminal RA generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the TBC method generated overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the TBC method generated superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the bidentate RNase III Dicer generated mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the bidentate RNase III Dicer generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the correct three-dimensional interaction surface is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the correct three-dimensional interaction surface is generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the correct three-dimensional interaction surface was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the correct three-dimensional interaction surface was generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the correct three-dimensional interaction surface will be generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the correct three-dimensional interaction surface will be generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the term N-AR generated a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the term N-AR generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the term N-AR generates a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generated a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generated a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this junction generated a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this union generated a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this union generated high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this union generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this union generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this union generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and us generated monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and us generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and us generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and us generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and 21-23 nt of long mature RNAs has been generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and Abeta peptides has been generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and Abeta peptides has been generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HLA has been generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HLA has been generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HLA has been generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HLA has been generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA has been generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA has been generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA has been generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface has been generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a higher DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a higher-order protein&#x13;DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a higher-order protein DNA complex has been generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a higher-order protein-DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a hypersensitive chromatin I remodeling complex has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I has been generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I has been generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I has been generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a monoclonal antibody vs. FHL2 has been generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and fumat has been generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and fumat has been generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and high-order DNA protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and high-order protein-DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and hypersensitive to DNase I has been generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and large transcriptions of 1.7 and 2.7 kb has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt has been generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and long mature RNAs of 21-23 nt has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and mRNA of heLa cells has been generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and matur HeLa cell mRNA has been generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt has been generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt has been generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and mature hela cell mRNA has been generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and moker has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and motor has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and sequential fragment overlapping has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and sequential overlapping fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and smoke has been generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions has been generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and some unusual symmetrical transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and specific fragments has been generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex has been generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has been generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has been generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex has been generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex has been generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex has been generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and superoxide has been generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and superoxide has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and superposed sequential defects has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and suspected has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and the 21-23 nt of long mature RNAs has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a has been generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface has been generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and 21-23 nt of long mature RNAs is generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and Abeta peptides is generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HLA is generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HLA is generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HLA is generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HLA is generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface is generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a higher DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a higher DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a higher-order protein&#x13;DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a higher-order protein DNA complex is generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a higher-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a monoclonal antibody vs. FHL2 is generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and fumat is generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and fumat is generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and high-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and large transcriptions of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt is generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and long RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb is generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb is generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt is generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt is generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and moker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody against FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and motor is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and sequential overlapping fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and smoke is generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and smoker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions is generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and some unusual chimeric transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and specific fragments is generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and superoxide is generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and superposed sequential defects is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and suspected is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface is generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>A0 generated Abeta peptides within the recombinant synapses.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>A0 generated Stat5aEE-AA within the recombinant synapses.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>A0 generated abeta peptides within the recombinant synapses.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>A0 generated peptides abeta within the recombinant synapses.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>A1 is generated by Mino-EE mutant acids (437 and 438) in AA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>A1 is generated by Minoan mutants EE (437 and 438) in AA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>A1 is generated by a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>A1 is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>A1 is generated by degradation (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>A1 is generated by mino acid mutants EE (437 and 438) in AA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>A1 is generated by muting amino acids EE (437 and 438) to AA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>Abeta peptides (carot, and permease from DcuB to motor, carot and aspartate) were generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>Abeta peptides (carot, and permease from DcuB to motor, carot and aspartate) were generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>Abeta peptides (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>Abeta peptides (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>Abeta peptides are generated by proteolysis of amyloid precursor proteins (APP) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>Abeta peptides are generated by proteolysis of amyloid precursor proteins (APP) .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>Abeta peptides are generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>Abeta peptides are generated by proteolysis of amyloid precursor proteins (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>Abeta peptides are generated by proteolysis of amyloid precursor proteins .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>Abeta peptides can be generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>Abeta peptides can be generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>Abeta peptides have been generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP) whose deletion removes the FHL2 binding.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP) whose elimination removes the FHL2 link.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP). The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins whose deletion removes the FHL2 binding.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins within the recombinant synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP) (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP) within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>Abeta peptides was generated by proteolysis of amyloid precursor proteins (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>Abeta peptides was generated by proteolysis of amyloid precursor proteins within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>Abeta peptides was generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>Abeta peptides were generated by proteolysis of amyloid precursor proteins (APP) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>Abeta peptides were generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>Abeta peptides were generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>Abeta peptides were generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>Abeta peptides will be generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>Abeta peptides will be generated by proteolysis of amyloid precursor proteins (APP). The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>Abeta peptides will be generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>Abeta peptides will be generated by proteolysis of amyloid precursor proteins. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Abeta peptides has been generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Abeta peptides has been generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Abeta peptides is generated by A0 (L723 in H3.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Abeta peptides was generated by A0 (L723 in H3.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Abeta peptides will be generated by A0 (L723 in H3.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Bydented RNase III dyce generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Bydented RNase III dyce has generated long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that EE amino acids (437 and 438) for AA has generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HeLa mature cell mRNA has been generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HeLa mature cell mRNA has been generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that L723 to H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that L723 to H3 has generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that NNOS has generated superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that NO reacts anaerobicly with the purified NRF Fe-S cluster has generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that None reacts anaerobically with the purified Fe-S group of NRF has generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that PRnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that PRnd has generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Prnd generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Prnd has generated large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Prnd has generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) has generated hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Stat5aEE-AA DNA-binding mutant has been generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Stat5aEE-AA DNA-binding mutant has been generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Stat5aEE-AA has been generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Stat5aEE-AA is generated by A0 (L723 in H3.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Stat5aEE-AA will be generated by A0 (L723 in H3.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method has generated overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method has generated sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method has generated sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that The biceps RNase III Dicer generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that The biceps RNase III Dicer generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that The biceps RNase III Dicer has generated long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that The biceps RNase III Dicer has generated long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that The biceps RNase III Dicer has generated the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863 bases RNA chain that occurs in the non-translated region 5 has generated mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-base RNA chunk that occurs in the 5-untranslated region has generated mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-interpreted region has generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-untranslated region has generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a 3863-based RNA fragment that occurs in the 5-untranslated region has generated matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a RNA fragment based on 3863 that occurs in the 5-untranslated region has generated mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex has generated a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) has generated a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) has generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) has generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a functional interaction surface has been generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a functional interaction surface has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a high-order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a high-order protein DNA complex is generated by A0 (L723 in H3.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a high-order protein DNA complex will be generated by A0 (L723 in H3.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a higher DNA complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a higher DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a higher order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a higher-order protein&#x13;DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a higher-order protein DNA complex has been generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a higher-order protein-DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a hypersensitive DNase I has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a hypersensitive chromatin I remodeling complex has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a hypersensitive to DNase I has been generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a hypersensitive to DNase I has been generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a monoclonal antibody vs. FHL2 has been generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a surface of functional interaction has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that abeta peptides is generated by A0 (L723 in H3.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that abeta peptides will be generated by A0 (L723 in H3.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an RNA fragment of 3863 bases occurring in the 5-interpreted region has generated mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of primary genetic transcription has generated HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of the primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of the primary transcription of the gene has generated HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that biceps RNase III Dicer generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that biceps RNase III Dicer has generated 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that bidentate RNase III generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that bidentate RNase III has generated mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that degradation generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that degradation has generated specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that does not react anaerobically with the purified Fe-S group of NRF has generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that ens generates a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that ens has generated a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat B generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat B has generated fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat has been generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat has been generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumatase B has generated fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that high-order DNA protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that high-order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that high-order protein-DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that hypersensitive to DNase I has been generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that in anaerobically reacted with the purified NR Fe-S cluster has generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic slicing with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic slicing with Prnp generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic slicing with Prnp has generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic slicing with Prnp has generated some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic slicing with Prnp has generated some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic spike with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that large transcriptions of 1.7 and 2.7 kb has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that long RNAs of 21-23 nt has been generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that long RNAs of 21-23 nt has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mRNA of heLa cells has been generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mRNA of mature HeLa cells has been generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that main transcripts of 1.7 and 2.7 kb has been generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that main transcripts of 1.7 and 2.7 kb has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that main transcripts of 1.7 and 2.7 kb has been generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that matur HeLa cell mRNA has been generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mature RNA 21-23 nt has been generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mature RNA 21-23 nt has been generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mature heLa cell mRNA has been generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mature hela cell mRNA has been generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that moker has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that monoclonal antibody against FHL2 has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that monoclonal antibody against FHL2 has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that motor has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that muting amino acids EE (437 and 438) to AA has generated Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nNOS generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nNOS has generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nNOS has generated suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that no anaerobic reactions with the purified FNR Fe-S group has generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nodes generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nodes generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nodes has generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that none reacts anaerobically with the purified F-S group of FNR has generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that overlapping sequential fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that peptides abeta was generated by A0 (L723 in H3.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that peptides abeta will be generated by A0 (L723 in H3.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that prnd has generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins (APP) generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins has generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that sequential superposition fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoke B generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoke B has generated smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoke has been generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker B generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker B generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker B has generated moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker B has generated smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that some unusual chemical transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that some unusual chemical transcriptions has been generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that some unusual chimeric transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that some unusual symmetrical transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex has been generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-cysteine complex has been generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has been generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has been generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex has been generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex has been generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosyl-cysteine complex has been generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that superoxide has been generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that superoxide has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that superposed sequential defects has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that suspected has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-terminal AR generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-terminal AR has generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-terminal RA generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-terminal RA has generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the TBC method generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the TBC method has generated overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the TBC method has generated superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the bidentate RNase III Dicer generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the bidentate RNase III Dicer has generated mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the correct three-dimensional interaction surface has been generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the term N-AR generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the term N-AR generates a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the term N-AR has generated a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the term N-AR has generated a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding has generated a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding has generated a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding has generated high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding has generated high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this junction generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this junction has generated a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this union generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this union generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this union generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this union has generated a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this union has generated a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that us generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that us generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that us has generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that 21-23 nt of long mature RNAs has been generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Abeta peptides has been generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Abeta peptides has been generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Abeta peptides is generated by A0 (L723 in H3.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Abeta peptides was generated by A0 (L723 in H3.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Abeta peptides will be generated by A0 (L723 in H3.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Bydented RNase III dyce generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Bydented RNase III dyce has generated long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that EE amino acids (437 and 438) for AA has generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HeLa mature cell mRNA has been generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HeLa mature cell mRNA has been generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that L723 to H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that L723 to H3 has generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that NNOS has generated superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that NO reacts anaerobicly with the purified NRF Fe-S cluster has generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that PRnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that PRnd has generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Prnd generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) has generated hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Stat5aEE-AA DNA-binding mutant has been generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Stat5aEE-AA DNA-binding mutant has been generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Stat5aEE-AA has been generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Stat5aEE-AA is generated by A0 (L723 in H3.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Stat5aEE-AA was generated by A0 (L723 in H3.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Stat5aEE-AA will be generated by A0 (L723 in H3.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method has generated overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method has generated sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method has generated sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that TBC method has generated sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that The biceps RNase III Dicer generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that The biceps RNase III Dicer generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that The biceps RNase III Dicer has generated long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that The biceps RNase III Dicer has generated long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that The biceps RNase III Dicer has generated the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863 bases RNA chain that occurs in the non-translated region 5 has generated mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-base RNA chunk that occurs in the 5-untranslated region has generated mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-interpreted region has generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-untranslated region has generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-based RNA fragment that occurs in the 5-untranslated region has generated matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex has generated a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) has generated a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) has generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) has generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a functional interaction surface has been generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a functional interaction surface has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a functional interaction surface has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a high-order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a high-order protein DNA complex is generated by A0 (L723 in H3.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a high-order protein DNA complex will be generated by A0 (L723 in H3.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a higher DNA complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a higher order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a higher-order protein&#x13;DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a higher-order protein DNA complex has been generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a higher-order protein-DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a hypersensitive DNase I has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a hypersensitive chromatin I remodeling complex has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a hypersensitive to DNase I has been generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a hypersensitive to DNase I has been generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a hypersensitive to DNase I has been generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a monoclonal antibody vs. FHL2 has been generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a surface of functional interaction has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that abeta peptides is generated by A0 (L723 in H3.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that abeta peptides was generated by A0 (L723 in H3.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that abeta peptides will be generated by A0 (L723 in H3.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an RNA fragment of 3863 bases occurring in the 5-interpreted region has generated mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of primary genetic transcription has generated HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that biceps RNase III Dicer generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that biceps RNase III Dicer has generated 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that bidentate RNase III generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that degradation generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that does not react anaerobically with the purified Fe-S group of NRF has generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that ens generates a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that ens has generated a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat B generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat B has generated fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat has been generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumatase B generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumatase B has generated fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that high-order DNA protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that high-order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that high-order protein-DNA complex has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that hypersensitive to DNase I has been generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that in anaerobically reacted with the purified NR Fe-S cluster has generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic slicing with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic slicing with Prnp generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic slicing with Prnp generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic slicing with Prnp has generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic slicing with Prnp has generated some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic slicing with Prnp has generated some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic spike with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic spike with Prnp has generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that large transcriptions of 1.7 and 2.7 kb has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that long RNAs of 21-23 nt has been generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that long mature RNAs of 21-23 nt has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mRNA of heLa cells has been generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mRNA of mature HeLa cells has been generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that main transcripts of 1.7 and 2.7 kb has been generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that matur HeLa cell mRNA has been generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mature RNA 21-23 nt has been generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mature RNA 21-23 nt has been generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mature heLa cell mRNA has been generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mature hela cell mRNA has been generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mino EE mutant acids (437 and 438) for AA has generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that mino mutant acids EE (437 and 438) to AA has generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that monoclonal antibody against FHL2 has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that monoclonal antibody vs. FHL2 has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that monoclonal antibody vs. FHL2 has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that muting amino acids EE (437 and 438) to AA has generated Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nNOS generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nNOS generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nNOS has generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nNOS has generated suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that no anaerobic reactions with the purified FNR Fe-S group has generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nodes generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nodes generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nodes has generated monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that nodes has generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that none reacts anaerobically with the purified F-S group of FNR has generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that none reacts anaerobically with the purified FNR group Fe-S has generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that overlapping sequential fragments has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that peptides abeta is generated by A0 (L723 in H3.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that peptides abeta was generated by A0 (L723 in H3.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that peptides abeta will be generated by A0 (L723 in H3.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that prnd has generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins (APP) generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins has generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that sequential overlapping fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that sequential superposition fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoke B generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoke B has generated smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoke has been generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker B generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker B generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker B generates smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker B has generated moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker B has generated motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker B has generated smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that smoker has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that some unusual chemical transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that some unusual chemical transcriptions has been generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that some unusual symmetrical transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that specific fragments has been generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex has been generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-cysteine complex has been generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-cysteine complex has been generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has been generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has been generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex has been generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex has been generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that superoxide has been generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that superoxide has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that superposed sequential defects has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the 21-23 nt of long mature RNAs has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the DNA-binding mutant (Stat5aEE-AA) of Stat5a has been generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-terminal AR generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-terminal AR has generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-terminal RA generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-terminal RA has generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the TBC method generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the TBC method has generated overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the TBC method has generated superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the bidentate RNase III Dicer generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the bidentate RNase III Dicer has generated mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the correct three-dimensional interaction surface has been generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the term N-AR generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the term N-AR generates a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the term N-AR has generated a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding has generated a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1237">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding has generated a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1238">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding has generated a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1239">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding has generated high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1240">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding has generated high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1241">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this junction generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1242">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this junction has generated a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1243">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this union generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1244">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this union generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1245">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this union generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1246">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this union has generated a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1247">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this union has generated a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1248">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this union has generated high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1249">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that us generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1250">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that us generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1251">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that us has generated monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1252">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that us has generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1253">
                    <text>Bydented RNase III dyce are able to generate long RNAs of 21-23 nt .</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1254">
                    <text>Bydented RNase III dyce can generate long RNAs of 21-23 nt (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1255">
                    <text>Bydented RNase III dyce can generate long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1256">
                    <text>Bydented RNase III dyce generated long RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1257">
                    <text>Bydented RNase III dyce generated long RNAs of 21-23 nt (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1258">
                    <text>Bydented RNase III dyce generated long RNAs of 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1259">
                    <text>Bydented RNase III dyce generated long RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1260">
                    <text>Bydented RNase III dyce generated long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1261">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1262">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1263">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt within the recombinant synapses.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1264">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt-G molecules of antigen human leukocytes.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1265">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1266">
                    <text>Bydented RNase III dyce has generated long RNAs of 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1267">
                    <text>Bydented RNase III dyce is able to generate long RNAs of 21-23 nt .</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1268">
                    <text>Bydented RNase III dyce is able to generate long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1269">
                    <text>CTB method are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1270">
                    <text>CTB method can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1271">
                    <text>CTB method generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1272">
                    <text>CTB method generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1273">
                    <text>CTB method generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1274">
                    <text>CTB method generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1275">
                    <text>CTB method generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1276">
                    <text>CTB method generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1277">
                    <text>EE amino acids (437 and 438) for AA are able to generate Stat5aEE-AA DNA-binding mutant .</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1278">
                    <text>EE amino acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1279">
                    <text>EE amino acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1280">
                    <text>EE amino acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1281">
                    <text>EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1282">
                    <text>EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1283">
                    <text>EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1284">
                    <text>EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant within the recombinant synapse.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1285">
                    <text>EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1286">
                    <text>EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1287">
                    <text>EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1288">
                    <text>EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1289">
                    <text>EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant within the recombinant synapse.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1290">
                    <text>EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant within the recombinant synapses.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1291">
                    <text>EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant-G molecules of antigen human leukocytes.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1292">
                    <text>EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1293">
                    <text>EE amino acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant .</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1294">
                    <text>EE amino acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1295">
                    <text>HLA (carot, and permease from DcuB to motor, carot and aspartate) were generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1296">
                    <text>HLA (carot, and permease from DcuB to motor, carot and aspartate) were generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1297">
                    <text>HLA (carot, and permease from DcuB to motor, carot and aspartate) were generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1298">
                    <text>HLA (carot, and permease from DcuB to motor, carot and aspartate) were generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1299">
                    <text>HLA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1300">
                    <text>HLA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1301">
                    <text>HLA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1302">
                    <text>HLA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1303">
                    <text>HLA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1304">
                    <text>HLA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1305">
                    <text>HLA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1306">
                    <text>HLA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1307">
                    <text>HLA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1308">
                    <text>HLA are generated by an alternative coupling of primary gene transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1309">
                    <text>HLA are generated by an alternative coupling of primary gene transcription .</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1310">
                    <text>HLA are generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1311">
                    <text>HLA are generated by an alternative coupling of primary genetic transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1312">
                    <text>HLA are generated by an alternative coupling of primary genetic transcription .</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1313">
                    <text>HLA are generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1314">
                    <text>HLA are generated by an alternative coupling of primary transcription of the gene (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1315">
                    <text>HLA are generated by an alternative coupling of primary transcription of the gene .</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1316">
                    <text>HLA are generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1317">
                    <text>HLA are generated by an alternative coupling of the primary transcription of the gene (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1318">
                    <text>HLA are generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1319">
                    <text>HLA can be generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1320">
                    <text>HLA can be generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1321">
                    <text>HLA can be generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1322">
                    <text>HLA is generated by an alternative coupling of primary gene transcription whose deletion removes the FHL2 binding.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1323">
                    <text>HLA is generated by an alternative coupling of primary gene transcription whose elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1324">
                    <text>HLA is generated by an alternative coupling of primary gene transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1325">
                    <text>HLA is generated by an alternative coupling of primary gene transcription within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1326">
                    <text>HLA is generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1327">
                    <text>HLA is generated by an alternative coupling of primary gene transcription. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1328">
                    <text>HLA is generated by an alternative coupling of primary genetic transcription whose elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1329">
                    <text>HLA is generated by an alternative coupling of primary genetic transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1330">
                    <text>HLA is generated by an alternative coupling of primary genetic transcription within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1331">
                    <text>HLA is generated by an alternative coupling of primary genetic transcription. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1332">
                    <text>HLA is generated by an alternative coupling of primary transcription of the gene whose deletion removes the FHL2 binding.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1333">
                    <text>HLA is generated by an alternative coupling of primary transcription of the gene whose elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1334">
                    <text>HLA is generated by an alternative coupling of primary transcription of the gene within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1335">
                    <text>HLA is generated by an alternative coupling of primary transcription of the gene within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1336">
                    <text>HLA is generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1337">
                    <text>HLA is generated by an alternative coupling of primary transcription of the gene. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1338">
                    <text>HLA is generated by an alternative coupling of the primary transcription of the gene whose deletion removes the FHL2 binding.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1339">
                    <text>HLA is generated by an alternative coupling of the primary transcription of the gene whose elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1340">
                    <text>HLA is generated by an alternative coupling of the primary transcription of the gene within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1341">
                    <text>HLA is generated by an alternative coupling of the primary transcription of the gene within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1342">
                    <text>HLA is generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1343">
                    <text>HLA is generated by an alternative coupling of the primary transcription of the gene. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1344">
                    <text>HLA was generated by an alternative coupling of primary gene transcription (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1345">
                    <text>HLA was generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1346">
                    <text>HLA was generated by an alternative coupling of primary genetic transcription (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1347">
                    <text>HLA was generated by an alternative coupling of primary genetic transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1348">
                    <text>HLA was generated by an alternative coupling of primary transcription of the gene (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1349">
                    <text>HLA was generated by an alternative coupling of primary transcription of the gene within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1350">
                    <text>HLA was generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1351">
                    <text>HLA was generated by an alternative coupling of the primary transcription of the gene (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1352">
                    <text>HLA was generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1353">
                    <text>HLA were generated by an alternative coupling of primary gene transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1354">
                    <text>HLA were generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1355">
                    <text>HLA were generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1356">
                    <text>HLA were generated by an alternative coupling of primary transcription of the gene (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1357">
                    <text>HLA were generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1358">
                    <text>HLA were generated by an alternative coupling of the primary transcription of the gene (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1359">
                    <text>HLA were generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1360">
                    <text>HLA will be generated by an alternative coupling of primary gene transcription. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1361">
                    <text>HLA will be generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1362">
                    <text>HLA will be generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1363">
                    <text>HLA will be generated by an alternative coupling of the primary transcription of the gene. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1364">
                    <text>HeLa mature cell mRNA (carot, and permease from DcuB to motor, carot and aspartate) were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1365">
                    <text>HeLa mature cell mRNA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1366">
                    <text>HeLa mature cell mRNA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1367">
                    <text>HeLa mature cell mRNA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1368">
                    <text>HeLa mature cell mRNA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1369">
                    <text>HeLa mature cell mRNA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1370">
                    <text>HeLa mature cell mRNA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1371">
                    <text>HeLa mature cell mRNA are generated by a 3863-base RNA fragment that occurs in the 5-interpreted region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1372">
                    <text>HeLa mature cell mRNA are generated by a 3863-base RNA fragment that occurs in the 5-interpreted region .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1373">
                    <text>HeLa mature cell mRNA are generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1374">
                    <text>HeLa mature cell mRNA are generated by a 3863-base RNA fragment that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1375">
                    <text>HeLa mature cell mRNA are generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1376">
                    <text>HeLa mature cell mRNA can be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1377">
                    <text>HeLa mature cell mRNA can be generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1378">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1379">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region whose elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1380">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1381">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1382">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1383">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1384">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region whose elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1385">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region within the recombinant synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1386">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1387">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1388">
                    <text>HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1389">
                    <text>HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1390">
                    <text>HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1391">
                    <text>HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1392">
                    <text>HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1393">
                    <text>HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1394">
                    <text>HeLa mature cell mRNA were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1395">
                    <text>HeLa mature cell mRNA were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1396">
                    <text>HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1397">
                    <text>HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1398">
                    <text>HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-untranslated region. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1399">
                    <text>In addition, Bydented RNase III dyce, whose elimination removes the FHL2 link, generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1400">
                    <text>In addition, EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant, as its elimination removes the FHL2 link.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1401">
                    <text>In addition, EE amino acids (437 and 438) for AA, whose elimination removes the FHL2 link, generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1402">
                    <text>In addition, L723 in H3, whose elimination removes the FHL2 link, generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1403">
                    <text>In addition, L723 to H3 generates the correct three-dimensional interaction surface, as its elimination removes the FHL2 link.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1404">
                    <text>In addition, L723 to H3, whose elimination removes the FHL2 link, generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1405">
                    <text>In addition, NNOS generates superoxide, as its elimination removes the FHL2 link.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1406">
                    <text>In addition, NNOS, whose elimination removes the FHL2 link, generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1407">
                    <text>In addition, NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1408">
                    <text>In addition, NO reacts anaerobicly with the purified NRF Fe-S cluster, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1409">
                    <text>In addition, NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1410">
                    <text>In addition, NONE reacts anaerobically with the purified FNR group FNR, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1411">
                    <text>In addition, None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1412">
                    <text>In addition, None reacts anaerobically with the purified Fe-S group of NRF, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1413">
                    <text>In addition, PRnd generates main transcripts of 1.7 and 2.7 kb, as its elimination removes the FHL2 link.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1414">
                    <text>In addition, Prnd generates large transcriptions of 1.7 and 2.7 kb, as its elimination removes the FHL2 link.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1415">
                    <text>In addition, Prnd generates main transcripts of 1.7 and 2.7 kb, as its elimination removes the FHL2 link.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1416">
                    <text>In addition, Prnd, whose elimination removes the FHL2 link, generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1417">
                    <text>In addition, Prnd, whose elimination removes the FHL2 link, generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1418">
                    <text>In addition, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), whose elimination removes the FHL2 link, generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1419">
                    <text>In addition, TBC method generates overlapping sequential fragments, as its elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1420">
                    <text>In addition, TBC method generates sequential fragment overlapping, as its elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1421">
                    <text>In addition, TBC method generates sequential superposition fragments, as its elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1422">
                    <text>In addition, TBC method, whose elimination removes the FHL2 link, generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1423">
                    <text>In addition, TBC method, whose elimination removes the FHL2 link, generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1424">
                    <text>In addition, TBC method, whose elimination removes the FHL2 link, generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1425">
                    <text>In addition, The biceps RNase III Dicer generates long RNAs of 21-23 nt, as its elimination removes the FHL2 link.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1426">
                    <text>In addition, The biceps RNase III Dicer generates long mature RNAs of 21-23 nt, as its elimination removes the FHL2 link.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1427">
                    <text>In addition, The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs, as its elimination removes the FHL2 link.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1428">
                    <text>In addition, The biceps RNase III Dicer, whose elimination removes the FHL2 link, generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1429">
                    <text>In addition, The biceps RNase III Dicer, whose elimination removes the FHL2 link, generates the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1430">
                    <text>In addition, a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1431">
                    <text>In addition, a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1432">
                    <text>In addition, a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1433">
                    <text>In addition, a 3863-base RNA fragment that occurs in the 5-interpreted region, whose elimination removes the FHL2 link, generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1434">
                    <text>In addition, a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1435">
                    <text>In addition, a 3863-base RNA fragment that occurs in the 5-untranslated region, whose elimination removes the FHL2 link, generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1436">
                    <text>In addition, a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1437">
                    <text>In addition, a RNA fragment based on 3863 that occurs in the 5-untranslated region, whose elimination removes the FHL2 link, generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1438">
                    <text>In addition, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1439">
                    <text>In addition, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1440">
                    <text>In addition, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, whose elimination removes the FHL2 link, generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1441">
                    <text>In addition, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, whose elimination removes the FHL2 link, generates a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1442">
                    <text>In addition, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1443">
                    <text>In addition, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), whose elimination removes the FHL2 link, generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1444">
                    <text>In addition, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1445">
                    <text>In addition, an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1446">
                    <text>In addition, an RNA fragment of 3863 bases occurring in the 5-interpreted region, whose elimination removes the FHL2 link, generates mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1447">
                    <text>In addition, an alternative coupling of primary gene transcription generates HLA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1448">
                    <text>In addition, an alternative coupling of primary gene transcription, whose elimination removes the FHL2 link, generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1449">
                    <text>In addition, an alternative coupling of primary genetic transcription, whose elimination removes the FHL2 link, generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1450">
                    <text>In addition, an alternative coupling of primary transcription of the gene generates HLA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1451">
                    <text>In addition, an alternative coupling of the primary transcription of the gene generates HLA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1452">
                    <text>In addition, an alternative coupling of the primary transcription of the gene, whose elimination removes the FHL2 link, generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1453">
                    <text>In addition, biceps RNase III Dicer generates 21-23 nt of long mature RNAs, as its elimination removes the FHL2 link.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1454">
                    <text>In addition, biceps RNase III Dicer, whose elimination removes the FHL2 link, generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1455">
                    <text>In addition, bidentate RNase III, whose elimination removes the FHL2 link, generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1456">
                    <text>In addition, degradation generates specific fragments, as its elimination removes the FHL2 link.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1457">
                    <text>In addition, degradation, whose elimination removes the FHL2 link, generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1458">
                    <text>In addition, does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1459">
                    <text>In addition, ens generates a monoclonal antibody vs. FHL2, as its elimination removes the FHL2 link.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1460">
                    <text>In addition, ens, whose elimination removes the FHL2 link, generates a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1461">
                    <text>In addition, fumat B generates fumat, as its elimination removes the FHL2 link.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1462">
                    <text>In addition, fumat B, whose elimination removes the FHL2 link, generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1463">
                    <text>In addition, fumatase B generates fumat, as its elimination removes the FHL2 link.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1464">
                    <text>In addition, fumatase B, whose elimination removes the FHL2 link, generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1465">
                    <text>In addition, in anaerobically reacted with the purified NR Fe-S cluster, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1466">
                    <text>In addition, intergenic slicing with Prnp generates some unusual chemical transcriptions, as its elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1467">
                    <text>In addition, intergenic slicing with Prnp generates some unusual chimeric transcriptions, as its elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1468">
                    <text>In addition, intergenic slicing with Prnp generates some unusual symmetrical transcriptions, as its elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1469">
                    <text>In addition, intergenic slicing with Prnp, whose elimination removes the FHL2 link, generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1470">
                    <text>In addition, intergenic slicing with Prnp, whose elimination removes the FHL2 link, generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1471">
                    <text>In addition, intergenic spike with Prnp generates some unusual chemical transcriptions, as its elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1472">
                    <text>In addition, intergenic spike with Prnp, whose elimination removes the FHL2 link, generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1473">
                    <text>In addition, mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant, as its elimination removes the FHL2 link.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1474">
                    <text>In addition, mino EE mutant acids (437 and 438) for AA, whose elimination removes the FHL2 link, generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1475">
                    <text>In addition, mino mutant acids EE (437 and 438) to AA, whose elimination removes the FHL2 link, generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1476">
                    <text>In addition, muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1477">
                    <text>In addition, muting amino acids EE (437 and 438) to AA, whose elimination removes the FHL2 link, generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1478">
                    <text>In addition, nNOS generates superoxide, as its elimination removes the FHL2 link.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1479">
                    <text>In addition, nNOS generates suspected, as its elimination removes the FHL2 link.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1480">
                    <text>In addition, nNOS, whose elimination removes the FHL2 link, generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1481">
                    <text>In addition, nNOS, whose elimination removes the FHL2 link, generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1482">
                    <text>In addition, no anaerobic reactions with the purified FNR Fe-S group, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1483">
                    <text>In addition, nodes generates monoclonal antibody against FHL2, as its elimination removes the FHL2 link.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1484">
                    <text>In addition, nodes generates monoclonal antibody vs. FHL2, as its elimination removes the FHL2 link.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1485">
                    <text>In addition, nodes, whose elimination removes the FHL2 link, generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1486">
                    <text>In addition, nodes, whose elimination removes the FHL2 link, generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1487">
                    <text>In addition, none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1488">
                    <text>In addition, none reacts anaerobically with the purified F-S group of FNR, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1489">
                    <text>In addition, none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1490">
                    <text>In addition, none reacts anaerobically with the purified FNR group Fe-S, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1491">
                    <text>In addition, prnd generates main transcripts of 1.7 and 2.7 kb, as its elimination removes the FHL2 link.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1492">
                    <text>In addition, proteolysis of amyloid precursor proteins (APP) generates Abeta peptides, as its elimination removes the FHL2 link.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1493">
                    <text>In addition, proteolysis of amyloid precursor proteins (APP), whose elimination removes the FHL2 link, generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1494">
                    <text>In addition, proteolysis of amyloid precursor proteins generates Abeta peptides, as its elimination removes the FHL2 link.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1495">
                    <text>In addition, proteolysis of amyloid precursor proteins, whose elimination removes the FHL2 link, generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1496">
                    <text>In addition, smoke B generates smoke, as its elimination removes the FHL2 link.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1497">
                    <text>In addition, smoke B, whose elimination removes the FHL2 link, generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1498">
                    <text>In addition, smoker B generates moker, as its elimination removes the FHL2 link.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1499">
                    <text>In addition, smoker B generates smoker, as its elimination removes the FHL2 link.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1500">
                    <text>In addition, smoker B, whose elimination removes the FHL2 link, generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1501">
                    <text>In addition, smoker B, whose elimination removes the FHL2 link, generates smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1502">
                    <text>In addition, the N-terminal AR generates a functional interaction surface, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1503">
                    <text>In addition, the N-terminal AR, whose elimination removes the FHL2 link, generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1504">
                    <text>In addition, the N-terminal RA generates a functional interaction surface, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1505">
                    <text>In addition, the N-terminal RA, whose elimination removes the FHL2 link, generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1506">
                    <text>In addition, the TBC method generates superposed sequential defects, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1507">
                    <text>In addition, the TBC method, whose elimination removes the FHL2 link, generates overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1508">
                    <text>In addition, the TBC method, whose elimination removes the FHL2 link, generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1509">
                    <text>In addition, the bidentate RNase III Dicer generates mature RNA 21-23 nt, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1510">
                    <text>In addition, the bidentate RNase III Dicer, whose elimination removes the FHL2 link, generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1511">
                    <text>In addition, the term N-AR generates a surface of functional interaction, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1512">
                    <text>In addition, the term N-AR, whose elimination removes the FHL2 link, generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1513">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, although again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt is generated by not for degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1514">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, although again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt will be generated by no by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1515">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, but again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt are no generated by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1516">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, but again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt would be no generated by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1517">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, though again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt are not generated by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1518">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, though again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt would be not generated by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1519">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of CTB method, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="1520">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, although again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant is generated by not for degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1521">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, although again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant will be generated by no by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1522">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant are no generated by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1523">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant would be no generated by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1524">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant are not generated by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1525">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant have not has been generated by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1526">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, although again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface is generated by not for degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1527">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, although again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface will be generated by no by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1528">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, but again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface are no generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1529">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, but again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface has no was generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1530">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, but again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface would be no generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1531">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, though again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface are not generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1532">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, though again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface have not has been generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1533">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 in H3, though again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface would be not generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1534">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, although again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface is generated by not for degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1535">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, although again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface will be generated by no by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1536">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, but again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface has no was generated by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1537">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, but again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface would be no generated by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1538">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, though again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface are not generated by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1539">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, though again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface have not has been generated by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1540">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, though again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface would be not generated by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1541">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Mino-EE mutant acids (437 and 438) in AA, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1542">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Mino-EE mutant acids (437 and 438) in AA, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1543">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Minoan mutants EE (437 and 438) in AA, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1544">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, but again the relatively small fraction involved and the possibility that superoxide are no generated by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1545">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, but again the relatively small fraction involved and the possibility that superoxide has no was generated by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1546">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, but again the relatively small fraction involved and the possibility that superoxide would be no generated by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1547">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, though again the relatively small fraction involved and the possibility that superoxide are not generated by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1548">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, though again the relatively small fraction involved and the possibility that superoxide have not has been generated by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1549">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by not for degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1550">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1551">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex are no generated by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1552">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1553">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1554">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex are not generated by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1555">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1556">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NO reacts anaerobicly with the purified NRF Fe-S cluster, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosyl-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1557">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by not for degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1558">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1559">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex are no generated by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1560">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1561">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1562">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by not for degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1563">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1564">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex are no generated by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1565">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1566">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1567">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex are not generated by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1568">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1569">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of None reacts anaerobically with the purified Fe-S group of NRF, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1570">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, although again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb is generated by not for degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1571">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, although again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb will be generated by no by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1572">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb has no was generated by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1573">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb would be no generated by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1574">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb are not generated by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1575">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb have not has been generated by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1576">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb would be not generated by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1577">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, although again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb is generated by not for degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1578">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, although again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb will be generated by no by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1579">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, although again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb is generated by not for degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1580">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, but again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb are no generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1581">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, but again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb has no was generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1582">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, but again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb would be no generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1583">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb are no generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1584">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb has no was generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1585">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb would be no generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1586">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, though again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb are not generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1587">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, though again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb have not has been generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1588">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, though again the relatively small fraction involved and the possibility that large transcriptions of 1.7 and 2.7 kb would be not generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1589">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb are not generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1590">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb would be not generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1591">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), although again the relatively small fraction involved and the possibility that hypersensitive to DNase I is generated by not for degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1592">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), although again the relatively small fraction involved and the possibility that hypersensitive to DNase I will be generated by no by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1593">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), but again the relatively small fraction involved and the possibility that hypersensitive to DNase I are no generated by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1594">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), but again the relatively small fraction involved and the possibility that hypersensitive to DNase I has no was generated by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1595">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), but again the relatively small fraction involved and the possibility that hypersensitive to DNase I would be no generated by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1596">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), though again the relatively small fraction involved and the possibility that hypersensitive to DNase I are not generated by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1597">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), though again the relatively small fraction involved and the possibility that hypersensitive to DNase I have not has been generated by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1598">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), though again the relatively small fraction involved and the possibility that hypersensitive to DNase I would be not generated by degradation.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1599">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that overlapping sequential fragments is generated by not for degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1600">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that overlapping sequential fragments will be generated by no by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1601">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that sequential fragment overlapping is generated by not for degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1602">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that sequential fragment overlapping will be generated by no by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1603">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that sequential overlapping fragments will be generated by no by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1604">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that sequential superposition fragments is generated by not for degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1605">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that sequential superposition fragments will be generated by no by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1606">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that overlapping sequential fragments are no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1607">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that overlapping sequential fragments has no was generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1608">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that overlapping sequential fragments would be no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1609">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential fragment overlapping would be no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1610">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential overlapping fragments are no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1611">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential overlapping fragments has no was generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1612">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential overlapping fragments would be no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1613">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential superposition fragments has no was generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1614">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential superposition fragments would be no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1615">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that overlapping sequential fragments are not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1616">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that overlapping sequential fragments have not has been generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1617">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that overlapping sequential fragments would be not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1618">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential fragment overlapping have not has been generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1619">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential overlapping fragments have not has been generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1620">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential overlapping fragments would be not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1621">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential superposition fragments are not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1622">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential superposition fragments would be not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1623">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt is generated by not for degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1624">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt will be generated by no by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1625">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt is generated by not for degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1626">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs is generated by not for degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1627">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs will be generated by no by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1628">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt are no generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1629">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt has no was generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1630">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt would be no generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1631">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt are no generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1632">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt has no was generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1633">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt would be no generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1634">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs has no was generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1635">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs would be no generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1636">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt are not generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1637">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt have not has been generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1638">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt would be not generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1639">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt are not generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1640">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt have not has been generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1641">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt would be not generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1642">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs are not generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1643">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs have not has been generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1644">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs would be not generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1645">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, but again the relatively small fraction involved and the possibility that mature hela cell mRNA are no generated by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1646">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, but again the relatively small fraction involved and the possibility that mature hela cell mRNA has no was generated by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1647">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, but again the relatively small fraction involved and the possibility that mature hela cell mRNA would be no generated by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1648">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, though again the relatively small fraction involved and the possibility that mature hela cell mRNA are not generated by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1649">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, though again the relatively small fraction involved and the possibility that mature hela cell mRNA have not has been generated by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1650">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, though again the relatively small fraction involved and the possibility that mature hela cell mRNA would be not generated by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1651">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that mature heLa cell mRNA is generated by not for degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1652">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that mature heLa cell mRNA will be generated by no by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1653">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that mature heLa cell mRNA has no was generated by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1654">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that mature heLa cell mRNA would be no generated by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1655">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that mature heLa cell mRNA are not generated by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1656">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that mature heLa cell mRNA have not has been generated by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1657">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that mature heLa cell mRNA would be not generated by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1658">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, although again the relatively small fraction involved and the possibility that HeLa mature cell mRNA is generated by not for degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1659">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, although again the relatively small fraction involved and the possibility that HeLa mature cell mRNA will be generated by no by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1660">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, but again the relatively small fraction involved and the possibility that HeLa mature cell mRNA are no generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1661">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, but again the relatively small fraction involved and the possibility that HeLa mature cell mRNA has no was generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1662">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, but again the relatively small fraction involved and the possibility that HeLa mature cell mRNA would be no generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1663">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, though again the relatively small fraction involved and the possibility that HeLa mature cell mRNA are not generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1664">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, though again the relatively small fraction involved and the possibility that HeLa mature cell mRNA have not has been generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1665">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-interpreted region, though again the relatively small fraction involved and the possibility that HeLa mature cell mRNA would be not generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1666">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that HeLa mature cell mRNA is generated by not for degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1667">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that HeLa mature cell mRNA will be generated by no by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1668">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that HeLa mature cell mRNA are no generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1669">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that HeLa mature cell mRNA has no was generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1670">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that HeLa mature cell mRNA would be no generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1671">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that HeLa mature cell mRNA are not generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1672">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that HeLa mature cell mRNA have not has been generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1673">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA fragment that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that HeLa mature cell mRNA would be not generated by degradation.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1674">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that matur HeLa cell mRNA is generated by not for degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1675">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that matur HeLa cell mRNA has no was generated by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1676">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that matur HeLa cell mRNA have not has been generated by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1677">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that matur HeLa cell mRNA would be not generated by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1678">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that mRNA of heLa cells is generated by not for degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1679">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that mRNA of heLa cells will be generated by no by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1680">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that mRNA of heLa cells are no generated by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1681">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that mRNA of heLa cells has no was generated by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1682">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that mRNA of heLa cells would be no generated by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1683">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that mRNA of heLa cells are not generated by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1684">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that mRNA of heLa cells have not has been generated by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1685">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a RNA fragment based on 3863 that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that mRNA of heLa cells would be not generated by degradation.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1686">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, although again the relatively small fraction involved and the possibility that a hypersensitive DNase I is generated by not for degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1687">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, although again the relatively small fraction involved and the possibility that a hypersensitive DNase I will be generated by no by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1688">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, although again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex is generated by not for degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1689">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, although again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex will be generated by no by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1690">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, but again the relatively small fraction involved and the possibility that a hypersensitive DNase I are no generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1691">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, but again the relatively small fraction involved and the possibility that a hypersensitive DNase I would be no generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1692">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, but again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex are no generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1693">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, but again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex has no was generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1694">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, but again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex would be no generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1695">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, though again the relatively small fraction involved and the possibility that a hypersensitive DNase I are not generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1696">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, though again the relatively small fraction involved and the possibility that a hypersensitive DNase I have not has been generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1697">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, though again the relatively small fraction involved and the possibility that a hypersensitive DNase I would be not generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1698">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, though again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex are not generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1699">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, though again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex have not has been generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="1700">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="1701">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), although again the relatively small fraction involved and the possibility that a hypersensitive to DNase I is generated by not for degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1702">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), although again the relatively small fraction involved and the possibility that a hypersensitive to DNase I will be generated by no by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1703">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I are no generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1704">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I has no was generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1705">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I are not generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1706">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I have not has been generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1707">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I would be not generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1708">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1), although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="1709">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1), though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="1710">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), although again the relatively small fraction involved and the possibility that a hypersensitive to DNase I is generated by not for degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1711">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), although again the relatively small fraction involved and the possibility that a hypersensitive to DNase I will be generated by no by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1712">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I are no generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1713">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I would be no generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1714">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I are not generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1715">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I would be not generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1716">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), although again the relatively small fraction involved and the possibility that a hypersensitive to DNase I is generated by not for degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1717">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), although again the relatively small fraction involved and the possibility that a hypersensitive to DNase I will be generated by no by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1718">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I are no generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1719">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I has no was generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1720">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I would be no generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1721">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I are not generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1722">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I have not has been generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1723">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), though again the relatively small fraction involved and the possibility that a hypersensitive to DNase I would be not generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1724">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, although again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells is generated by not for degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1725">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, although again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells will be generated by no by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1726">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, but again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells are no generated by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1727">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, but again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells would be no generated by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1728">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, though again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells are not generated by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1729">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, though again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells have not has been generated by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1730">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, though again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells would be not generated by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1731">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, although again the relatively small fraction involved and the possibility that HLA is generated by not for degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1732">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, although again the relatively small fraction involved and the possibility that HLA will be generated by no by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1733">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, but again the relatively small fraction involved and the possibility that HLA are no generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1734">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, though again the relatively small fraction involved and the possibility that HLA are not generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1735">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, though again the relatively small fraction involved and the possibility that HLA have not has been generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1736">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, though again the relatively small fraction involved and the possibility that HLA would be not generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1737">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, although again the relatively small fraction involved and the possibility that HLA is generated by not for degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1738">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, although again the relatively small fraction involved and the possibility that HLA will be generated by no by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1739">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, but again the relatively small fraction involved and the possibility that HLA are no generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1740">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, but again the relatively small fraction involved and the possibility that HLA has no was generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1741">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, but again the relatively small fraction involved and the possibility that HLA would be no generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1742">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, though again the relatively small fraction involved and the possibility that HLA are not generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1743">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, though again the relatively small fraction involved and the possibility that HLA would be not generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1744">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, although again the relatively small fraction involved and the possibility that HLA will be generated by no by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1745">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, but again the relatively small fraction involved and the possibility that HLA are no generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1746">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, but again the relatively small fraction involved and the possibility that HLA has no was generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1747">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, but again the relatively small fraction involved and the possibility that HLA would be no generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1748">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, though again the relatively small fraction involved and the possibility that HLA are not generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1749">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, though again the relatively small fraction involved and the possibility that HLA have not has been generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1750">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, though again the relatively small fraction involved and the possibility that HLA would be not generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1751">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, although again the relatively small fraction involved and the possibility that HLA is generated by not for degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1752">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, although again the relatively small fraction involved and the possibility that HLA will be generated by no by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1753">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, but again the relatively small fraction involved and the possibility that HLA are no generated by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1754">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, but again the relatively small fraction involved and the possibility that HLA has no was generated by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1755">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, but again the relatively small fraction involved and the possibility that HLA would be no generated by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1756">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, though again the relatively small fraction involved and the possibility that HLA are not generated by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1757">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, though again the relatively small fraction involved and the possibility that HLA have not has been generated by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1758">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of the primary transcription of the gene, though again the relatively small fraction involved and the possibility that HLA would be not generated by degradation.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="1759">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs will be generated by no by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1760">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs are no generated by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1761">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs would be no generated by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1762">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs are not generated by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1763">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, although again the relatively small fraction involved and the possibility that mature RNA 21-23 nt will be generated by no by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1764">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, but again the relatively small fraction involved and the possibility that mature RNA 21-23 nt are no generated by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1765">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, but again the relatively small fraction involved and the possibility that mature RNA 21-23 nt has no was generated by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1766">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, though again the relatively small fraction involved and the possibility that mature RNA 21-23 nt are not generated by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1767">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, though again the relatively small fraction involved and the possibility that mature RNA 21-23 nt have not has been generated by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1768">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, though again the relatively small fraction involved and the possibility that mature RNA 21-23 nt would be not generated by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1769">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by not for degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1770">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1771">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex are no generated by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1772">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1773">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1774">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex are not generated by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1775">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1776">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of does not react anaerobically with the purified Fe-S group of NRF, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1777">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, although again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 is generated by not for degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1778">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, although again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 will be generated by no by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1779">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, but again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 are no generated by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1780">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, but again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 has no was generated by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1781">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, but again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 would be no generated by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1782">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, though again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 are not generated by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1783">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, though again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 have not has been generated by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1784">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of ens, though again the relatively small fraction involved and the possibility that a monoclonal antibody vs. FHL2 would be not generated by degradation.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1785">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, although again the relatively small fraction involved and the possibility that fumat is generated by not for degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1786">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, but again the relatively small fraction involved and the possibility that fumat are no generated by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1787">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, but again the relatively small fraction involved and the possibility that fumat would be no generated by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1788">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, though again the relatively small fraction involved and the possibility that fumat are not generated by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1789">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, though again the relatively small fraction involved and the possibility that fumat have not has been generated by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1790">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, though again the relatively small fraction involved and the possibility that fumat would be not generated by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1791">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, although again the relatively small fraction involved and the possibility that fumat will be generated by no by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1792">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, but again the relatively small fraction involved and the possibility that fumat are no generated by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1793">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, but again the relatively small fraction involved and the possibility that fumat has no was generated by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1794">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, but again the relatively small fraction involved and the possibility that fumat would be no generated by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1795">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, though again the relatively small fraction involved and the possibility that fumat are not generated by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1796">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, though again the relatively small fraction involved and the possibility that fumat have not has been generated by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1797">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, though again the relatively small fraction involved and the possibility that fumat would be not generated by degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1798">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by not for degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1799">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1800">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are no generated by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1801">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1802">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1803">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are not generated by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1804">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1805">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of in anaerobically reacted with the purified NR Fe-S cluster, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1806">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chemical transcriptions is generated by not for degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1807">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chemical transcriptions will be generated by no by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1808">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions is generated by not for degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1809">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions is generated by not for degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1810">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions will be generated by no by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1811">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemical transcriptions are no generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1812">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemical transcriptions has no was generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1813">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions are no generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1814">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions has no was generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1815">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions would be no generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1816">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions are no generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1817">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions would be no generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1818">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemical transcriptions have not has been generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1819">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemical transcriptions would be not generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1820">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions are not generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1821">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions have not has been generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1822">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions would be not generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1823">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions are not generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1824">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions have not has been generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1825">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, although again the relatively small fraction involved and the possibility that some unusual chemical transcriptions is generated by not for degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1826">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, although again the relatively small fraction involved and the possibility that some unusual chemical transcriptions will be generated by no by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1827">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemical transcriptions are no generated by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1828">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemical transcriptions has no was generated by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1829">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemical transcriptions are not generated by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1830">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemical transcriptions have not has been generated by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1831">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemical transcriptions would be not generated by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1832">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, although again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant is generated by not for degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1833">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, although again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant will be generated by no by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1834">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant are no generated by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1835">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant has no was generated by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1836">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant would be no generated by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1837">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant are not generated by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1838">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant have not has been generated by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1839">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino EE mutant acids (437 and 438) for AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant would be not generated by degradation.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1840">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino acid mutants EE (437 and 438) in AA, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1841">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino acid mutants EE (437 and 438) in AA, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1842">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, although again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by not for degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1843">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, but again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a are no generated by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1844">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, but again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a has no was generated by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1845">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, but again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a would be no generated by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1846">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a are not generated by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1847">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a have not has been generated by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1848">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a would be not generated by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1849">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, although again the relatively small fraction involved and the possibility that Stat5aEE-AA is generated by not for degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1850">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, although again the relatively small fraction involved and the possibility that Stat5aEE-AA will be generated by no by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1851">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA are no generated by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1852">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA has no was generated by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1853">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA are not generated by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1854">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA would be not generated by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1855">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="1856">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, although again the relatively small fraction involved and the possibility that superoxide will be generated by no by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1857">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, although again the relatively small fraction involved and the possibility that suspected will be generated by no by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1858">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, but again the relatively small fraction involved and the possibility that superoxide are no generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1859">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, but again the relatively small fraction involved and the possibility that superoxide has no was generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1860">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, but again the relatively small fraction involved and the possibility that superoxide would be no generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1861">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, but again the relatively small fraction involved and the possibility that suspected are no generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1862">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, but again the relatively small fraction involved and the possibility that suspected has no was generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1863">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, but again the relatively small fraction involved and the possibility that suspected would be no generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1864">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, though again the relatively small fraction involved and the possibility that superoxide are not generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1865">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, though again the relatively small fraction involved and the possibility that superoxide have not has been generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1866">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, though again the relatively small fraction involved and the possibility that superoxide would be not generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1867">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, though again the relatively small fraction involved and the possibility that suspected are not generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1868">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, though again the relatively small fraction involved and the possibility that suspected have not has been generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1869">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, though again the relatively small fraction involved and the possibility that suspected would be not generated by degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1870">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1871">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are no generated by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1872">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1873">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1874">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are not generated by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1875">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1876">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, although again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 is generated by not for degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1877">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, although again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 will be generated by no by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1878">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, although again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 will be generated by no by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1879">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, but again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 are no generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1880">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, but again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 has no was generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1881">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, but again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 would be no generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1882">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, but again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 are no generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1883">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, but again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 has no was generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1884">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, but again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 would be no generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1885">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, though again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 are not generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1886">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, though again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 have not has been generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1887">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, though again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 would be not generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1888">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, though again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 have not has been generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1889">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by not for degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1890">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex will be generated by no by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1891">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1892">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex would be no generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1893">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex are not generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1894">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1895">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by not for degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1896">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, although again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex will be generated by no by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1897">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex are no generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1898">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex would be no generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1899">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex would be not generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1900">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, although again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb is generated by not for degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1901">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, although again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb will be generated by no by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1902">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb are no generated by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1903">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb has no was generated by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1904">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb would be no generated by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1905">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb have not has been generated by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1906">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb would be not generated by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1907">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), although again the relatively small fraction involved and the possibility that Abeta peptides is generated by not for degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1908">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), although again the relatively small fraction involved and the possibility that Abeta peptides will be generated by no by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1909">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), but again the relatively small fraction involved and the possibility that Abeta peptides are no generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1910">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), but again the relatively small fraction involved and the possibility that Abeta peptides has no was generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1911">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), but again the relatively small fraction involved and the possibility that Abeta peptides would be no generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1912">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), though again the relatively small fraction involved and the possibility that Abeta peptides have not has been generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1913">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), though again the relatively small fraction involved and the possibility that Abeta peptides would be not generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1914">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, although again the relatively small fraction involved and the possibility that Abeta peptides is generated by not for degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1915">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, although again the relatively small fraction involved and the possibility that Abeta peptides will be generated by no by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1916">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, but again the relatively small fraction involved and the possibility that Abeta peptides are no generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1917">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, but again the relatively small fraction involved and the possibility that Abeta peptides has no was generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1918">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, but again the relatively small fraction involved and the possibility that Abeta peptides would be no generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1919">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, though again the relatively small fraction involved and the possibility that Abeta peptides are not generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1920">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, though again the relatively small fraction involved and the possibility that Abeta peptides would be not generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1921">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, although again the relatively small fraction involved and the possibility that smoke is generated by not for degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1922">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, although again the relatively small fraction involved and the possibility that smoke will be generated by no by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1923">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, but again the relatively small fraction involved and the possibility that smoke are no generated by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1924">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, but again the relatively small fraction involved and the possibility that smoke would be no generated by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1925">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, though again the relatively small fraction involved and the possibility that smoke are not generated by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1926">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, though again the relatively small fraction involved and the possibility that smoke have not has been generated by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1927">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, though again the relatively small fraction involved and the possibility that smoke would be not generated by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1928">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, although again the relatively small fraction involved and the possibility that moker is generated by not for degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1929">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, although again the relatively small fraction involved and the possibility that motor is generated by not for degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1930">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, although again the relatively small fraction involved and the possibility that motor will be generated by no by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1931">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, although again the relatively small fraction involved and the possibility that smoker is generated by not for degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1932">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, although again the relatively small fraction involved and the possibility that smoker will be generated by no by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1933">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that moker are no generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1934">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that moker has no was generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1935">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that moker would be no generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1936">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that motor are no generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1937">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that motor has no was generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1938">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that motor would be no generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1939">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that smoker are no generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1940">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that smoker has no was generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1941">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, but again the relatively small fraction involved and the possibility that smoker would be no generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1942">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that moker have not has been generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1943">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that moker would be not generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1944">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that motor are not generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1945">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that motor have not has been generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1946">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that motor would be not generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1947">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that smoker are not generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1948">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that smoker have not has been generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1949">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, though again the relatively small fraction involved and the possibility that smoker would be not generated by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1950">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, although again the relatively small fraction involved and the possibility that a functional interaction surface is generated by not for degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1951">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, although again the relatively small fraction involved and the possibility that a functional interaction surface will be generated by no by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1952">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, but again the relatively small fraction involved and the possibility that a functional interaction surface are no generated by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1953">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, but again the relatively small fraction involved and the possibility that a functional interaction surface has no was generated by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1954">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, but again the relatively small fraction involved and the possibility that a functional interaction surface would be no generated by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1955">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, though again the relatively small fraction involved and the possibility that a functional interaction surface are not generated by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1956">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, though again the relatively small fraction involved and the possibility that a functional interaction surface have not has been generated by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1957">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal AR, though again the relatively small fraction involved and the possibility that a functional interaction surface would be not generated by degradation.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1958">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, although again the relatively small fraction involved and the possibility that a functional interaction surface is generated by not for degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1959">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, but again the relatively small fraction involved and the possibility that a functional interaction surface are no generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1960">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, but again the relatively small fraction involved and the possibility that a functional interaction surface would be no generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1961">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that a functional interaction surface have not has been generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1962">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that a functional interaction surface would be not generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1963">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, although again the relatively small fraction involved and the possibility that overlapping sequential fragments is generated by not for degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1964">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, although again the relatively small fraction involved and the possibility that overlapping sequential fragments will be generated by no by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1965">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, although again the relatively small fraction involved and the possibility that superposed sequential defects is generated by not for degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1966">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, although again the relatively small fraction involved and the possibility that superposed sequential defects will be generated by no by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1967">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, but again the relatively small fraction involved and the possibility that overlapping sequential fragments are no generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1968">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, but again the relatively small fraction involved and the possibility that overlapping sequential fragments has no was generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1969">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, but again the relatively small fraction involved and the possibility that overlapping sequential fragments would be no generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1970">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, but again the relatively small fraction involved and the possibility that superposed sequential defects are no generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1971">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, but again the relatively small fraction involved and the possibility that superposed sequential defects has no was generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1972">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, but again the relatively small fraction involved and the possibility that superposed sequential defects would be no generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1973">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, though again the relatively small fraction involved and the possibility that overlapping sequential fragments are not generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1974">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, though again the relatively small fraction involved and the possibility that overlapping sequential fragments would be not generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1975">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, though again the relatively small fraction involved and the possibility that superposed sequential defects are not generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1976">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, though again the relatively small fraction involved and the possibility that superposed sequential defects have not has been generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1977">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, though again the relatively small fraction involved and the possibility that superposed sequential defects would be not generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1978">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, but again the relatively small fraction involved and the possibility that mature RNA 21-23 nt has no was generated by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1979">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, but again the relatively small fraction involved and the possibility that mature RNA 21-23 nt would be no generated by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1980">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, though again the relatively small fraction involved and the possibility that mature RNA 21-23 nt are not generated by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1981">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, though again the relatively small fraction involved and the possibility that mature RNA 21-23 nt would be not generated by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1982">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, although again the relatively small fraction involved and the possibility that a functional interaction surface is generated by not for degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1983">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, although again the relatively small fraction involved and the possibility that a functional interaction surface will be generated by no by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1984">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, although again the relatively small fraction involved and the possibility that a surface of functional interaction is generated by not for degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1985">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, although again the relatively small fraction involved and the possibility that a surface of functional interaction will be generated by no by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1986">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, but again the relatively small fraction involved and the possibility that a functional interaction surface are no generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1987">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, but again the relatively small fraction involved and the possibility that a functional interaction surface has no was generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1988">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, but again the relatively small fraction involved and the possibility that a functional interaction surface would be no generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1989">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction are no generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1990">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction has no was generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1991">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction would be no generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1992">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that a functional interaction surface are not generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1993">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that a functional interaction surface have not has been generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1994">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction have not has been generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1995">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a high-order DNA-protein complex is generated by not for degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1996">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a high-order DNA-protein complex will be generated by no by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1997">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher DNA complex is generated by not for degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1998">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher DNA complex will be generated by no by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1999">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher DNA-protein complex is generated by not for degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2000">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher DNA-protein complex will be generated by no by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2001">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher order DNA-protein complex will be generated by no by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2002">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that high-order DNA protein complex is generated by not for degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2003">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that high-order DNA protein complex will be generated by no by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2004">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that high-order DNA-protein complex is generated by not for degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2005">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that high-order DNA-protein complex will be generated by no by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2006">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a high-order DNA-protein complex are no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2007">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a high-order DNA-protein complex has no was generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2008">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a high-order DNA-protein complex would be no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2009">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher DNA complex has no was generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2010">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher DNA complex would be no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2011">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher DNA-protein complex are no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2012">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher DNA-protein complex has no was generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2013">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher DNA-protein complex would be no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2014">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher order DNA-protein complex are no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2015">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher order DNA-protein complex has no was generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2016">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher order DNA-protein complex would be no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2017">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that high-order DNA protein complex are no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2018">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that high-order DNA protein complex has no was generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2019">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that high-order DNA protein complex would be no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2020">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that high-order DNA-protein complex are no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2021">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that high-order DNA-protein complex has no was generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2022">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that high-order DNA-protein complex would be no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2023">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a high-order DNA-protein complex are not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2024">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a high-order DNA-protein complex have not has been generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2025">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a high-order DNA-protein complex would be not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2026">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher DNA complex are not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2027">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher DNA complex have not has been generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2028">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher DNA complex would be not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2029">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher DNA-protein complex are not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2030">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher DNA-protein complex would be not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2031">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher order DNA-protein complex are not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2032">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher order DNA-protein complex have not has been generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2033">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher order DNA-protein complex would be not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2034">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that high-order DNA protein complex are not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2035">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that high-order DNA protein complex have not has been generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2036">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that high-order DNA-protein complex are not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2037">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that high-order DNA-protein complex have not has been generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2038">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that high-order DNA-protein complex would be not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2039">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, although again the relatively small fraction involved and the possibility that a higher-order protein DNA complex is generated by not for degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2040">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, although again the relatively small fraction involved and the possibility that a higher-order protein DNA complex will be generated by no by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2041">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, but again the relatively small fraction involved and the possibility that a higher-order protein DNA complex are no generated by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2042">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, but again the relatively small fraction involved and the possibility that a higher-order protein DNA complex has no was generated by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2043">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, but again the relatively small fraction involved and the possibility that a higher-order protein DNA complex would be no generated by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2044">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, though again the relatively small fraction involved and the possibility that a higher-order protein DNA complex are not generated by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2045">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, though again the relatively small fraction involved and the possibility that a higher-order protein DNA complex have not has been generated by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2046">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this junction, though again the relatively small fraction involved and the possibility that a higher-order protein DNA complex would be not generated by degradation.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2047">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, although again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex is generated by not for degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2048">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, although again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex will be generated by no by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2049">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, although again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex is generated by not for degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2050">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, although again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex will be generated by no by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2051">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, although again the relatively small fraction involved and the possibility that high-order protein-DNA complex is generated by not for degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2052">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, although again the relatively small fraction involved and the possibility that high-order protein-DNA complex will be generated by no by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2053">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex are no generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2054">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex has no was generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2055">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex would be no generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2056">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex are no generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2057">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex has no was generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2058">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex would be no generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2059">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that high-order protein-DNA complex are no generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2060">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that high-order protein-DNA complex has no was generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2061">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, but again the relatively small fraction involved and the possibility that high-order protein-DNA complex would be no generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2062">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex have not has been generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2063">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex are not generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2064">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex have not has been generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2065">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that high-order protein-DNA complex have not has been generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2066">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that high-order protein-DNA complex would be not generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2067">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, although again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 is generated by not for degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2068">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, although again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 is generated by not for degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2069">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, but again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 are no generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2070">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, but again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 has no was generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2071">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, but again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 are no generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2072">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, but again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 has no was generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2073">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, but again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 would be no generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2074">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, though again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 are not generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2075">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, though again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 would be not generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2076">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, though again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 are not generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2077">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, though again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 have not has been generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2078">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, though again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 would be not generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2079">
                    <text>In addition, this binding generates a high-order DNA-protein complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2080">
                    <text>In addition, this binding generates a higher DNA complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2081">
                    <text>In addition, this binding generates a higher DNA-protein complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2082">
                    <text>In addition, this binding generates a higher order DNA-protein complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2083">
                    <text>In addition, this binding generates high-order DNA-protein complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2084">
                    <text>In addition, this binding, whose elimination removes the FHL2 link, generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2085">
                    <text>In addition, this binding, whose elimination removes the FHL2 link, generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2086">
                    <text>In addition, this junction generates a higher-order protein DNA complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2087">
                    <text>In addition, this junction, whose elimination removes the FHL2 link, generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2088">
                    <text>In addition, this union generates a higher-order protein&#x13;DNA complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2089">
                    <text>In addition, this union generates a higher-order protein-DNA complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2090">
                    <text>In addition, this union generates high-order protein-DNA complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2091">
                    <text>In addition, this union, whose elimination removes the FHL2 link, generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2092">
                    <text>In addition, this union, whose elimination removes the FHL2 link, generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2093">
                    <text>In addition, this union, whose elimination removes the FHL2 link, generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2094">
                    <text>In addition, us generates monoclonal antibody against FHL2, as its elimination removes the FHL2 link.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2095">
                    <text>In addition, us generates monoclonal antibody vs. FHL2, as its elimination removes the FHL2 link.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2096">
                    <text>In addition, us, whose elimination removes the FHL2 link, generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2097">
                    <text>In the absence of L-arginine, 21-23 nt of long mature RNAs (O(2)-) is generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2098">
                    <text>In the absence of L-arginine, 21-23 nt of long mature RNAs (O(2)-) was generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2099">
                    <text>In the absence of L-arginine, 21-23 nt of long mature RNAs (O(2)-) will be generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2100">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) has been generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2101">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) has been generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2102">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) is generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2103">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) was generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2104">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) was generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2105">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) will be generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2106">
                    <text>In the absence of L-arginine, Bydented RNase III dyce generated long RNAs of 21-23 nt (O(2)-).</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2107">
                    <text>In the absence of L-arginine, EE amino acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant (O(2)-).</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2108">
                    <text>In the absence of L-arginine, EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant (O(2)-).</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2109">
                    <text>In the absence of L-arginine, HLA (O(2)-) has been generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2110">
                    <text>In the absence of L-arginine, HLA (O(2)-) has been generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2111">
                    <text>In the absence of L-arginine, HLA (O(2)-) has been generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2112">
                    <text>In the absence of L-arginine, HLA (O(2)-) is generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2113">
                    <text>In the absence of L-arginine, HLA (O(2)-) is generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2114">
                    <text>In the absence of L-arginine, HLA (O(2)-) is generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2115">
                    <text>In the absence of L-arginine, HLA (O(2)-) was generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2116">
                    <text>In the absence of L-arginine, HLA (O(2)-) was generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2117">
                    <text>In the absence of L-arginine, HLA (O(2)-) will be generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2118">
                    <text>In the absence of L-arginine, HLA (O(2)-) will be generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2119">
                    <text>In the absence of L-arginine, HLA (O(2)-) will be generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2120">
                    <text>In the absence of L-arginine, HLA (O(2)-) will be generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2121">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) has been generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2122">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2123">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2124">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2125">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2126">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) will be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2127">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) will be generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2128">
                    <text>In the absence of L-arginine, L723 in H3 generated the correct three-dimensional interaction surface (O(2)-).</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2129">
                    <text>In the absence of L-arginine, L723 in H3 generates the correct three-dimensional interaction surface (O(2)-).</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2130">
                    <text>In the absence of L-arginine, L723 to H3 generated the correct three-dimensional interaction surface (O(2)-).</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2131">
                    <text>In the absence of L-arginine, NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex (O(2)-).</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2132">
                    <text>In the absence of L-arginine, NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex (O(2)-).</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2133">
                    <text>In the absence of L-arginine, NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (O(2)-).</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2134">
                    <text>In the absence of L-arginine, NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (O(2)-).</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2135">
                    <text>In the absence of L-arginine, None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-).</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2136">
                    <text>In the absence of L-arginine, None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-).</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2137">
                    <text>In the absence of L-arginine, PRnd generated main transcripts of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2138">
                    <text>In the absence of L-arginine, Prnd generated large transcriptions of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2139">
                    <text>In the absence of L-arginine, Prnd generated main transcripts of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2140">
                    <text>In the absence of L-arginine, Prnd generates large transcriptions of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2141">
                    <text>In the absence of L-arginine, Prnd generates main transcripts of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2142">
                    <text>In the absence of L-arginine, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2143">
                    <text>In the absence of L-arginine, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2144">
                    <text>In the absence of L-arginine, Stat5aEE-AA (O(2)-) has been generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2145">
                    <text>In the absence of L-arginine, Stat5aEE-AA (O(2)-) is generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2146">
                    <text>In the absence of L-arginine, Stat5aEE-AA (O(2)-) was generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2147">
                    <text>In the absence of L-arginine, Stat5aEE-AA (O(2)-) will be generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2148">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) has been generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2149">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) is generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2150">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) is generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2151">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) was generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2152">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) was generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2153">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) will be generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2154">
                    <text>In the absence of L-arginine, TBC method generated overlapping sequential fragments (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2155">
                    <text>In the absence of L-arginine, TBC method generated sequential fragment overlapping (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2156">
                    <text>In the absence of L-arginine, TBC method generates overlapping sequential fragments (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2157">
                    <text>In the absence of L-arginine, TBC method generates sequential fragment overlapping (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2158">
                    <text>In the absence of L-arginine, TBC method generates sequential overlapping fragments (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2159">
                    <text>In the absence of L-arginine, TBC method generates sequential superposition fragments (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2160">
                    <text>In the absence of L-arginine, The biceps RNase III Dicer generated long RNAs of 21-23 nt (O(2)-).</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2161">
                    <text>In the absence of L-arginine, The biceps RNase III Dicer generated long mature RNAs of 21-23 nt (O(2)-).</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2162">
                    <text>In the absence of L-arginine, The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs (O(2)-).</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2163">
                    <text>In the absence of L-arginine, The biceps RNase III Dicer generates long mature RNAs of 21-23 nt (O(2)-).</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2164">
                    <text>In the absence of L-arginine, a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2165">
                    <text>In the absence of L-arginine, a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2166">
                    <text>In the absence of L-arginine, a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2167">
                    <text>In the absence of L-arginine, a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2168">
                    <text>In the absence of L-arginine, a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2169">
                    <text>In the absence of L-arginine, a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells (O(2)-).</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2170">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2171">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2172">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2173">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2174">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2175">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2176">
                    <text>In the absence of L-arginine, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2177">
                    <text>In the absence of L-arginine, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2178">
                    <text>In the absence of L-arginine, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I (O(2)-).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2179">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) has been generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2180">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2181">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2182">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) is generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2183">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2184">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2185">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) was generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2186">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2187">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2188">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) will be generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2189">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2190">
                    <text>In the absence of L-arginine, a high-order DNA-protein complex (O(2)-) has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2191">
                    <text>In the absence of L-arginine, a high-order DNA-protein complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2192">
                    <text>In the absence of L-arginine, a high-order DNA-protein complex (O(2)-) was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2193">
                    <text>In the absence of L-arginine, a high-order DNA-protein complex (O(2)-) will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2194">
                    <text>In the absence of L-arginine, a higher DNA complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2195">
                    <text>In the absence of L-arginine, a higher DNA complex (O(2)-) was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2196">
                    <text>In the absence of L-arginine, a higher DNA complex (O(2)-) will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2197">
                    <text>In the absence of L-arginine, a higher DNA-protein complex (O(2)-) has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2198">
                    <text>In the absence of L-arginine, a higher DNA-protein complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2199">
                    <text>In the absence of L-arginine, a higher DNA-protein complex (O(2)-) was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2200">
                    <text>In the absence of L-arginine, a higher DNA-protein complex (O(2)-) will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2201">
                    <text>In the absence of L-arginine, a higher order DNA-protein complex (O(2)-) has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2202">
                    <text>In the absence of L-arginine, a higher order DNA-protein complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2203">
                    <text>In the absence of L-arginine, a higher order DNA-protein complex (O(2)-) was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2204">
                    <text>In the absence of L-arginine, a higher-order protein&#x13;DNA complex (O(2)-) has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2205">
                    <text>In the absence of L-arginine, a higher-order protein&#x13;DNA complex (O(2)-) is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2206">
                    <text>In the absence of L-arginine, a higher-order protein&#x13;DNA complex (O(2)-) was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2207">
                    <text>In the absence of L-arginine, a higher-order protein&#x13;DNA complex (O(2)-) will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2208">
                    <text>In the absence of L-arginine, a higher-order protein DNA complex (O(2)-) has been generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2209">
                    <text>In the absence of L-arginine, a higher-order protein DNA complex (O(2)-) is generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2210">
                    <text>In the absence of L-arginine, a higher-order protein DNA complex (O(2)-) was generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2211">
                    <text>In the absence of L-arginine, a higher-order protein-DNA complex (O(2)-) has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2212">
                    <text>In the absence of L-arginine, a hypersensitive DNase I (O(2)-) has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2213">
                    <text>In the absence of L-arginine, a hypersensitive DNase I (O(2)-) is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2214">
                    <text>In the absence of L-arginine, a hypersensitive chromatin I remodeling complex (O(2)-) has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2215">
                    <text>In the absence of L-arginine, a hypersensitive chromatin I remodeling complex (O(2)-) is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2216">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) has been generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2217">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) has been generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2218">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2219">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2220">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2221">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2222">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2223">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) will be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2224">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) will be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2225">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) will be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2226">
                    <text>In the absence of L-arginine, a monoclonal antibody vs. FHL2 (O(2)-) has been generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2227">
                    <text>In the absence of L-arginine, a monoclonal antibody vs. FHL2 (O(2)-) is generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2228">
                    <text>In the absence of L-arginine, a monoclonal antibody vs. FHL2 (O(2)-) was generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2229">
                    <text>In the absence of L-arginine, a monoclonal antibody vs. FHL2 (O(2)-) will be generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2230">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) has been generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2231">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2232">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2233">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2234">
                    <text>In the absence of L-arginine, an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells (O(2)-).</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2235">
                    <text>In the absence of L-arginine, an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells (O(2)-).</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2236">
                    <text>In the absence of L-arginine, an alternative coupling of primary gene transcription generated HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2237">
                    <text>In the absence of L-arginine, an alternative coupling of primary gene transcription generates HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2238">
                    <text>In the absence of L-arginine, an alternative coupling of the primary transcription of the gene generated HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2239">
                    <text>In the absence of L-arginine, an alternative coupling of the primary transcription of the gene generates HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2240">
                    <text>In the absence of L-arginine, biceps RNase III Dicer generated 21-23 nt of long mature RNAs (O(2)-).</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2241">
                    <text>In the absence of L-arginine, biceps RNase III Dicer generates 21-23 nt of long mature RNAs (O(2)-).</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2242">
                    <text>In the absence of L-arginine, bidentate RNase III generated mature RNA 21-23 nt (O(2)-).</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2243">
                    <text>In the absence of L-arginine, bidentate RNase III generates mature RNA 21-23 nt (O(2)-).</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2244">
                    <text>In the absence of L-arginine, degradation generates specific fragments (O(2)-).</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="2245">
                    <text>In the absence of L-arginine, does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-).</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2246">
                    <text>In the absence of L-arginine, does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-).</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2247">
                    <text>In the absence of L-arginine, ens generated a monoclonal antibody vs. FHL2 (O(2)-).</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2248">
                    <text>In the absence of L-arginine, fumat (O(2)-) has been generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2249">
                    <text>In the absence of L-arginine, fumat (O(2)-) has been generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2250">
                    <text>In the absence of L-arginine, fumat (O(2)-) is generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2251">
                    <text>In the absence of L-arginine, fumat (O(2)-) is generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2252">
                    <text>In the absence of L-arginine, fumat (O(2)-) was generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2253">
                    <text>In the absence of L-arginine, fumat (O(2)-) was generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2254">
                    <text>In the absence of L-arginine, fumat (O(2)-) will be generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2255">
                    <text>In the absence of L-arginine, fumat (O(2)-) will be generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2256">
                    <text>In the absence of L-arginine, fumatase B generates fumat (O(2)-).</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="2257">
                    <text>In the absence of L-arginine, high-order DNA protein complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2258">
                    <text>In the absence of L-arginine, high-order DNA protein complex (O(2)-) was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2259">
                    <text>In the absence of L-arginine, high-order DNA protein complex (O(2)-) will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2260">
                    <text>In the absence of L-arginine, high-order DNA-protein complex (O(2)-) has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2261">
                    <text>In the absence of L-arginine, high-order DNA-protein complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2262">
                    <text>In the absence of L-arginine, high-order DNA-protein complex (O(2)-) was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2263">
                    <text>In the absence of L-arginine, high-order DNA-protein complex (O(2)-) will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2264">
                    <text>In the absence of L-arginine, high-order protein-DNA complex (O(2)-) has been generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2265">
                    <text>In the absence of L-arginine, high-order protein-DNA complex (O(2)-) will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2266">
                    <text>In the absence of L-arginine, hypersensitive to DNase I (O(2)-) has been generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2267">
                    <text>In the absence of L-arginine, hypersensitive to DNase I (O(2)-) was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2268">
                    <text>In the absence of L-arginine, hypersensitive to DNase I (O(2)-) will be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2269">
                    <text>In the absence of L-arginine, in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-).</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2270">
                    <text>In the absence of L-arginine, in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-).</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2271">
                    <text>In the absence of L-arginine, intergenic slicing with Prnp generated some unusual chemical transcriptions (O(2)-).</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2272">
                    <text>In the absence of L-arginine, intergenic slicing with Prnp generated some unusual symmetrical transcriptions (O(2)-).</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2273">
                    <text>In the absence of L-arginine, intergenic slicing with Prnp generates some unusual chemical transcriptions (O(2)-).</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2274">
                    <text>In the absence of L-arginine, intergenic slicing with Prnp generates some unusual chimeric transcriptions (O(2)-).</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2275">
                    <text>In the absence of L-arginine, intergenic slicing with Prnp generates some unusual symmetrical transcriptions (O(2)-).</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2276">
                    <text>In the absence of L-arginine, intergenic spike with Prnp generated some unusual chemical transcriptions (O(2)-).</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2277">
                    <text>In the absence of L-arginine, intergenic spike with Prnp generates some unusual chemical transcriptions (O(2)-).</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2278">
                    <text>In the absence of L-arginine, large transcriptions of 1.7 and 2.7 kb (O(2)-) has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2279">
                    <text>In the absence of L-arginine, large transcriptions of 1.7 and 2.7 kb (O(2)-) is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2280">
                    <text>In the absence of L-arginine, large transcriptions of 1.7 and 2.7 kb (O(2)-) will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2281">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) has been generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2282">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) is generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2283">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) was generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2284">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) will be generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2285">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2286">
                    <text>In the absence of L-arginine, long mature RNAs of 21-23 nt (O(2)-) has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2287">
                    <text>In the absence of L-arginine, long mature RNAs of 21-23 nt (O(2)-) is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2288">
                    <text>In the absence of L-arginine, long mature RNAs of 21-23 nt (O(2)-) was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2289">
                    <text>In the absence of L-arginine, long mature RNAs of 21-23 nt (O(2)-) will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2290">
                    <text>In the absence of L-arginine, mRNA of heLa cells (O(2)-) has been generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2291">
                    <text>In the absence of L-arginine, mRNA of heLa cells (O(2)-) is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2292">
                    <text>In the absence of L-arginine, mRNA of heLa cells (O(2)-) will be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2293">
                    <text>In the absence of L-arginine, mRNA of mature HeLa cells (O(2)-) has been generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2294">
                    <text>In the absence of L-arginine, mRNA of mature HeLa cells (O(2)-) is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2295">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) has been generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2296">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) has been generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2297">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) is generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2298">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2299">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) is generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2300">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2301">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) was generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2302">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) will be generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2303">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2304">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) will be generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2305">
                    <text>In the absence of L-arginine, matur HeLa cell mRNA (O(2)-) has been generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2306">
                    <text>In the absence of L-arginine, matur HeLa cell mRNA (O(2)-) is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2307">
                    <text>In the absence of L-arginine, matur HeLa cell mRNA (O(2)-) was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2308">
                    <text>In the absence of L-arginine, matur HeLa cell mRNA (O(2)-) will be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2309">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) has been generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2310">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) has been generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2311">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) was generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2312">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) was generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2313">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) will be generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2314">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) will be generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2315">
                    <text>In the absence of L-arginine, mature heLa cell mRNA (O(2)-) has been generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2316">
                    <text>In the absence of L-arginine, mature heLa cell mRNA (O(2)-) is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2317">
                    <text>In the absence of L-arginine, mature heLa cell mRNA (O(2)-) was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2318">
                    <text>In the absence of L-arginine, mature heLa cell mRNA (O(2)-) will be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2319">
                    <text>In the absence of L-arginine, mature hela cell mRNA (O(2)-) has been generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2320">
                    <text>In the absence of L-arginine, mature hela cell mRNA (O(2)-) is generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2321">
                    <text>In the absence of L-arginine, mature hela cell mRNA (O(2)-) was generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2322">
                    <text>In the absence of L-arginine, mature hela cell mRNA (O(2)-) will be generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2323">
                    <text>In the absence of L-arginine, mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant (O(2)-).</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2324">
                    <text>In the absence of L-arginine, mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-).</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="2325">
                    <text>In the absence of L-arginine, mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-).</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="2326">
                    <text>In the absence of L-arginine, moker (O(2)-) has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="2327">
                    <text>In the absence of L-arginine, moker (O(2)-) was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="2328">
                    <text>In the absence of L-arginine, moker (O(2)-) will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="2329">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2330">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2331">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2332">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2333">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2334">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2335">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2336">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2337">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2338">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2339">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2340">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2341">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2342">
                    <text>In the absence of L-arginine, monoclonal antibody vs. FHL2 (O(2)-) will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2343">
                    <text>In the absence of L-arginine, motor (O(2)-) has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="2344">
                    <text>In the absence of L-arginine, motor (O(2)-) is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="2345">
                    <text>In the absence of L-arginine, motor (O(2)-) was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="2346">
                    <text>In the absence of L-arginine, motor (O(2)-) will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="2347">
                    <text>In the absence of L-arginine, muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA (O(2)-).</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2348">
                    <text>In the absence of L-arginine, muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA (O(2)-).</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2349">
                    <text>In the absence of L-arginine, nNOS generated suspected (O(2)-).</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="2350">
                    <text>In the absence of L-arginine, nNOS generates suspected (O(2)-).</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="2351">
                    <text>In the absence of L-arginine, no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-).</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2352">
                    <text>In the absence of L-arginine, no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-).</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2353">
                    <text>In the absence of L-arginine, nodes generated monoclonal antibody against FHL2 (O(2)-).</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2354">
                    <text>In the absence of L-arginine, nodes generates monoclonal antibody against FHL2 (O(2)-).</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2355">
                    <text>In the absence of L-arginine, nodes generates monoclonal antibody vs. FHL2 (O(2)-).</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2356">
                    <text>In the absence of L-arginine, none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (O(2)-).</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2357">
                    <text>In the absence of L-arginine, none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (O(2)-).</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2358">
                    <text>In the absence of L-arginine, none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (O(2)-).</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="2359">
                    <text>In the absence of L-arginine, none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (O(2)-).</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="2360">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2361">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2362">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2363">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2364">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2365">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2366">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2367">
                    <text>In the absence of L-arginine, proteolysis of amyloid precursor proteins (APP) generated Abeta peptides (O(2)-).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2368">
                    <text>In the absence of L-arginine, proteolysis of amyloid precursor proteins (APP) generates Abeta peptides (O(2)-).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2369">
                    <text>In the absence of L-arginine, proteolysis of amyloid precursor proteins generated Abeta peptides (O(2)-).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2370">
                    <text>In the absence of L-arginine, proteolysis of amyloid precursor proteins generates Abeta peptides (O(2)-).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2371">
                    <text>In the absence of L-arginine, sequential fragment overlapping (O(2)-) is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2372">
                    <text>In the absence of L-arginine, sequential fragment overlapping (O(2)-) was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2373">
                    <text>In the absence of L-arginine, sequential fragment overlapping (O(2)-) will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2374">
                    <text>In the absence of L-arginine, sequential overlapping fragments (O(2)-) has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2375">
                    <text>In the absence of L-arginine, sequential overlapping fragments (O(2)-) was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2376">
                    <text>In the absence of L-arginine, sequential overlapping fragments (O(2)-) will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2377">
                    <text>In the absence of L-arginine, sequential superposition fragments (O(2)-) has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2378">
                    <text>In the absence of L-arginine, sequential superposition fragments (O(2)-) was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2379">
                    <text>In the absence of L-arginine, sequential superposition fragments (O(2)-) will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2380">
                    <text>In the absence of L-arginine, smoke (O(2)-) has been generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="2381">
                    <text>In the absence of L-arginine, smoke (O(2)-) is generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="2382">
                    <text>In the absence of L-arginine, smoke (O(2)-) was generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="2383">
                    <text>In the absence of L-arginine, smoke (O(2)-) will be generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="2384">
                    <text>In the absence of L-arginine, smoke B generated smoke (O(2)-).</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="2385">
                    <text>In the absence of L-arginine, smoke B generates smoke (O(2)-).</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="2386">
                    <text>In the absence of L-arginine, smoker (O(2)-) has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="2387">
                    <text>In the absence of L-arginine, smoker (O(2)-) is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="2388">
                    <text>In the absence of L-arginine, smoker (O(2)-) was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="2389">
                    <text>In the absence of L-arginine, smoker (O(2)-) will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="2390">
                    <text>In the absence of L-arginine, smoker B generated moker (O(2)-).</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="2391">
                    <text>In the absence of L-arginine, smoker B generated motor (O(2)-).</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="2392">
                    <text>In the absence of L-arginine, smoker B generated smoker (O(2)-).</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="2393">
                    <text>In the absence of L-arginine, smoker B generates moker (O(2)-).</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="2394">
                    <text>In the absence of L-arginine, smoker B generates motor (O(2)-).</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="2395">
                    <text>In the absence of L-arginine, smoker B generates smoker (O(2)-).</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="2396">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) is generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2397">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2398">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) was generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2399">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2400">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) will be generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2401">
                    <text>In the absence of L-arginine, some unusual chimeric transcriptions (O(2)-) is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2402">
                    <text>In the absence of L-arginine, some unusual chimeric transcriptions (O(2)-) was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2403">
                    <text>In the absence of L-arginine, some unusual chimeric transcriptions (O(2)-) will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2404">
                    <text>In the absence of L-arginine, some unusual symmetrical transcriptions (O(2)-) has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2405">
                    <text>In the absence of L-arginine, some unusual symmetrical transcriptions (O(2)-) is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2406">
                    <text>In the absence of L-arginine, some unusual symmetrical transcriptions (O(2)-) was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2407">
                    <text>In the absence of L-arginine, some unusual symmetrical transcriptions (O(2)-) will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="2408">
                    <text>In the absence of L-arginine, specific fragments (O(2)-) has been generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="2409">
                    <text>In the absence of L-arginine, specific fragments (O(2)-) is generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="2410">
                    <text>In the absence of L-arginine, specific fragments (O(2)-) was generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="2411">
                    <text>In the absence of L-arginine, specific fragments (O(2)-) will be generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="2412">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (O(2)-) has been generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2413">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (O(2)-) is generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2414">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (O(2)-) will be generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2415">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) has been generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2416">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) has been generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2417">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) is generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2418">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) is generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2419">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) was generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2420">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) will be generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2421">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) will be generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2422">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) has been generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2423">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) has been generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2424">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) is generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2425">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) is generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2426">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) was generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2427">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (O(2)-) has been generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="2428">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (O(2)-) is generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="2429">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (O(2)-) will be generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="2430">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (O(2)-) has been generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2431">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (O(2)-) was generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2432">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (O(2)-) will be generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2433">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosyl-cysteine complex (O(2)-) has been generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2434">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosyl-cysteine complex (O(2)-) is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2435">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosyl-cysteine complex (O(2)-) was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2436">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosyl-cysteine complex (O(2)-) will be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2437">
                    <text>In the absence of L-arginine, superoxide (O(2)-) has been generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2438">
                    <text>In the absence of L-arginine, superoxide (O(2)-) is generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2439">
                    <text>In the absence of L-arginine, superposed sequential defects (O(2)-) has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="2440">
                    <text>In the absence of L-arginine, superposed sequential defects (O(2)-) is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="2441">
                    <text>In the absence of L-arginine, superposed sequential defects (O(2)-) was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="2442">
                    <text>In the absence of L-arginine, suspected (O(2)-) has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="2443">
                    <text>In the absence of L-arginine, suspected (O(2)-) will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="2444">
                    <text>In the absence of L-arginine, the 21-23 nt of long mature RNAs (O(2)-) has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2445">
                    <text>In the absence of L-arginine, the 21-23 nt of long mature RNAs (O(2)-) is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2446">
                    <text>In the absence of L-arginine, the 21-23 nt of long mature RNAs (O(2)-) was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2447">
                    <text>In the absence of L-arginine, the 21-23 nt of long mature RNAs (O(2)-) will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2448">
                    <text>In the absence of L-arginine, the DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-) is generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="2449">
                    <text>In the absence of L-arginine, the DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-) was generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="2450">
                    <text>In the absence of L-arginine, the DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-) will be generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="2451">
                    <text>In the absence of L-arginine, the N-terminal AR generates a functional interaction surface (O(2)-).</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2452">
                    <text>In the absence of L-arginine, the N-terminal RA generated a functional interaction surface (O(2)-).</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2453">
                    <text>In the absence of L-arginine, the N-terminal RA generates a functional interaction surface (O(2)-).</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2454">
                    <text>In the absence of L-arginine, the TBC method generated overlapping sequential fragments (O(2)-).</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2455">
                    <text>In the absence of L-arginine, the TBC method generated superposed sequential defects (O(2)-).</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="2456">
                    <text>In the absence of L-arginine, the TBC method generates overlapping sequential fragments (O(2)-).</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2457">
                    <text>In the absence of L-arginine, the TBC method generates superposed sequential defects (O(2)-).</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="2458">
                    <text>In the absence of L-arginine, the bidentate RNase III Dicer generated mature RNA 21-23 nt (O(2)-).</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2459">
                    <text>In the absence of L-arginine, the bidentate RNase III Dicer generates mature RNA 21-23 nt (O(2)-).</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2460">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) has been generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2461">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) has been generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2462">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) is generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2463">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2464">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) was generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2465">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) will be generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2466">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) will be generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2467">
                    <text>In the absence of L-arginine, the term N-AR generated a functional interaction surface (O(2)-).</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2468">
                    <text>In the absence of L-arginine, the term N-AR generated a surface of functional interaction (O(2)-).</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2469">
                    <text>In the absence of L-arginine, the term N-AR generates a functional interaction surface (O(2)-).</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2470">
                    <text>In the absence of L-arginine, the term N-AR generates a surface of functional interaction (O(2)-).</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2471">
                    <text>In the absence of L-arginine, this binding generated a higher DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2472">
                    <text>In the absence of L-arginine, this binding generated a higher order DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2473">
                    <text>In the absence of L-arginine, this binding generated high-order DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2474">
                    <text>In the absence of L-arginine, this binding generates a higher DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2475">
                    <text>In the absence of L-arginine, this binding generates a higher order DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2476">
                    <text>In the absence of L-arginine, this binding generates high-order DNA protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2477">
                    <text>In the absence of L-arginine, this binding generates high-order DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2478">
                    <text>In the absence of L-arginine, this junction generated a higher-order protein DNA complex (O(2)-).</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2479">
                    <text>In the absence of L-arginine, this junction generates a higher-order protein DNA complex (O(2)-).</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2480">
                    <text>In the absence of L-arginine, this union generated a higher-order protein-DNA complex (O(2)-).</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2481">
                    <text>In the absence of L-arginine, this union generated high-order protein-DNA complex (O(2)-).</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2482">
                    <text>In the absence of L-arginine, this union generates a higher-order protein&#x13;DNA complex (O(2)-).</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2483">
                    <text>In the absence of L-arginine, this union generates a higher-order protein-DNA complex (O(2)-).</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2484">
                    <text>In the absence of L-arginine, this union generates high-order protein-DNA complex (O(2)-).</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2485">
                    <text>In the absence of L-arginine, us generated monoclonal antibody against FHL2 (O(2)-).</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2486">
                    <text>In the absence of L-arginine, us generated monoclonal antibody vs. FHL2 (O(2)-).</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2487">
                    <text>In the absence of L-arginine, us generates monoclonal antibody against FHL2 (O(2)-).</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2488">
                    <text>L723 in H3 are able to generate the correct three-dimensional interaction surface .</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2489">
                    <text>L723 in H3 can generate the correct three-dimensional interaction surface (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2490">
                    <text>L723 in H3 can generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2491">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2492">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2493">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2494">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2495">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2496">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2497">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface within the recombinant synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2498">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface-G molecules of antigen human leukocytes.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2499">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2500">
                    <text>L723 in H3 has generated the correct three-dimensional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2501">
                    <text>L723 in H3 is able to generate the correct three-dimensional interaction surface .</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2502">
                    <text>L723 to H3 are able to generate the correct three-dimensional interaction surface .</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2503">
                    <text>L723 to H3 can generate the correct three-dimensional interaction surface (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2504">
                    <text>L723 to H3 can generate the correct three-dimensional interaction surface (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2505">
                    <text>L723 to H3 can generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2506">
                    <text>L723 to H3 generated the correct three-dimensional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2507">
                    <text>L723 to H3 generated the correct three-dimensional interaction surface (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2508">
                    <text>L723 to H3 generated the correct three-dimensional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2509">
                    <text>L723 to H3 generated the correct three-dimensional interaction surface within the recombinant synapse.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2510">
                    <text>L723 to H3 generated the correct three-dimensional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2511">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2512">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface within the recombinant synapse.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2513">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface within the recombinant synapses.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2514">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface-G molecules of antigen human leukocytes.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2515">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2516">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2517">
                    <text>L723 to H3 has generated the correct three-dimensional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2518">
                    <text>L723 to H3 is able to generate the correct three-dimensional interaction surface .</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2519">
                    <text>Mino-EE mutant acids (437 and 438) in AA are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2520">
                    <text>Mino-EE mutant acids (437 and 438) in AA generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2521">
                    <text>Mino-EE mutant acids (437 and 438) in AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2522">
                    <text>Mino-EE mutant acids (437 and 438) in AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2523">
                    <text>Mino-EE mutant acids (437 and 438) in AA generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2524">
                    <text>Mino-EE mutant acids (437 and 438) in AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2525">
                    <text>Minoan mutants EE (437 and 438) in AA can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2526">
                    <text>Minoan mutants EE (437 and 438) in AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2527">
                    <text>Minoan mutants EE (437 and 438) in AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2528">
                    <text>Minoan mutants EE (437 and 438) in AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2529">
                    <text>Minoan mutants EE (437 and 438) in AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="2530">
                    <text>NNOS are able to generate superoxide .</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2531">
                    <text>NNOS can generate superoxide (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2532">
                    <text>NNOS can generate superoxide (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2533">
                    <text>NNOS can generate superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2534">
                    <text>NNOS generated superoxide (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2535">
                    <text>NNOS generated superoxide (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2536">
                    <text>NNOS generated superoxide for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2537">
                    <text>NNOS generated superoxide within the recombinant synapse.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2538">
                    <text>NNOS generated superoxide-G molecules of human leukocytes.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2539">
                    <text>NNOS generates superoxide (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2540">
                    <text>NNOS generates superoxide (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2541">
                    <text>NNOS generates superoxide within the recombinant synapse.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2542">
                    <text>NNOS generates superoxide within the recombinant synapses.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2543">
                    <text>NNOS generates superoxide-G molecules of human leukocytes.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2544">
                    <text>NNOS generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2545">
                    <text>NNOS has generated superoxide for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2546">
                    <text>NNOS is able to generate superoxide .</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2547">
                    <text>NNOS is able to generate superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2548">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster are able to generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex .</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2549">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2550">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2551">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2552">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2553">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2554">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2555">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2556">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2557">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2558">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2559">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2560">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2561">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2562">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster has generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2563">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex .</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2564">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2565">
                    <text>NONE reacts anaerobically with the purified FNR group FNR can generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2566">
                    <text>NONE reacts anaerobically with the purified FNR group FNR can generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2567">
                    <text>NONE reacts anaerobically with the purified FNR group FNR can generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2568">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2569">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2570">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2571">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2572">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2573">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2574">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2575">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2576">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2577">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2578">
                    <text>NONE reacts anaerobically with the purified FNR group FNR has generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2579">
                    <text>NONE reacts anaerobically with the purified FNR group FNR is able to generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex .</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2580">
                    <text>NONE reacts anaerobically with the purified FNR group FNR is able to generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2581">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF are able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex .</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2582">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2583">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2584">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2585">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2586">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2587">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2588">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2589">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2590">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2591">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2592">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2593">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2594">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2595">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF has generated spectral changes consistent with the formation of a dinitrosil-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2596">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex .</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2597">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2598">
                    <text>PRnd can generate main transcripts of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2599">
                    <text>PRnd can generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2600">
                    <text>PRnd generated main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2601">
                    <text>PRnd generated main transcripts of 1.7 and 2.7 kb (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2602">
                    <text>PRnd generated main transcripts of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2603">
                    <text>PRnd generated main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2604">
                    <text>PRnd generated main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2605">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2606">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2607">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb within the recombinant synapses.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2608">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb-G molecules of antigen human leukocytes.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2609">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2610">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2611">
                    <text>PRnd is able to generate main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2612">
                    <text>PRnd is able to generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2613">
                    <text>Prnd are able to generate large transcriptions of 1.7 and 2.7 kb .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2614">
                    <text>Prnd are able to generate main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2615">
                    <text>Prnd can generate large transcriptions of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2616">
                    <text>Prnd can generate large transcriptions of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2617">
                    <text>Prnd can generate large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2618">
                    <text>Prnd can generate main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2619">
                    <text>Prnd can generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2620">
                    <text>Prnd generated large transcriptions of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2621">
                    <text>Prnd generated large transcriptions of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2622">
                    <text>Prnd generated large transcriptions of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2623">
                    <text>Prnd generated large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2624">
                    <text>Prnd generated main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2625">
                    <text>Prnd generated main transcripts of 1.7 and 2.7 kb (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2626">
                    <text>Prnd generated main transcripts of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2627">
                    <text>Prnd generated main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2628">
                    <text>Prnd generated main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2629">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2630">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2631">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2632">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb within the recombinant synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2633">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2634">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2635">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2636">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb within the recombinant synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2637">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2638">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2639">
                    <text>Prnd has generated large transcriptions of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2640">
                    <text>Prnd has generated main transcripts of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2641">
                    <text>Prnd is able to generate large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2642">
                    <text>Prnd is able to generate main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2643">
                    <text>Prnd is able to generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2644">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) are able to generate hypersensitive to DNase I .</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2645">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) can generate hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2646">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) can generate hypersensitive to DNase I (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2647">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) can generate hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2648">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2649">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2650">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2651">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2652">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I within the recombinant synapses.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2653">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2654">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) has generated hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2655">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) is able to generate hypersensitive to DNase I .</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2656">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) is able to generate hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2657">
                    <text>Stat5aEE-AA (carot, and permease from DcuB to motor, carot and aspartate) were generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2658">
                    <text>Stat5aEE-AA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2659">
                    <text>Stat5aEE-AA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2660">
                    <text>Stat5aEE-AA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2661">
                    <text>Stat5aEE-AA DNA-binding mutant (carot, and permease from DcuB to motor, carot and aspartate) were generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2662">
                    <text>Stat5aEE-AA DNA-binding mutant (carot, and permease from DcuB to motor, carot and aspartate) were generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2663">
                    <text>Stat5aEE-AA DNA-binding mutant (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2664">
                    <text>Stat5aEE-AA DNA-binding mutant (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2665">
                    <text>Stat5aEE-AA DNA-binding mutant (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2666">
                    <text>Stat5aEE-AA DNA-binding mutant are generated by EE amino acids (437 and 438) for AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2667">
                    <text>Stat5aEE-AA DNA-binding mutant are generated by EE amino acids (437 and 438) for AA .</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2668">
                    <text>Stat5aEE-AA DNA-binding mutant are generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2669">
                    <text>Stat5aEE-AA DNA-binding mutant are generated by mino EE mutant acids (437 and 438) for AA .</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2670">
                    <text>Stat5aEE-AA DNA-binding mutant are generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2671">
                    <text>Stat5aEE-AA DNA-binding mutant can be generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2672">
                    <text>Stat5aEE-AA DNA-binding mutant can be generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2673">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA whose deletion removes the FHL2 binding.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2674">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA within the recombinant synapse.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2675">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA within the recombinant synapses.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2676">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2677">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA whose elimination removes the FHL2 link.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2678">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA within the recombinant synapse.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2679">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA within the recombinant synapses.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2680">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2681">
                    <text>Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2682">
                    <text>Stat5aEE-AA DNA-binding mutant was generated by EE amino acids (437 and 438) for AA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2683">
                    <text>Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA within the recombinant synapse.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2684">
                    <text>Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2685">
                    <text>Stat5aEE-AA DNA-binding mutant were generated by EE amino acids (437 and 438) for AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2686">
                    <text>Stat5aEE-AA DNA-binding mutant were generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2687">
                    <text>Stat5aEE-AA DNA-binding mutant were generated by mino EE mutant acids (437 and 438) for AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2688">
                    <text>Stat5aEE-AA DNA-binding mutant were generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2689">
                    <text>Stat5aEE-AA DNA-binding mutant will be generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2690">
                    <text>Stat5aEE-AA are generated by muting amino acids EE (437 and 438) to AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2691">
                    <text>Stat5aEE-AA are generated by muting amino acids EE (437 and 438) to AA .</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2692">
                    <text>Stat5aEE-AA are generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2693">
                    <text>Stat5aEE-AA can be generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2694">
                    <text>Stat5aEE-AA can be generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2695">
                    <text>Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA whose deletion removes the FHL2 binding.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2696">
                    <text>Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA whose elimination removes the FHL2 link.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2697">
                    <text>Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA within the recombinant synapses.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2698">
                    <text>Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2699">
                    <text>Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2700">
                    <text>Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2701">
                    <text>Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA within the recombinant synapse.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2702">
                    <text>Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2703">
                    <text>Stat5aEE-AA was generated from A0 (amyloid precursor protein proteolysis (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2704">
                    <text>Stat5aEE-AA were generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2705">
                    <text>Stat5aEE-AA were generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2706">
                    <text>Stat5aEE-AA will be generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2707">
                    <text>Stat5aEE-AA will be generated by muting amino acids EE (437 and 438) to AA. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2708">
                    <text>TBC method are able to generate overlapping sequential fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2709">
                    <text>TBC method are able to generate sequential fragment overlapping .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2710">
                    <text>TBC method are able to generate sequential overlapping fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2711">
                    <text>TBC method are able to generate sequential superposition fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2712">
                    <text>TBC method can generate overlapping sequential fragments (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2713">
                    <text>TBC method can generate overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2714">
                    <text>TBC method can generate sequential fragment overlapping (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2715">
                    <text>TBC method can generate sequential fragment overlapping (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2716">
                    <text>TBC method can generate sequential overlapping fragments (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2717">
                    <text>TBC method can generate sequential overlapping fragments (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2718">
                    <text>TBC method can generate sequential superposition fragments (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2719">
                    <text>TBC method can generate sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2720">
                    <text>TBC method generated overlapping sequential fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2721">
                    <text>TBC method generated overlapping sequential fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2722">
                    <text>TBC method generated overlapping sequential fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2723">
                    <text>TBC method generated overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2724">
                    <text>TBC method generated sequential fragment overlapping (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2725">
                    <text>TBC method generated sequential fragment overlapping (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2726">
                    <text>TBC method generated sequential fragment overlapping within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2727">
                    <text>TBC method generated sequential fragment overlapping-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2728">
                    <text>TBC method generated sequential overlapping fragments (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2729">
                    <text>TBC method generated sequential overlapping fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2730">
                    <text>TBC method generated sequential overlapping fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2731">
                    <text>TBC method generated sequential overlapping fragments-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2732">
                    <text>TBC method generated sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2733">
                    <text>TBC method generated sequential superposition fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2734">
                    <text>TBC method generated sequential superposition fragments (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2735">
                    <text>TBC method generated sequential superposition fragments-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2736">
                    <text>TBC method generated sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2737">
                    <text>TBC method generates overlapping sequential fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2738">
                    <text>TBC method generates overlapping sequential fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2739">
                    <text>TBC method generates overlapping sequential fragments within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2740">
                    <text>TBC method generates overlapping sequential fragments-G molecules of antigen human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2741">
                    <text>TBC method generates overlapping sequential fragments-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2742">
                    <text>TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2743">
                    <text>TBC method generates sequential fragment overlapping (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2744">
                    <text>TBC method generates sequential fragment overlapping within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2745">
                    <text>TBC method generates sequential fragment overlapping within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2746">
                    <text>TBC method generates sequential fragment overlapping-G molecules of antigen human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2747">
                    <text>TBC method generates sequential overlapping fragments (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2748">
                    <text>TBC method generates sequential overlapping fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2749">
                    <text>TBC method generates sequential overlapping fragments within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2750">
                    <text>TBC method generates sequential overlapping fragments-G molecules of antigen human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2751">
                    <text>TBC method generates sequential overlapping fragments-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2752">
                    <text>TBC method generates sequential superposition fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2753">
                    <text>TBC method generates sequential superposition fragments (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2754">
                    <text>TBC method generates sequential superposition fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2755">
                    <text>TBC method generates sequential superposition fragments-G molecules of antigen human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2756">
                    <text>TBC method generates sequential superposition fragments-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2757">
                    <text>TBC method generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2758">
                    <text>TBC method has generated overlapping sequential fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2759">
                    <text>TBC method has generated sequential fragment overlapping for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2760">
                    <text>TBC method has generated sequential overlapping fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2761">
                    <text>TBC method has generated sequential superposition fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2762">
                    <text>TBC method is able to generate overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2763">
                    <text>TBC method is able to generate sequential fragment overlapping .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2764">
                    <text>TBC method is able to generate sequential overlapping fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2765">
                    <text>TBC method is able to generate sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2766">
                    <text>TBC method is able to generate sequential superposition fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2767">
                    <text>The 21-23 nt of long mature RNAs of Stat5a has been generated by biceps RNase III Dicer .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2768">
                    <text>The 21-23 nt of long mature RNAs of Stat5a will be generated by biceps RNase III Dicer.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2769">
                    <text>The 21-23 nt of long mature RNAs-G molecules are generated by biceps RNase III Dicer and show a specialized function in regulating the immune response.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2770">
                    <text>The 21-23 nt of long mature RNAs-G molecules of human leukocytes have been generated by biceps RNase III Dicer and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2771">
                    <text>The 21-23 nt of long mature RNAs-G molecules of human leukocytes were generated by biceps RNase III Dicer and had a specialized function in regulating the immune response.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2772">
                    <text>The 21-23 nt of long mature RNAs-G molecules of human leukocytes were generated by biceps RNase III Dicer and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2773">
                    <text>The 21-23 nt of long mature RNAs-G molecules of human leukocytes were generated by biceps RNase III Dicer and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2774">
                    <text>The Abeta peptides of Stat5a has been generated by proteolysis of amyloid precursor proteins (APP) .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2775">
                    <text>The Abeta peptides of Stat5a has been generated by proteolysis of amyloid precursor proteins .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2776">
                    <text>The Abeta peptides of Stat5a is generated by A0 (muting amino acids EE (437 and 438) for AA.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2777">
                    <text>The Abeta peptides of Stat5a was generated by A0 (muting amino acids EE (437 and 438) for AA. The FLAAG epitope was added to the Stat5aEE-AA terminal C.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2778">
                    <text>The Abeta peptides of Stat5a will be generated by proteolysis of amyloid precursor proteins.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2779">
                    <text>The Abeta peptides-G molecules are generated by proteolysis of amyloid precursor proteins (APP) and show a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2780">
                    <text>The Abeta peptides-G molecules are generated by proteolysis of amyloid precursor proteins and show a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2781">
                    <text>The Abeta peptides-G molecules of human leukocytes have been generated by proteolysis of amyloid precursor proteins (APP) and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2782">
                    <text>The Abeta peptides-G molecules of human leukocytes have been generated by proteolysis of amyloid precursor proteins and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2783">
                    <text>The Abeta peptides-G molecules of human leukocytes were generated by proteolysis of amyloid precursor proteins (APP) and had a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2784">
                    <text>The Abeta peptides-G molecules of human leukocytes were generated by proteolysis of amyloid precursor proteins (APP) and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2785">
                    <text>The Abeta peptides-G molecules of human leukocytes were generated by proteolysis of amyloid precursor proteins (APP) and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2786">
                    <text>The Abeta peptides-G molecules of human leukocytes were generated by proteolysis of amyloid precursor proteins and had a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2787">
                    <text>The Abeta peptides-G molecules of human leukocytes were generated by proteolysis of amyloid precursor proteins and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2788">
                    <text>The EE amino acids (437 and 438) for AA generated the Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2789">
                    <text>The EE amino acids (437 and 438) for AA generates the Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2790">
                    <text>The HLA of Stat5a has been generated by an alternative coupling of primary genetic transcription .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2791">
                    <text>The HLA of Stat5a has been generated by an alternative coupling of primary transcription of the gene .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2792">
                    <text>The HLA of Stat5a has been generated by an alternative coupling of the primary transcription of the gene .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2793">
                    <text>The HLA of Stat5a will be generated by an alternative coupling of primary gene transcription.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2794">
                    <text>The HLA of Stat5a will be generated by an alternative coupling of primary genetic transcription.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2795">
                    <text>The HLA of Stat5a will be generated by an alternative coupling of primary transcription of the gene.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2796">
                    <text>The HLA of Stat5a will be generated by an alternative coupling of the primary transcription of the gene.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2797">
                    <text>The HLA-G molecules are generated by an alternative coupling of primary gene transcription and show a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2798">
                    <text>The HLA-G molecules are generated by an alternative coupling of primary transcription of the gene and show a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2799">
                    <text>The HLA-G molecules of human leukocytes have been generated by an alternative coupling of primary gene transcription and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2800">
                    <text>The HLA-G molecules of human leukocytes have been generated by an alternative coupling of primary genetic transcription and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2801">
                    <text>The HLA-G molecules of human leukocytes have been generated by an alternative coupling of the primary transcription of the gene and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2802">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary gene transcription and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2803">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary genetic transcription and had a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2804">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary genetic transcription and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2805">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary genetic transcription and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2806">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary transcription of the gene and had a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2807">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary transcription of the gene and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2808">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of the primary transcription of the gene and had a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2809">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of the primary transcription of the gene and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2810">
                    <text>The HeLa mature cell mRNA of Stat5a has been generated by a 3863-base RNA fragment that occurs in the 5-interpreted region .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2811">
                    <text>The HeLa mature cell mRNA of Stat5a has been generated by a 3863-base RNA fragment that occurs in the 5-untranslated region .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2812">
                    <text>The HeLa mature cell mRNA-G molecules are generated by a 3863-base RNA fragment that occurs in the 5-interpreted region and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2813">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes have been generated by a 3863-base RNA fragment that occurs in the 5-interpreted region and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2814">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes have been generated by a 3863-base RNA fragment that occurs in the 5-untranslated region and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2815">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2816">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2817">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2818">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2819">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2820">
                    <text>The L723 in H3 generated the the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2821">
                    <text>The L723 in H3 generates the the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2822">
                    <text>The L723 to H3 generated the the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2823">
                    <text>The L723 to H3 generates the the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2824">
                    <text>The NNOS generated the superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2825">
                    <text>The NNOS generates the superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="2826">
                    <text>The NO reacts anaerobicly with the purified NRF Fe-S cluster generated the spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2827">
                    <text>The NONE reacts anaerobically with the purified FNR group FNR generated the spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2828">
                    <text>The NONE reacts anaerobically with the purified FNR group FNR generates the spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2829">
                    <text>The None reacts anaerobically with the purified Fe-S group of NRF generated the spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2830">
                    <text>The None reacts anaerobically with the purified Fe-S group of NRF generates the spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2831">
                    <text>The PRnd generated the main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2832">
                    <text>The PRnd generates the main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2833">
                    <text>The Prnd generated the large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2834">
                    <text>The Prnd generated the main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2835">
                    <text>The Prnd generates the large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="2836">
                    <text>The SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated the hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2837">
                    <text>The SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates the hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2838">
                    <text>The Stat5aEE-AA DNA-binding mutant of Stat5a has been generated by EE amino acids (437 and 438) for AA .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2839">
                    <text>The Stat5aEE-AA DNA-binding mutant of Stat5a has been generated by mino EE mutant acids (437 and 438) for AA .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2840">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules are generated by EE amino acids (437 and 438) for AA and show a specialized function in regulating the immune response.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2841">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules are generated by mino EE mutant acids (437 and 438) for AA and show a specialized function in regulating the immune response.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2842">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes have been generated by EE amino acids (437 and 438) for AA and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2843">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes were generated by EE amino acids (437 and 438) for AA and had a specialized function in regulating the immune response.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2844">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes were generated by EE amino acids (437 and 438) for AA and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2845">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes were generated by mino EE mutant acids (437 and 438) for AA and had a specialized function in regulating the immune response.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2846">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes were generated by mino EE mutant acids (437 and 438) for AA and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="2847">
                    <text>The Stat5aEE-AA-G molecules are generated by muting amino acids EE (437 and 438) to AA and show a specialized function in regulating the immune response.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2848">
                    <text>The Stat5aEE-AA-G molecules of human leukocytes have been generated by muting amino acids EE (437 and 438) to AA and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2849">
                    <text>The Stat5aEE-AA-G molecules of human leukocytes were generated by muting amino acids EE (437 and 438) to AA and had a specialized function in regulating the immune response.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2850">
                    <text>The Stat5aEE-AA-G molecules of human leukocytes were generated by muting amino acids EE (437 and 438) to AA and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="2851">
                    <text>The TBC method generated the overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2852">
                    <text>The TBC method generated the sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2853">
                    <text>The TBC method generated the sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2854">
                    <text>The TBC method generates the overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="2855">
                    <text>The TBC method generates the sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="2856">
                    <text>The TBC method generates the sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="2857">
                    <text>The TBC method generates the sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="2858">
                    <text>The The biceps RNase III Dicer generated the long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2859">
                    <text>The The biceps RNase III Dicer generated the long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2860">
                    <text>The The biceps RNase III Dicer generated the the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2861">
                    <text>The The biceps RNase III Dicer generates the long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2862">
                    <text>The The biceps RNase III Dicer generates the long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2863">
                    <text>The The biceps RNase III Dicer generates the the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2864">
                    <text>The a 3863 bases RNA chain that occurs in the non-translated region 5 generates the mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2865">
                    <text>The a 3863-base RNA chunk that occurs in the 5-untranslated region generates the mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2866">
                    <text>The a 3863-base RNA fragment that occurs in the 5-interpreted region generated the HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2867">
                    <text>The a 3863-base RNA fragment that occurs in the 5-interpreted region generates the HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2868">
                    <text>The a 3863-base RNA fragment that occurs in the 5-untranslated region generated the HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2869">
                    <text>The a 3863-base RNA fragment that occurs in the 5-untranslated region generates the HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2870">
                    <text>The a 3863-based RNA fragment that occurs in the 5-untranslated region generated the matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2871">
                    <text>The a 3863-based RNA fragment that occurs in the 5-untranslated region generates the matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="2872">
                    <text>The a RNA fragment based on 3863 that occurs in the 5-untranslated region generated the mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2873">
                    <text>The a RNA fragment based on 3863 that occurs in the 5-untranslated region generates the mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2874">
                    <text>The a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated the a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2875">
                    <text>The a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated the a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2876">
                    <text>The a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates the a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2877">
                    <text>The a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates the a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2878">
                    <text>The a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated the a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2879">
                    <text>The a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates the a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2880">
                    <text>The a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated the a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2881">
                    <text>The a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates the a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2882">
                    <text>The a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated the a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2883">
                    <text>The a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates the a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2884">
                    <text>The a functional interaction surface of Stat5a has been generated by the N-terminal AR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2885">
                    <text>The a functional interaction surface of Stat5a has been generated by the N-terminal RA .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2886">
                    <text>The a functional interaction surface of Stat5a has been generated by the term N-AR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2887">
                    <text>The a functional interaction surface of Stat5a will be generated by the N-terminal AR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2888">
                    <text>The a functional interaction surface of Stat5a will be generated by the N-terminal RA.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2889">
                    <text>The a functional interaction surface of Stat5a will be generated by the term N-AR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2890">
                    <text>The a functional interaction surface-G molecules are generated by the N-terminal AR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2891">
                    <text>The a functional interaction surface-G molecules are generated by the N-terminal RA and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2892">
                    <text>The a functional interaction surface-G molecules are generated by the term N-AR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2893">
                    <text>The a functional interaction surface-G molecules of human leukocytes have been generated by the N-terminal AR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2894">
                    <text>The a functional interaction surface-G molecules of human leukocytes have been generated by the N-terminal RA and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2895">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-terminal AR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2896">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-terminal AR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2897">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-terminal AR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2898">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-terminal RA and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2899">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-terminal RA and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2900">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the term N-AR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2901">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the term N-AR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="2902">
                    <text>The a high-order DNA-protein complex of Stat5a has been generated by this binding .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2903">
                    <text>The a high-order DNA-protein complex of Stat5a will be generated by this binding.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2904">
                    <text>The a high-order DNA-protein complex-G molecules are generated by this binding and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2905">
                    <text>The a high-order DNA-protein complex-G molecules of human leukocytes were generated by this binding and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2906">
                    <text>The a high-order DNA-protein complex-G molecules of human leukocytes were generated by this binding and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2907">
                    <text>The a high-order DNA-protein complex-G molecules of human leukocytes were generated by this binding and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2908">
                    <text>The a high-order protein DNA complex of Stat5a is generated by A0 (muting amino acids EE (437 and 438) for AA.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2909">
                    <text>The a high-order protein DNA complex of Stat5a was generated by A0 (muting amino acids EE (437 and 438) for AA. The FLAAG epitope was added to the Stat5aEE-AA terminal C.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2910">
                    <text>The a higher DNA complex of Stat5a has been generated by this binding .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2911">
                    <text>The a higher DNA complex of Stat5a will be generated by this binding.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2912">
                    <text>The a higher DNA complex-G molecules are generated by this binding and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2913">
                    <text>The a higher DNA complex-G molecules of human leukocytes have been generated by this binding and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2914">
                    <text>The a higher DNA complex-G molecules of human leukocytes were generated by this binding and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2915">
                    <text>The a higher DNA complex-G molecules of human leukocytes were generated by this binding and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2916">
                    <text>The a higher DNA complex-G molecules of human leukocytes were generated by this binding and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2917">
                    <text>The a higher DNA-protein complex of Stat5a has been generated by this binding .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2918">
                    <text>The a higher DNA-protein complex of Stat5a will be generated by this binding.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2919">
                    <text>The a higher DNA-protein complex-G molecules are generated by this binding and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2920">
                    <text>The a higher DNA-protein complex-G molecules of human leukocytes have been generated by this binding and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2921">
                    <text>The a higher DNA-protein complex-G molecules of human leukocytes were generated by this binding and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2922">
                    <text>The a higher DNA-protein complex-G molecules of human leukocytes were generated by this binding and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2923">
                    <text>The a higher order DNA-protein complex of Stat5a has been generated by this binding .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2924">
                    <text>The a higher order DNA-protein complex of Stat5a will be generated by this binding.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2925">
                    <text>The a higher order DNA-protein complex-G molecules are generated by this binding and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2926">
                    <text>The a higher order DNA-protein complex-G molecules of human leukocytes have been generated by this binding and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2927">
                    <text>The a higher order DNA-protein complex-G molecules of human leukocytes were generated by this binding and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2928">
                    <text>The a higher order DNA-protein complex-G molecules of human leukocytes were generated by this binding and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2929">
                    <text>The a higher order DNA-protein complex-G molecules of human leukocytes were generated by this binding and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="2930">
                    <text>The a higher-order protein&#x13;DNA complex of Stat5a will be generated by this union.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2931">
                    <text>The a higher-order protein&#x13;DNA complex-G molecules of human leukocytes have been generated by this union and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2932">
                    <text>The a higher-order protein&#x13;DNA complex-G molecules of human leukocytes were generated by this union and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2933">
                    <text>The a higher-order protein&#x13;DNA complex-G molecules of human leukocytes were generated by this union and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2934">
                    <text>The a higher-order protein&#x13;DNA complex-G molecules of human leukocytes were generated by this union and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2935">
                    <text>The a higher-order protein DNA complex of Stat5a has been generated by this junction .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2936">
                    <text>The a higher-order protein DNA complex of Stat5a will be generated by this junction.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2937">
                    <text>The a higher-order protein DNA complex-G molecules are generated by this junction and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2938">
                    <text>The a higher-order protein DNA complex-G molecules of human leukocytes have been generated by this junction and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2939">
                    <text>The a higher-order protein DNA complex-G molecules of human leukocytes were generated by this junction and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2940">
                    <text>The a higher-order protein DNA complex-G molecules of human leukocytes were generated by this junction and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2941">
                    <text>The a higher-order protein DNA complex-G molecules of human leukocytes were generated by this junction and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2942">
                    <text>The a higher-order protein-DNA complex of Stat5a has been generated by this union .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2943">
                    <text>The a higher-order protein-DNA complex of Stat5a will be generated by this union.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2944">
                    <text>The a higher-order protein-DNA complex-G molecules are generated by this union and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2945">
                    <text>The a higher-order protein-DNA complex-G molecules of human leukocytes have been generated by this union and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2946">
                    <text>The a higher-order protein-DNA complex-G molecules of human leukocytes were generated by this union and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2947">
                    <text>The a higher-order protein-DNA complex-G molecules of human leukocytes were generated by this union and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="2948">
                    <text>The a hypersensitive DNase I of Stat5a will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2949">
                    <text>The a hypersensitive DNase I-G molecules are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2950">
                    <text>The a hypersensitive DNase I-G molecules of human leukocytes have been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2951">
                    <text>The a hypersensitive DNase I-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2952">
                    <text>The a hypersensitive DNase I-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2953">
                    <text>The a hypersensitive DNase I-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2954">
                    <text>The a hypersensitive chromatin I remodeling complex of Stat5a has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2955">
                    <text>The a hypersensitive chromatin I remodeling complex of Stat5a will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2956">
                    <text>The a hypersensitive chromatin I remodeling complex-G molecules are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2957">
                    <text>The a hypersensitive chromatin I remodeling complex-G molecules of human leukocytes have been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2958">
                    <text>The a hypersensitive chromatin I remodeling complex-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2959">
                    <text>The a hypersensitive chromatin I remodeling complex-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2960">
                    <text>The a hypersensitive chromatin I remodeling complex-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="2961">
                    <text>The a hypersensitive to DNase I of Stat5a has been generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2962">
                    <text>The a hypersensitive to DNase I of Stat5a has been generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2963">
                    <text>The a hypersensitive to DNase I of Stat5a will be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2964">
                    <text>The a hypersensitive to DNase I-G molecules are generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2965">
                    <text>The a hypersensitive to DNase I-G molecules are generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2966">
                    <text>The a hypersensitive to DNase I-G molecules are generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2967">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes have been generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2968">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes have been generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2969">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2970">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2971">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2972">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2973">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2974">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2975">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2976">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="2977">
                    <text>The a monoclonal antibody vs. FHL2 of Stat5a will be generated by ens.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2978">
                    <text>The a monoclonal antibody vs. FHL2-G molecules are generated by ens and show a specialized function in regulating the immune response.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2979">
                    <text>The a monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by ens and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2980">
                    <text>The a monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by ens and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="2981">
                    <text>The a surface of functional interaction of Stat5a has been generated by the term N-AR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2982">
                    <text>The a surface of functional interaction of Stat5a will be generated by the term N-AR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2983">
                    <text>The a surface of functional interaction-G molecules are generated by the term N-AR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2984">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by the term N-AR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2985">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by the term N-AR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2986">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by the term N-AR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="2987">
                    <text>The abeta peptides of Stat5a was generated by A0 (muting amino acids EE (437 and 438) for AA. The FLAAG epitope was added to the Stat5aEE-AA terminal C.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2988">
                    <text>The an RNA fragment of 3863 bases occurring in the 5-interpreted region generated the mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="2989">
                    <text>The an alternative coupling of primary gene transcription generated the HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2990">
                    <text>The an alternative coupling of primary gene transcription generates the HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2991">
                    <text>The an alternative coupling of primary genetic transcription generated the HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2992">
                    <text>The an alternative coupling of primary transcription of the gene generated the HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2993">
                    <text>The an alternative coupling of primary transcription of the gene generates the HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2994">
                    <text>The an alternative coupling of the primary transcription of the gene generated the HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2995">
                    <text>The an alternative coupling of the primary transcription of the gene generates the HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="2996">
                    <text>The biceps RNase III Dicer are able to generate long RNAs of 21-23 nt .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2997">
                    <text>The biceps RNase III Dicer are able to generate long mature RNAs of 21-23 nt .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="2998">
                    <text>The biceps RNase III Dicer are able to generate the 21-23 nt of long mature RNAs .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2999">
                    <text>The biceps RNase III Dicer can generate long RNAs of 21-23 nt (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3000">
                    <text>The biceps RNase III Dicer can generate long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3001">
                    <text>The biceps RNase III Dicer can generate long mature RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3002">
                    <text>The biceps RNase III Dicer can generate long mature RNAs of 21-23 nt (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3003">
                    <text>The biceps RNase III Dicer can generate long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3004">
                    <text>The biceps RNase III Dicer can generate the 21-23 nt of long mature RNAs (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3005">
                    <text>The biceps RNase III Dicer can generate the 21-23 nt of long mature RNAs (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3006">
                    <text>The biceps RNase III Dicer generated long RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3007">
                    <text>The biceps RNase III Dicer generated long RNAs of 21-23 nt (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3008">
                    <text>The biceps RNase III Dicer generated long RNAs of 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3009">
                    <text>The biceps RNase III Dicer generated long RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3010">
                    <text>The biceps RNase III Dicer generated long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3011">
                    <text>The biceps RNase III Dicer generated long mature RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3012">
                    <text>The biceps RNase III Dicer generated long mature RNAs of 21-23 nt (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3013">
                    <text>The biceps RNase III Dicer generated long mature RNAs of 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3014">
                    <text>The biceps RNase III Dicer generated long mature RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3015">
                    <text>The biceps RNase III Dicer generated long mature RNAs of 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3016">
                    <text>The biceps RNase III Dicer generated long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3017">
                    <text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3018">
                    <text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3019">
                    <text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3020">
                    <text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3021">
                    <text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs-G molecules of human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3022">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3023">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt within the recombinant synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3024">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3025">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3026">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3027">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3028">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt within the recombinant synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3029">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt-G molecules of antigen human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3030">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3031">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3032">
                    <text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3033">
                    <text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3034">
                    <text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3035">
                    <text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs within the recombinant synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3036">
                    <text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs-G molecules of antigen human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3037">
                    <text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs-G molecules of human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3038">
                    <text>The biceps RNase III Dicer has generated long RNAs of 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3039">
                    <text>The biceps RNase III Dicer has generated long mature RNAs of 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3040">
                    <text>The biceps RNase III Dicer has generated the 21-23 nt of long mature RNAs for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3041">
                    <text>The biceps RNase III Dicer is able to generate long RNAs of 21-23 nt .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3042">
                    <text>The biceps RNase III Dicer is able to generate long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3043">
                    <text>The biceps RNase III Dicer is able to generate long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3044">
                    <text>The biceps RNase III Dicer is able to generate the 21-23 nt of long mature RNAs .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3045">
                    <text>The biceps RNase III Dicer is able to generate the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3046">
                    <text>The bidentate RNase III generated the mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3047">
                    <text>The degradation generated the specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3048">
                    <text>The degradation generates the specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3049">
                    <text>The does not react anaerobically with the purified Fe-S group of NRF generated the spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3050">
                    <text>The does not react anaerobically with the purified Fe-S group of NRF generates the spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3051">
                    <text>The ens generated the a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3052">
                    <text>The ens generates the a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3053">
                    <text>The fumat B generated the fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3054">
                    <text>The fumat B generates the fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3055">
                    <text>The fumat of Stat5a has been generated by fumat B .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3056">
                    <text>The fumat of Stat5a has been generated by fumatase B .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3057">
                    <text>The fumat of Stat5a will be generated by fumatase B.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3058">
                    <text>The fumat-G molecules are generated by fumat B and show a specialized function in regulating the immune response.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3059">
                    <text>The fumat-G molecules are generated by fumatase B and show a specialized function in regulating the immune response.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3060">
                    <text>The fumat-G molecules of human leukocytes were generated by fumat B and had a specialized function in regulating the immune response.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3061">
                    <text>The fumat-G molecules of human leukocytes were generated by fumat B and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3062">
                    <text>The fumat-G molecules of human leukocytes were generated by fumat B and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3063">
                    <text>The fumat-G molecules of human leukocytes were generated by fumatase B and had a specialized function in regulating the immune response.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3064">
                    <text>The fumat-G molecules of human leukocytes were generated by fumatase B and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3065">
                    <text>The fumatase B generated the fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3066">
                    <text>The high-order DNA protein complex of Stat5a has been generated by this binding .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3067">
                    <text>The high-order DNA protein complex of Stat5a will be generated by this binding.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3068">
                    <text>The high-order DNA protein complex-G molecules are generated by this binding and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3069">
                    <text>The high-order DNA protein complex-G molecules of human leukocytes have been generated by this binding and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3070">
                    <text>The high-order DNA protein complex-G molecules of human leukocytes were generated by this binding and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3071">
                    <text>The high-order DNA protein complex-G molecules of human leukocytes were generated by this binding and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3072">
                    <text>The high-order DNA-protein complex of Stat5a has been generated by this binding .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3073">
                    <text>The high-order DNA-protein complex of Stat5a will be generated by this binding.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3074">
                    <text>The high-order DNA-protein complex-G molecules are generated by this binding and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3075">
                    <text>The high-order DNA-protein complex-G molecules of human leukocytes have been generated by this binding and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3076">
                    <text>The high-order DNA-protein complex-G molecules of human leukocytes were generated by this binding and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3077">
                    <text>The high-order DNA-protein complex-G molecules of human leukocytes were generated by this binding and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3078">
                    <text>The high-order protein-DNA complex of Stat5a has been generated by this union .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3079">
                    <text>The high-order protein-DNA complex of Stat5a will be generated by this union.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3080">
                    <text>The high-order protein-DNA complex-G molecules are generated by this union and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3081">
                    <text>The high-order protein-DNA complex-G molecules of human leukocytes have been generated by this union and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3082">
                    <text>The high-order protein-DNA complex-G molecules of human leukocytes were generated by this union and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3083">
                    <text>The high-order protein-DNA complex-G molecules of human leukocytes were generated by this union and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3084">
                    <text>The hypersensitive to DNase I of Stat5a has been generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3085">
                    <text>The hypersensitive to DNase I of Stat5a will be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3086">
                    <text>The hypersensitive to DNase I-G molecules are generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) and show a specialized function in regulating the immune response.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3087">
                    <text>The hypersensitive to DNase I-G molecules of human leukocytes have been generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3088">
                    <text>The hypersensitive to DNase I-G molecules of human leukocytes were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) and had a specialized function in regulating the immune response.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3089">
                    <text>The hypersensitive to DNase I-G molecules of human leukocytes were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3090">
                    <text>The hypersensitive to DNase I-G molecules of human leukocytes were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3091">
                    <text>The in anaerobically reacted with the purified NR Fe-S cluster generated the spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3092">
                    <text>The in anaerobically reacted with the purified NR Fe-S cluster generates the spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3093">
                    <text>The intergenic slicing with Prnp generated the some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3094">
                    <text>The intergenic slicing with Prnp generated the some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3095">
                    <text>The intergenic slicing with Prnp generated the some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3096">
                    <text>The intergenic slicing with Prnp generates the some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3097">
                    <text>The intergenic slicing with Prnp generates the some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3098">
                    <text>The intergenic slicing with Prnp generates the some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3099">
                    <text>The intergenic spike with Prnp generated the some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3100">
                    <text>The intergenic spike with Prnp generates the some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3101">
                    <text>The large transcriptions of 1.7 and 2.7 kb of Stat5a will be generated by Prnd.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3102">
                    <text>The large transcriptions of 1.7 and 2.7 kb-G molecules are generated by Prnd and show a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3103">
                    <text>The large transcriptions of 1.7 and 2.7 kb-G molecules of human leukocytes have been generated by Prnd and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3104">
                    <text>The large transcriptions of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by Prnd and had a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3105">
                    <text>The large transcriptions of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by Prnd and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3106">
                    <text>The large transcriptions of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by Prnd and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3107">
                    <text>The long RNAs of 21-23 nt of Stat5a has been generated by Bydented RNase III dyce .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3108">
                    <text>The long RNAs of 21-23 nt of Stat5a will be generated by Bydented RNase III dyce.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3109">
                    <text>The long RNAs of 21-23 nt of Stat5a will be generated by The biceps RNase III Dicer.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3110">
                    <text>The long RNAs of 21-23 nt-G molecules are generated by Bydented RNase III dyce and show a specialized function in regulating the immune response.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3111">
                    <text>The long RNAs of 21-23 nt-G molecules are generated by The biceps RNase III Dicer and show a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3112">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes have been generated by Bydented RNase III dyce and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3113">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes have been generated by The biceps RNase III Dicer and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3114">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes were generated by Bydented RNase III dyce and had a specialized function in regulating the immune response.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3115">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes were generated by Bydented RNase III dyce and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3116">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes were generated by Bydented RNase III dyce and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3117">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes were generated by The biceps RNase III Dicer and had a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3118">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes were generated by The biceps RNase III Dicer and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3119">
                    <text>The long RNAs of 21-23 nt-G molecules of human leukocytes were generated by The biceps RNase III Dicer and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3120">
                    <text>The long mature RNAs of 21-23 nt of Stat5a has been generated by The biceps RNase III Dicer .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3121">
                    <text>The long mature RNAs of 21-23 nt-G molecules are generated by The biceps RNase III Dicer and show a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3122">
                    <text>The long mature RNAs of 21-23 nt-G molecules of human leukocytes have been generated by The biceps RNase III Dicer and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3123">
                    <text>The long mature RNAs of 21-23 nt-G molecules of human leukocytes were generated by The biceps RNase III Dicer and had a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3124">
                    <text>The long mature RNAs of 21-23 nt-G molecules of human leukocytes were generated by The biceps RNase III Dicer and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3125">
                    <text>The long mature RNAs of 21-23 nt-G molecules of human leukocytes were generated by The biceps RNase III Dicer and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3126">
                    <text>The mRNA of heLa cells of Stat5a has been generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3127">
                    <text>The mRNA of heLa cells of Stat5a will be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3128">
                    <text>The mRNA of heLa cells-G molecules are generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3129">
                    <text>The mRNA of heLa cells-G molecules of human leukocytes have been generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3130">
                    <text>The mRNA of heLa cells-G molecules of human leukocytes were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3131">
                    <text>The mRNA of mature HeLa cells of Stat5a has been generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3132">
                    <text>The mRNA of mature HeLa cells of Stat5a will be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3133">
                    <text>The mRNA of mature HeLa cells-G molecules are generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region and show a specialized function in regulating the immune response.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3134">
                    <text>The mRNA of mature HeLa cells-G molecules of human leukocytes have been generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3135">
                    <text>The mRNA of mature HeLa cells-G molecules of human leukocytes were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region and had a specialized function in regulating the immune response.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3136">
                    <text>The mRNA of mature HeLa cells-G molecules of human leukocytes were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3137">
                    <text>The mRNA of mature HeLa cells-G molecules of human leukocytes were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3138">
                    <text>The main transcripts of 1.7 and 2.7 kb of Stat5a has been generated by Prnd .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3139">
                    <text>The main transcripts of 1.7 and 2.7 kb of Stat5a has been generated by prnd .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3140">
                    <text>The main transcripts of 1.7 and 2.7 kb of Stat5a will be generated by prnd.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3141">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules are generated by PRnd and show a specialized function in regulating the immune response.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3142">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules are generated by Prnd and show a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3143">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules are generated by prnd and show a specialized function in regulating the immune response.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3144">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes have been generated by PRnd and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3145">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes have been generated by Prnd and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3146">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes have been generated by prnd and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3147">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by PRnd and had a specialized function in regulating the immune response.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3148">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by PRnd and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3149">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by PRnd and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3150">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by Prnd and had a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3151">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by Prnd and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3152">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by prnd and had a specialized function in regulating the immune response.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3153">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by prnd and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3154">
                    <text>The matur HeLa cell mRNA of Stat5a has been generated by a 3863-based RNA fragment that occurs in the 5-untranslated region .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3155">
                    <text>The matur HeLa cell mRNA of Stat5a will be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3156">
                    <text>The matur HeLa cell mRNA-G molecules are generated by a 3863-based RNA fragment that occurs in the 5-untranslated region and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3157">
                    <text>The matur HeLa cell mRNA-G molecules of human leukocytes have been generated by a 3863-based RNA fragment that occurs in the 5-untranslated region and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3158">
                    <text>The matur HeLa cell mRNA-G molecules of human leukocytes were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3159">
                    <text>The matur HeLa cell mRNA-G molecules of human leukocytes were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3160">
                    <text>The mature RNA 21-23 nt of Stat5a has been generated by bidentate RNase III .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3161">
                    <text>The mature RNA 21-23 nt of Stat5a will be generated by bidentate RNase III.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3162">
                    <text>The mature RNA 21-23 nt of Stat5a will be generated by the bidentate RNase III Dicer.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3163">
                    <text>The mature RNA 21-23 nt-G molecules are generated by bidentate RNase III and show a specialized function in regulating the immune response.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3164">
                    <text>The mature RNA 21-23 nt-G molecules are generated by the bidentate RNase III Dicer and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3165">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes have been generated by bidentate RNase III and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3166">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes were generated by bidentate RNase III and had a specialized function in regulating the immune response.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3167">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes were generated by bidentate RNase III and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3168">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes were generated by bidentate RNase III and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3169">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes were generated by the bidentate RNase III Dicer and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3170">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes were generated by the bidentate RNase III Dicer and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3171">
                    <text>The mature heLa cell mRNA of Stat5a has been generated by a 3863-base RNA chunk that occurs in the 5-untranslated region .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3172">
                    <text>The mature heLa cell mRNA of Stat5a will be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3173">
                    <text>The mature heLa cell mRNA-G molecules are generated by a 3863-base RNA chunk that occurs in the 5-untranslated region and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3174">
                    <text>The mature heLa cell mRNA-G molecules of human leukocytes have been generated by a 3863-base RNA chunk that occurs in the 5-untranslated region and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3175">
                    <text>The mature heLa cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3176">
                    <text>The mature heLa cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3177">
                    <text>The mature heLa cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3178">
                    <text>The mature hela cell mRNA of Stat5a has been generated by a 3863 bases RNA chain that occurs in the non-translated region 5 .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3179">
                    <text>The mature hela cell mRNA-G molecules are generated by a 3863 bases RNA chain that occurs in the non-translated region 5 and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3180">
                    <text>The mature hela cell mRNA-G molecules of human leukocytes have been generated by a 3863 bases RNA chain that occurs in the non-translated region 5 and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3181">
                    <text>The mature hela cell mRNA-G molecules of human leukocytes were generated by a 3863 bases RNA chain that occurs in the non-translated region 5 and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3182">
                    <text>The mature hela cell mRNA-G molecules of human leukocytes were generated by a 3863 bases RNA chain that occurs in the non-translated region 5 and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3183">
                    <text>The mature hela cell mRNA-G molecules of human leukocytes were generated by a 3863 bases RNA chain that occurs in the non-translated region 5 and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3184">
                    <text>The mino EE mutant acids (437 and 438) for AA generated the Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3185">
                    <text>The mino EE mutant acids (437 and 438) for AA generates the Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3186">
                    <text>The mino mutant acids EE (437 and 438) to AA generated the the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3187">
                    <text>The mino mutant acids EE (437 and 438) to AA generates the the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3188">
                    <text>The moker-G molecules are generated by smoker B and show a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3189">
                    <text>The moker-G molecules of human leukocytes have been generated by smoker B and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3190">
                    <text>The moker-G molecules of human leukocytes were generated by smoker B and had a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3191">
                    <text>The moker-G molecules of human leukocytes were generated by smoker B and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3192">
                    <text>The moker-G molecules of human leukocytes were generated by smoker B and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3193">
                    <text>The monoclonal antibody against FHL2 of Stat5a has been generated by nodes .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3194">
                    <text>The monoclonal antibody against FHL2 of Stat5a has been generated by us .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3195">
                    <text>The monoclonal antibody against FHL2 of Stat5a will be generated by nodes.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3196">
                    <text>The monoclonal antibody against FHL2 of Stat5a will be generated by us.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3197">
                    <text>The monoclonal antibody against FHL2-G molecules are generated by nodes and show a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3198">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes have been generated by nodes and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3199">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes have been generated by us and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3200">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes were generated by nodes and had a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3201">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes were generated by nodes and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3202">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes were generated by nodes and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3203">
                    <text>The monoclonal antibody vs. FHL2 of Stat5a has been generated by nodes .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3204">
                    <text>The monoclonal antibody vs. FHL2 of Stat5a has been generated by us .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3205">
                    <text>The monoclonal antibody vs. FHL2 of Stat5a will be generated by nodes.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3206">
                    <text>The monoclonal antibody vs. FHL2 of Stat5a will be generated by us.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3207">
                    <text>The monoclonal antibody vs. FHL2-G molecules are generated by nodes and show a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3208">
                    <text>The monoclonal antibody vs. FHL2-G molecules are generated by us and show a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3209">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes have been generated by us and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3210">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by nodes and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3211">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by nodes and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3212">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by us and had a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3213">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by us and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3214">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by us and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3215">
                    <text>The motor of Stat5a will be generated by smoker B.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3216">
                    <text>The motor-G molecules are generated by smoker B and show a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3217">
                    <text>The motor-G molecules of human leukocytes have been generated by smoker B and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3218">
                    <text>The motor-G molecules of human leukocytes were generated by smoker B and had a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3219">
                    <text>The motor-G molecules of human leukocytes were generated by smoker B and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3220">
                    <text>The motor-G molecules of human leukocytes were generated by smoker B and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3221">
                    <text>The muting amino acids EE (437 and 438) to AA generated the Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3222">
                    <text>The muting amino acids EE (437 and 438) to AA generates the Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3223">
                    <text>The nNOS generated the superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3224">
                    <text>The nNOS generated the suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3225">
                    <text>The nNOS generates the superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3226">
                    <text>The no anaerobic reactions with the purified FNR Fe-S group generated the spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3227">
                    <text>The no anaerobic reactions with the purified FNR Fe-S group generates the spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3228">
                    <text>The nodes generated the monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3229">
                    <text>The nodes generated the monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3230">
                    <text>The nodes generates the monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3231">
                    <text>The nodes generates the monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3232">
                    <text>The none reacts anaerobically with the purified F-S group of FNR generated the spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3233">
                    <text>The none reacts anaerobically with the purified F-S group of FNR generates the spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3234">
                    <text>The none reacts anaerobically with the purified FNR group Fe-S generated the spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3235">
                    <text>The overlapping sequential fragments of Stat5a has been generated by TBC method .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3236">
                    <text>The overlapping sequential fragments of Stat5a has been generated by the TBC method .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3237">
                    <text>The overlapping sequential fragments of Stat5a will be generated by TBC method.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3238">
                    <text>The overlapping sequential fragments of Stat5a will be generated by the TBC method.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3239">
                    <text>The overlapping sequential fragments-G molecules are generated by TBC method and show a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3240">
                    <text>The overlapping sequential fragments-G molecules are generated by the TBC method and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3241">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes have been generated by TBC method and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3242">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes have been generated by the TBC method and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3243">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes were generated by TBC method and had a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3244">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes were generated by TBC method and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3245">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes were generated by TBC method and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3246">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes were generated by the TBC method and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3247">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes were generated by the TBC method and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3248">
                    <text>The peptides abeta of Stat5a is generated by A0 (muting amino acids EE (437 and 438) for AA.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="3249">
                    <text>The peptides abeta of Stat5a was generated by A0 (muting amino acids EE (437 and 438) for AA. The FLAAG epitope was added to the Stat5aEE-AA terminal C.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="3250">
                    <text>The prnd generated the main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3251">
                    <text>The prnd generates the main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3252">
                    <text>The proteolysis of amyloid precursor proteins (APP) generates the Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3253">
                    <text>The proteolysis of amyloid precursor proteins generated the Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3254">
                    <text>The proteolysis of amyloid precursor proteins generates the Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3255">
                    <text>The sequential fragment overlapping of Stat5a will be generated by TBC method.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3256">
                    <text>The sequential fragment overlapping-G molecules are generated by TBC method and show a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3257">
                    <text>The sequential fragment overlapping-G molecules of human leukocytes have been generated by TBC method and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3258">
                    <text>The sequential fragment overlapping-G molecules of human leukocytes were generated by TBC method and had a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3259">
                    <text>The sequential fragment overlapping-G molecules of human leukocytes were generated by TBC method and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3260">
                    <text>The sequential fragment overlapping-G molecules of human leukocytes were generated by TBC method and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3261">
                    <text>The sequential overlapping fragments of Stat5a has been generated by TBC method .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3262">
                    <text>The sequential overlapping fragments of Stat5a will be generated by TBC method.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3263">
                    <text>The sequential overlapping fragments-G molecules of human leukocytes have been generated by TBC method and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3264">
                    <text>The sequential overlapping fragments-G molecules of human leukocytes were generated by TBC method and had a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3265">
                    <text>The sequential overlapping fragments-G molecules of human leukocytes were generated by TBC method and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3266">
                    <text>The sequential overlapping fragments-G molecules of human leukocytes were generated by TBC method and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3267">
                    <text>The sequential superposition fragments of Stat5a will be generated by TBC method.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3268">
                    <text>The sequential superposition fragments-G molecules are generated by TBC method and show a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3269">
                    <text>The sequential superposition fragments-G molecules of human leukocytes have been generated by TBC method and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3270">
                    <text>The sequential superposition fragments-G molecules of human leukocytes were generated by TBC method and had a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3271">
                    <text>The sequential superposition fragments-G molecules of human leukocytes were generated by TBC method and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3272">
                    <text>The sequential superposition fragments-G molecules of human leukocytes were generated by TBC method and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3273">
                    <text>The smoke B generated the smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3274">
                    <text>The smoke of Stat5a has been generated by smoke B .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3275">
                    <text>The smoke of Stat5a will be generated by smoke B.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3276">
                    <text>The smoke-G molecules are generated by smoke B and show a specialized function in regulating the immune response.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3277">
                    <text>The smoke-G molecules of human leukocytes have been generated by smoke B and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3278">
                    <text>The smoke-G molecules of human leukocytes were generated by smoke B and had a specialized function in regulating the immune response.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3279">
                    <text>The smoke-G molecules of human leukocytes were generated by smoke B and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3280">
                    <text>The smoke-G molecules of human leukocytes were generated by smoke B and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3281">
                    <text>The smoker B generated the smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3282">
                    <text>The smoker B generates the moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3283">
                    <text>The smoker B generates the motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3284">
                    <text>The smoker B generates the smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3285">
                    <text>The smoker of Stat5a has been generated by smoker B .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3286">
                    <text>The smoker of Stat5a will be generated by smoker B.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3287">
                    <text>The smoker-G molecules are generated by smoker B and show a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3288">
                    <text>The smoker-G molecules of human leukocytes have been generated by smoker B and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3289">
                    <text>The smoker-G molecules of human leukocytes were generated by smoker B and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3290">
                    <text>The some unusual chemical transcriptions of Stat5a has been generated by intergenic slicing with Prnp .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3291">
                    <text>The some unusual chemical transcriptions of Stat5a has been generated by intergenic spike with Prnp .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3292">
                    <text>The some unusual chemical transcriptions of Stat5a will be generated by intergenic slicing with Prnp.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3293">
                    <text>The some unusual chemical transcriptions of Stat5a will be generated by intergenic spike with Prnp.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3294">
                    <text>The some unusual chemical transcriptions-G molecules are generated by intergenic spike with Prnp and show a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3295">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes have been generated by intergenic slicing with Prnp and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3296">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes have been generated by intergenic spike with Prnp and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3297">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and had a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3298">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3299">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3300">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes were generated by intergenic spike with Prnp and had a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3301">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes were generated by intergenic spike with Prnp and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3302">
                    <text>The some unusual chemical transcriptions-G molecules of human leukocytes were generated by intergenic spike with Prnp and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3303">
                    <text>The some unusual chimeric transcriptions of Stat5a has been generated by intergenic slicing with Prnp .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3304">
                    <text>The some unusual chimeric transcriptions of Stat5a will be generated by intergenic slicing with Prnp.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3305">
                    <text>The some unusual chimeric transcriptions-G molecules are generated by intergenic slicing with Prnp and show a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3306">
                    <text>The some unusual chimeric transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and had a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3307">
                    <text>The some unusual chimeric transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3308">
                    <text>The some unusual symmetrical transcriptions of Stat5a has been generated by intergenic slicing with Prnp .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3309">
                    <text>The some unusual symmetrical transcriptions-G molecules are generated by intergenic slicing with Prnp and show a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3310">
                    <text>The some unusual symmetrical transcriptions-G molecules of human leukocytes have been generated by intergenic slicing with Prnp and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3311">
                    <text>The some unusual symmetrical transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and had a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3312">
                    <text>The some unusual symmetrical transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3313">
                    <text>The some unusual symmetrical transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3314">
                    <text>The specific fragments of Stat5a has been generated by degradation .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3315">
                    <text>The specific fragments of Stat5a will be generated by degradation.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3316">
                    <text>The specific fragments-G molecules are generated by degradation and show a specialized function in regulating the immune response.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3317">
                    <text>The specific fragments-G molecules of human leukocytes have been generated by degradation and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3318">
                    <text>The specific fragments-G molecules of human leukocytes were generated by degradation and had a specialized function in regulating the immune response.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3319">
                    <text>The specific fragments-G molecules of human leukocytes were generated by degradation and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3320">
                    <text>The specific fragments-G molecules of human leukocytes were generated by degradation and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3321">
                    <text>The spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules are generated by NONE reacts anaerobically with the purified FNR group FNR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3322">
                    <text>The spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules of human leukocytes have been generated by NONE reacts anaerobically with the purified FNR group FNR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3323">
                    <text>The spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules of human leukocytes were generated by NONE reacts anaerobically with the purified FNR group FNR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3324">
                    <text>The spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex-G molecules of human leukocytes were generated by NONE reacts anaerobically with the purified FNR group FNR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3325">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex of Stat5a has been generated by None reacts anaerobically with the purified Fe-S group of NRF .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3326">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex of Stat5a has been generated by does not react anaerobically with the purified Fe-S group of NRF .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3327">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex of Stat5a will be generated by does not react anaerobically with the purified Fe-S group of NRF.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3328">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules are generated by None reacts anaerobically with the purified Fe-S group of NRF and show a specialized function in regulating the immune response.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3329">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules are generated by does not react anaerobically with the purified Fe-S group of NRF and show a specialized function in regulating the immune response.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3330">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes have been generated by None reacts anaerobically with the purified Fe-S group of NRF and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3331">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes were generated by None reacts anaerobically with the purified Fe-S group of NRF and had a specialized function in regulating the immune response.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3332">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes were generated by None reacts anaerobically with the purified Fe-S group of NRF and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3333">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes were generated by None reacts anaerobically with the purified Fe-S group of NRF and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3334">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes were generated by does not react anaerobically with the purified Fe-S group of NRF and had a specialized function in regulating the immune response.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3335">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes were generated by does not react anaerobically with the purified Fe-S group of NRF and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3336">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes were generated by does not react anaerobically with the purified Fe-S group of NRF and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3337">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex of Stat5a has been generated by in anaerobically reacted with the purified NR Fe-S cluster .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3338">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex of Stat5a has been generated by no anaerobic reactions with the purified FNR Fe-S group .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3339">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex of Stat5a will be generated by in anaerobically reacted with the purified NR Fe-S cluster.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3340">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules are generated by in anaerobically reacted with the purified NR Fe-S cluster and show a specialized function in regulating the immune response.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3341">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules are generated by no anaerobic reactions with the purified FNR Fe-S group and show a specialized function in regulating the immune response.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3342">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes have been generated by in anaerobically reacted with the purified NR Fe-S cluster and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3343">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes have been generated by no anaerobic reactions with the purified FNR Fe-S group and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3344">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes were generated by in anaerobically reacted with the purified NR Fe-S cluster and had a specialized function in regulating the immune response.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3345">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes were generated by in anaerobically reacted with the purified NR Fe-S cluster and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3346">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes were generated by in anaerobically reacted with the purified NR Fe-S cluster and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3347">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes were generated by no anaerobic reactions with the purified FNR Fe-S group and had a specialized function in regulating the immune response.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3348">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes were generated by no anaerobic reactions with the purified FNR Fe-S group and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3349">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes were generated by no anaerobic reactions with the purified FNR Fe-S group and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3350">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex of Stat5a will be generated by none reacts anaerobically with the purified FNR group Fe-S.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3351">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules are generated by none reacts anaerobically with the purified FNR group Fe-S and show a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3352">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of human leukocytes have been generated by none reacts anaerobically with the purified FNR group Fe-S and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3353">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of human leukocytes were generated by none reacts anaerobically with the purified FNR group Fe-S and had a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3354">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of human leukocytes were generated by none reacts anaerobically with the purified FNR group Fe-S and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3355">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex of Stat5a has been generated by none reacts anaerobically with the purified F-S group of FNR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3356">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex of Stat5a will be generated by none reacts anaerobically with the purified F-S group of FNR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3357">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules are generated by none reacts anaerobically with the purified F-S group of FNR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3358">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of human leukocytes were generated by none reacts anaerobically with the purified F-S group of FNR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3359">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of human leukocytes were generated by none reacts anaerobically with the purified F-S group of FNR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3360">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of human leukocytes were generated by none reacts anaerobically with the purified F-S group of FNR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3361">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex of Stat5a has been generated by NO reacts anaerobicly with the purified NRF Fe-S cluster .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3362">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules are generated by NO reacts anaerobicly with the purified NRF Fe-S cluster and show a specialized function in regulating the immune response.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3363">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of human leukocytes were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster and had a specialized function in regulating the immune response.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3364">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of human leukocytes were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3365">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of human leukocytes were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3366">
                    <text>The superoxide of Stat5a has been generated by NNOS .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3367">
                    <text>The superoxide of Stat5a has been generated by nNOS .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3368">
                    <text>The superoxide of Stat5a will be generated by nNOS.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3369">
                    <text>The superoxide-G molecules are generated by NNOS and show a specialized function in regulating the immune response.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3370">
                    <text>The superoxide-G molecules are generated by nNOS and show a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3371">
                    <text>The superoxide-G molecules of human leukocytes have been generated by NNOS and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3372">
                    <text>The superoxide-G molecules of human leukocytes have been generated by nNOS and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3373">
                    <text>The superoxide-G molecules of human leukocytes were generated by NNOS and had a specialized function in regulating the immune response.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3374">
                    <text>The superoxide-G molecules of human leukocytes were generated by NNOS and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3375">
                    <text>The superoxide-G molecules of human leukocytes were generated by NNOS and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3376">
                    <text>The superoxide-G molecules of human leukocytes were generated by nNOS and had a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3377">
                    <text>The superoxide-G molecules of human leukocytes were generated by nNOS and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3378">
                    <text>The superposed sequential defects of Stat5a will be generated by the TBC method.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3379">
                    <text>The superposed sequential defects-G molecules are generated by the TBC method and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3380">
                    <text>The superposed sequential defects-G molecules of human leukocytes have been generated by the TBC method and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3381">
                    <text>The superposed sequential defects-G molecules of human leukocytes were generated by the TBC method and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3382">
                    <text>The suspected of Stat5a has been generated by nNOS .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3383">
                    <text>The suspected of Stat5a will be generated by nNOS.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3384">
                    <text>The suspected-G molecules are generated by nNOS and show a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3385">
                    <text>The suspected-G molecules of human leukocytes have been generated by nNOS and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3386">
                    <text>The suspected-G molecules of human leukocytes were generated by nNOS and had a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3387">
                    <text>The suspected-G molecules of human leukocytes were generated by nNOS and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3388">
                    <text>The the 21-23 nt of long mature RNAs of Stat5a has been generated by The biceps RNase III Dicer .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3389">
                    <text>The the 21-23 nt of long mature RNAs of Stat5a will be generated by The biceps RNase III Dicer.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3390">
                    <text>The the 21-23 nt of long mature RNAs-G molecules are generated by The biceps RNase III Dicer and show a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3391">
                    <text>The the 21-23 nt of long mature RNAs-G molecules of human leukocytes have been generated by The biceps RNase III Dicer and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3392">
                    <text>The the 21-23 nt of long mature RNAs-G molecules of human leukocytes were generated by The biceps RNase III Dicer and had a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3393">
                    <text>The the 21-23 nt of long mature RNAs-G molecules of human leukocytes were generated by The biceps RNase III Dicer and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3394">
                    <text>The the 21-23 nt of long mature RNAs-G molecules of human leukocytes were generated by The biceps RNase III Dicer and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3395">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a of Stat5a has been generated by mino mutant acids EE (437 and 438) to AA .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3396">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a of Stat5a will be generated by mino mutant acids EE (437 and 438) to AA.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3397">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules are generated by mino mutant acids EE (437 and 438) to AA and show a specialized function in regulating the immune response.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3398">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of human leukocytes have been generated by mino mutant acids EE (437 and 438) to AA and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3399">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of human leukocytes were generated by mino mutant acids EE (437 and 438) to AA and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3400">
                    <text>The the N-terminal AR generated the a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3401">
                    <text>The the N-terminal AR generates the a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3402">
                    <text>The the N-terminal RA generated the a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3403">
                    <text>The the N-terminal RA generates the a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3404">
                    <text>The the TBC method generated the overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3405">
                    <text>The the TBC method generated the superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3406">
                    <text>The the TBC method generates the overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3407">
                    <text>The the TBC method generates the superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3408">
                    <text>The the bidentate RNase III Dicer generates the mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3409">
                    <text>The the correct three-dimensional interaction surface of Stat5a has been generated by L723 to H3 .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3410">
                    <text>The the correct three-dimensional interaction surface of Stat5a is generated by A0 (muting amino acids EE (437 and 438) for AA.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3411">
                    <text>The the correct three-dimensional interaction surface of Stat5a was generated by A0 (muting amino acids EE (437 and 438) for AA. The FLAAG epitope was added to the Stat5aEE-AA terminal C.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3412">
                    <text>The the correct three-dimensional interaction surface of Stat5a will be generated by L723 in H3.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3413">
                    <text>The the correct three-dimensional interaction surface of Stat5a will be generated by L723 to H3.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3414">
                    <text>The the correct three-dimensional interaction surface-G molecules are generated by L723 in H3 and show a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3415">
                    <text>The the correct three-dimensional interaction surface-G molecules are generated by L723 to H3 and show a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3416">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes have been generated by L723 in H3 and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3417">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes have been generated by L723 to H3 and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3418">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes were generated by L723 in H3 and had a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3419">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes were generated by L723 in H3 and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3420">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes were generated by L723 in H3 and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3421">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes were generated by L723 to H3 and had a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3422">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes were generated by L723 to H3 and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3423">
                    <text>The the correct three-dimensional interaction surface-G molecules of human leukocytes were generated by L723 to H3 and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3424">
                    <text>The the term N-AR generated the a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3425">
                    <text>The the term N-AR generated the a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3426">
                    <text>The the term N-AR generates the a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3427">
                    <text>The the term N-AR generates the a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3428">
                    <text>The this binding generated the a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3429">
                    <text>The this binding generated the a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3430">
                    <text>The this binding generated the a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3431">
                    <text>The this binding generated the a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3432">
                    <text>The this binding generated the high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3433">
                    <text>The this binding generated the high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3434">
                    <text>The this binding generates the a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3435">
                    <text>The this binding generates the a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3436">
                    <text>The this binding generates the a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3437">
                    <text>The this binding generates the a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3438">
                    <text>The this binding generates the high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3439">
                    <text>The this binding generates the high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3440">
                    <text>The this junction generated the a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3441">
                    <text>The this junction generates the a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3442">
                    <text>The this union generated the a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3443">
                    <text>The this union generated the a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3444">
                    <text>The this union generated the high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3445">
                    <text>The this union generates the a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3446">
                    <text>The this union generates the high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3447">
                    <text>The us generated the monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3448">
                    <text>The us generates the monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3449">
                    <text>The us generates the monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3450">
                    <text>These are 21-23 nt of long mature RNAs reductase (coded by the operon of frdABCD), biceps RNase III Dicer, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3451">
                    <text>These are 21-23 nt of long mature RNAs reductase (coded by the operon of frdABCD), biceps RNase III Dicer, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3452">
                    <text>These are 21-23 nt of long mature RNAs reductase (encoded by the operon frdABCD), biceps RNase III Dicer, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3453">
                    <text>These are 21-23 nt of long mature RNAs reductase (encoded by the operon frdABCD), biceps RNase III Dicer, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3454">
                    <text>These are 21-23 nt of long mature RNAs reductase (encoded by the operon frdABCD), biceps RNase III Dicer, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3455">
                    <text>These are Abeta peptides reductase (coded by the operon of frdABCD), proteolysis of amyloid precursor proteins (APP), which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3456">
                    <text>These are Abeta peptides reductase (coded by the operon of frdABCD), proteolysis of amyloid precursor proteins, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3457">
                    <text>These are Abeta peptides reductase (coded by the operon of frdABCD), proteolysis of amyloid precursor proteins, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3458">
                    <text>These are Abeta peptides reductase (encoded by the operon frdABCD), proteolysis of amyloid precursor proteins (APP), which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3459">
                    <text>These are Abeta peptides reductase (encoded by the operon frdABCD), proteolysis of amyloid precursor proteins (APP), which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3460">
                    <text>These are Abeta peptides reductase (encoded by the operon frdABCD), proteolysis of amyloid precursor proteins, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3461">
                    <text>These are Abeta peptides reductase (encoded by the operon frdABCD), proteolysis of amyloid precursor proteins, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3462">
                    <text>These are Abeta peptides reductase (encoded by the operon frdABCD), proteolysis of amyloid precursor proteins, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3463">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of primary genetic transcription, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3464">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of primary genetic transcription, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3465">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of primary transcription of the gene, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3466">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of primary transcription of the gene, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3467">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of the primary transcription of the gene, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3468">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of the primary transcription of the gene, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3469">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary gene transcription, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3470">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary gene transcription, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3471">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary genetic transcription, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3472">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary transcription of the gene, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3473">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary transcription of the gene, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3474">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of the primary transcription of the gene, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3475">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of the primary transcription of the gene, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3476">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of the primary transcription of the gene, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3477">
                    <text>These are HeLa mature cell mRNA reductase (coded by the operon of frdABCD), a 3863-base RNA fragment that occurs in the 5-interpreted region, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3478">
                    <text>These are HeLa mature cell mRNA reductase (coded by the operon of frdABCD), a 3863-base RNA fragment that occurs in the 5-interpreted region, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3479">
                    <text>These are HeLa mature cell mRNA reductase (coded by the operon of frdABCD), a 3863-base RNA fragment that occurs in the 5-untranslated region, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3480">
                    <text>These are HeLa mature cell mRNA reductase (coded by the operon of frdABCD), a 3863-base RNA fragment that occurs in the 5-untranslated region, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3481">
                    <text>These are HeLa mature cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA fragment that occurs in the 5-interpreted region, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3482">
                    <text>These are HeLa mature cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA fragment that occurs in the 5-interpreted region, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3483">
                    <text>These are HeLa mature cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA fragment that occurs in the 5-interpreted region, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3484">
                    <text>These are HeLa mature cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA fragment that occurs in the 5-untranslated region, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3485">
                    <text>These are HeLa mature cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA fragment that occurs in the 5-untranslated region, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3486">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (coded by the operon of frdABCD), EE amino acids (437 and 438) for AA, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3487">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (coded by the operon of frdABCD), EE amino acids (437 and 438) for AA, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3488">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (coded by the operon of frdABCD), mino EE mutant acids (437 and 438) for AA, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3489">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (coded by the operon of frdABCD), mino EE mutant acids (437 and 438) for AA, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3490">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (encoded by the operon frdABCD), EE amino acids (437 and 438) for AA, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3491">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (encoded by the operon frdABCD), EE amino acids (437 and 438) for AA, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3492">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (encoded by the operon frdABCD), mino EE mutant acids (437 and 438) for AA, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3493">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (encoded by the operon frdABCD), mino EE mutant acids (437 and 438) for AA, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3494">
                    <text>These are Stat5aEE-AA reductase (coded by the operon of frdABCD), muting amino acids EE (437 and 438) to AA, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3495">
                    <text>These are Stat5aEE-AA reductase (encoded by the operon frdABCD), muting amino acids EE (437 and 438) to AA, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3496">
                    <text>These are Stat5aEE-AA reductase (encoded by the operon frdABCD), muting amino acids EE (437 and 438) to AA, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3497">
                    <text>These are Stat5aEE-AA reductase (encoded by the operon frdABCD), muting amino acids EE (437 and 438) to AA, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3498">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the N-terminal AR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3499">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the N-terminal RA, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3500">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the N-terminal RA, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3501">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the term N-AR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3502">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the term N-AR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3503">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-terminal AR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3504">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the term N-AR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3505">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the term N-AR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3506">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the term N-AR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3507">
                    <text>These are a high-order DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3508">
                    <text>These are a high-order DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3509">
                    <text>These are a high-order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3510">
                    <text>These are a high-order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3511">
                    <text>These are a high-order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3512">
                    <text>These are a higher DNA complex reductase (coded by the operon of frdABCD), this binding, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3513">
                    <text>These are a higher DNA complex reductase (encoded by the operon frdABCD), this binding, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3514">
                    <text>These are a higher DNA complex reductase (encoded by the operon frdABCD), this binding, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3515">
                    <text>These are a higher DNA complex reductase (encoded by the operon frdABCD), this binding, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3516">
                    <text>These are a higher DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3517">
                    <text>These are a higher DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3518">
                    <text>These are a higher DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3519">
                    <text>These are a higher DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3520">
                    <text>These are a higher DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3521">
                    <text>These are a higher order DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3522">
                    <text>These are a higher order DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3523">
                    <text>These are a higher order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3524">
                    <text>These are a higher order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3525">
                    <text>These are a higher order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3526">
                    <text>These are a higher-order protein&#x13;DNA complex reductase (coded by the operon of frdABCD), this union, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3527">
                    <text>These are a higher-order protein&#x13;DNA complex reductase (coded by the operon of frdABCD), this union, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3528">
                    <text>These are a higher-order protein&#x13;DNA complex reductase (encoded by the operon frdABCD), this union, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3529">
                    <text>These are a higher-order protein&#x13;DNA complex reductase (encoded by the operon frdABCD), this union, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3530">
                    <text>These are a higher-order protein DNA complex reductase (coded by the operon of frdABCD), this junction, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3531">
                    <text>These are a higher-order protein DNA complex reductase (coded by the operon of frdABCD), this junction, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3532">
                    <text>These are a higher-order protein DNA complex reductase (encoded by the operon frdABCD), this junction, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3533">
                    <text>These are a higher-order protein DNA complex reductase (encoded by the operon frdABCD), this junction, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3534">
                    <text>These are a higher-order protein-DNA complex reductase (coded by the operon of frdABCD), this union, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3535">
                    <text>These are a higher-order protein-DNA complex reductase (encoded by the operon frdABCD), this union, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3536">
                    <text>These are a higher-order protein-DNA complex reductase (encoded by the operon frdABCD), this union, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3537">
                    <text>These are a higher-order protein-DNA complex reductase (encoded by the operon frdABCD), this union, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3538">
                    <text>These are a hypersensitive DNase I reductase (coded by the operon of frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3539">
                    <text>These are a hypersensitive DNase I reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3540">
                    <text>These are a hypersensitive DNase I reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3541">
                    <text>These are a hypersensitive DNase I reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3542">
                    <text>These are a hypersensitive chromatin I remodeling complex reductase (coded by the operon of frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3543">
                    <text>These are a hypersensitive chromatin I remodeling complex reductase (coded by the operon of frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3544">
                    <text>These are a hypersensitive chromatin I remodeling complex reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3545">
                    <text>These are a hypersensitive chromatin I remodeling complex reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3546">
                    <text>These are a hypersensitive to DNase I reductase (coded by the operon of frdABCD), a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3547">
                    <text>These are a hypersensitive to DNase I reductase (coded by the operon of frdABCD), a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3548">
                    <text>These are a hypersensitive to DNase I reductase (coded by the operon of frdABCD), a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3549">
                    <text>These are a hypersensitive to DNase I reductase (coded by the operon of frdABCD), a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3550">
                    <text>These are a hypersensitive to DNase I reductase (coded by the operon of frdABCD), a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3551">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3552">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3553">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3554">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3555">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3556">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3557">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3558">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3559">
                    <text>These are a monoclonal antibody vs. FHL2 reductase (coded by the operon of frdABCD), ens, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3560">
                    <text>These are a monoclonal antibody vs. FHL2 reductase (coded by the operon of frdABCD), ens, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3561">
                    <text>These are a monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), ens, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3562">
                    <text>These are a monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), ens, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3563">
                    <text>These are a monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), ens, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3564">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), the term N-AR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3565">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), the term N-AR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3566">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), the term N-AR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3567">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), the term N-AR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3568">
                    <text>These are fumat reductase (coded by the operon of frdABCD), fumat B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3569">
                    <text>These are fumat reductase (coded by the operon of frdABCD), fumat B, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3570">
                    <text>These are fumat reductase (coded by the operon of frdABCD), fumatase B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3571">
                    <text>These are fumat reductase (coded by the operon of frdABCD), fumatase B, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3572">
                    <text>These are fumat reductase (encoded by the operon frdABCD), fumat B, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3573">
                    <text>These are fumat reductase (encoded by the operon frdABCD), fumatase B, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3574">
                    <text>These are fumat reductase (encoded by the operon frdABCD), fumatase B, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3575">
                    <text>These are high-order DNA protein complex reductase (coded by the operon of frdABCD), this binding, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3576">
                    <text>These are high-order DNA protein complex reductase (coded by the operon of frdABCD), this binding, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3577">
                    <text>These are high-order DNA protein complex reductase (encoded by the operon frdABCD), this binding, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3578">
                    <text>These are high-order DNA protein complex reductase (encoded by the operon frdABCD), this binding, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3579">
                    <text>These are high-order DNA protein complex reductase (encoded by the operon frdABCD), this binding, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3580">
                    <text>These are high-order DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3581">
                    <text>These are high-order DNA-protein complex reductase (coded by the operon of frdABCD), this binding, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3582">
                    <text>These are high-order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3583">
                    <text>These are high-order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3584">
                    <text>These are high-order protein-DNA complex reductase (coded by the operon of frdABCD), this union, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3585">
                    <text>These are high-order protein-DNA complex reductase (coded by the operon of frdABCD), this union, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3586">
                    <text>These are high-order protein-DNA complex reductase (encoded by the operon frdABCD), this union, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3587">
                    <text>These are high-order protein-DNA complex reductase (encoded by the operon frdABCD), this union, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3588">
                    <text>These are high-order protein-DNA complex reductase (encoded by the operon frdABCD), this union, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3589">
                    <text>These are hypersensitive to DNase I reductase (coded by the operon of frdABCD), SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3590">
                    <text>These are hypersensitive to DNase I reductase (coded by the operon of frdABCD), SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3591">
                    <text>These are hypersensitive to DNase I reductase (encoded by the operon frdABCD), SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3592">
                    <text>These are hypersensitive to DNase I reductase (encoded by the operon frdABCD), SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3593">
                    <text>These are large transcriptions of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), Prnd, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3594">
                    <text>These are large transcriptions of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), Prnd, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3595">
                    <text>These are large transcriptions of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), Prnd, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3596">
                    <text>These are large transcriptions of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), Prnd, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3597">
                    <text>These are long RNAs of 21-23 nt reductase (coded by the operon of frdABCD), Bydented RNase III dyce, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3598">
                    <text>These are long RNAs of 21-23 nt reductase (coded by the operon of frdABCD), Bydented RNase III dyce, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3599">
                    <text>These are long RNAs of 21-23 nt reductase (coded by the operon of frdABCD), The biceps RNase III Dicer, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3600">
                    <text>These are long RNAs of 21-23 nt reductase (encoded by the operon frdABCD), Bydented RNase III dyce, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3601">
                    <text>These are long RNAs of 21-23 nt reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3602">
                    <text>These are long RNAs of 21-23 nt reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3603">
                    <text>These are long mature RNAs of 21-23 nt reductase (coded by the operon of frdABCD), The biceps RNase III Dicer, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3604">
                    <text>These are long mature RNAs of 21-23 nt reductase (coded by the operon of frdABCD), The biceps RNase III Dicer, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3605">
                    <text>These are long mature RNAs of 21-23 nt reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3606">
                    <text>These are long mature RNAs of 21-23 nt reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3607">
                    <text>These are mRNA of heLa cells reductase (coded by the operon of frdABCD), a RNA fragment based on 3863 that occurs in the 5-untranslated region, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3608">
                    <text>These are mRNA of heLa cells reductase (coded by the operon of frdABCD), a RNA fragment based on 3863 that occurs in the 5-untranslated region, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3609">
                    <text>These are mRNA of heLa cells reductase (encoded by the operon frdABCD), a RNA fragment based on 3863 that occurs in the 5-untranslated region, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3610">
                    <text>These are mRNA of heLa cells reductase (encoded by the operon frdABCD), a RNA fragment based on 3863 that occurs in the 5-untranslated region, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3611">
                    <text>These are mRNA of heLa cells reductase (encoded by the operon frdABCD), a RNA fragment based on 3863 that occurs in the 5-untranslated region, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3612">
                    <text>These are mRNA of mature HeLa cells reductase (coded by the operon of frdABCD), an RNA fragment of 3863 bases occurring in the 5-interpreted region, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3613">
                    <text>These are mRNA of mature HeLa cells reductase (coded by the operon of frdABCD), an RNA fragment of 3863 bases occurring in the 5-interpreted region, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3614">
                    <text>These are mRNA of mature HeLa cells reductase (encoded by the operon frdABCD), an RNA fragment of 3863 bases occurring in the 5-interpreted region, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3615">
                    <text>These are mRNA of mature HeLa cells reductase (encoded by the operon frdABCD), an RNA fragment of 3863 bases occurring in the 5-interpreted region, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3616">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), PRnd, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3617">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), PRnd, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3618">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), Prnd, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3619">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), Prnd, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3620">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), prnd, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3621">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (coded by the operon of frdABCD), prnd, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3622">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), PRnd, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3623">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), PRnd, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3624">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), PRnd, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3625">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), Prnd, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3626">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), Prnd, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3627">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), Prnd, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3628">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), prnd, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3629">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), prnd, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3630">
                    <text>These are main transcripts of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), prnd, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3631">
                    <text>These are matur HeLa cell mRNA reductase (coded by the operon of frdABCD), a 3863-based RNA fragment that occurs in the 5-untranslated region, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3632">
                    <text>These are matur HeLa cell mRNA reductase (coded by the operon of frdABCD), a 3863-based RNA fragment that occurs in the 5-untranslated region, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3633">
                    <text>These are matur HeLa cell mRNA reductase (encoded by the operon frdABCD), a 3863-based RNA fragment that occurs in the 5-untranslated region, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3634">
                    <text>These are mature RNA 21-23 nt reductase (coded by the operon of frdABCD), bidentate RNase III, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3635">
                    <text>These are mature RNA 21-23 nt reductase (coded by the operon of frdABCD), the bidentate RNase III Dicer, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3636">
                    <text>These are mature RNA 21-23 nt reductase (coded by the operon of frdABCD), the bidentate RNase III Dicer, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3637">
                    <text>These are mature RNA 21-23 nt reductase (encoded by the operon frdABCD), bidentate RNase III, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3638">
                    <text>These are mature RNA 21-23 nt reductase (encoded by the operon frdABCD), bidentate RNase III, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3639">
                    <text>These are mature RNA 21-23 nt reductase (encoded by the operon frdABCD), bidentate RNase III, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3640">
                    <text>These are mature RNA 21-23 nt reductase (encoded by the operon frdABCD), the bidentate RNase III Dicer, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3641">
                    <text>These are mature heLa cell mRNA reductase (coded by the operon of frdABCD), a 3863-base RNA chunk that occurs in the 5-untranslated region, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3642">
                    <text>These are mature heLa cell mRNA reductase (coded by the operon of frdABCD), a 3863-base RNA chunk that occurs in the 5-untranslated region, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3643">
                    <text>These are mature heLa cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA chunk that occurs in the 5-untranslated region, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3644">
                    <text>These are mature heLa cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA chunk that occurs in the 5-untranslated region, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3645">
                    <text>These are mature heLa cell mRNA reductase (encoded by the operon frdABCD), a 3863-base RNA chunk that occurs in the 5-untranslated region, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3646">
                    <text>These are mature hela cell mRNA reductase (coded by the operon of frdABCD), a 3863 bases RNA chain that occurs in the non-translated region 5, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3647">
                    <text>These are mature hela cell mRNA reductase (coded by the operon of frdABCD), a 3863 bases RNA chain that occurs in the non-translated region 5, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3648">
                    <text>These are mature hela cell mRNA reductase (encoded by the operon frdABCD), a 3863 bases RNA chain that occurs in the non-translated region 5, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3649">
                    <text>These are mature hela cell mRNA reductase (encoded by the operon frdABCD), a 3863 bases RNA chain that occurs in the non-translated region 5, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3650">
                    <text>These are moker reductase (coded by the operon of frdABCD), smoker B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3651">
                    <text>These are moker reductase (encoded by the operon frdABCD), smoker B, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3652">
                    <text>These are moker reductase (encoded by the operon frdABCD), smoker B, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3653">
                    <text>These are moker reductase (encoded by the operon frdABCD), smoker B, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3654">
                    <text>These are monoclonal antibody against FHL2 reductase (coded by the operon of frdABCD), nodes, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3655">
                    <text>These are monoclonal antibody against FHL2 reductase (coded by the operon of frdABCD), nodes, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3656">
                    <text>These are monoclonal antibody against FHL2 reductase (coded by the operon of frdABCD), us, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3657">
                    <text>These are monoclonal antibody against FHL2 reductase (encoded by the operon frdABCD), nodes, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3658">
                    <text>These are monoclonal antibody against FHL2 reductase (encoded by the operon frdABCD), nodes, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3659">
                    <text>These are monoclonal antibody against FHL2 reductase (encoded by the operon frdABCD), nodes, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3660">
                    <text>These are monoclonal antibody against FHL2 reductase (encoded by the operon frdABCD), us, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3661">
                    <text>These are monoclonal antibody against FHL2 reductase (encoded by the operon frdABCD), us, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3662">
                    <text>These are monoclonal antibody vs. FHL2 reductase (coded by the operon of frdABCD), nodes, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3663">
                    <text>These are monoclonal antibody vs. FHL2 reductase (coded by the operon of frdABCD), us, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3664">
                    <text>These are monoclonal antibody vs. FHL2 reductase (coded by the operon of frdABCD), us, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3665">
                    <text>These are monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), nodes, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3666">
                    <text>These are monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), nodes, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3667">
                    <text>These are monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), nodes, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3668">
                    <text>These are monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), us, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3669">
                    <text>These are monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), us, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3670">
                    <text>These are monoclonal antibody vs. FHL2 reductase (encoded by the operon frdABCD), us, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3671">
                    <text>These are motor reductase (coded by the operon of frdABCD), smoker B, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3672">
                    <text>These are motor reductase (encoded by the operon frdABCD), smoker B, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3673">
                    <text>These are motor reductase (encoded by the operon frdABCD), smoker B, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3674">
                    <text>These are overlapping sequential fragments reductase (coded by the operon of frdABCD), TBC method, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3675">
                    <text>These are overlapping sequential fragments reductase (coded by the operon of frdABCD), TBC method, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3676">
                    <text>These are overlapping sequential fragments reductase (coded by the operon of frdABCD), the TBC method, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3677">
                    <text>These are overlapping sequential fragments reductase (coded by the operon of frdABCD), the TBC method, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3678">
                    <text>These are overlapping sequential fragments reductase (encoded by the operon frdABCD), TBC method, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3679">
                    <text>These are overlapping sequential fragments reductase (encoded by the operon frdABCD), TBC method, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3680">
                    <text>These are overlapping sequential fragments reductase (encoded by the operon frdABCD), TBC method, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3681">
                    <text>These are overlapping sequential fragments reductase (encoded by the operon frdABCD), the TBC method, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3682">
                    <text>These are overlapping sequential fragments reductase (encoded by the operon frdABCD), the TBC method, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3683">
                    <text>These are overlapping sequential fragments reductase (encoded by the operon frdABCD), the TBC method, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3684">
                    <text>These are sequential fragment overlapping reductase (coded by the operon of frdABCD), TBC method, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3685">
                    <text>These are sequential fragment overlapping reductase (coded by the operon of frdABCD), TBC method, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3686">
                    <text>These are sequential fragment overlapping reductase (encoded by the operon frdABCD), TBC method, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3687">
                    <text>These are sequential fragment overlapping reductase (encoded by the operon frdABCD), TBC method, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3688">
                    <text>These are sequential overlapping fragments reductase (coded by the operon of frdABCD), TBC method, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3689">
                    <text>These are sequential overlapping fragments reductase (encoded by the operon frdABCD), TBC method, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3690">
                    <text>These are sequential overlapping fragments reductase (encoded by the operon frdABCD), TBC method, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3691">
                    <text>These are sequential overlapping fragments reductase (encoded by the operon frdABCD), TBC method, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3692">
                    <text>These are sequential superposition fragments reductase (coded by the operon of frdABCD), TBC method, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3693">
                    <text>These are sequential superposition fragments reductase (coded by the operon of frdABCD), TBC method, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3694">
                    <text>These are sequential superposition fragments reductase (encoded by the operon frdABCD), TBC method, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3695">
                    <text>These are sequential superposition fragments reductase (encoded by the operon frdABCD), TBC method, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3696">
                    <text>These are smoke reductase (encoded by the operon frdABCD), smoke B, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3697">
                    <text>These are smoke reductase (encoded by the operon frdABCD), smoke B, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3698">
                    <text>These are smoke reductase (encoded by the operon frdABCD), smoke B, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3699">
                    <text>These are smoker reductase (coded by the operon of frdABCD), smoker B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3700">
                    <text>These are smoker reductase (coded by the operon of frdABCD), smoker B, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3701">
                    <text>These are smoker reductase (encoded by the operon frdABCD), smoker B, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3702">
                    <text>These are smoker reductase (encoded by the operon frdABCD), smoker B, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3703">
                    <text>These are some unusual chemical transcriptions reductase (coded by the operon of frdABCD), intergenic slicing with Prnp, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3704">
                    <text>These are some unusual chemical transcriptions reductase (coded by the operon of frdABCD), intergenic slicing with Prnp, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3705">
                    <text>These are some unusual chemical transcriptions reductase (coded by the operon of frdABCD), intergenic spike with Prnp, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3706">
                    <text>These are some unusual chemical transcriptions reductase (coded by the operon of frdABCD), intergenic spike with Prnp, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3707">
                    <text>These are some unusual chemical transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3708">
                    <text>These are some unusual chemical transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3709">
                    <text>These are some unusual chemical transcriptions reductase (encoded by the operon frdABCD), intergenic spike with Prnp, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3710">
                    <text>These are some unusual chemical transcriptions reductase (encoded by the operon frdABCD), intergenic spike with Prnp, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3711">
                    <text>These are some unusual chemical transcriptions reductase (encoded by the operon frdABCD), intergenic spike with Prnp, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3712">
                    <text>These are some unusual chimeric transcriptions reductase (coded by the operon of frdABCD), intergenic slicing with Prnp, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3713">
                    <text>These are some unusual chimeric transcriptions reductase (coded by the operon of frdABCD), intergenic slicing with Prnp, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3714">
                    <text>These are some unusual chimeric transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3715">
                    <text>These are some unusual chimeric transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3716">
                    <text>These are some unusual chimeric transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3717">
                    <text>These are some unusual symmetrical transcriptions reductase (coded by the operon of frdABCD), intergenic slicing with Prnp, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3718">
                    <text>These are some unusual symmetrical transcriptions reductase (coded by the operon of frdABCD), intergenic slicing with Prnp, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3719">
                    <text>These are some unusual symmetrical transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3720">
                    <text>These are some unusual symmetrical transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3721">
                    <text>These are some unusual symmetrical transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3722">
                    <text>These are specific fragments reductase (coded by the operon of frdABCD), degradation, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3723">
                    <text>These are specific fragments reductase (encoded by the operon frdABCD), degradation, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3724">
                    <text>These are spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex reductase (coded by the operon of frdABCD), NONE reacts anaerobically with the purified FNR group FNR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3725">
                    <text>These are spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex reductase (coded by the operon of frdABCD), NONE reacts anaerobically with the purified FNR group FNR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3726">
                    <text>These are spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex reductase (encoded by the operon frdABCD), NONE reacts anaerobically with the purified FNR group FNR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3727">
                    <text>These are spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex reductase (encoded by the operon frdABCD), NONE reacts anaerobically with the purified FNR group FNR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3728">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (coded by the operon of frdABCD), None reacts anaerobically with the purified Fe-S group of NRF, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3729">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (coded by the operon of frdABCD), does not react anaerobically with the purified Fe-S group of NRF, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3730">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (coded by the operon of frdABCD), does not react anaerobically with the purified Fe-S group of NRF, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3731">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (encoded by the operon frdABCD), None reacts anaerobically with the purified Fe-S group of NRF, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3732">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (encoded by the operon frdABCD), None reacts anaerobically with the purified Fe-S group of NRF, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3733">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (encoded by the operon frdABCD), None reacts anaerobically with the purified Fe-S group of NRF, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3734">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (encoded by the operon frdABCD), does not react anaerobically with the purified Fe-S group of NRF, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3735">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (encoded by the operon frdABCD), does not react anaerobically with the purified Fe-S group of NRF, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3736">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (encoded by the operon frdABCD), does not react anaerobically with the purified Fe-S group of NRF, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3737">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (coded by the operon of frdABCD), in anaerobically reacted with the purified NR Fe-S cluster, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3738">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (coded by the operon of frdABCD), in anaerobically reacted with the purified NR Fe-S cluster, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3739">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (coded by the operon of frdABCD), no anaerobic reactions with the purified FNR Fe-S group, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3740">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (encoded by the operon frdABCD), in anaerobically reacted with the purified NR Fe-S cluster, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3741">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (encoded by the operon frdABCD), in anaerobically reacted with the purified NR Fe-S cluster, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3742">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (encoded by the operon frdABCD), no anaerobic reactions with the purified FNR Fe-S group, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3743">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (encoded by the operon frdABCD), no anaerobic reactions with the purified FNR Fe-S group, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3744">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cystein complex reductase (coded by the operon of frdABCD), none reacts anaerobically with the purified FNR group Fe-S, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3745">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cystein complex reductase (coded by the operon of frdABCD), none reacts anaerobically with the purified FNR group Fe-S, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3746">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cystein complex reductase (encoded by the operon frdABCD), none reacts anaerobically with the purified FNR group Fe-S, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3747">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cystein complex reductase (encoded by the operon frdABCD), none reacts anaerobically with the purified FNR group Fe-S, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3748">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cystein complex reductase (encoded by the operon frdABCD), none reacts anaerobically with the purified FNR group Fe-S, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3749">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex reductase (coded by the operon of frdABCD), none reacts anaerobically with the purified F-S group of FNR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3750">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex reductase (coded by the operon of frdABCD), none reacts anaerobically with the purified F-S group of FNR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3751">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex reductase (encoded by the operon frdABCD), none reacts anaerobically with the purified F-S group of FNR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3752">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex reductase (encoded by the operon frdABCD), none reacts anaerobically with the purified F-S group of FNR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3753">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex reductase (encoded by the operon frdABCD), none reacts anaerobically with the purified F-S group of FNR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3754">
                    <text>These are spectral changes consistent with the formation of a dinitrosyl-cysteine complex reductase (coded by the operon of frdABCD), NO reacts anaerobicly with the purified NRF Fe-S cluster, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3755">
                    <text>These are spectral changes consistent with the formation of a dinitrosyl-cysteine complex reductase (encoded by the operon frdABCD), NO reacts anaerobicly with the purified NRF Fe-S cluster, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3756">
                    <text>These are superoxide reductase (coded by the operon of frdABCD), NNOS, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3757">
                    <text>These are superoxide reductase (coded by the operon of frdABCD), nNOS, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3758">
                    <text>These are superoxide reductase (coded by the operon of frdABCD), nNOS, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3759">
                    <text>These are superoxide reductase (encoded by the operon frdABCD), NNOS, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3760">
                    <text>These are superoxide reductase (encoded by the operon frdABCD), nNOS, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3761">
                    <text>These are superoxide reductase (encoded by the operon frdABCD), nNOS, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3762">
                    <text>These are superoxide reductase (encoded by the operon frdABCD), nNOS, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3763">
                    <text>These are superposed sequential defects reductase (coded by the operon of frdABCD), the TBC method, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3764">
                    <text>These are superposed sequential defects reductase (coded by the operon of frdABCD), the TBC method, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3765">
                    <text>These are superposed sequential defects reductase (encoded by the operon frdABCD), the TBC method, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3766">
                    <text>These are superposed sequential defects reductase (encoded by the operon frdABCD), the TBC method, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3767">
                    <text>These are suspected reductase (coded by the operon of frdABCD), nNOS, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3768">
                    <text>These are suspected reductase (coded by the operon of frdABCD), nNOS, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3769">
                    <text>These are suspected reductase (encoded by the operon frdABCD), nNOS, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3770">
                    <text>These are suspected reductase (encoded by the operon frdABCD), nNOS, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3771">
                    <text>These are suspected reductase (encoded by the operon frdABCD), nNOS, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3772">
                    <text>These are the 21-23 nt of long mature RNAs reductase (coded by the operon of frdABCD), The biceps RNase III Dicer, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3773">
                    <text>These are the 21-23 nt of long mature RNAs reductase (coded by the operon of frdABCD), The biceps RNase III Dicer, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3774">
                    <text>These are the 21-23 nt of long mature RNAs reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3775">
                    <text>These are the 21-23 nt of long mature RNAs reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3776">
                    <text>These are the DNA-binding mutant (Stat5aEE-AA) of Stat5a reductase (coded by the operon of frdABCD), mino mutant acids EE (437 and 438) to AA, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3777">
                    <text>These are the DNA-binding mutant (Stat5aEE-AA) of Stat5a reductase (coded by the operon of frdABCD), mino mutant acids EE (437 and 438) to AA, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3778">
                    <text>These are the DNA-binding mutant (Stat5aEE-AA) of Stat5a reductase (encoded by the operon frdABCD), mino mutant acids EE (437 and 438) to AA, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3779">
                    <text>These are the DNA-binding mutant (Stat5aEE-AA) of Stat5a reductase (encoded by the operon frdABCD), mino mutant acids EE (437 and 438) to AA, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3780">
                    <text>These are the DNA-binding mutant (Stat5aEE-AA) of Stat5a reductase (encoded by the operon frdABCD), mino mutant acids EE (437 and 438) to AA, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3781">
                    <text>These are the correct three-dimensional interaction surface reductase (coded by the operon of frdABCD), L723 in H3, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3782">
                    <text>These are the correct three-dimensional interaction surface reductase (coded by the operon of frdABCD), L723 in H3, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3783">
                    <text>These are the correct three-dimensional interaction surface reductase (coded by the operon of frdABCD), L723 to H3, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3784">
                    <text>These are the correct three-dimensional interaction surface reductase (coded by the operon of frdABCD), L723 to H3, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3785">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the operon frdABCD), L723 in H3, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3786">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the operon frdABCD), L723 in H3, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3787">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the operon frdABCD), L723 in H3, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3788">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the operon frdABCD), L723 to H3, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3789">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the operon frdABCD), L723 to H3, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3790">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the operon frdABCD), L723 to H3, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3791">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, 21-23 nt of long mature RNAs is generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3792">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, Abeta peptides is generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3793">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HLA is generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3794">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HLA is generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3795">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3796">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3797">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3798">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3799">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3800">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a functional interaction surface is generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3801">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a functional interaction surface is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3802">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a functional interaction surface is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3803">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3804">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a higher DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3805">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a higher order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3806">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a higher-order protein&#x13;DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3807">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a higher-order protein DNA complex is generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3808">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a higher-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3809">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3810">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3811">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3812">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3813">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3814">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a monoclonal antibody vs. FHL2 is generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3815">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a surface of functional interaction is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3816">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, fumat is generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3817">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, fumat is generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3818">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, high-order DNA protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3819">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3820">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, long RNAs of 21-23 nt is generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3821">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, long RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3822">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3823">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3824">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3825">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, main transcripts of 1.7 and 2.7 kb is generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3826">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, main transcripts of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3827">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3828">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, mature RNA 21-23 nt is generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3829">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, mature RNA 21-23 nt is generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3830">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3831">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3832">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, moker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3833">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, monoclonal antibody against FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3834">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, monoclonal antibody against FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3835">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, monoclonal antibody vs. FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3836">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, motor is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3837">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, overlapping sequential fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3838">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, overlapping sequential fragments is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3839">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, sequential overlapping fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3840">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, sequential superposition fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3841">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, smoke is generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="3842">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, smoker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="3843">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, some unusual chemical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3844">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, some unusual chemical transcriptions is generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3845">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, some unusual chimeric transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3846">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3847">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, specific fragments is generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3848">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3849">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3850">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3851">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3852">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3853">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3854">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, superoxide is generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3855">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3856">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, superposed sequential defects is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="3857">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3858">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3859">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, the correct three-dimensional interaction surface is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3860">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, the correct three-dimensional interaction surface is generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3861">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, 21-23 nt of long mature RNAs is generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3862">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3863">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Abeta peptides is generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="3864">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Bydented RNase III dyce generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3865">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3866">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HLA is generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3867">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HLA is generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3868">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HLA is generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3869">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HLA is generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3870">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3871">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, L723 in H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3872">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, L723 to H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3873">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, L723 to H3 will generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3874">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, NNOS generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3875">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3876">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, NO reacts anaerobicly with the purified NRF Fe-S cluster will generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3877">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, NONE reacts anaerobically with the purified FNR group FNR will generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3878">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3879">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, None reacts anaerobically with the purified Fe-S group of NRF will generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3880">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, PRnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3881">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, PRnd will generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3882">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Prnd generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3883">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3884">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Prnd will generate large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3885">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Prnd will generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3886">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3887">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) will generate hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3888">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3889">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3890">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3891">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3892">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method generates sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3893">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method will generate overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="3894">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method will generate sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="3895">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method will generate sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="3896">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method will generate sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="3897">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, The biceps RNase III Dicer generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3898">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3899">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, The biceps RNase III Dicer will generate long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3900">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, The biceps RNase III Dicer will generate long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3901">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3902">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3903">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-base RNA chunk that occurs in the 5-untranslated region will generate mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3904">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3905">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-interpreted region will generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3906">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3907">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-untranslated region will generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3908">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3909">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3910">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a RNA fragment based on 3863 that occurs in the 5-untranslated region will generate mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3911">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3912">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3913">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex will generate a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3914">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex will generate a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="3915">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3916">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) will generate a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3917">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3918">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) will generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3919">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3920">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a functional interaction surface is generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="3921">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3922">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a higher DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3923">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a higher DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3924">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a higher order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3925">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a higher-order protein&#x13;DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3926">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a higher-order protein DNA complex is generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3927">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a higher-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3928">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3929">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3930">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3931">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3932">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a monoclonal antibody vs. FHL2 is generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3933">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a surface of functional interaction is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="3934">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3935">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an RNA fragment of 3863 bases occurring in the 5-interpreted region will generate mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3936">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3937">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of primary gene transcription will generate HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3938">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3939">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3940">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of primary transcription of the gene will generate HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3941">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of the primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3942">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of the primary transcription of the gene will generate HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="3943">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, biceps RNase III Dicer generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3944">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, biceps RNase III Dicer will generate 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="3945">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, bidentate RNase III generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3946">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, bidentate RNase III will generate mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3947">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, degradation will generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="3948">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3949">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, does not react anaerobically with the purified Fe-S group of NRF will generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3950">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, ens will generate a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3951">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat B generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3952">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat B will generate fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3953">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat is generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3954">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat is generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3955">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumatase B generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="3956">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, high-order DNA protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3957">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3958">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, high-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="3959">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="3960">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3961">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, in anaerobically reacted with the purified NR Fe-S cluster will generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3962">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic slicing with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3963">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic slicing with Prnp generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3964">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic slicing with Prnp will generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3965">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic slicing with Prnp will generate some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3966">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic slicing with Prnp will generate some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3967">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic spike with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3968">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic spike with Prnp will generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="3969">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, large transcriptions of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3970">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, long RNAs of 21-23 nt is generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3971">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3972">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3973">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="3974">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, main transcripts of 1.7 and 2.7 kb is generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3975">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, main transcripts of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3976">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, main transcripts of 1.7 and 2.7 kb is generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3977">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3978">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mature RNA 21-23 nt is generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3979">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mature RNA 21-23 nt is generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="3980">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3981">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3982">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="3983">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mino mutant acids EE (437 and 438) to AA will generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="3984">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, moker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="3985">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, monoclonal antibody vs. FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3986">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, monoclonal antibody vs. FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3987">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, motor is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="3988">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3989">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, muting amino acids EE (437 and 438) to AA will generate Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="3990">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nNOS generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3991">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nNOS will generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="3992">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nNOS will generate suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="3993">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3994">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nodes generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3995">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nodes generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3996">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nodes will generate monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="3997">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3998">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified FNR group Fe-S will generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="3999">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, overlapping sequential fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4000">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, overlapping sequential fragments is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4001">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, prnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4002">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, prnd will generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4003">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins (APP) generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4004">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins (APP) will generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4005">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4006">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, sequential fragment overlapping is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4007">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, sequential superposition fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4008">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoke B generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4009">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoke is generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4010">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoker B will generate moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4011">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4012">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, some unusual chemical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4013">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, some unusual chemical transcriptions is generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4014">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, some unusual chimeric transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4015">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4016">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, specific fragments is generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4017">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4018">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4019">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4020">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4021">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4022">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4023">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4024">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4025">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, superposed sequential defects is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4026">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, suspected is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4027">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4028">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4029">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-terminal AR generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4030">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-terminal AR will generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4031">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-terminal RA generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4032">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-terminal RA will generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4033">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4034">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the TBC method generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4035">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the TBC method will generate superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4036">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the bidentate RNase III Dicer generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4037">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the bidentate RNase III Dicer will generate mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4038">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the correct three-dimensional interaction surface is generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4039">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the term N-AR generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4040">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the term N-AR generates a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4041">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the term N-AR will generate a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4042">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the term N-AR will generate a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4043">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4044">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4045">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4046">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4047">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding will generate a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4048">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding will generate a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4049">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding will generate a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4050">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding will generate a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4051">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding will generate high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4052">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding will generate high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4053">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this junction generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4054">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this junction will generate a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4055">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this union generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4056">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this union generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4057">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this union will generate a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4058">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this union will generate a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4059">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, us generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4060">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, us generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4061">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, us will generate monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4062">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, us will generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4063">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, 21-23 nt of long mature RNAs was generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4064">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4065">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, Abeta peptides was generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4066">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HLA was generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4067">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HLA was generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4068">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HLA was generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4069">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4070">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4071">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, Stat5aEE-AA DNA-binding mutant was generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4072">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4073">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4074">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a functional interaction surface was generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4075">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a functional interaction surface was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4076">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a functional interaction surface was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4077">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4078">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a higher DNA complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4079">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a higher DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4080">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a higher-order protein DNA complex was generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4081">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4082">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4083">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4084">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a monoclonal antibody vs. FHL2 was generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4085">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a surface of functional interaction was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4086">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, fumat was generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4087">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4088">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, high-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4089">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4090">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, large transcriptions of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4091">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, long RNAs of 21-23 nt was generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4092">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, long RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4093">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4094">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4095">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4096">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, main transcripts of 1.7 and 2.7 kb was generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4097">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, main transcripts of 1.7 and 2.7 kb was generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4098">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4099">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, mature RNA 21-23 nt was generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4100">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, mature RNA 21-23 nt was generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4101">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, moker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4102">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, monoclonal antibody against FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4103">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, monoclonal antibody against FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4104">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, monoclonal antibody vs. FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4105">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, motor was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4106">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, overlapping sequential fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4107">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, overlapping sequential fragments was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4108">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, sequential fragment overlapping was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4109">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, sequential overlapping fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4110">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, sequential superposition fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4111">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, smoke was generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4112">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, smoker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4113">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, some unusual chemical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4114">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, some unusual chemical transcriptions was generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4115">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, some unusual chimeric transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4116">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4117">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, specific fragments was generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4118">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4119">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4120">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4121">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4122">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4123">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, superoxide was generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4124">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, superoxide was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4125">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, superposed sequential defects was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4126">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, suspected was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4127">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4128">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4129">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, the correct three-dimensional interaction surface was generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4130">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues Bydented RNase III dyce can generate long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4131">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues EE amino acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4132">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues L723 in H3 can generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4133">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues L723 to H3 can generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4134">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues NNOS can generate superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4135">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues NO reacts anaerobicly with the purified NRF Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4136">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues NONE reacts anaerobically with the purified FNR group FNR can generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4137">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues None reacts anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4138">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues PRnd can generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4139">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues Prnd can generate large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4140">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues Prnd can generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4141">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues TBC method can generate overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4142">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues TBC method can generate sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4143">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues TBC method can generate sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4144">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues TBC method can generate sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4145">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues The biceps RNase III Dicer can generate long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4146">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues The biceps RNase III Dicer can generate long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4147">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues The biceps RNase III Dicer can generate the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4148">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a 3863 bases RNA chain that occurs in the non-translated region 5 can generate mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4149">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a 3863-base RNA chunk that occurs in the 5-untranslated region can generate mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4150">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a 3863-base RNA fragment that occurs in the 5-interpreted region can generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4151">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a 3863-base RNA fragment that occurs in the 5-untranslated region can generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4152">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a 3863-based RNA fragment that occurs in the 5-untranslated region can generate matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4153">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4154">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4155">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) can generate a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4156">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4157">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4158">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an RNA fragment of 3863 bases occurring in the 5-interpreted region can generate mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4159">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an alternative coupling of primary gene transcription can generate HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4160">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an alternative coupling of primary genetic transcription can generate HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4161">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an alternative coupling of the primary transcription of the gene can generate HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4162">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues biceps RNase III Dicer can generate 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4163">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues bidentate RNase III can generate mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4164">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues degradation can generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4165">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues does not react anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4166">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues fumat B can generate fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4167">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues fumatase B can generate fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4168">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues in anaerobically reacted with the purified NR Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4169">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues intergenic slicing with Prnp can generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4170">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues intergenic slicing with Prnp can generate some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4171">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues intergenic slicing with Prnp can generate some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4172">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues intergenic spike with Prnp can generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4173">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues mino mutant acids EE (437 and 438) to AA can generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4174">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues muting amino acids EE (437 and 438) to AA can generate Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4175">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues nNOS can generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4176">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues nNOS can generate suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4177">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues no anaerobic reactions with the purified FNR Fe-S group can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4178">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues none reacts anaerobically with the purified F-S group of FNR can generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4179">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues none reacts anaerobically with the purified FNR group Fe-S can generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4180">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues prnd can generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4181">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues proteolysis of amyloid precursor proteins (APP) can generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4182">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues smoke B can generate smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4183">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues smoker B can generate moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4184">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues smoker B can generate motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4185">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues smoker B can generate smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4186">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the N-terminal RA can generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4187">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the TBC method can generate overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4188">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the bidentate RNase III Dicer can generate mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4189">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the term N-AR can generate a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4190">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the term N-AR can generate a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4191">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this binding can generate a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4192">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this binding can generate a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4193">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this binding can generate high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4194">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this binding can generate high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4195">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this junction can generate a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4196">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this union can generate a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4197">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this union can generate high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4198">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues us can generate monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4199">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues us can generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4200">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, 21-23 nt of long mature RNAs was generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4201">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Abeta peptides was generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4202">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Abeta peptides was generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4203">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Bydented RNase III dyce generates long RNAs of 21-23 nt .</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4204">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Bydented RNase III dyce may generate long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4205">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Bydented RNase III dyce will generate long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4206">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant .</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4207">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, EE amino acids (437 and 438) for AA will generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4208">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HLA was generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4209">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HLA was generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4210">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HLA was generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4211">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4212">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4213">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, L723 in H3 generates the correct three-dimensional interaction surface .</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4214">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, L723 in H3 may generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4215">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, L723 to H3 generates the correct three-dimensional interaction surface .</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4216">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, L723 to H3 will generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4217">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NNOS generates superoxide .</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4218">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NNOS may generate superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4219">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex .</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4220">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NO reacts anaerobicly with the purified NRF Fe-S cluster may generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4221">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NO reacts anaerobicly with the purified NRF Fe-S cluster will generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4222">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex .</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4223">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NONE reacts anaerobically with the purified FNR group FNR will generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4224">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex .</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4225">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, None reacts anaerobically with the purified Fe-S group of NRF may generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4226">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, None reacts anaerobically with the purified Fe-S group of NRF will generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4227">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, PRnd generates main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4228">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, PRnd may generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4229">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, PRnd will generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4230">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Prnd generates large transcriptions of 1.7 and 2.7 kb .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4231">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Prnd generates main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4232">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Prnd may generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4233">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Prnd will generate large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4234">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Prnd will generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4235">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I .</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4236">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) may generate hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4237">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) will generate hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4238">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Stat5aEE-AA DNA-binding mutant was generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4239">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Stat5aEE-AA was generated by muting amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4240">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method generates overlapping sequential fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4241">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method generates sequential fragment overlapping .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4242">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method generates sequential overlapping fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4243">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method generates sequential superposition fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4244">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method may generate overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4245">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method may generate sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4246">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method may generate sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4247">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method will generate sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4248">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method will generate sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4249">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method will generate sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4250">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer generates long mature RNAs of 21-23 nt .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4251">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4252">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer may generate long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4253">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer may generate the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4254">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer will generate long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4255">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer will generate long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4256">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer will generate the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4257">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA .</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4258">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863 bases RNA chain that occurs in the non-translated region 5 will generate mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4259">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA .</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4260">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA chunk that occurs in the 5-untranslated region will generate mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4261">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4262">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-interpreted region may generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4263">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-interpreted region will generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4264">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4265">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-untranslated region may generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4266">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA fragment that occurs in the 5-untranslated region will generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4267">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA .</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4268">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-based RNA fragment that occurs in the 5-untranslated region may generate matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4269">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-based RNA fragment that occurs in the 5-untranslated region will generate matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4270">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a RNA fragment based on 3863 that occurs in the 5-untranslated region may generate mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4271">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a RNA fragment based on 3863 that occurs in the 5-untranslated region will generate mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4272">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4273">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4274">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex may generate a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4275">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex may generate a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4276">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex will generate a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4277">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex will generate a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4278">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4279">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) may generate a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4280">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4281">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) may generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4282">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) will generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4283">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4284">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) may generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4285">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) will generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4286">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a functional interaction surface was generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4287">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a functional interaction surface was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4288">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4289">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a higher DNA complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4290">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a higher order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4291">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a higher-order protein&#x13;DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4292">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a higher-order protein DNA complex was generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4293">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a higher-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4294">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4295">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4296">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4297">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4298">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4299">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a monoclonal antibody vs. FHL2 was generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4300">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a surface of functional interaction was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4301">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an RNA fragment of 3863 bases occurring in the 5-interpreted region may generate mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4302">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary gene transcription generates HLA .</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4303">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary gene transcription may generate HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4304">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary gene transcription will generate HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4305">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary genetic transcription generates HLA .</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4306">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary genetic transcription will generate HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4307">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary transcription of the gene generates HLA .</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4308">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary transcription of the gene will generate HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4309">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of the primary transcription of the gene may generate HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4310">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of the primary transcription of the gene will generate HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4311">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, biceps RNase III Dicer generates 21-23 nt of long mature RNAs .</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4312">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, biceps RNase III Dicer may generate 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4313">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, biceps RNase III Dicer will generate 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4314">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, bidentate RNase III generates mature RNA 21-23 nt .</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4315">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, bidentate RNase III may generate mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4316">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, degradation generates specific fragments .</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4317">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, degradation may generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4318">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex .</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4319">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, does not react anaerobically with the purified Fe-S group of NRF may generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4320">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, does not react anaerobically with the purified Fe-S group of NRF will generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4321">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, ens may generate a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4322">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, ens will generate a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4323">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat B generates fumat .</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4324">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat B may generate fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4325">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat B will generate fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4326">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat was generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4327">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumatase B will generate fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4328">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4329">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, high-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4330">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4331">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex .</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4332">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, in anaerobically reacted with the purified NR Fe-S cluster may generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4333">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, in anaerobically reacted with the purified NR Fe-S cluster will generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4334">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp generates some unusual chemical transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4335">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp generates some unusual chimeric transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4336">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp generates some unusual symmetrical transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4337">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp may generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4338">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp may generate some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4339">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp may generate some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4340">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp will generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4341">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp will generate some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4342">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic slicing with Prnp will generate some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4343">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic spike with Prnp generates some unusual chemical transcriptions .</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4344">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic spike with Prnp may generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4345">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic spike with Prnp will generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4346">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, large transcriptions of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4347">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, long RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4348">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4349">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4350">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, main transcripts of 1.7 and 2.7 kb was generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4351">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, main transcripts of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4352">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, main transcripts of 1.7 and 2.7 kb was generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4353">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4354">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mature RNA 21-23 nt was generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4355">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mature RNA 21-23 nt was generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4356">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4357">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant .</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4358">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mino EE mutant acids (437 and 438) for AA may generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4359">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mino EE mutant acids (437 and 438) for AA will generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4360">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a .</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4361">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mino mutant acids EE (437 and 438) to AA may generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4362">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mino mutant acids EE (437 and 438) to AA will generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4363">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, moker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4364">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, monoclonal antibody against FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4365">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, monoclonal antibody vs. FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4366">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, motor was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4367">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA .</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4368">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, muting amino acids EE (437 and 438) to AA may generate Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4369">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, muting amino acids EE (437 and 438) to AA will generate Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4370">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nNOS generates superoxide .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4371">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nNOS generates suspected .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4372">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nNOS may generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4373">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nNOS may generate suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4374">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nNOS will generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4375">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nNOS will generate suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4376">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, no anaerobic reactions with the purified FNR Fe-S group may generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4377">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, no anaerobic reactions with the purified FNR Fe-S group will generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4378">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nodes generates monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4379">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nodes may generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4380">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, nodes will generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4381">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex .</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4382">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex .</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4383">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified FNR group Fe-S may generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4384">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified FNR group Fe-S will generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4385">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, overlapping sequential fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4386">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, overlapping sequential fragments was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4387">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, prnd generates main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4388">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, prnd may generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4389">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, prnd will generate main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4390">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins (APP) may generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4391">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins (APP) will generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4392">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins generates Abeta peptides .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4393">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins may generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4394">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, sequential fragment overlapping was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4395">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, sequential overlapping fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4396">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, sequential superposition fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4397">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoke B generates smoke .</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4398">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoke B may generate smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4399">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoke B will generate smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4400">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoke was generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4401">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B generates moker .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4402">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B generates motor .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4403">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B generates smoker .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4404">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B may generate moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4405">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B may generate motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4406">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B may generate smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4407">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B will generate moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4408">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B will generate motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4409">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4410">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, some unusual chemical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4411">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, some unusual chemical transcriptions was generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4412">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, some unusual chimeric transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4413">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4414">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, specific fragments was generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4415">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4416">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4417">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4418">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4419">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4420">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex was generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4421">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4422">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4423">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, superoxide was generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4424">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, superoxide was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4425">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, suspected was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4426">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4427">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4428">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal AR generates a functional interaction surface .</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4429">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal AR may generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4430">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal AR will generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4431">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal RA generates a functional interaction surface .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4432">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal RA may generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4433">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal RA will generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4434">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the TBC method generates overlapping sequential fragments .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4435">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the TBC method generates superposed sequential defects .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4436">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the TBC method may generate superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4437">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the TBC method will generate overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4438">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the TBC method will generate superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4439">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the bidentate RNase III Dicer generates mature RNA 21-23 nt .</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4440">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the bidentate RNase III Dicer may generate mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4441">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the bidentate RNase III Dicer will generate mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4442">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the correct three-dimensional interaction surface was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4443">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the correct three-dimensional interaction surface was generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4444">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the term N-AR generates a functional interaction surface .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4445">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the term N-AR generates a surface of functional interaction .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4446">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the term N-AR will generate a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4447">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the term N-AR will generate a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4448">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding generates a high-order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4449">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding generates a higher DNA complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4450">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding generates high-order DNA protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4451">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding may generate a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4452">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding may generate a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4453">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding may generate high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4454">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding will generate a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4455">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding will generate a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4456">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding will generate a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4457">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding will generate a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4458">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding will generate high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4459">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding will generate high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4460">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this junction generates a higher-order protein DNA complex .</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4461">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this junction may generate a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4462">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this junction will generate a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4463">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union generates a higher-order protein&#x13;DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4464">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union generates a higher-order protein-DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4465">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union generates high-order protein-DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4466">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union may generate a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4467">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union may generate a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4468">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union may generate high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4469">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union will generate a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4470">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union will generate a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4471">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this union will generate high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4472">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, us generates monoclonal antibody against FHL2 .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4473">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, us generates monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4474">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, us may generate monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4475">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, us may generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4476">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, us will generate monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4477">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, us will generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4478">
                    <text>We believe that Bydented RNase III dyce is able to generate long RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4479">
                    <text>We believe that Bydented RNase III dyce is able to generate long RNAs of 21-23 nt within the reombian synapses.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4480">
                    <text>We believe that EE amino acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant within the recombinant synapse.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4481">
                    <text>We believe that EE amino acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant within the reombian synapses.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4482">
                    <text>We believe that EE amino acids (437 and 438) for AA is shown to generate Stat5aEE-AA DNA-binding mutant within the reombine synapses.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4483">
                    <text>We believe that L723 in H3 is able to generate the correct three-dimensional interaction surface within the recombinant synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4484">
                    <text>We believe that L723 in H3 is able to generate the correct three-dimensional interaction surface within the reombian synapses.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4485">
                    <text>We believe that L723 in H3 is shown to generate the correct three-dimensional interaction surface within the reombine synapses.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4486">
                    <text>We believe that L723 to H3 is shown to generate the correct three-dimensional interaction surface within the reombine synapses.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4487">
                    <text>We believe that NNOS is able to generate superoxide within the recombinant synapse.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4488">
                    <text>We believe that NNOS is able to generate superoxide within the reombian synapses.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4489">
                    <text>We believe that NO reacts anaerobicly with the purified NRF Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4490">
                    <text>We believe that NO reacts anaerobicly with the purified NRF Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex within the reombian synapses.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4491">
                    <text>We believe that NO reacts anaerobicly with the purified NRF Fe-S cluster is shown to generate spectral changes consistent with the formation of a dinitrosyl-cysteine complex within the reombine synapses.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4492">
                    <text>We believe that NONE reacts anaerobically with the purified FNR group FNR is able to generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4493">
                    <text>We believe that NONE reacts anaerobically with the purified FNR group FNR is able to generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex within the reombian synapses.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4494">
                    <text>We believe that NONE reacts anaerobically with the purified FNR group FNR is shown to generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex within the reombine synapses.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4495">
                    <text>We believe that None reacts anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4496">
                    <text>We believe that None reacts anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex within the reombian synapses.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4497">
                    <text>We believe that None reacts anaerobically with the purified Fe-S group of NRF is shown to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex within the reombine synapses.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4498">
                    <text>We believe that PRnd is able to generate main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4499">
                    <text>We believe that PRnd is able to generate main transcripts of 1.7 and 2.7 kb within the reombian synapses.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4500">
                    <text>We believe that PRnd is shown to generate main transcripts of 1.7 and 2.7 kb within the reombine synapses.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4501">
                    <text>We believe that Prnd is able to generate large transcriptions of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4502">
                    <text>We believe that Prnd is able to generate large transcriptions of 1.7 and 2.7 kb within the reombian synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4503">
                    <text>We believe that Prnd is able to generate main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4504">
                    <text>We believe that Prnd is able to generate main transcripts of 1.7 and 2.7 kb within the reombian synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4505">
                    <text>We believe that Prnd is shown to generate large transcriptions of 1.7 and 2.7 kb within the reombine synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4506">
                    <text>We believe that Prnd is shown to generate main transcripts of 1.7 and 2.7 kb within the reombine synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4507">
                    <text>We believe that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) is able to generate hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4508">
                    <text>We believe that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) is able to generate hypersensitive to DNase I within the reombian synapses.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4509">
                    <text>We believe that TBC method is able to generate overlapping sequential fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4510">
                    <text>We believe that TBC method is able to generate overlapping sequential fragments within the reombian synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4511">
                    <text>We believe that TBC method is able to generate sequential fragment overlapping within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4512">
                    <text>We believe that TBC method is able to generate sequential fragment overlapping within the reombian synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4513">
                    <text>We believe that TBC method is able to generate sequential overlapping fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4514">
                    <text>We believe that TBC method is able to generate sequential overlapping fragments within the reombian synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="4515">
                    <text>We believe that TBC method is able to generate sequential superposition fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4516">
                    <text>We believe that TBC method is able to generate sequential superposition fragments within the reombian synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4517">
                    <text>We believe that TBC method is shown to generate sequential fragment overlapping within the reombine synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="4518">
                    <text>We believe that TBC method is shown to generate sequential superposition fragments within the reombine synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="4519">
                    <text>We believe that The biceps RNase III Dicer is able to generate long RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4520">
                    <text>We believe that The biceps RNase III Dicer is able to generate long RNAs of 21-23 nt within the reombian synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4521">
                    <text>We believe that The biceps RNase III Dicer is able to generate long mature RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4522">
                    <text>We believe that The biceps RNase III Dicer is able to generate long mature RNAs of 21-23 nt within the reombian synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4523">
                    <text>We believe that The biceps RNase III Dicer is able to generate the 21-23 nt of long mature RNAs within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4524">
                    <text>We believe that The biceps RNase III Dicer is able to generate the 21-23 nt of long mature RNAs within the reombian synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4525">
                    <text>We believe that The biceps RNase III Dicer is shown to generate long mature RNAs of 21-23 nt within the reombine synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4526">
                    <text>We believe that The biceps RNase III Dicer is shown to generate the 21-23 nt of long mature RNAs within the reombine synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4527">
                    <text>We believe that a 3863 bases RNA chain that occurs in the non-translated region 5 is able to generate mature hela cell mRNA within the reombian synapses.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4528">
                    <text>We believe that a 3863 bases RNA chain that occurs in the non-translated region 5 is shown to generate mature hela cell mRNA within the reombine synapses.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4529">
                    <text>We believe that a 3863-base RNA chunk that occurs in the 5-untranslated region is able to generate mature heLa cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4530">
                    <text>We believe that a 3863-base RNA chunk that occurs in the 5-untranslated region is able to generate mature heLa cell mRNA within the reombian synapses.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4531">
                    <text>We believe that a 3863-base RNA chunk that occurs in the 5-untranslated region is shown to generate mature heLa cell mRNA within the reombine synapses.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4532">
                    <text>We believe that a 3863-base RNA fragment that occurs in the 5-interpreted region is able to generate HeLa mature cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4533">
                    <text>We believe that a 3863-base RNA fragment that occurs in the 5-interpreted region is able to generate HeLa mature cell mRNA within the reombian synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4534">
                    <text>We believe that a 3863-base RNA fragment that occurs in the 5-interpreted region is shown to generate HeLa mature cell mRNA within the reombine synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4535">
                    <text>We believe that a 3863-base RNA fragment that occurs in the 5-untranslated region is able to generate HeLa mature cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4536">
                    <text>We believe that a 3863-base RNA fragment that occurs in the 5-untranslated region is able to generate HeLa mature cell mRNA within the reombian synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4537">
                    <text>We believe that a 3863-base RNA fragment that occurs in the 5-untranslated region is shown to generate HeLa mature cell mRNA within the reombine synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4538">
                    <text>We believe that a 3863-based RNA fragment that occurs in the 5-untranslated region is able to generate matur HeLa cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4539">
                    <text>We believe that a 3863-based RNA fragment that occurs in the 5-untranslated region is able to generate matur HeLa cell mRNA within the reombian synapses.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4540">
                    <text>We believe that a 3863-based RNA fragment that occurs in the 5-untranslated region is shown to generate matur HeLa cell mRNA within the reombine synapses.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4541">
                    <text>We believe that a RNA fragment based on 3863 that occurs in the 5-untranslated region is able to generate mRNA of heLa cells within the recombinant synapse.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4542">
                    <text>We believe that a RNA fragment based on 3863 that occurs in the 5-untranslated region is able to generate mRNA of heLa cells within the reombian synapses.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4543">
                    <text>We believe that a RNA fragment based on 3863 that occurs in the 5-untranslated region is shown to generate mRNA of heLa cells within the reombine synapses.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4544">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive DNase I within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4545">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive DNase I within the reombian synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4546">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive chromatin I remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4547">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is shown to generate a hypersensitive DNase I within the reombine synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4548">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is shown to generate a hypersensitive chromatin I remodeling complex within the reombine synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4549">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) is able to generate a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4550">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) is able to generate a hypersensitive to DNase I within the reombian synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4551">
                    <text>We believe that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I within the reombian synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4552">
                    <text>We believe that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) is shown to generate a hypersensitive to DNase I within the reombine synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4553">
                    <text>We believe that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4554">
                    <text>We believe that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I within the reombian synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4555">
                    <text>We believe that a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) is shown to generate a hypersensitive to DNase I within the reombine synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4556">
                    <text>We believe that an RNA fragment of 3863 bases occurring in the 5-interpreted region is able to generate mRNA of mature HeLa cells within the recombinant synapse.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4557">
                    <text>We believe that an RNA fragment of 3863 bases occurring in the 5-interpreted region is shown to generate mRNA of mature HeLa cells within the reombine synapses.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4558">
                    <text>We believe that an alternative coupling of primary gene transcription is able to generate HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4559">
                    <text>We believe that an alternative coupling of primary gene transcription is able to generate HLA within the reombian synapses.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4560">
                    <text>We believe that an alternative coupling of primary genetic transcription is able to generate HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4561">
                    <text>We believe that an alternative coupling of primary genetic transcription is able to generate HLA within the reombian synapses.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4562">
                    <text>We believe that an alternative coupling of primary genetic transcription is shown to generate HLA within the reombine synapses.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4563">
                    <text>We believe that an alternative coupling of primary transcription of the gene is able to generate HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4564">
                    <text>We believe that an alternative coupling of primary transcription of the gene is able to generate HLA within the reombian synapses.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4565">
                    <text>We believe that an alternative coupling of primary transcription of the gene is shown to generate HLA within the reombine synapses.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4566">
                    <text>We believe that an alternative coupling of the primary transcription of the gene is able to generate HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4567">
                    <text>We believe that an alternative coupling of the primary transcription of the gene is able to generate HLA within the reombian synapses.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4568">
                    <text>We believe that an alternative coupling of the primary transcription of the gene is shown to generate HLA within the reombine synapses.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="4569">
                    <text>We believe that biceps RNase III Dicer is able to generate 21-23 nt of long mature RNAs within the recombinant synapse.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4570">
                    <text>We believe that biceps RNase III Dicer is shown to generate 21-23 nt of long mature RNAs within the reombine synapses.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="4571">
                    <text>We believe that bidentate RNase III is able to generate mature RNA 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4572">
                    <text>We believe that degradation is able to generate specific fragments within the reombian synapses.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4573">
                    <text>We believe that degradation is shown to generate specific fragments within the reombine synapses.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="4574">
                    <text>We believe that does not react anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4575">
                    <text>We believe that does not react anaerobically with the purified Fe-S group of NRF is shown to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex within the reombine synapses.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4576">
                    <text>We believe that ens is shown to generate a monoclonal antibody vs. FHL2 within the reombine synapses.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4577">
                    <text>We believe that fumat B is able to generate fumat within the recombinant synapse.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4578">
                    <text>We believe that fumat B is able to generate fumat within the reombian synapses.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4579">
                    <text>We believe that fumatase B is able to generate fumat within the recombinant synapse.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4580">
                    <text>We believe that fumatase B is able to generate fumat within the reombian synapses.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4581">
                    <text>We believe that fumatase B is shown to generate fumat within the reombine synapses.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="4582">
                    <text>We believe that in anaerobically reacted with the purified NR Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4583">
                    <text>We believe that in anaerobically reacted with the purified NR Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the reombian synapses.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4584">
                    <text>We believe that in anaerobically reacted with the purified NR Fe-S cluster is shown to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the reombine synapses.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4585">
                    <text>We believe that intergenic slicing with Prnp is able to generate some unusual chemical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4586">
                    <text>We believe that intergenic slicing with Prnp is able to generate some unusual chemical transcriptions within the reombian synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4587">
                    <text>We believe that intergenic slicing with Prnp is able to generate some unusual chimeric transcriptions within the reombian synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4588">
                    <text>We believe that intergenic slicing with Prnp is able to generate some unusual symmetrical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4589">
                    <text>We believe that intergenic slicing with Prnp is shown to generate some unusual chemical transcriptions within the reombine synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4590">
                    <text>We believe that intergenic slicing with Prnp is shown to generate some unusual chimeric transcriptions within the reombine synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4591">
                    <text>We believe that intergenic slicing with Prnp is shown to generate some unusual symmetrical transcriptions within the reombine synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4592">
                    <text>We believe that intergenic spike with Prnp is able to generate some unusual chemical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4593">
                    <text>We believe that intergenic spike with Prnp is able to generate some unusual chemical transcriptions within the reombian synapses.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4594">
                    <text>We believe that intergenic spike with Prnp is shown to generate some unusual chemical transcriptions within the reombine synapses.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="4595">
                    <text>We believe that mino EE mutant acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant within the reombian synapses.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4596">
                    <text>We believe that mino EE mutant acids (437 and 438) for AA is shown to generate Stat5aEE-AA DNA-binding mutant within the reombine synapses.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="4597">
                    <text>We believe that mino mutant acids EE (437 and 438) to AA is able to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a within the recombinant synapse.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4598">
                    <text>We believe that mino mutant acids EE (437 and 438) to AA is able to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a within the reombian synapses.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4599">
                    <text>We believe that mino mutant acids EE (437 and 438) to AA is shown to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a within the reombine synapses.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="4600">
                    <text>We believe that muting amino acids EE (437 and 438) to AA is able to generate Stat5aEE-AA within the recombinant synapse.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="4601">
                    <text>We believe that nNOS is able to generate superoxide within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4602">
                    <text>We believe that nNOS is able to generate superoxide within the reombian synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4603">
                    <text>We believe that nNOS is able to generate suspected within the reombian synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4604">
                    <text>We believe that nNOS is shown to generate superoxide within the reombine synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="4605">
                    <text>We believe that nNOS is shown to generate suspected within the reombine synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="4606">
                    <text>We believe that no anaerobic reactions with the purified FNR Fe-S group is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4607">
                    <text>We believe that no anaerobic reactions with the purified FNR Fe-S group is shown to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the reombine synapses.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4608">
                    <text>We believe that nodes is able to generate monoclonal antibody against FHL2 within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4609">
                    <text>We believe that nodes is able to generate monoclonal antibody against FHL2 within the reombian synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4610">
                    <text>We believe that nodes is able to generate monoclonal antibody vs. FHL2 within the reombian synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4611">
                    <text>We believe that nodes is shown to generate monoclonal antibody against FHL2 within the reombine synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4612">
                    <text>We believe that nodes is shown to generate monoclonal antibody vs. FHL2 within the reombine synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4613">
                    <text>We believe that none reacts anaerobically with the purified F-S group of FNR is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4614">
                    <text>We believe that none reacts anaerobically with the purified F-S group of FNR is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex within the reombian synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4615">
                    <text>We believe that none reacts anaerobically with the purified F-S group of FNR is shown to generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex within the reombine synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="4616">
                    <text>We believe that none reacts anaerobically with the purified FNR group Fe-S is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4617">
                    <text>We believe that none reacts anaerobically with the purified FNR group Fe-S is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex within the reombian synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4618">
                    <text>We believe that none reacts anaerobically with the purified FNR group Fe-S is shown to generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex within the reombine synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="4619">
                    <text>We believe that prnd is able to generate main transcripts of 1.7 and 2.7 kb within the reombian synapses.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4620">
                    <text>We believe that prnd is shown to generate main transcripts of 1.7 and 2.7 kb within the reombine synapses.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4621">
                    <text>We believe that proteolysis of amyloid precursor proteins (APP) is able to generate Abeta peptides within the reombian synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4622">
                    <text>We believe that proteolysis of amyloid precursor proteins (APP) is shown to generate Abeta peptides within the reombine synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4623">
                    <text>We believe that proteolysis of amyloid precursor proteins is able to generate Abeta peptides within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4624">
                    <text>We believe that proteolysis of amyloid precursor proteins is able to generate Abeta peptides within the reombian synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4625">
                    <text>We believe that proteolysis of amyloid precursor proteins is shown to generate Abeta peptides within the reombine synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="4626">
                    <text>We believe that smoke B is able to generate smoke within the recombinant synapse.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4627">
                    <text>We believe that smoke B is able to generate smoke within the reombian synapses.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4628">
                    <text>We believe that smoke B is shown to generate smoke within the reombine synapses.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="4629">
                    <text>We believe that smoker B is able to generate moker within the reombian synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4630">
                    <text>We believe that smoker B is able to generate motor within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4631">
                    <text>We believe that smoker B is able to generate motor within the reombian synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4632">
                    <text>We believe that smoker B is able to generate smoker within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4633">
                    <text>We believe that smoker B is shown to generate moker within the reombine synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="4634">
                    <text>We believe that smoker B is shown to generate motor within the reombine synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="4635">
                    <text>We believe that smoker B is shown to generate smoker within the reombine synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="4636">
                    <text>We believe that the N-terminal AR is able to generate a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4637">
                    <text>We believe that the N-terminal AR is able to generate a functional interaction surface within the reombian synapses.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4638">
                    <text>We believe that the N-terminal AR is shown to generate a functional interaction surface within the reombine synapses.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4639">
                    <text>We believe that the N-terminal RA is able to generate a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4640">
                    <text>We believe that the N-terminal RA is able to generate a functional interaction surface within the reombian synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4641">
                    <text>We believe that the N-terminal RA is shown to generate a functional interaction surface within the reombine synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4642">
                    <text>We believe that the TBC method is able to generate overlapping sequential fragments within the reombian synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4643">
                    <text>We believe that the TBC method is able to generate superposed sequential defects within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4644">
                    <text>We believe that the TBC method is able to generate superposed sequential defects within the reombian synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4645">
                    <text>We believe that the TBC method is shown to generate overlapping sequential fragments within the reombine synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="4646">
                    <text>We believe that the TBC method is shown to generate superposed sequential defects within the reombine synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="4647">
                    <text>We believe that the bidentate RNase III Dicer is able to generate mature RNA 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4648">
                    <text>We believe that the bidentate RNase III Dicer is able to generate mature RNA 21-23 nt within the reombian synapses.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="4649">
                    <text>We believe that the term N-AR is able to generate a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4650">
                    <text>We believe that the term N-AR is able to generate a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4651">
                    <text>We believe that the term N-AR is able to generate a surface of functional interaction within the reombian synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4652">
                    <text>We believe that the term N-AR is shown to generate a functional interaction surface within the reombine synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4653">
                    <text>We believe that the term N-AR is shown to generate a surface of functional interaction within the reombine synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="4654">
                    <text>We believe that this binding is able to generate a high-order DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4655">
                    <text>We believe that this binding is able to generate a high-order DNA-protein complex within the reombian synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4656">
                    <text>We believe that this binding is able to generate a higher DNA complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4657">
                    <text>We believe that this binding is able to generate a higher DNA complex within the reombian synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4658">
                    <text>We believe that this binding is able to generate a higher DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4659">
                    <text>We believe that this binding is able to generate a higher order DNA-protein complex within the reombian synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4660">
                    <text>We believe that this binding is able to generate high-order DNA protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4661">
                    <text>We believe that this binding is able to generate high-order DNA protein complex within the reombian synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4662">
                    <text>We believe that this binding is able to generate high-order DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4663">
                    <text>We believe that this binding is able to generate high-order DNA-protein complex within the reombian synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4664">
                    <text>We believe that this binding is shown to generate a high-order DNA-protein complex within the reombine synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4665">
                    <text>We believe that this binding is shown to generate a higher DNA complex within the reombine synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4666">
                    <text>We believe that this binding is shown to generate a higher DNA-protein complex within the reombine synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4667">
                    <text>We believe that this binding is shown to generate a higher order DNA-protein complex within the reombine synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4668">
                    <text>We believe that this binding is shown to generate high-order DNA protein complex within the reombine synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4669">
                    <text>We believe that this binding is shown to generate high-order DNA-protein complex within the reombine synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4670">
                    <text>We believe that this junction is able to generate a higher-order protein DNA complex within the recombinant synapse.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4671">
                    <text>We believe that this junction is able to generate a higher-order protein DNA complex within the reombian synapses.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4672">
                    <text>We believe that this junction is shown to generate a higher-order protein DNA complex within the reombine synapses.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4673">
                    <text>We believe that this union is able to generate a higher-order protein&#x13;DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4674">
                    <text>We believe that this union is able to generate a higher-order protein&#x13;DNA complex within the reombian synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4675">
                    <text>We believe that this union is able to generate a higher-order protein-DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4676">
                    <text>We believe that this union is able to generate high-order protein-DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4677">
                    <text>We believe that this union is shown to generate a higher-order protein-DNA complex within the reombine synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4678">
                    <text>We believe that this union is shown to generate high-order protein-DNA complex within the reombine synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4679">
                    <text>We believe that us is able to generate monoclonal antibody against FHL2 within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4680">
                    <text>We believe that us is able to generate monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4681">
                    <text>We believe that us is able to generate monoclonal antibody vs. FHL2 within the reombian synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4682">
                    <text>We believe that us is shown to generate monoclonal antibody against FHL2 within the reombine synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4683">
                    <text>We believe that us is shown to generate monoclonal antibody vs. FHL2 within the reombine synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="4684">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 are able to generate mature hela cell mRNA .</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4685">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 can generate mature hela cell mRNA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4686">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4687">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4688">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4689">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4690">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4691">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4692">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA within the recombinant synapses.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4693">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4694">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4695">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4696">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 is able to generate mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4697">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region are able to generate mature heLa cell mRNA .</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4698">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region can generate mature heLa cell mRNA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4699">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region can generate mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4700">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4701">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4702">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4703">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4704">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4705">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4706">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA within the recombinant synapses.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4707">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4708">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4709">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4710">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region is able to generate mature heLa cell mRNA .</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4711">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region is able to generate mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4712">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region are able to generate HeLa mature cell mRNA .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4713">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region can generate HeLa mature cell mRNA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4714">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region can generate HeLa mature cell mRNA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4715">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region can generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4716">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4717">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4718">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4719">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4720">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4721">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4722">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4723">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4724">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA within the recombinant synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4725">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4726">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4727">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4728">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region has generated HeLa mature cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4729">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region is able to generate HeLa mature cell mRNA .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4730">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region is able to generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4731">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region are able to generate HeLa mature cell mRNA .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4732">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region can generate HeLa mature cell mRNA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4733">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region can generate HeLa mature cell mRNA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4734">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4735">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4736">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4737">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4738">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4739">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4740">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4741">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4742">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4743">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4744">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4745">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4746">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region is able to generate HeLa mature cell mRNA .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4747">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region is able to generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4748">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region are able to generate matur HeLa cell mRNA .</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4749">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region can generate matur HeLa cell mRNA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4750">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4751">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4752">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4753">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4754">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4755">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4756">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4757">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA within the recombinant synapses.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4758">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4759">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA-G molecules of human leukocytes.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4760">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region has generated matur HeLa cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4761">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region is able to generate matur HeLa cell mRNA .</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4762">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region is able to generate matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="4763">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region are able to generate mRNA of heLa cells .</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4764">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region can generate mRNA of heLa cells (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4765">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region can generate mRNA of heLa cells (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4766">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region can generate mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4767">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4768">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4769">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4770">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells within the recombinant synapse.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4771">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4772">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4773">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4774">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells within the recombinant synapse.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4775">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells within the recombinant synapses.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4776">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4777">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells-G molecules of human leukocytes.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4778">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4779">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region has generated mRNA of heLa cells for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4780">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region is able to generate mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="4781">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex are able to generate a hypersensitive DNase I .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4782">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex are able to generate a hypersensitive chromatin I remodeling complex .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4783">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive DNase I (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4784">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive DNase I (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4785">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4786">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive chromatin I remodeling complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4787">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive chromatin I remodeling complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4788">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex can generate a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4789">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4790">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4791">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4792">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4793">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4794">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4795">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4796">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4797">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4798">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4799">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4800">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4801">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4802">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4803">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4804">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4805">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex within the recombinant synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4806">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4807">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex-G molecules of human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4808">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex has generated a hypersensitive DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4809">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex has generated a hypersensitive chromatin I remodeling complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4810">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4811">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="4812">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="4813">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="4814">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="4815">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="4816">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="4817">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="4818">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) are able to generate a hypersensitive to DNase I .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4819">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) can generate a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4820">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) can generate a hypersensitive to DNase I (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4821">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) can generate a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4822">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4823">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4824">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4825">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4826">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4827">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4828">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4829">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4830">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I within the recombinant synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4831">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4832">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4833">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4834">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) has generated a hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4835">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) is able to generate a hypersensitive to DNase I .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4836">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) is able to generate a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4837">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4838">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4839">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4840">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4841">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4842">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4843">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
                </example>
                <example src="PERMUTATE" no="4844">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) are able to generate a hypersensitive to DNase I .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4845">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4846">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4847">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4848">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4849">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4850">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4851">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4852">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4853">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4854">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4855">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I within the recombinant synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4856">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4857">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4858">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4859">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) has generated a hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4860">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4861">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4862">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) are able to generate a hypersensitive to DNase I .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4863">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4864">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4865">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4866">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4867">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4868">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4869">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4870">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4871">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4872">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I within the recombinant synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4873">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4874">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4875">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) has generated a hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4876">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4877">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="4878">
                    <text>a functional interaction surface (carot, and permease from DcuB to motor, carot and aspartate) were generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4879">
                    <text>a functional interaction surface (carot, and permease from DcuB to motor, carot and aspartate) were generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4880">
                    <text>a functional interaction surface (carot, and permease from DcuB to motor, carot and aspartate) were generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4881">
                    <text>a functional interaction surface (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4882">
                    <text>a functional interaction surface (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4883">
                    <text>a functional interaction surface (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4884">
                    <text>a functional interaction surface (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4885">
                    <text>a functional interaction surface (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4886">
                    <text>a functional interaction surface (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4887">
                    <text>a functional interaction surface (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4888">
                    <text>a functional interaction surface (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4889">
                    <text>a functional interaction surface are generated by the N-terminal AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4890">
                    <text>a functional interaction surface are generated by the N-terminal AR .</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4891">
                    <text>a functional interaction surface are generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4892">
                    <text>a functional interaction surface are generated by the N-terminal RA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4893">
                    <text>a functional interaction surface are generated by the N-terminal RA .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4894">
                    <text>a functional interaction surface are generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4895">
                    <text>a functional interaction surface are generated by the term N-AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4896">
                    <text>a functional interaction surface are generated by the term N-AR .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4897">
                    <text>a functional interaction surface are generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4898">
                    <text>a functional interaction surface can be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4899">
                    <text>a functional interaction surface is generated by the N-terminal AR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4900">
                    <text>a functional interaction surface is generated by the N-terminal AR within the recombinant synapse.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4901">
                    <text>a functional interaction surface is generated by the N-terminal AR within the recombinant synapses.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4902">
                    <text>a functional interaction surface is generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4903">
                    <text>a functional interaction surface is generated by the N-terminal AR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4904">
                    <text>a functional interaction surface is generated by the N-terminal RA whose elimination removes the FHL2 link.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4905">
                    <text>a functional interaction surface is generated by the N-terminal RA within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4906">
                    <text>a functional interaction surface is generated by the N-terminal RA within the recombinant synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4907">
                    <text>a functional interaction surface is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4908">
                    <text>a functional interaction surface is generated by the N-terminal RA. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4909">
                    <text>a functional interaction surface is generated by the term N-AR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4910">
                    <text>a functional interaction surface is generated by the term N-AR whose elimination removes the FHL2 link.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4911">
                    <text>a functional interaction surface is generated by the term N-AR within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4912">
                    <text>a functional interaction surface is generated by the term N-AR within the recombinant synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4913">
                    <text>a functional interaction surface is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4914">
                    <text>a functional interaction surface is generated by the term N-AR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4915">
                    <text>a functional interaction surface was generated by the N-terminal AR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4916">
                    <text>a functional interaction surface was generated by the N-terminal AR within the recombinant synapse.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4917">
                    <text>a functional interaction surface was generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4918">
                    <text>a functional interaction surface was generated by the N-terminal RA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4919">
                    <text>a functional interaction surface was generated by the N-terminal RA within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4920">
                    <text>a functional interaction surface was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4921">
                    <text>a functional interaction surface was generated by the term N-AR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4922">
                    <text>a functional interaction surface was generated by the term N-AR within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4923">
                    <text>a functional interaction surface was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4924">
                    <text>a functional interaction surface were generated by the N-terminal AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4925">
                    <text>a functional interaction surface were generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4926">
                    <text>a functional interaction surface were generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4927">
                    <text>a functional interaction surface were generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4928">
                    <text>a functional interaction surface will be generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4929">
                    <text>a functional interaction surface will be generated by the N-terminal AR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4930">
                    <text>a functional interaction surface will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4931">
                    <text>a functional interaction surface will be generated by the N-terminal RA. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4932">
                    <text>a functional interaction surface will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4933">
                    <text>a functional interaction surface will be generated by the term N-AR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="4934">
                    <text>a high-order DNA-protein complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4935">
                    <text>a high-order DNA-protein complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4936">
                    <text>a high-order DNA-protein complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4937">
                    <text>a high-order DNA-protein complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4938">
                    <text>a high-order DNA-protein complex are generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4939">
                    <text>a high-order DNA-protein complex are generated by this binding .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4940">
                    <text>a high-order DNA-protein complex are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4941">
                    <text>a high-order DNA-protein complex can be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4942">
                    <text>a high-order DNA-protein complex is generated by this binding whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4943">
                    <text>a high-order DNA-protein complex is generated by this binding whose elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4944">
                    <text>a high-order DNA-protein complex is generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4945">
                    <text>a high-order DNA-protein complex is generated by this binding within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4946">
                    <text>a high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4947">
                    <text>a high-order DNA-protein complex was generated by this binding (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4948">
                    <text>a high-order DNA-protein complex was generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4949">
                    <text>a high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4950">
                    <text>a high-order DNA-protein complex were generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4951">
                    <text>a high-order DNA-protein complex were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4952">
                    <text>a high-order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4953">
                    <text>a high-order DNA-protein complex will be generated by this binding. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4954">
                    <text>a high-order protein DNA complex can be generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4955">
                    <text>a high-order protein DNA complex can be generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4956">
                    <text>a high-order protein DNA complex have been generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4957">
                    <text>a high-order protein DNA complex was generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4958">
                    <text>a high-order protein DNA complex was generated from A0 (amyloid precursor protein proteolysis (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4959">
                    <text>a high-order protein DNA complex were generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4960">
                    <text>a higher DNA complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4961">
                    <text>a higher DNA complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4962">
                    <text>a higher DNA complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4963">
                    <text>a higher DNA complex are generated by this binding .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4964">
                    <text>a higher DNA complex can be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4965">
                    <text>a higher DNA complex is generated by this binding whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4966">
                    <text>a higher DNA complex is generated by this binding whose elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4967">
                    <text>a higher DNA complex is generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4968">
                    <text>a higher DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4969">
                    <text>a higher DNA complex is generated by this binding. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4970">
                    <text>a higher DNA complex was generated by this binding (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4971">
                    <text>a higher DNA complex was generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4972">
                    <text>a higher DNA complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4973">
                    <text>a higher DNA complex were generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4974">
                    <text>a higher DNA complex were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4975">
                    <text>a higher DNA complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4976">
                    <text>a higher DNA complex will be generated by this binding. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4977">
                    <text>a higher DNA-protein complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4978">
                    <text>a higher DNA-protein complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4979">
                    <text>a higher DNA-protein complex are generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4980">
                    <text>a higher DNA-protein complex are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4981">
                    <text>a higher DNA-protein complex can be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4982">
                    <text>a higher DNA-protein complex is generated by this binding whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4983">
                    <text>a higher DNA-protein complex is generated by this binding within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4984">
                    <text>a higher DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4985">
                    <text>a higher DNA-protein complex is generated by this binding. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4986">
                    <text>a higher DNA-protein complex was generated by this binding (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4987">
                    <text>a higher DNA-protein complex was generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4988">
                    <text>a higher DNA-protein complex were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4989">
                    <text>a higher DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4990">
                    <text>a higher DNA-protein complex will be generated by this binding. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4991">
                    <text>a higher order DNA-protein complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4992">
                    <text>a higher order DNA-protein complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4993">
                    <text>a higher order DNA-protein complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4994">
                    <text>a higher order DNA-protein complex are generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4995">
                    <text>a higher order DNA-protein complex are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4996">
                    <text>a higher order DNA-protein complex can be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4997">
                    <text>a higher order DNA-protein complex is generated by this binding whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4998">
                    <text>a higher order DNA-protein complex is generated by this binding whose elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="4999">
                    <text>a higher order DNA-protein complex is generated by this binding within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5000">
                    <text>a higher order DNA-protein complex is generated by this binding. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5001">
                    <text>a higher order DNA-protein complex was generated by this binding (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5002">
                    <text>a higher order DNA-protein complex was generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5003">
                    <text>a higher order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5004">
                    <text>a higher order DNA-protein complex were generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5005">
                    <text>a higher order DNA-protein complex were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5006">
                    <text>a higher order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5007">
                    <text>a higher order DNA-protein complex will be generated by this binding. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5008">
                    <text>a higher-order protein&#x13;DNA complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5009">
                    <text>a higher-order protein&#x13;DNA complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5010">
                    <text>a higher-order protein&#x13;DNA complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5011">
                    <text>a higher-order protein&#x13;DNA complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5012">
                    <text>a higher-order protein&#x13;DNA complex are generated by this union (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5013">
                    <text>a higher-order protein&#x13;DNA complex are generated by this union .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5014">
                    <text>a higher-order protein&#x13;DNA complex are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5015">
                    <text>a higher-order protein&#x13;DNA complex can be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5016">
                    <text>a higher-order protein&#x13;DNA complex is generated by this union whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5017">
                    <text>a higher-order protein&#x13;DNA complex is generated by this union whose elimination removes the FHL2 link.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5018">
                    <text>a higher-order protein&#x13;DNA complex is generated by this union within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5019">
                    <text>a higher-order protein&#x13;DNA complex is generated by this union within the recombinant synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5020">
                    <text>a higher-order protein&#x13;DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5021">
                    <text>a higher-order protein&#x13;DNA complex was generated by this union (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5022">
                    <text>a higher-order protein&#x13;DNA complex was generated by this union within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5023">
                    <text>a higher-order protein&#x13;DNA complex were generated by this union (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5024">
                    <text>a higher-order protein&#x13;DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5025">
                    <text>a higher-order protein&#x13;DNA complex will be generated by this union. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5026">
                    <text>a higher-order protein DNA complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5027">
                    <text>a higher-order protein DNA complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5028">
                    <text>a higher-order protein DNA complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5029">
                    <text>a higher-order protein DNA complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5030">
                    <text>a higher-order protein DNA complex are generated by this junction (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5031">
                    <text>a higher-order protein DNA complex are generated by this junction .</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5032">
                    <text>a higher-order protein DNA complex are generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5033">
                    <text>a higher-order protein DNA complex can be generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5034">
                    <text>a higher-order protein DNA complex is generated by this junction whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5035">
                    <text>a higher-order protein DNA complex is generated by this junction whose elimination removes the FHL2 link.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5036">
                    <text>a higher-order protein DNA complex is generated by this junction within the recombinant synapses.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5037">
                    <text>a higher-order protein DNA complex is generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5038">
                    <text>a higher-order protein DNA complex is generated by this junction. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5039">
                    <text>a higher-order protein DNA complex was generated by this junction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5040">
                    <text>a higher-order protein DNA complex was generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5041">
                    <text>a higher-order protein DNA complex were generated by this junction (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5042">
                    <text>a higher-order protein DNA complex were generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5043">
                    <text>a higher-order protein DNA complex will be generated by this junction. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5044">
                    <text>a higher-order protein-DNA complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5045">
                    <text>a higher-order protein-DNA complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5046">
                    <text>a higher-order protein-DNA complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5047">
                    <text>a higher-order protein-DNA complex are generated by this union (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5048">
                    <text>a higher-order protein-DNA complex are generated by this union .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5049">
                    <text>a higher-order protein-DNA complex are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5050">
                    <text>a higher-order protein-DNA complex can be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5051">
                    <text>a higher-order protein-DNA complex is generated by this union whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5052">
                    <text>a higher-order protein-DNA complex is generated by this union whose elimination removes the FHL2 link.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5053">
                    <text>a higher-order protein-DNA complex is generated by this union within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5054">
                    <text>a higher-order protein-DNA complex is generated by this union within the recombinant synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5055">
                    <text>a higher-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5056">
                    <text>a higher-order protein-DNA complex was generated by this union (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5057">
                    <text>a higher-order protein-DNA complex was generated by this union within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5058">
                    <text>a higher-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5059">
                    <text>a higher-order protein-DNA complex were generated by this union (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5060">
                    <text>a higher-order protein-DNA complex were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5061">
                    <text>a higher-order protein-DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5062">
                    <text>a hypersensitive DNase I (carot, and permease from DcuB to motor, carot and aspartate) were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5063">
                    <text>a hypersensitive DNase I (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5064">
                    <text>a hypersensitive DNase I (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5065">
                    <text>a hypersensitive DNase I are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5066">
                    <text>a hypersensitive DNase I are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5067">
                    <text>a hypersensitive DNase I are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5068">
                    <text>a hypersensitive DNase I can be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5069">
                    <text>a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex whose elimination removes the FHL2 link.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5070">
                    <text>a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5071">
                    <text>a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex within the recombinant synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5072">
                    <text>a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5073">
                    <text>a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5074">
                    <text>a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5075">
                    <text>a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5076">
                    <text>a hypersensitive DNase I were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5077">
                    <text>a hypersensitive DNase I were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5078">
                    <text>a hypersensitive DNase I will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5079">
                    <text>a hypersensitive DNase I will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5080">
                    <text>a hypersensitive chromatin I remodeling complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5081">
                    <text>a hypersensitive chromatin I remodeling complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5082">
                    <text>a hypersensitive chromatin I remodeling complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5083">
                    <text>a hypersensitive chromatin I remodeling complex are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5084">
                    <text>a hypersensitive chromatin I remodeling complex are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5085">
                    <text>a hypersensitive chromatin I remodeling complex are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5086">
                    <text>a hypersensitive chromatin I remodeling complex can be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5087">
                    <text>a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5088">
                    <text>a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex whose elimination removes the FHL2 link.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5089">
                    <text>a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5090">
                    <text>a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex within the recombinant synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5091">
                    <text>a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5092">
                    <text>a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5093">
                    <text>a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5094">
                    <text>a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5095">
                    <text>a hypersensitive chromatin I remodeling complex was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5096">
                    <text>a hypersensitive chromatin I remodeling complex were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5097">
                    <text>a hypersensitive chromatin I remodeling complex were generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5098">
                    <text>a hypersensitive chromatin I remodeling complex will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5099">
                    <text>a hypersensitive chromatin I remodeling complex will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="5100">
                    <text>a hypersensitive to DNase I (carot, and permease from DcuB to motor, carot and aspartate) were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5101">
                    <text>a hypersensitive to DNase I (carot, and permease from DcuB to motor, carot and aspartate) were generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5102">
                    <text>a hypersensitive to DNase I (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5103">
                    <text>a hypersensitive to DNase I (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5104">
                    <text>a hypersensitive to DNase I (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5105">
                    <text>a hypersensitive to DNase I (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5106">
                    <text>a hypersensitive to DNase I (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5107">
                    <text>a hypersensitive to DNase I (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5108">
                    <text>a hypersensitive to DNase I (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5109">
                    <text>a hypersensitive to DNase I are generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5110">
                    <text>a hypersensitive to DNase I are generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5111">
                    <text>a hypersensitive to DNase I are generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5112">
                    <text>a hypersensitive to DNase I are generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5113">
                    <text>a hypersensitive to DNase I are generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5114">
                    <text>a hypersensitive to DNase I are generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5115">
                    <text>a hypersensitive to DNase I are generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5116">
                    <text>a hypersensitive to DNase I are generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5117">
                    <text>a hypersensitive to DNase I can be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5118">
                    <text>a hypersensitive to DNase I can be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5119">
                    <text>a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5120">
                    <text>a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) whose elimination removes the FHL2 link.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5121">
                    <text>a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5122">
                    <text>a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1). The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5123">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5124">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) whose elimination removes the FHL2 link.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5125">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) within the recombinant synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5126">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1). The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5127">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5128">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) whose elimination removes the FHL2 link.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5129">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5130">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5131">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1). The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5132">
                    <text>a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5133">
                    <text>a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5134">
                    <text>a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5135">
                    <text>a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5136">
                    <text>a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5137">
                    <text>a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5138">
                    <text>a hypersensitive to DNase I were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5139">
                    <text>a hypersensitive to DNase I were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5140">
                    <text>a hypersensitive to DNase I were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5141">
                    <text>a hypersensitive to DNase I were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5142">
                    <text>a hypersensitive to DNase I were generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5143">
                    <text>a hypersensitive to DNase I will be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5144">
                    <text>a hypersensitive to DNase I will be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1). The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5145">
                    <text>a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5146">
                    <text>a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1). The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5147">
                    <text>a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5148">
                    <text>a hypersensitive to DNase I will be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1). The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5149">
                    <text>a monoclonal antibody vs. FHL2 (carot, and permease from DcuB to motor, carot and aspartate) were generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5150">
                    <text>a monoclonal antibody vs. FHL2 (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5151">
                    <text>a monoclonal antibody vs. FHL2 (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5152">
                    <text>a monoclonal antibody vs. FHL2 (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5153">
                    <text>a monoclonal antibody vs. FHL2 are generated by ens (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5154">
                    <text>a monoclonal antibody vs. FHL2 are generated by ens .</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5155">
                    <text>a monoclonal antibody vs. FHL2 are generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5156">
                    <text>a monoclonal antibody vs. FHL2 can be generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5157">
                    <text>a monoclonal antibody vs. FHL2 is generated by ens whose deletion removes the FHL2 binding.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5158">
                    <text>a monoclonal antibody vs. FHL2 is generated by ens whose elimination removes the FHL2 link.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5159">
                    <text>a monoclonal antibody vs. FHL2 is generated by ens within the recombinant synapses.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5160">
                    <text>a monoclonal antibody vs. FHL2 is generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5161">
                    <text>a monoclonal antibody vs. FHL2 is generated by ens. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5162">
                    <text>a monoclonal antibody vs. FHL2 was generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5163">
                    <text>a monoclonal antibody vs. FHL2 were generated by ens (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5164">
                    <text>a monoclonal antibody vs. FHL2 were generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5165">
                    <text>a monoclonal antibody vs. FHL2 will be generated by ens.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5166">
                    <text>a surface of functional interaction (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5167">
                    <text>a surface of functional interaction (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5168">
                    <text>a surface of functional interaction (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5169">
                    <text>a surface of functional interaction are generated by the term N-AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5170">
                    <text>a surface of functional interaction are generated by the term N-AR .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5171">
                    <text>a surface of functional interaction are generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5172">
                    <text>a surface of functional interaction can be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5173">
                    <text>a surface of functional interaction is generated by the term N-AR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5174">
                    <text>a surface of functional interaction is generated by the term N-AR within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5175">
                    <text>a surface of functional interaction is generated by the term N-AR within the recombinant synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5176">
                    <text>a surface of functional interaction is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5177">
                    <text>a surface of functional interaction is generated by the term N-AR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5178">
                    <text>a surface of functional interaction was generated by the term N-AR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5179">
                    <text>a surface of functional interaction was generated by the term N-AR within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5180">
                    <text>a surface of functional interaction was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5181">
                    <text>a surface of functional interaction were generated by the term N-AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5182">
                    <text>a surface of functional interaction were generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5183">
                    <text>a surface of functional interaction will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="5184">
                    <text>abeta peptides can be generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="5185">
                    <text>abeta peptides was generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="5186">
                    <text>abeta peptides was generated from A0 (amyloid precursor protein proteolysis (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="5187">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region are able to generate mRNA of mature HeLa cells .</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5188">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region can generate mRNA of mature HeLa cells (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5189">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region can generate mRNA of mature HeLa cells (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5190">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region can generate mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5191">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5192">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5193">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5194">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells within the recombinant synapse.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5195">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells-G molecules of human leukocytes.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5196">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generated mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5197">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5198">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5199">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells within the recombinant synapse.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5200">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells within the recombinant synapses.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5201">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells-G molecules of antigen human leukocytes.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5202">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells-G molecules of human leukocytes.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5203">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5204">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region has generated mRNA of mature HeLa cells for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5205">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region is able to generate mRNA of mature HeLa cells .</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5206">
                    <text>an RNA fragment of 3863 bases occurring in the 5-interpreted region is able to generate mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5207">
                    <text>an alternative coupling of primary gene transcription are able to generate HLA .</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5208">
                    <text>an alternative coupling of primary gene transcription can generate HLA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5209">
                    <text>an alternative coupling of primary gene transcription can generate HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5210">
                    <text>an alternative coupling of primary gene transcription generated HLA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5211">
                    <text>an alternative coupling of primary gene transcription generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5212">
                    <text>an alternative coupling of primary gene transcription generated HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5213">
                    <text>an alternative coupling of primary gene transcription generated HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5214">
                    <text>an alternative coupling of primary gene transcription generated HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5215">
                    <text>an alternative coupling of primary gene transcription generates HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5216">
                    <text>an alternative coupling of primary gene transcription generates HLA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5217">
                    <text>an alternative coupling of primary gene transcription generates HLA within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5218">
                    <text>an alternative coupling of primary gene transcription generates HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5219">
                    <text>an alternative coupling of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5220">
                    <text>an alternative coupling of primary gene transcription has generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5221">
                    <text>an alternative coupling of primary gene transcription is able to generate HLA .</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5222">
                    <text>an alternative coupling of primary gene transcription is able to generate HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5223">
                    <text>an alternative coupling of primary genetic transcription are able to generate HLA .</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5224">
                    <text>an alternative coupling of primary genetic transcription can generate HLA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5225">
                    <text>an alternative coupling of primary genetic transcription can generate HLA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5226">
                    <text>an alternative coupling of primary genetic transcription generated HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5227">
                    <text>an alternative coupling of primary genetic transcription generated HLA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5228">
                    <text>an alternative coupling of primary genetic transcription generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5229">
                    <text>an alternative coupling of primary genetic transcription generated HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5230">
                    <text>an alternative coupling of primary genetic transcription generated HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5231">
                    <text>an alternative coupling of primary genetic transcription generated HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5232">
                    <text>an alternative coupling of primary genetic transcription generates HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5233">
                    <text>an alternative coupling of primary genetic transcription generates HLA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5234">
                    <text>an alternative coupling of primary genetic transcription generates HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5235">
                    <text>an alternative coupling of primary genetic transcription generates HLA within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5236">
                    <text>an alternative coupling of primary genetic transcription generates HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5237">
                    <text>an alternative coupling of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5238">
                    <text>an alternative coupling of primary genetic transcription has generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5239">
                    <text>an alternative coupling of primary genetic transcription is able to generate HLA .</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5240">
                    <text>an alternative coupling of primary genetic transcription is able to generate HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5241">
                    <text>an alternative coupling of primary transcription of the gene are able to generate HLA .</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5242">
                    <text>an alternative coupling of primary transcription of the gene can generate HLA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5243">
                    <text>an alternative coupling of primary transcription of the gene can generate HLA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5244">
                    <text>an alternative coupling of primary transcription of the gene can generate HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5245">
                    <text>an alternative coupling of primary transcription of the gene generated HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5246">
                    <text>an alternative coupling of primary transcription of the gene generated HLA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5247">
                    <text>an alternative coupling of primary transcription of the gene generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5248">
                    <text>an alternative coupling of primary transcription of the gene generated HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5249">
                    <text>an alternative coupling of primary transcription of the gene generated HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5250">
                    <text>an alternative coupling of primary transcription of the gene generated HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5251">
                    <text>an alternative coupling of primary transcription of the gene generates HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5252">
                    <text>an alternative coupling of primary transcription of the gene generates HLA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5253">
                    <text>an alternative coupling of primary transcription of the gene generates HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5254">
                    <text>an alternative coupling of primary transcription of the gene generates HLA within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5255">
                    <text>an alternative coupling of primary transcription of the gene generates HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5256">
                    <text>an alternative coupling of primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5257">
                    <text>an alternative coupling of the primary transcription of the gene can generate HLA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5258">
                    <text>an alternative coupling of the primary transcription of the gene can generate HLA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5259">
                    <text>an alternative coupling of the primary transcription of the gene can generate HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5260">
                    <text>an alternative coupling of the primary transcription of the gene generated HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5261">
                    <text>an alternative coupling of the primary transcription of the gene generated HLA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5262">
                    <text>an alternative coupling of the primary transcription of the gene generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5263">
                    <text>an alternative coupling of the primary transcription of the gene generated HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5264">
                    <text>an alternative coupling of the primary transcription of the gene generated HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5265">
                    <text>an alternative coupling of the primary transcription of the gene generates HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5266">
                    <text>an alternative coupling of the primary transcription of the gene generates HLA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5267">
                    <text>an alternative coupling of the primary transcription of the gene generates HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5268">
                    <text>an alternative coupling of the primary transcription of the gene generates HLA within the recombinant synapses.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5269">
                    <text>an alternative coupling of the primary transcription of the gene generates HLA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5270">
                    <text>an alternative coupling of the primary transcription of the gene has generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5271">
                    <text>an alternative coupling of the primary transcription of the gene is able to generate HLA .</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5272">
                    <text>an alternative coupling of the primary transcription of the gene is able to generate HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="5273">
                    <text>biceps RNase III Dicer are able to generate 21-23 nt of long mature RNAs .</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5274">
                    <text>biceps RNase III Dicer can generate 21-23 nt of long mature RNAs (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5275">
                    <text>biceps RNase III Dicer can generate 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5276">
                    <text>biceps RNase III Dicer generated 21-23 nt of long mature RNAs (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5277">
                    <text>biceps RNase III Dicer generated 21-23 nt of long mature RNAs (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5278">
                    <text>biceps RNase III Dicer generated 21-23 nt of long mature RNAs within the recombinant synapse.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5279">
                    <text>biceps RNase III Dicer generated 21-23 nt of long mature RNAs-G molecules of human leukocytes.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5280">
                    <text>biceps RNase III Dicer generated 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5281">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5282">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5283">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs within the recombinant synapse.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5284">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs within the recombinant synapses.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5285">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs-G molecules of human leukocytes.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5286">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5287">
                    <text>biceps RNase III Dicer is able to generate 21-23 nt of long mature RNAs .</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5288">
                    <text>biceps RNase III Dicer is able to generate 21-23 nt of long mature RNAs.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="5289">
                    <text>bidentate RNase III are able to generate mature RNA 21-23 nt .</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5290">
                    <text>bidentate RNase III can generate mature RNA 21-23 nt (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5291">
                    <text>bidentate RNase III can generate mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5292">
                    <text>bidentate RNase III generated mature RNA 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5293">
                    <text>bidentate RNase III generated mature RNA 21-23 nt (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5294">
                    <text>bidentate RNase III generated mature RNA 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5295">
                    <text>bidentate RNase III generated mature RNA 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5296">
                    <text>bidentate RNase III generated mature RNA 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5297">
                    <text>bidentate RNase III generated mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5298">
                    <text>bidentate RNase III generates mature RNA 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5299">
                    <text>bidentate RNase III generates mature RNA 21-23 nt (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5300">
                    <text>bidentate RNase III generates mature RNA 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5301">
                    <text>bidentate RNase III generates mature RNA 21-23 nt within the recombinant synapses.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5302">
                    <text>bidentate RNase III generates mature RNA 21-23 nt-G molecules of antigen human leukocytes.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5303">
                    <text>bidentate RNase III generates mature RNA 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5304">
                    <text>bidentate RNase III generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5305">
                    <text>bidentate RNase III has generated mature RNA 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5306">
                    <text>bidentate RNase III is able to generate mature RNA 21-23 nt .</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5307">
                    <text>degradation are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5308">
                    <text>degradation are able to generate specific fragments .</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5309">
                    <text>degradation can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5310">
                    <text>degradation can generate specific fragments (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5311">
                    <text>degradation can generate specific fragments (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5312">
                    <text>degradation generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5313">
                    <text>degradation generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5314">
                    <text>degradation generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5315">
                    <text>degradation generated specific fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5316">
                    <text>degradation generated specific fragments (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5317">
                    <text>degradation generated specific fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5318">
                    <text>degradation generated specific fragments within the recombinant synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5319">
                    <text>degradation generated specific fragments-G molecules of human leukocytes.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5320">
                    <text>degradation generated specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5321">
                    <text>degradation generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5322">
                    <text>degradation generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5323">
                    <text>degradation generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="5324">
                    <text>degradation generates specific fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5325">
                    <text>degradation generates specific fragments (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5326">
                    <text>degradation generates specific fragments within the recombinant synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5327">
                    <text>degradation generates specific fragments within the recombinant synapses.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5328">
                    <text>degradation generates specific fragments-G molecules of human leukocytes.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5329">
                    <text>degradation generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5330">
                    <text>degradation is able to generate specific fragments .</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5331">
                    <text>degradation is able to generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="5332">
                    <text>does not react anaerobically with the purified Fe-S group of NRF are able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex .</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5333">
                    <text>does not react anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5334">
                    <text>does not react anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5335">
                    <text>does not react anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5336">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5337">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5338">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5339">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5340">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5341">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5342">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5343">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5344">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5345">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5346">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5347">
                    <text>does not react anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex .</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5348">
                    <text>does not react anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5349">
                    <text>ens are able to generate a monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5350">
                    <text>ens can generate a monoclonal antibody vs. FHL2 (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5351">
                    <text>ens can generate a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5352">
                    <text>ens generated a monoclonal antibody vs. FHL2 (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5353">
                    <text>ens generated a monoclonal antibody vs. FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5354">
                    <text>ens generated a monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5355">
                    <text>ens generated a monoclonal antibody vs. FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5356">
                    <text>ens generated a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5357">
                    <text>ens generates a monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5358">
                    <text>ens generates a monoclonal antibody vs. FHL2 (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5359">
                    <text>ens generates a monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5360">
                    <text>ens generates a monoclonal antibody vs. FHL2 within the recombinant synapses.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5361">
                    <text>ens generates a monoclonal antibody vs. FHL2-G molecules of antigen human leukocytes.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5362">
                    <text>ens generates a monoclonal antibody vs. FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5363">
                    <text>ens generates a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5364">
                    <text>ens has generated a monoclonal antibody vs. FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5365">
                    <text>ens is able to generate a monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5366">
                    <text>ens is able to generate a monoclonal antibody vs. FHL2.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5367">
                    <text>fumat (carot, and permease from DcuB to motor, carot and aspartate) were generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5368">
                    <text>fumat (carot, and permease from DcuB to motor, carot and aspartate) were generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5369">
                    <text>fumat (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5370">
                    <text>fumat (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5371">
                    <text>fumat (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5372">
                    <text>fumat (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5373">
                    <text>fumat (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5374">
                    <text>fumat B are able to generate fumat .</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5375">
                    <text>fumat B can generate fumat (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5376">
                    <text>fumat B can generate fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5377">
                    <text>fumat B generated fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5378">
                    <text>fumat B generated fumat (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5379">
                    <text>fumat B generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5380">
                    <text>fumat B generated fumat within the recombinant synapse.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5381">
                    <text>fumat B generated fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5382">
                    <text>fumat B generates fumat within the recombinant synapse.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5383">
                    <text>fumat B generates fumat within the recombinant synapses.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5384">
                    <text>fumat B generates fumat-G molecules of antigen human leukocytes.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5385">
                    <text>fumat B generates fumat-G molecules of human leukocytes.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5386">
                    <text>fumat B generates fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5387">
                    <text>fumat B has generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5388">
                    <text>fumat B is able to generate fumat .</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5389">
                    <text>fumat B is able to generate fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5390">
                    <text>fumat are generated by fumat B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5391">
                    <text>fumat are generated by fumat B .</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5392">
                    <text>fumat are generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5393">
                    <text>fumat are generated by fumatase B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5394">
                    <text>fumat are generated by fumatase B .</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5395">
                    <text>fumat are generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5396">
                    <text>fumat can be generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5397">
                    <text>fumat can be generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5398">
                    <text>fumat is generated by fumat B whose deletion removes the FHL2 binding.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5399">
                    <text>fumat is generated by fumat B whose elimination removes the FHL2 link.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5400">
                    <text>fumat is generated by fumat B within the recombinant synapse.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5401">
                    <text>fumat is generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5402">
                    <text>fumat is generated by fumatase B whose deletion removes the FHL2 binding.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5403">
                    <text>fumat is generated by fumatase B whose elimination removes the FHL2 link.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5404">
                    <text>fumat is generated by fumatase B within the recombinant synapse.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5405">
                    <text>fumat is generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5406">
                    <text>fumat is generated by fumatase B. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5407">
                    <text>fumat was generated by fumat B (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5408">
                    <text>fumat was generated by fumat B within the recombinant synapse.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5409">
                    <text>fumat was generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5410">
                    <text>fumat was generated by fumatase B (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5411">
                    <text>fumat was generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5412">
                    <text>fumat were generated by fumat B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5413">
                    <text>fumat were generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5414">
                    <text>fumat were generated by fumatase B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5415">
                    <text>fumat were generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5416">
                    <text>fumat will be generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5417">
                    <text>fumat will be generated by fumatase B. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5418">
                    <text>fumatase B are able to generate fumat .</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5419">
                    <text>fumatase B can generate fumat (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5420">
                    <text>fumatase B generated fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5421">
                    <text>fumatase B generated fumat (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5422">
                    <text>fumatase B generated fumat within the recombinant synapse.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5423">
                    <text>fumatase B generated fumat-G molecules of human leukocytes.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5424">
                    <text>fumatase B generated fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5425">
                    <text>fumatase B generates fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5426">
                    <text>fumatase B generates fumat (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5427">
                    <text>fumatase B generates fumat within the recombinant synapse.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5428">
                    <text>fumatase B generates fumat within the recombinant synapses.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5429">
                    <text>fumatase B generates fumat-G molecules of antigen human leukocytes.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5430">
                    <text>fumatase B generates fumat-G molecules of human leukocytes.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5431">
                    <text>fumatase B generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5432">
                    <text>fumatase B has generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5433">
                    <text>fumatase B is able to generate fumat .</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5434">
                    <text>fumatase B is able to generate fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="5435">
                    <text>high-order DNA protein complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5436">
                    <text>high-order DNA protein complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5437">
                    <text>high-order DNA protein complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5438">
                    <text>high-order DNA protein complex are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5439">
                    <text>high-order DNA protein complex can be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5440">
                    <text>high-order DNA protein complex is generated by this binding whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5441">
                    <text>high-order DNA protein complex is generated by this binding whose elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5442">
                    <text>high-order DNA protein complex is generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5443">
                    <text>high-order DNA protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5444">
                    <text>high-order DNA protein complex is generated by this binding. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5445">
                    <text>high-order DNA protein complex was generated by this binding (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5446">
                    <text>high-order DNA protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5447">
                    <text>high-order DNA protein complex were generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5448">
                    <text>high-order DNA protein complex were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5449">
                    <text>high-order DNA protein complex will be generated by this binding. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5450">
                    <text>high-order DNA-protein complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5451">
                    <text>high-order DNA-protein complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5452">
                    <text>high-order DNA-protein complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5453">
                    <text>high-order DNA-protein complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5454">
                    <text>high-order DNA-protein complex are generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5455">
                    <text>high-order DNA-protein complex are generated by this binding .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5456">
                    <text>high-order DNA-protein complex are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5457">
                    <text>high-order DNA-protein complex can be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5458">
                    <text>high-order DNA-protein complex is generated by this binding whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5459">
                    <text>high-order DNA-protein complex is generated by this binding whose elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5460">
                    <text>high-order DNA-protein complex is generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5461">
                    <text>high-order DNA-protein complex is generated by this binding within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5462">
                    <text>high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5463">
                    <text>high-order DNA-protein complex is generated by this binding. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5464">
                    <text>high-order DNA-protein complex was generated by this binding (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5465">
                    <text>high-order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5466">
                    <text>high-order DNA-protein complex were generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5467">
                    <text>high-order DNA-protein complex were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5468">
                    <text>high-order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5469">
                    <text>high-order DNA-protein complex will be generated by this binding. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="5470">
                    <text>high-order protein-DNA complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5471">
                    <text>high-order protein-DNA complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5472">
                    <text>high-order protein-DNA complex are generated by this union (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5473">
                    <text>high-order protein-DNA complex are generated by this union .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5474">
                    <text>high-order protein-DNA complex are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5475">
                    <text>high-order protein-DNA complex can be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5476">
                    <text>high-order protein-DNA complex is generated by this union whose deletion removes the FHL2 binding.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5477">
                    <text>high-order protein-DNA complex is generated by this union whose elimination removes the FHL2 link.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5478">
                    <text>high-order protein-DNA complex is generated by this union within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5479">
                    <text>high-order protein-DNA complex is generated by this union within the recombinant synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5480">
                    <text>high-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5481">
                    <text>high-order protein-DNA complex is generated by this union. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5482">
                    <text>high-order protein-DNA complex was generated by this union within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5483">
                    <text>high-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5484">
                    <text>high-order protein-DNA complex were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5485">
                    <text>high-order protein-DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5486">
                    <text>high-order protein-DNA complex will be generated by this union. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="5487">
                    <text>hypersensitive to DNase I (carot, and permease from DcuB to motor, carot and aspartate) were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5488">
                    <text>hypersensitive to DNase I (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5489">
                    <text>hypersensitive to DNase I (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5490">
                    <text>hypersensitive to DNase I are generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5491">
                    <text>hypersensitive to DNase I are generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5492">
                    <text>hypersensitive to DNase I can be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5493">
                    <text>hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) whose deletion removes the FHL2 binding.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5494">
                    <text>hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) whose elimination removes the FHL2 link.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5495">
                    <text>hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) within the recombinant synapse.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5496">
                    <text>hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) within the recombinant synapses.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5497">
                    <text>hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5498">
                    <text>hypersensitive to DNase I is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1). The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5499">
                    <text>hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5500">
                    <text>hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) within the recombinant synapse.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5501">
                    <text>hypersensitive to DNase I were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5502">
                    <text>hypersensitive to DNase I were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5503">
                    <text>hypersensitive to DNase I will be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5504">
                    <text>hypersensitive to DNase I will be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1). The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="5505">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster are able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex .</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5506">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5507">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5508">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5509">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5510">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5511">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5512">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5513">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5514">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5515">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5516">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5517">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5518">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5519">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5520">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster has generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5521">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex .</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5522">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="5523">
                    <text>intergenic slicing with Prnp are able to generate some unusual chemical transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5524">
                    <text>intergenic slicing with Prnp are able to generate some unusual chimeric transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5525">
                    <text>intergenic slicing with Prnp can generate some unusual chemical transcriptions (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5526">
                    <text>intergenic slicing with Prnp can generate some unusual chemical transcriptions (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5527">
                    <text>intergenic slicing with Prnp can generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5528">
                    <text>intergenic slicing with Prnp can generate some unusual chimeric transcriptions (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5529">
                    <text>intergenic slicing with Prnp can generate some unusual symmetrical transcriptions (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5530">
                    <text>intergenic slicing with Prnp can generate some unusual symmetrical transcriptions (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5531">
                    <text>intergenic slicing with Prnp can generate some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5532">
                    <text>intergenic slicing with Prnp generated some unusual chemical transcriptions (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5533">
                    <text>intergenic slicing with Prnp generated some unusual chemical transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5534">
                    <text>intergenic slicing with Prnp generated some unusual chemical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5535">
                    <text>intergenic slicing with Prnp generated some unusual chemical transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5536">
                    <text>intergenic slicing with Prnp generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5537">
                    <text>intergenic slicing with Prnp generated some unusual chimeric transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5538">
                    <text>intergenic slicing with Prnp generated some unusual chimeric transcriptions (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5539">
                    <text>intergenic slicing with Prnp generated some unusual chimeric transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5540">
                    <text>intergenic slicing with Prnp generated some unusual chimeric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5541">
                    <text>intergenic slicing with Prnp generated some unusual chimeric transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5542">
                    <text>intergenic slicing with Prnp generated some unusual symmetrical transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5543">
                    <text>intergenic slicing with Prnp generated some unusual symmetrical transcriptions (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5544">
                    <text>intergenic slicing with Prnp generated some unusual symmetrical transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5545">
                    <text>intergenic slicing with Prnp generated some unusual symmetrical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5546">
                    <text>intergenic slicing with Prnp generated some unusual symmetrical transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5547">
                    <text>intergenic slicing with Prnp generates some unusual chemical transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5548">
                    <text>intergenic slicing with Prnp generates some unusual chemical transcriptions (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5549">
                    <text>intergenic slicing with Prnp generates some unusual chemical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5550">
                    <text>intergenic slicing with Prnp generates some unusual chemical transcriptions within the recombinant synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5551">
                    <text>intergenic slicing with Prnp generates some unusual chemical transcriptions-G molecules of antigen human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5552">
                    <text>intergenic slicing with Prnp generates some unusual chemical transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5553">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5554">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5555">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5556">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions within the recombinant synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5557">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5558">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5559">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5560">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5561">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5562">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions within the recombinant synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5563">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5564">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5565">
                    <text>intergenic slicing with Prnp has generated some unusual chemical transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5566">
                    <text>intergenic slicing with Prnp has generated some unusual chimeric transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5567">
                    <text>intergenic slicing with Prnp has generated some unusual symmetrical transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5568">
                    <text>intergenic slicing with Prnp is able to generate some unusual chemical transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5569">
                    <text>intergenic slicing with Prnp is able to generate some unusual chimeric transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5570">
                    <text>intergenic slicing with Prnp is able to generate some unusual symmetrical transcriptions .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5571">
                    <text>intergenic slicing with Prnp is able to generate some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5572">
                    <text>intergenic spike with Prnp are able to generate some unusual chemical transcriptions .</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5573">
                    <text>intergenic spike with Prnp can generate some unusual chemical transcriptions (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5574">
                    <text>intergenic spike with Prnp generated some unusual chemical transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5575">
                    <text>intergenic spike with Prnp generated some unusual chemical transcriptions (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5576">
                    <text>intergenic spike with Prnp generated some unusual chemical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5577">
                    <text>intergenic spike with Prnp generated some unusual chemical transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5578">
                    <text>intergenic spike with Prnp generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5579">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5580">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions within the recombinant synapses.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5581">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions-G molecules of antigen human leukocytes.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5582">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5583">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5584">
                    <text>intergenic spike with Prnp has generated some unusual chemical transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5585">
                    <text>intergenic spike with Prnp is able to generate some unusual chemical transcriptions .</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="5586">
                    <text>large transcriptions of 1.7 and 2.7 kb (carot, and permease from DcuB to motor, carot and aspartate) were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5587">
                    <text>large transcriptions of 1.7 and 2.7 kb (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5588">
                    <text>large transcriptions of 1.7 and 2.7 kb (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5589">
                    <text>large transcriptions of 1.7 and 2.7 kb (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5590">
                    <text>large transcriptions of 1.7 and 2.7 kb are generated by Prnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5591">
                    <text>large transcriptions of 1.7 and 2.7 kb are generated by Prnd .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5592">
                    <text>large transcriptions of 1.7 and 2.7 kb are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5593">
                    <text>large transcriptions of 1.7 and 2.7 kb can be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5594">
                    <text>large transcriptions of 1.7 and 2.7 kb is generated by Prnd whose deletion removes the FHL2 binding.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5595">
                    <text>large transcriptions of 1.7 and 2.7 kb is generated by Prnd within the recombinant synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5596">
                    <text>large transcriptions of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5597">
                    <text>large transcriptions of 1.7 and 2.7 kb is generated by Prnd. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5598">
                    <text>large transcriptions of 1.7 and 2.7 kb was generated by Prnd (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5599">
                    <text>large transcriptions of 1.7 and 2.7 kb was generated by Prnd within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5600">
                    <text>large transcriptions of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5601">
                    <text>large transcriptions of 1.7 and 2.7 kb were generated by Prnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5602">
                    <text>large transcriptions of 1.7 and 2.7 kb were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5603">
                    <text>large transcriptions of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5604">
                    <text>large transcriptions of 1.7 and 2.7 kb will be generated by Prnd. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5605">
                    <text>long RNAs of 21-23 nt (carot, and permease from DcuB to motor, carot and aspartate) were generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5606">
                    <text>long RNAs of 21-23 nt (carot, and permease from DcuB to motor, carot and aspartate) were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5607">
                    <text>long RNAs of 21-23 nt (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5608">
                    <text>long RNAs of 21-23 nt (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5609">
                    <text>long RNAs of 21-23 nt (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5610">
                    <text>long RNAs of 21-23 nt (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5611">
                    <text>long RNAs of 21-23 nt (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5612">
                    <text>long RNAs of 21-23 nt are generated by Bydented RNase III dyce (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5613">
                    <text>long RNAs of 21-23 nt are generated by Bydented RNase III dyce .</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5614">
                    <text>long RNAs of 21-23 nt are generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5615">
                    <text>long RNAs of 21-23 nt can be generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5616">
                    <text>long RNAs of 21-23 nt can be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5617">
                    <text>long RNAs of 21-23 nt is generated by Bydented RNase III dyce whose deletion removes the FHL2 binding.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5618">
                    <text>long RNAs of 21-23 nt is generated by Bydented RNase III dyce whose elimination removes the FHL2 link.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5619">
                    <text>long RNAs of 21-23 nt is generated by Bydented RNase III dyce within the recombinant synapses.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5620">
                    <text>long RNAs of 21-23 nt is generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5621">
                    <text>long RNAs of 21-23 nt is generated by Bydented RNase III dyce. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5622">
                    <text>long RNAs of 21-23 nt is generated by The biceps RNase III Dicer whose deletion removes the FHL2 binding.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5623">
                    <text>long RNAs of 21-23 nt is generated by The biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5624">
                    <text>long RNAs of 21-23 nt is generated by The biceps RNase III Dicer within the recombinant synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5625">
                    <text>long RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5626">
                    <text>long RNAs of 21-23 nt is generated by The biceps RNase III Dicer. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5627">
                    <text>long RNAs of 21-23 nt was generated by Bydented RNase III dyce (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5628">
                    <text>long RNAs of 21-23 nt was generated by Bydented RNase III dyce within the recombinant synapse.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5629">
                    <text>long RNAs of 21-23 nt was generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5630">
                    <text>long RNAs of 21-23 nt was generated by The biceps RNase III Dicer (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5631">
                    <text>long RNAs of 21-23 nt was generated by The biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5632">
                    <text>long RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5633">
                    <text>long RNAs of 21-23 nt were generated by The biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5634">
                    <text>long RNAs of 21-23 nt will be generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5635">
                    <text>long RNAs of 21-23 nt will be generated by Bydented RNase III dyce. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5636">
                    <text>long RNAs of 21-23 nt will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5637">
                    <text>long RNAs of 21-23 nt will be generated by The biceps RNase III Dicer. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5638">
                    <text>long mature RNAs of 21-23 nt (carot, and permease from DcuB to motor, carot and aspartate) were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5639">
                    <text>long mature RNAs of 21-23 nt (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5640">
                    <text>long mature RNAs of 21-23 nt (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5641">
                    <text>long mature RNAs of 21-23 nt are generated by The biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5642">
                    <text>long mature RNAs of 21-23 nt are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5643">
                    <text>long mature RNAs of 21-23 nt can be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5644">
                    <text>long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer whose deletion removes the FHL2 binding.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5645">
                    <text>long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer whose elimination removes the FHL2 link.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5646">
                    <text>long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5647">
                    <text>long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5648">
                    <text>long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5649">
                    <text>long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5650">
                    <text>long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5651">
                    <text>long mature RNAs of 21-23 nt was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5652">
                    <text>long mature RNAs of 21-23 nt were generated by The biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5653">
                    <text>long mature RNAs of 21-23 nt were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5654">
                    <text>long mature RNAs of 21-23 nt will be generated by The biceps RNase III Dicer. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5655">
                    <text>mRNA of heLa cells (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5656">
                    <text>mRNA of heLa cells (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5657">
                    <text>mRNA of heLa cells (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5658">
                    <text>mRNA of heLa cells are generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region .</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5659">
                    <text>mRNA of heLa cells are generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5660">
                    <text>mRNA of heLa cells can be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5661">
                    <text>mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region whose elimination removes the FHL2 link.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5662">
                    <text>mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5663">
                    <text>mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region within the recombinant synapses.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5664">
                    <text>mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5665">
                    <text>mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5666">
                    <text>mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5667">
                    <text>mRNA of heLa cells were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5668">
                    <text>mRNA of heLa cells were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5669">
                    <text>mRNA of heLa cells will be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5670">
                    <text>mRNA of heLa cells will be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5671">
                    <text>mRNA of mature HeLa cells (carot, and permease from DcuB to motor, carot and aspartate) were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5672">
                    <text>mRNA of mature HeLa cells (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5673">
                    <text>mRNA of mature HeLa cells (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5674">
                    <text>mRNA of mature HeLa cells (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5675">
                    <text>mRNA of mature HeLa cells are generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5676">
                    <text>mRNA of mature HeLa cells are generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region .</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5677">
                    <text>mRNA of mature HeLa cells can be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5678">
                    <text>mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region whose deletion removes the FHL2 binding.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5679">
                    <text>mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region whose elimination removes the FHL2 link.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5680">
                    <text>mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region within the recombinant synapse.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5681">
                    <text>mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region within the recombinant synapses.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5682">
                    <text>mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5683">
                    <text>mRNA of mature HeLa cells is generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5684">
                    <text>mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5685">
                    <text>mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region within the recombinant synapse.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5686">
                    <text>mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5687">
                    <text>mRNA of mature HeLa cells were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5688">
                    <text>mRNA of mature HeLa cells will be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5689">
                    <text>mRNA of mature HeLa cells will be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="5690">
                    <text>main transcripts of 1.7 and 2.7 kb (carot, and permease from DcuB to motor, carot and aspartate) were generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5691">
                    <text>main transcripts of 1.7 and 2.7 kb (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5692">
                    <text>main transcripts of 1.7 and 2.7 kb (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5693">
                    <text>main transcripts of 1.7 and 2.7 kb (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5694">
                    <text>main transcripts of 1.7 and 2.7 kb (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5695">
                    <text>main transcripts of 1.7 and 2.7 kb (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5696">
                    <text>main transcripts of 1.7 and 2.7 kb (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5697">
                    <text>main transcripts of 1.7 and 2.7 kb (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5698">
                    <text>main transcripts of 1.7 and 2.7 kb (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5699">
                    <text>main transcripts of 1.7 and 2.7 kb (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5700">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by PRnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5701">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by Prnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5702">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5703">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by prnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5704">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by prnd .</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5705">
                    <text>main transcripts of 1.7 and 2.7 kb can be generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5706">
                    <text>main transcripts of 1.7 and 2.7 kb can be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5707">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by PRnd whose deletion removes the FHL2 binding.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5708">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by PRnd whose elimination removes the FHL2 link.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5709">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by PRnd within the recombinant synapse.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5710">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by PRnd within the recombinant synapses.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5711">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by Prnd whose deletion removes the FHL2 binding.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5712">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by Prnd within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5713">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5714">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by Prnd. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5715">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by prnd whose deletion removes the FHL2 binding.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5716">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by prnd within the recombinant synapses.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5717">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5718">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by PRnd within the recombinant synapse.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5719">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by Prnd (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5720">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by Prnd within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5721">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5722">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by prnd (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5723">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by prnd within the recombinant synapse.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5724">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5725">
                    <text>main transcripts of 1.7 and 2.7 kb were generated by PRnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5726">
                    <text>main transcripts of 1.7 and 2.7 kb were generated by Prnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5727">
                    <text>main transcripts of 1.7 and 2.7 kb were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5728">
                    <text>main transcripts of 1.7 and 2.7 kb were generated by prnd (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5729">
                    <text>main transcripts of 1.7 and 2.7 kb were generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5730">
                    <text>main transcripts of 1.7 and 2.7 kb will be generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5731">
                    <text>main transcripts of 1.7 and 2.7 kb will be generated by PRnd. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5732">
                    <text>main transcripts of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5733">
                    <text>main transcripts of 1.7 and 2.7 kb will be generated by Prnd. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5734">
                    <text>main transcripts of 1.7 and 2.7 kb will be generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5735">
                    <text>main transcripts of 1.7 and 2.7 kb will be generated by prnd. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="5736">
                    <text>matur HeLa cell mRNA (carot, and permease from DcuB to motor, carot and aspartate) were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5737">
                    <text>matur HeLa cell mRNA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5738">
                    <text>matur HeLa cell mRNA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5739">
                    <text>matur HeLa cell mRNA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5740">
                    <text>matur HeLa cell mRNA are generated by a 3863-based RNA fragment that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5741">
                    <text>matur HeLa cell mRNA can be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5742">
                    <text>matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region whose elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5743">
                    <text>matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region within the recombinant synapses.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5744">
                    <text>matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5745">
                    <text>matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5746">
                    <text>matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5747">
                    <text>matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5748">
                    <text>matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5749">
                    <text>matur HeLa cell mRNA were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5750">
                    <text>matur HeLa cell mRNA will be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5751">
                    <text>matur HeLa cell mRNA will be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5752">
                    <text>mature RNA 21-23 nt (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5753">
                    <text>mature RNA 21-23 nt (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5754">
                    <text>mature RNA 21-23 nt (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5755">
                    <text>mature RNA 21-23 nt (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5756">
                    <text>mature RNA 21-23 nt are generated by bidentate RNase III (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5757">
                    <text>mature RNA 21-23 nt are generated by bidentate RNase III .</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5758">
                    <text>mature RNA 21-23 nt are generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5759">
                    <text>mature RNA 21-23 nt are generated by the bidentate RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5760">
                    <text>mature RNA 21-23 nt are generated by the bidentate RNase III Dicer .</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5761">
                    <text>mature RNA 21-23 nt are generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5762">
                    <text>mature RNA 21-23 nt can be generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5763">
                    <text>mature RNA 21-23 nt can be generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5764">
                    <text>mature RNA 21-23 nt is generated by bidentate RNase III whose deletion removes the FHL2 binding.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5765">
                    <text>mature RNA 21-23 nt is generated by bidentate RNase III whose elimination removes the FHL2 link.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5766">
                    <text>mature RNA 21-23 nt is generated by bidentate RNase III within the recombinant synapse.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5767">
                    <text>mature RNA 21-23 nt is generated by bidentate RNase III within the recombinant synapses.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5768">
                    <text>mature RNA 21-23 nt is generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5769">
                    <text>mature RNA 21-23 nt is generated by bidentate RNase III. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5770">
                    <text>mature RNA 21-23 nt is generated by the bidentate RNase III Dicer whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5771">
                    <text>mature RNA 21-23 nt is generated by the bidentate RNase III Dicer whose elimination removes the FHL2 link.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5772">
                    <text>mature RNA 21-23 nt is generated by the bidentate RNase III Dicer within the recombinant synapses.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5773">
                    <text>mature RNA 21-23 nt is generated by the bidentate RNase III Dicer. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5774">
                    <text>mature RNA 21-23 nt was generated by bidentate RNase III (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5775">
                    <text>mature RNA 21-23 nt was generated by bidentate RNase III within the recombinant synapse.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5776">
                    <text>mature RNA 21-23 nt was generated by the bidentate RNase III Dicer (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5777">
                    <text>mature RNA 21-23 nt was generated by the bidentate RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5778">
                    <text>mature RNA 21-23 nt was generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5779">
                    <text>mature RNA 21-23 nt were generated by bidentate RNase III (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5780">
                    <text>mature RNA 21-23 nt were generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5781">
                    <text>mature RNA 21-23 nt were generated by the bidentate RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5782">
                    <text>mature RNA 21-23 nt were generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5783">
                    <text>mature RNA 21-23 nt will be generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5784">
                    <text>mature RNA 21-23 nt will be generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5785">
                    <text>mature RNA 21-23 nt will be generated by the bidentate RNase III Dicer. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="5786">
                    <text>mature heLa cell mRNA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5787">
                    <text>mature heLa cell mRNA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5788">
                    <text>mature heLa cell mRNA are generated by a 3863-base RNA chunk that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5789">
                    <text>mature heLa cell mRNA are generated by a 3863-base RNA chunk that occurs in the 5-untranslated region .</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5790">
                    <text>mature heLa cell mRNA are generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5791">
                    <text>mature heLa cell mRNA can be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5792">
                    <text>mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5793">
                    <text>mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region whose elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5794">
                    <text>mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5795">
                    <text>mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region within the recombinant synapses.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5796">
                    <text>mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5797">
                    <text>mature heLa cell mRNA is generated by a 3863-base RNA chunk that occurs in the 5-untranslated region. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5798">
                    <text>mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5799">
                    <text>mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5800">
                    <text>mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5801">
                    <text>mature heLa cell mRNA were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5802">
                    <text>mature heLa cell mRNA will be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5803">
                    <text>mature heLa cell mRNA will be generated by a 3863-base RNA chunk that occurs in the 5-untranslated region. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5804">
                    <text>mature hela cell mRNA (carot, and permease from DcuB to motor, carot and aspartate) were generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5805">
                    <text>mature hela cell mRNA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5806">
                    <text>mature hela cell mRNA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5807">
                    <text>mature hela cell mRNA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5808">
                    <text>mature hela cell mRNA are generated by a 3863 bases RNA chain that occurs in the non-translated region 5 (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5809">
                    <text>mature hela cell mRNA are generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5810">
                    <text>mature hela cell mRNA can be generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5811">
                    <text>mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5 whose elimination removes the FHL2 link.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5812">
                    <text>mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5 within the recombinant synapse.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5813">
                    <text>mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5 within the recombinant synapses.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5814">
                    <text>mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5815">
                    <text>mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5816">
                    <text>mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5817">
                    <text>mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5 within the recombinant synapse.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5818">
                    <text>mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5819">
                    <text>mature hela cell mRNA were generated by a 3863 bases RNA chain that occurs in the non-translated region 5 (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5820">
                    <text>mature hela cell mRNA were generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5821">
                    <text>mature hela cell mRNA will be generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5822">
                    <text>mature hela cell mRNA will be generated by a 3863 bases RNA chain that occurs in the non-translated region 5. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="5823">
                    <text>mino EE mutant acids (437 and 438) for AA are able to generate Stat5aEE-AA DNA-binding mutant .</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5824">
                    <text>mino EE mutant acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5825">
                    <text>mino EE mutant acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5826">
                    <text>mino EE mutant acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5827">
                    <text>mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5828">
                    <text>mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5829">
                    <text>mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5830">
                    <text>mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant within the recombinant synapse.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5831">
                    <text>mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5832">
                    <text>mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5833">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5834">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5835">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant-G molecules of antigen human leukocytes.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5836">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5837">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5838">
                    <text>mino EE mutant acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5839">
                    <text>mino acid mutants EE (437 and 438) in AA are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="5840">
                    <text>mino acid mutants EE (437 and 438) in AA can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="5841">
                    <text>mino acid mutants EE (437 and 438) in AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="5842">
                    <text>mino acid mutants EE (437 and 438) in AA generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="5843">
                    <text>mino mutant acids EE (437 and 438) to AA are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5844">
                    <text>mino mutant acids EE (437 and 438) to AA can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5845">
                    <text>mino mutant acids EE (437 and 438) to AA can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5846">
                    <text>mino mutant acids EE (437 and 438) to AA can generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5847">
                    <text>mino mutant acids EE (437 and 438) to AA can generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5848">
                    <text>mino mutant acids EE (437 and 438) to AA generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5849">
                    <text>mino mutant acids EE (437 and 438) to AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5850">
                    <text>mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5851">
                    <text>mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5852">
                    <text>mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5853">
                    <text>mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a within the recombinant synapse.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5854">
                    <text>mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of human leukocytes.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5855">
                    <text>mino mutant acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5856">
                    <text>mino mutant acids EE (437 and 438) to AA generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5857">
                    <text>mino mutant acids EE (437 and 438) to AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5858">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5859">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a within the recombinant synapse.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5860">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a within the recombinant synapses.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5861">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of antigen human leukocytes.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5862">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5863">
                    <text>mino mutant acids EE (437 and 438) to AA has generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5864">
                    <text>mino mutant acids EE (437 and 438) to AA is able to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a .</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5865">
                    <text>mino mutant acids EE (437 and 438) to AA is able to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="5866">
                    <text>moker (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5867">
                    <text>moker (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5868">
                    <text>moker are generated by smoker B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5869">
                    <text>moker are generated by smoker B .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5870">
                    <text>moker is generated by smoker B whose elimination removes the FHL2 link.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5871">
                    <text>moker is generated by smoker B within the recombinant synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5872">
                    <text>moker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5873">
                    <text>moker is generated by smoker B. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5874">
                    <text>moker was generated by smoker B (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5875">
                    <text>moker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5876">
                    <text>moker were generated by smoker B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5877">
                    <text>moker will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5878">
                    <text>moker will be generated by smoker B. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="5879">
                    <text>monoclonal antibody against FHL2 (carot, and permease from DcuB to motor, carot and aspartate) were generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5880">
                    <text>monoclonal antibody against FHL2 (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5881">
                    <text>monoclonal antibody against FHL2 (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5882">
                    <text>monoclonal antibody against FHL2 (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5883">
                    <text>monoclonal antibody against FHL2 (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5884">
                    <text>monoclonal antibody against FHL2 (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5885">
                    <text>monoclonal antibody against FHL2 are generated by nodes .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5886">
                    <text>monoclonal antibody against FHL2 are generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5887">
                    <text>monoclonal antibody against FHL2 are generated by us (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5888">
                    <text>monoclonal antibody against FHL2 are generated by us .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5889">
                    <text>monoclonal antibody against FHL2 are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5890">
                    <text>monoclonal antibody against FHL2 can be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5891">
                    <text>monoclonal antibody against FHL2 can be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5892">
                    <text>monoclonal antibody against FHL2 is generated by nodes whose deletion removes the FHL2 binding.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5893">
                    <text>monoclonal antibody against FHL2 is generated by nodes whose elimination removes the FHL2 link.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5894">
                    <text>monoclonal antibody against FHL2 is generated by nodes within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5895">
                    <text>monoclonal antibody against FHL2 is generated by nodes within the recombinant synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5896">
                    <text>monoclonal antibody against FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5897">
                    <text>monoclonal antibody against FHL2 is generated by nodes. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5898">
                    <text>monoclonal antibody against FHL2 is generated by us whose deletion removes the FHL2 binding.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5899">
                    <text>monoclonal antibody against FHL2 is generated by us whose elimination removes the FHL2 link.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5900">
                    <text>monoclonal antibody against FHL2 is generated by us within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5901">
                    <text>monoclonal antibody against FHL2 is generated by us within the recombinant synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5902">
                    <text>monoclonal antibody against FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5903">
                    <text>monoclonal antibody against FHL2 is generated by us. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5904">
                    <text>monoclonal antibody against FHL2 was generated by nodes (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5905">
                    <text>monoclonal antibody against FHL2 was generated by nodes within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5906">
                    <text>monoclonal antibody against FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5907">
                    <text>monoclonal antibody against FHL2 was generated by us (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5908">
                    <text>monoclonal antibody against FHL2 was generated by us within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5909">
                    <text>monoclonal antibody against FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5910">
                    <text>monoclonal antibody against FHL2 were generated by nodes (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5911">
                    <text>monoclonal antibody against FHL2 were generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5912">
                    <text>monoclonal antibody against FHL2 were generated by us (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5913">
                    <text>monoclonal antibody against FHL2 were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5914">
                    <text>monoclonal antibody against FHL2 will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5915">
                    <text>monoclonal antibody against FHL2 will be generated by nodes. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5916">
                    <text>monoclonal antibody against FHL2 will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5917">
                    <text>monoclonal antibody vs. FHL2 (carot, and permease from DcuB to motor, carot and aspartate) were generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5918">
                    <text>monoclonal antibody vs. FHL2 (carot, and permease from DcuB to motor, carot and aspartate) were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5919">
                    <text>monoclonal antibody vs. FHL2 (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5920">
                    <text>monoclonal antibody vs. FHL2 (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5921">
                    <text>monoclonal antibody vs. FHL2 (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5922">
                    <text>monoclonal antibody vs. FHL2 (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5923">
                    <text>monoclonal antibody vs. FHL2 (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5924">
                    <text>monoclonal antibody vs. FHL2 (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5925">
                    <text>monoclonal antibody vs. FHL2 are generated by nodes (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5926">
                    <text>monoclonal antibody vs. FHL2 are generated by nodes .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5927">
                    <text>monoclonal antibody vs. FHL2 are generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5928">
                    <text>monoclonal antibody vs. FHL2 are generated by us (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5929">
                    <text>monoclonal antibody vs. FHL2 are generated by us .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5930">
                    <text>monoclonal antibody vs. FHL2 are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5931">
                    <text>monoclonal antibody vs. FHL2 can be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5932">
                    <text>monoclonal antibody vs. FHL2 can be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5933">
                    <text>monoclonal antibody vs. FHL2 is generated by nodes whose elimination removes the FHL2 link.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5934">
                    <text>monoclonal antibody vs. FHL2 is generated by nodes within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5935">
                    <text>monoclonal antibody vs. FHL2 is generated by nodes within the recombinant synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5936">
                    <text>monoclonal antibody vs. FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5937">
                    <text>monoclonal antibody vs. FHL2 is generated by nodes. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5938">
                    <text>monoclonal antibody vs. FHL2 is generated by us whose deletion removes the FHL2 binding.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5939">
                    <text>monoclonal antibody vs. FHL2 is generated by us whose elimination removes the FHL2 link.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5940">
                    <text>monoclonal antibody vs. FHL2 is generated by us within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5941">
                    <text>monoclonal antibody vs. FHL2 is generated by us within the recombinant synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5942">
                    <text>monoclonal antibody vs. FHL2 is generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5943">
                    <text>monoclonal antibody vs. FHL2 is generated by us. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5944">
                    <text>monoclonal antibody vs. FHL2 was generated by nodes within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5945">
                    <text>monoclonal antibody vs. FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5946">
                    <text>monoclonal antibody vs. FHL2 was generated by us (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5947">
                    <text>monoclonal antibody vs. FHL2 was generated by us within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5948">
                    <text>monoclonal antibody vs. FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5949">
                    <text>monoclonal antibody vs. FHL2 were generated by nodes (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5950">
                    <text>monoclonal antibody vs. FHL2 were generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5951">
                    <text>monoclonal antibody vs. FHL2 were generated by us (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5952">
                    <text>monoclonal antibody vs. FHL2 were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5953">
                    <text>monoclonal antibody vs. FHL2 will be generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5954">
                    <text>monoclonal antibody vs. FHL2 will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5955">
                    <text>monoclonal antibody vs. FHL2 will be generated by us. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5956">
                    <text>motor (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5957">
                    <text>motor (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5958">
                    <text>motor (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5959">
                    <text>motor are generated by smoker B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5960">
                    <text>motor are generated by smoker B .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5961">
                    <text>motor are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5962">
                    <text>motor can be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5963">
                    <text>motor is generated by smoker B whose deletion removes the FHL2 binding.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5964">
                    <text>motor is generated by smoker B whose elimination removes the FHL2 link.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5965">
                    <text>motor is generated by smoker B within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5966">
                    <text>motor is generated by smoker B within the recombinant synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5967">
                    <text>motor is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5968">
                    <text>motor was generated by smoker B (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5969">
                    <text>motor was generated by smoker B within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5970">
                    <text>motor was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5971">
                    <text>motor were generated by smoker B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5972">
                    <text>motor were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5973">
                    <text>motor will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="5974">
                    <text>muting amino acids EE (437 and 438) to AA are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5975">
                    <text>muting amino acids EE (437 and 438) to AA are able to generate Stat5aEE-AA .</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5976">
                    <text>muting amino acids EE (437 and 438) to AA can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5977">
                    <text>muting amino acids EE (437 and 438) to AA can generate Stat5aEE-AA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5978">
                    <text>muting amino acids EE (437 and 438) to AA can generate Stat5aEE-AA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5979">
                    <text>muting amino acids EE (437 and 438) to AA generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5980">
                    <text>muting amino acids EE (437 and 438) to AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5981">
                    <text>muting amino acids EE (437 and 438) to AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5982">
                    <text>muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5983">
                    <text>muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5984">
                    <text>muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA within the recombinant synapse.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5985">
                    <text>muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA-G molecules of human leukocytes.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5986">
                    <text>muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5987">
                    <text>muting amino acids EE (437 and 438) to AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5988">
                    <text>muting amino acids EE (437 and 438) to AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="5989">
                    <text>muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5990">
                    <text>muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA within the recombinant synapse.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5991">
                    <text>muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA within the recombinant synapses.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5992">
                    <text>muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5993">
                    <text>muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5994">
                    <text>muting amino acids EE (437 and 438) to AA has generated Stat5aEE-AA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5995">
                    <text>muting amino acids EE (437 and 438) to AA is able to generate Stat5aEE-AA .</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5996">
                    <text>muting amino acids EE (437 and 438) to AA is able to generate Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="5997">
                    <text>nNOS are able to generate suspected .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="5998">
                    <text>nNOS can generate superoxide (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="5999">
                    <text>nNOS can generate superoxide (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6000">
                    <text>nNOS can generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6001">
                    <text>nNOS can generate suspected (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6002">
                    <text>nNOS can generate suspected (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6003">
                    <text>nNOS can generate suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6004">
                    <text>nNOS generated superoxide (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6005">
                    <text>nNOS generated superoxide (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6006">
                    <text>nNOS generated superoxide for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6007">
                    <text>nNOS generated superoxide within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6008">
                    <text>nNOS generated superoxide-G molecules of human leukocytes.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6009">
                    <text>nNOS generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6010">
                    <text>nNOS generated suspected (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6011">
                    <text>nNOS generated suspected for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6012">
                    <text>nNOS generated suspected within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6013">
                    <text>nNOS generated suspected-G molecules of human leukocytes.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6014">
                    <text>nNOS generated suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6015">
                    <text>nNOS generates superoxide (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6016">
                    <text>nNOS generates superoxide (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6017">
                    <text>nNOS generates superoxide within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6018">
                    <text>nNOS generates superoxide within the recombinant synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6019">
                    <text>nNOS generates superoxide-G molecules of antigen human leukocytes.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6020">
                    <text>nNOS generates superoxide-G molecules of human leukocytes.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6021">
                    <text>nNOS generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6022">
                    <text>nNOS generates suspected (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6023">
                    <text>nNOS generates suspected (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6024">
                    <text>nNOS generates suspected within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6025">
                    <text>nNOS generates suspected within the recombinant synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6026">
                    <text>nNOS generates suspected-G molecules of human leukocytes.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6027">
                    <text>nNOS generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6028">
                    <text>nNOS has generated superoxide for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6029">
                    <text>nNOS is able to generate superoxide .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6030">
                    <text>nNOS is able to generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6031">
                    <text>nNOS is able to generate suspected .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6032">
                    <text>nNOS is able to generate suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6033">
                    <text>no anaerobic reactions with the purified FNR Fe-S group are able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex .</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6034">
                    <text>no anaerobic reactions with the purified FNR Fe-S group can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6035">
                    <text>no anaerobic reactions with the purified FNR Fe-S group can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6036">
                    <text>no anaerobic reactions with the purified FNR Fe-S group can generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6037">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6038">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6039">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6040">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6041">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6042">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6043">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6044">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6045">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6046">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6047">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6048">
                    <text>no anaerobic reactions with the purified FNR Fe-S group has generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6049">
                    <text>no anaerobic reactions with the purified FNR Fe-S group is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex .</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6050">
                    <text>no anaerobic reactions with the purified FNR Fe-S group is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6051">
                    <text>nodes are able to generate monoclonal antibody against FHL2 .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6052">
                    <text>nodes are able to generate monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6053">
                    <text>nodes can generate monoclonal antibody against FHL2 (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6054">
                    <text>nodes can generate monoclonal antibody against FHL2 (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6055">
                    <text>nodes can generate monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6056">
                    <text>nodes can generate monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6057">
                    <text>nodes can generate monoclonal antibody vs. FHL2 (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6058">
                    <text>nodes can generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6059">
                    <text>nodes generated monoclonal antibody against FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6060">
                    <text>nodes generated monoclonal antibody against FHL2 (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6061">
                    <text>nodes generated monoclonal antibody against FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6062">
                    <text>nodes generated monoclonal antibody against FHL2 within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6063">
                    <text>nodes generated monoclonal antibody against FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6064">
                    <text>nodes generated monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6065">
                    <text>nodes generated monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6066">
                    <text>nodes generated monoclonal antibody vs. FHL2 (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6067">
                    <text>nodes generated monoclonal antibody vs. FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6068">
                    <text>nodes generated monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6069">
                    <text>nodes generated monoclonal antibody vs. FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6070">
                    <text>nodes generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6071">
                    <text>nodes generates monoclonal antibody against FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6072">
                    <text>nodes generates monoclonal antibody against FHL2 within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6073">
                    <text>nodes generates monoclonal antibody against FHL2 within the recombinant synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6074">
                    <text>nodes generates monoclonal antibody against FHL2-G molecules of antigen human leukocytes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6075">
                    <text>nodes generates monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6076">
                    <text>nodes generates monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6077">
                    <text>nodes generates monoclonal antibody vs. FHL2 within the recombinant synapses.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6078">
                    <text>nodes generates monoclonal antibody vs. FHL2-G molecules of antigen human leukocytes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6079">
                    <text>nodes generates monoclonal antibody vs. FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6080">
                    <text>nodes generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6081">
                    <text>nodes is able to generate monoclonal antibody against FHL2 .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6082">
                    <text>nodes is able to generate monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6083">
                    <text>nodes is able to generate monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6084">
                    <text>nodes is able to generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="6085">
                    <text>none reacts anaerobically with the purified F-S group of FNR are able to generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex .</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6086">
                    <text>none reacts anaerobically with the purified F-S group of FNR can generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6087">
                    <text>none reacts anaerobically with the purified F-S group of FNR can generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6088">
                    <text>none reacts anaerobically with the purified F-S group of FNR can generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6089">
                    <text>none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6090">
                    <text>none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6091">
                    <text>none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6092">
                    <text>none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6093">
                    <text>none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6094">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6095">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6096">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6097">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6098">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6099">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of human leukocytes.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6100">
                    <text>none reacts anaerobically with the purified F-S group of FNR generates spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6101">
                    <text>none reacts anaerobically with the purified F-S group of FNR has generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6102">
                    <text>none reacts anaerobically with the purified F-S group of FNR is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex .</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6103">
                    <text>none reacts anaerobically with the purified F-S group of FNR is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6104">
                    <text>none reacts anaerobically with the purified FNR group Fe-S are able to generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex .</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6105">
                    <text>none reacts anaerobically with the purified FNR group Fe-S can generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6106">
                    <text>none reacts anaerobically with the purified FNR group Fe-S can generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6107">
                    <text>none reacts anaerobically with the purified FNR group Fe-S can generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6108">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6109">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6110">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6111">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6112">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6113">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6114">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6115">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6116">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex within the recombinant synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6117">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6118">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of human leukocytes.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6119">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6120">
                    <text>none reacts anaerobically with the purified FNR group Fe-S has generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6121">
                    <text>none reacts anaerobically with the purified FNR group Fe-S is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex .</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6122">
                    <text>none reacts anaerobically with the purified FNR group Fe-S is able to generate spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6123">
                    <text>overlapping sequential fragments (carot, and permease from DcuB to motor, carot and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6124">
                    <text>overlapping sequential fragments (carot, and permease from DcuB to motor, carot and aspartate) were generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6125">
                    <text>overlapping sequential fragments (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6126">
                    <text>overlapping sequential fragments (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6127">
                    <text>overlapping sequential fragments (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6128">
                    <text>overlapping sequential fragments (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6129">
                    <text>overlapping sequential fragments (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6130">
                    <text>overlapping sequential fragments (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6131">
                    <text>overlapping sequential fragments are generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6132">
                    <text>overlapping sequential fragments are generated by TBC method .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6133">
                    <text>overlapping sequential fragments are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6134">
                    <text>overlapping sequential fragments are generated by the TBC method .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6135">
                    <text>overlapping sequential fragments are generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6136">
                    <text>overlapping sequential fragments can be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6137">
                    <text>overlapping sequential fragments can be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6138">
                    <text>overlapping sequential fragments is generated by TBC method whose deletion removes the FHL2 binding.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6139">
                    <text>overlapping sequential fragments is generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6140">
                    <text>overlapping sequential fragments is generated by TBC method within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6141">
                    <text>overlapping sequential fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6142">
                    <text>overlapping sequential fragments is generated by TBC method. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6143">
                    <text>overlapping sequential fragments is generated by the TBC method whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6144">
                    <text>overlapping sequential fragments is generated by the TBC method whose elimination removes the FHL2 link.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6145">
                    <text>overlapping sequential fragments is generated by the TBC method within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6146">
                    <text>overlapping sequential fragments is generated by the TBC method within the recombinant synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6147">
                    <text>overlapping sequential fragments is generated by the TBC method. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6148">
                    <text>overlapping sequential fragments was generated by TBC method (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6149">
                    <text>overlapping sequential fragments was generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6150">
                    <text>overlapping sequential fragments was generated by the TBC method (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6151">
                    <text>overlapping sequential fragments was generated by the TBC method within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6152">
                    <text>overlapping sequential fragments was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6153">
                    <text>overlapping sequential fragments were generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6154">
                    <text>overlapping sequential fragments were generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6155">
                    <text>overlapping sequential fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6156">
                    <text>overlapping sequential fragments will be generated by TBC method. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6157">
                    <text>overlapping sequential fragments will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6158">
                    <text>overlapping sequential fragments will be generated by the TBC method. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6159">
                    <text>peptides abeta have been generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="6160">
                    <text>peptides abeta were generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="6161">
                    <text>prnd are able to generate main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6162">
                    <text>prnd can generate main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6163">
                    <text>prnd can generate main transcripts of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6164">
                    <text>prnd generated main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6165">
                    <text>prnd generated main transcripts of 1.7 and 2.7 kb (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6166">
                    <text>prnd generated main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6167">
                    <text>prnd generated main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6168">
                    <text>prnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6169">
                    <text>prnd generates main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6170">
                    <text>prnd generates main transcripts of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6171">
                    <text>prnd generates main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6172">
                    <text>prnd generates main transcripts of 1.7 and 2.7 kb within the recombinant synapses.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6173">
                    <text>prnd generates main transcripts of 1.7 and 2.7 kb-G molecules of antigen human leukocytes.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6174">
                    <text>prnd generates main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6175">
                    <text>prnd has generated main transcripts of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6176">
                    <text>prnd is able to generate main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="6177">
                    <text>proteolysis of amyloid precursor proteins (APP) are able to generate Abeta peptides .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6178">
                    <text>proteolysis of amyloid precursor proteins (APP) can generate Abeta peptides (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6179">
                    <text>proteolysis of amyloid precursor proteins (APP) generated Abeta peptides (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6180">
                    <text>proteolysis of amyloid precursor proteins (APP) generated Abeta peptides for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6181">
                    <text>proteolysis of amyloid precursor proteins (APP) generated Abeta peptides within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6182">
                    <text>proteolysis of amyloid precursor proteins (APP) generated Abeta peptides-G molecules of human leukocytes.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6183">
                    <text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6184">
                    <text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6185">
                    <text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6186">
                    <text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides within the recombinant synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6187">
                    <text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides-G molecules of human leukocytes.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6188">
                    <text>proteolysis of amyloid precursor proteins (APP) has generated Abeta peptides for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6189">
                    <text>proteolysis of amyloid precursor proteins (APP) is able to generate Abeta peptides .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6190">
                    <text>proteolysis of amyloid precursor proteins (APP) is able to generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6191">
                    <text>proteolysis of amyloid precursor proteins are able to generate Abeta peptides .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6192">
                    <text>proteolysis of amyloid precursor proteins can generate Abeta peptides (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6193">
                    <text>proteolysis of amyloid precursor proteins can generate Abeta peptides (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6194">
                    <text>proteolysis of amyloid precursor proteins can generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6195">
                    <text>proteolysis of amyloid precursor proteins generated Abeta peptides (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6196">
                    <text>proteolysis of amyloid precursor proteins generated Abeta peptides (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6197">
                    <text>proteolysis of amyloid precursor proteins generated Abeta peptides for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6198">
                    <text>proteolysis of amyloid precursor proteins generated Abeta peptides within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6199">
                    <text>proteolysis of amyloid precursor proteins generated Abeta peptides-G molecules of human leukocytes.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6200">
                    <text>proteolysis of amyloid precursor proteins generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6201">
                    <text>proteolysis of amyloid precursor proteins generates Abeta peptides-G molecules of antigen human leukocytes.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6202">
                    <text>proteolysis of amyloid precursor proteins generates Abeta peptides-G molecules of human leukocytes.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6203">
                    <text>proteolysis of amyloid precursor proteins has generated Abeta peptides for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6204">
                    <text>proteolysis of amyloid precursor proteins is able to generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="6205">
                    <text>sequential fragment overlapping (carot, and permease from DcuB to motor, carot and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6206">
                    <text>sequential fragment overlapping (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6207">
                    <text>sequential fragment overlapping (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6208">
                    <text>sequential fragment overlapping (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6209">
                    <text>sequential fragment overlapping are generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6210">
                    <text>sequential fragment overlapping are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6211">
                    <text>sequential fragment overlapping can be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6212">
                    <text>sequential fragment overlapping is generated by TBC method whose deletion removes the FHL2 binding.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6213">
                    <text>sequential fragment overlapping is generated by TBC method whose elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6214">
                    <text>sequential fragment overlapping is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6215">
                    <text>sequential fragment overlapping is generated by TBC method. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6216">
                    <text>sequential fragment overlapping was generated by TBC method (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6217">
                    <text>sequential fragment overlapping was generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6218">
                    <text>sequential fragment overlapping will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6219">
                    <text>sequential fragment overlapping will be generated by TBC method. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="6220">
                    <text>sequential overlapping fragments (carot, and permease from DcuB to motor, carot and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6221">
                    <text>sequential overlapping fragments (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6222">
                    <text>sequential overlapping fragments (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6223">
                    <text>sequential overlapping fragments (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6224">
                    <text>sequential overlapping fragments are generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6225">
                    <text>sequential overlapping fragments can be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6226">
                    <text>sequential overlapping fragments is generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6227">
                    <text>sequential overlapping fragments is generated by TBC method within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6228">
                    <text>sequential overlapping fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6229">
                    <text>sequential overlapping fragments is generated by TBC method. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6230">
                    <text>sequential overlapping fragments was generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6231">
                    <text>sequential overlapping fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6232">
                    <text>sequential overlapping fragments were generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6233">
                    <text>sequential overlapping fragments were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6234">
                    <text>sequential overlapping fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6235">
                    <text>sequential overlapping fragments will be generated by TBC method. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="6236">
                    <text>sequential superposition fragments (carot, and permease from DcuB to motor, carot and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6237">
                    <text>sequential superposition fragments (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6238">
                    <text>sequential superposition fragments (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6239">
                    <text>sequential superposition fragments (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6240">
                    <text>sequential superposition fragments are generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6241">
                    <text>sequential superposition fragments are generated by TBC method .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6242">
                    <text>sequential superposition fragments are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6243">
                    <text>sequential superposition fragments can be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6244">
                    <text>sequential superposition fragments is generated by TBC method whose deletion removes the FHL2 binding.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6245">
                    <text>sequential superposition fragments is generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6246">
                    <text>sequential superposition fragments is generated by TBC method within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6247">
                    <text>sequential superposition fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6248">
                    <text>sequential superposition fragments is generated by TBC method. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6249">
                    <text>sequential superposition fragments was generated by TBC method (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6250">
                    <text>sequential superposition fragments was generated by TBC method within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6251">
                    <text>sequential superposition fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6252">
                    <text>sequential superposition fragments were generated by TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6253">
                    <text>sequential superposition fragments were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6254">
                    <text>sequential superposition fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6255">
                    <text>sequential superposition fragments will be generated by TBC method. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="6256">
                    <text>smoke (carot, and permease from DcuB to motor, carot and aspartate) were generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6257">
                    <text>smoke (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6258">
                    <text>smoke B are able to generate smoke .</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6259">
                    <text>smoke B can generate smoke (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6260">
                    <text>smoke B can generate smoke (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6261">
                    <text>smoke B can generate smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6262">
                    <text>smoke B generated smoke (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6263">
                    <text>smoke B generated smoke (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6264">
                    <text>smoke B generated smoke for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6265">
                    <text>smoke B generated smoke within the recombinant synapse.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6266">
                    <text>smoke B generated smoke-G molecules of human leukocytes.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6267">
                    <text>smoke B generated smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6268">
                    <text>smoke B generates smoke (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6269">
                    <text>smoke B generates smoke (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6270">
                    <text>smoke B generates smoke within the recombinant synapses.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6271">
                    <text>smoke B generates smoke-G molecules of human leukocytes.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6272">
                    <text>smoke B generates smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6273">
                    <text>smoke B has generated smoke for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6274">
                    <text>smoke B is able to generate smoke .</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6275">
                    <text>smoke B is able to generate smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6276">
                    <text>smoke are generated by smoke B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6277">
                    <text>smoke are generated by smoke B .</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6278">
                    <text>smoke are generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6279">
                    <text>smoke can be generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6280">
                    <text>smoke is generated by smoke B whose deletion removes the FHL2 binding.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6281">
                    <text>smoke is generated by smoke B within the recombinant synapses.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6282">
                    <text>smoke is generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6283">
                    <text>smoke was generated by smoke B (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6284">
                    <text>smoke was generated by smoke B within the recombinant synapse.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6285">
                    <text>smoke was generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6286">
                    <text>smoke were generated by smoke B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6287">
                    <text>smoke were generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6288">
                    <text>smoke will be generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6289">
                    <text>smoke will be generated by smoke B. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="6290">
                    <text>smoker (carot, and permease from DcuB to motor, carot and aspartate) were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6291">
                    <text>smoker (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6292">
                    <text>smoker B are able to generate moker .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6293">
                    <text>smoker B are able to generate motor .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6294">
                    <text>smoker B are able to generate smoker .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6295">
                    <text>smoker B can generate moker (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6296">
                    <text>smoker B can generate moker (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6297">
                    <text>smoker B can generate moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6298">
                    <text>smoker B can generate motor (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6299">
                    <text>smoker B can generate smoker (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6300">
                    <text>smoker B can generate smoker (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6301">
                    <text>smoker B can generate smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6302">
                    <text>smoker B generated moker (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6303">
                    <text>smoker B generated moker for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6304">
                    <text>smoker B generated moker within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6305">
                    <text>smoker B generated moker-G molecules of human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6306">
                    <text>smoker B generated motor (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6307">
                    <text>smoker B generated motor (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6308">
                    <text>smoker B generated motor for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6309">
                    <text>smoker B generated motor within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6310">
                    <text>smoker B generated motor-G molecules of human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6311">
                    <text>smoker B generated motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6312">
                    <text>smoker B generated smoker (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6313">
                    <text>smoker B generated smoker for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6314">
                    <text>smoker B generated smoker within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6315">
                    <text>smoker B generated smoker-G molecules of human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6316">
                    <text>smoker B generated smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6317">
                    <text>smoker B generates moker (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6318">
                    <text>smoker B generates moker within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6319">
                    <text>smoker B generates moker within the recombinant synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6320">
                    <text>smoker B generates moker-G molecules of human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6321">
                    <text>smoker B generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6322">
                    <text>smoker B generates motor (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6323">
                    <text>smoker B generates motor (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6324">
                    <text>smoker B generates motor within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6325">
                    <text>smoker B generates motor within the recombinant synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6326">
                    <text>smoker B generates motor-G molecules of antigen human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6327">
                    <text>smoker B generates motor-G molecules of human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6328">
                    <text>smoker B generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6329">
                    <text>smoker B generates smoker (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6330">
                    <text>smoker B generates smoker (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6331">
                    <text>smoker B generates smoker within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6332">
                    <text>smoker B generates smoker within the recombinant synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6333">
                    <text>smoker B generates smoker-G molecules of antigen human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6334">
                    <text>smoker B generates smoker-G molecules of human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6335">
                    <text>smoker B has generated moker for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6336">
                    <text>smoker B has generated motor for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6337">
                    <text>smoker B has generated smoker for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6338">
                    <text>smoker B is able to generate moker .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6339">
                    <text>smoker B is able to generate moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="6340">
                    <text>smoker B is able to generate motor .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6341">
                    <text>smoker B is able to generate motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="6342">
                    <text>smoker B is able to generate smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6343">
                    <text>smoker are generated by smoker B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6344">
                    <text>smoker are generated by smoker B .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6345">
                    <text>smoker are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6346">
                    <text>smoker can be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6347">
                    <text>smoker is generated by smoker B whose elimination removes the FHL2 link.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6348">
                    <text>smoker is generated by smoker B within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6349">
                    <text>smoker is generated by smoker B within the recombinant synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6350">
                    <text>smoker is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6351">
                    <text>smoker was generated by smoker B (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6352">
                    <text>smoker was generated by smoker B within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6353">
                    <text>smoker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6354">
                    <text>smoker were generated by smoker B (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6355">
                    <text>smoker were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6356">
                    <text>smoker will be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6357">
                    <text>smoker will be generated by smoker B. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="6358">
                    <text>some unusual chemical transcriptions (carot, and permease from DcuB to motor, carot and aspartate) were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6359">
                    <text>some unusual chemical transcriptions (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6360">
                    <text>some unusual chemical transcriptions (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6361">
                    <text>some unusual chemical transcriptions (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6362">
                    <text>some unusual chemical transcriptions (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6363">
                    <text>some unusual chemical transcriptions (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6364">
                    <text>some unusual chemical transcriptions are generated by intergenic slicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6365">
                    <text>some unusual chemical transcriptions are generated by intergenic slicing with Prnp .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6366">
                    <text>some unusual chemical transcriptions are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6367">
                    <text>some unusual chemical transcriptions are generated by intergenic spike with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6368">
                    <text>some unusual chemical transcriptions are generated by intergenic spike with Prnp .</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6369">
                    <text>some unusual chemical transcriptions can be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6370">
                    <text>some unusual chemical transcriptions is generated by intergenic slicing with Prnp whose deletion removes the FHL2 binding.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6371">
                    <text>some unusual chemical transcriptions is generated by intergenic slicing with Prnp whose elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6372">
                    <text>some unusual chemical transcriptions is generated by intergenic slicing with Prnp within the recombinant synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6373">
                    <text>some unusual chemical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6374">
                    <text>some unusual chemical transcriptions is generated by intergenic slicing with Prnp. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6375">
                    <text>some unusual chemical transcriptions is generated by intergenic spike with Prnp whose deletion removes the FHL2 binding.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6376">
                    <text>some unusual chemical transcriptions is generated by intergenic spike with Prnp whose elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6377">
                    <text>some unusual chemical transcriptions is generated by intergenic spike with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6378">
                    <text>some unusual chemical transcriptions is generated by intergenic spike with Prnp within the recombinant synapses.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6379">
                    <text>some unusual chemical transcriptions is generated by intergenic spike with Prnp. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6380">
                    <text>some unusual chemical transcriptions was generated by intergenic slicing with Prnp (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6381">
                    <text>some unusual chemical transcriptions was generated by intergenic slicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6382">
                    <text>some unusual chemical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6383">
                    <text>some unusual chemical transcriptions was generated by intergenic spike with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6384">
                    <text>some unusual chemical transcriptions were generated by intergenic slicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6385">
                    <text>some unusual chemical transcriptions were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6386">
                    <text>some unusual chemical transcriptions were generated by intergenic spike with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6387">
                    <text>some unusual chemical transcriptions were generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6388">
                    <text>some unusual chemical transcriptions will be generated by intergenic slicing with Prnp. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6389">
                    <text>some unusual chemical transcriptions will be generated by intergenic spike with Prnp. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6390">
                    <text>some unusual chimeric transcriptions (carot, and permease from DcuB to motor, carot and aspartate) were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6391">
                    <text>some unusual chimeric transcriptions (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6392">
                    <text>some unusual chimeric transcriptions (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6393">
                    <text>some unusual chimeric transcriptions (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6394">
                    <text>some unusual chimeric transcriptions are generated by intergenic slicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6395">
                    <text>some unusual chimeric transcriptions are generated by intergenic slicing with Prnp .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6396">
                    <text>some unusual chimeric transcriptions are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6397">
                    <text>some unusual chimeric transcriptions is generated by intergenic slicing with Prnp whose deletion removes the FHL2 binding.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6398">
                    <text>some unusual chimeric transcriptions is generated by intergenic slicing with Prnp whose elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6399">
                    <text>some unusual chimeric transcriptions is generated by intergenic slicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6400">
                    <text>some unusual chimeric transcriptions is generated by intergenic slicing with Prnp within the recombinant synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6401">
                    <text>some unusual chimeric transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6402">
                    <text>some unusual chimeric transcriptions is generated by intergenic slicing with Prnp. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6403">
                    <text>some unusual chimeric transcriptions was generated by intergenic slicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6404">
                    <text>some unusual chimeric transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6405">
                    <text>some unusual chimeric transcriptions were generated by intergenic slicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6406">
                    <text>some unusual chimeric transcriptions were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6407">
                    <text>some unusual chimeric transcriptions will be generated by intergenic slicing with Prnp. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6408">
                    <text>some unusual symmetrical transcriptions (carot, and permease from DcuB to motor, carot and aspartate) were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6409">
                    <text>some unusual symmetrical transcriptions (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6410">
                    <text>some unusual symmetrical transcriptions (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6411">
                    <text>some unusual symmetrical transcriptions are generated by intergenic slicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6412">
                    <text>some unusual symmetrical transcriptions are generated by intergenic slicing with Prnp .</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6413">
                    <text>some unusual symmetrical transcriptions are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6414">
                    <text>some unusual symmetrical transcriptions can be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6415">
                    <text>some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp whose deletion removes the FHL2 binding.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6416">
                    <text>some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp whose elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6417">
                    <text>some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6418">
                    <text>some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp within the recombinant synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6419">
                    <text>some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6420">
                    <text>some unusual symmetrical transcriptions is generated by intergenic slicing with Prnp. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6421">
                    <text>some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6422">
                    <text>some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6423">
                    <text>some unusual symmetrical transcriptions was generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6424">
                    <text>some unusual symmetrical transcriptions were generated by intergenic slicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6425">
                    <text>some unusual symmetrical transcriptions were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6426">
                    <text>some unusual symmetrical transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6427">
                    <text>some unusual symmetrical transcriptions will be generated by intergenic slicing with Prnp. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="6428">
                    <text>specific fragments (carot, and permease from DcuB to motor, carot and aspartate) were generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6429">
                    <text>specific fragments (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6430">
                    <text>specific fragments (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6431">
                    <text>specific fragments (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6432">
                    <text>specific fragments are generated by degradation (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6433">
                    <text>specific fragments are generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6434">
                    <text>specific fragments can be generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6435">
                    <text>specific fragments is generated by degradation whose deletion removes the FHL2 binding.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6436">
                    <text>specific fragments is generated by degradation whose elimination removes the FHL2 link.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6437">
                    <text>specific fragments is generated by degradation within the recombinant synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6438">
                    <text>specific fragments is generated by degradation within the recombinant synapses.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6439">
                    <text>specific fragments is generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6440">
                    <text>specific fragments is generated by degradation. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6441">
                    <text>specific fragments was generated by degradation (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6442">
                    <text>specific fragments was generated by degradation within the recombinant synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6443">
                    <text>specific fragments was generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6444">
                    <text>specific fragments were generated by degradation (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6445">
                    <text>specific fragments were generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6446">
                    <text>specific fragments will be generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6447">
                    <text>specific fragments will be generated by degradation. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="6448">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6449">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6450">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6451">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6452">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex are generated by NONE reacts anaerobically with the purified FNR group FNR .</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6453">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex are generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6454">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6455">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR whose elimination removes the FHL2 link.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6456">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR within the recombinant synapse.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6457">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR within the recombinant synapses.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6458">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6459">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6460">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6461">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex were generated by NONE reacts anaerobically with the purified FNR group FNR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6462">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex were generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6463">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex will be generated by NONE reacts anaerobically with the purified FNR group FNR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6464">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6465">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6466">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6467">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6468">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6469">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex are generated by None reacts anaerobically with the purified Fe-S group of NRF (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6470">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex are generated by None reacts anaerobically with the purified Fe-S group of NRF .</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6471">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex are generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6472">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex are generated by does not react anaerobically with the purified Fe-S group of NRF (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6473">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex are generated by does not react anaerobically with the purified Fe-S group of NRF .</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6474">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex are generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6475">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex can be generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6476">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex can be generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6477">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF whose deletion removes the FHL2 binding.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6478">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF whose elimination removes the FHL2 link.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6479">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF within the recombinant synapse.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6480">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF within the recombinant synapses.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6481">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6482">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6483">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF whose deletion removes the FHL2 binding.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6484">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF whose elimination removes the FHL2 link.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6485">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF within the recombinant synapse.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6486">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF within the recombinant synapses.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6487">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6488">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6489">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6490">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF within the recombinant synapse.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6491">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6492">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF within the recombinant synapse.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6493">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6494">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex were generated by None reacts anaerobically with the purified Fe-S group of NRF (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6495">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex were generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6496">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex were generated by does not react anaerobically with the purified Fe-S group of NRF (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6497">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex were generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6498">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6499">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by None reacts anaerobically with the purified Fe-S group of NRF. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6500">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by does not react anaerobically with the purified Fe-S group of NRF. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6501">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6502">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6503">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6504">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6505">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6506">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6507">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are generated by in anaerobically reacted with the purified NR Fe-S cluster (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6508">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are generated by in anaerobically reacted with the purified NR Fe-S cluster .</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6509">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are generated by no anaerobic reactions with the purified FNR Fe-S group (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6510">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are generated by no anaerobic reactions with the purified FNR Fe-S group .</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6511">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex can be generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6512">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex can be generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6513">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster whose deletion removes the FHL2 binding.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6514">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster whose elimination removes the FHL2 link.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6515">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster within the recombinant synapse.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6516">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster within the recombinant synapses.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6517">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6518">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by in anaerobically reacted with the purified NR Fe-S cluster. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6519">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group whose deletion removes the FHL2 binding.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6520">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group whose elimination removes the FHL2 link.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6521">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group within the recombinant synapse.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6522">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group within the recombinant synapses.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6523">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6524">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6525">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster within the recombinant synapse.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6526">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6527">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6528">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group within the recombinant synapse.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6529">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex were generated by in anaerobically reacted with the purified NR Fe-S cluster (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6530">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex were generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6531">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex were generated by no anaerobic reactions with the purified FNR Fe-S group (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6532">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex were generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6533">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by in anaerobically reacted with the purified NR Fe-S cluster. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6534">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6535">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6536">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6537">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6538">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex are generated by none reacts anaerobically with the purified FNR group Fe-S (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6539">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex are generated by none reacts anaerobically with the purified FNR group Fe-S .</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6540">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex are generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6541">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex can be generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6542">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S whose deletion removes the FHL2 binding.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6543">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S whose elimination removes the FHL2 link.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6544">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6545">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S within the recombinant synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6546">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6547">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6548">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex was generated by none reacts anaerobically with the purified FNR group Fe-S within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6549">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex was generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6550">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex were generated by none reacts anaerobically with the purified FNR group Fe-S (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6551">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex will be generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6552">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex will be generated by none reacts anaerobically with the purified FNR group Fe-S. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="6553">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6554">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6555">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6556">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6557">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex are generated by none reacts anaerobically with the purified F-S group of FNR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6558">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex are generated by none reacts anaerobically with the purified F-S group of FNR .</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6559">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex can be generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6560">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6561">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR whose elimination removes the FHL2 link.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6562">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6563">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR within the recombinant synapses.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6564">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6565">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6566">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR within the recombinant synapse.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6567">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6568">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex were generated by none reacts anaerobically with the purified F-S group of FNR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6569">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex were generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6570">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex will be generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6571">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex will be generated by none reacts anaerobically with the purified F-S group of FNR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6572">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6573">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6574">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6575">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex are generated by NO reacts anaerobicly with the purified NRF Fe-S cluster (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6576">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex are generated by NO reacts anaerobicly with the purified NRF Fe-S cluster .</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6577">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex are generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6578">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex can be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6579">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster whose deletion removes the FHL2 binding.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6580">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster whose elimination removes the FHL2 link.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6581">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster within the recombinant synapse.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6582">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster within the recombinant synapses.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6583">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6584">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6585">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6586">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster within the recombinant synapse.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6587">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6588">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6589">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex were generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6590">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex will be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6591">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex will be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="6592">
                    <text>superoxide (carot, and permease from DcuB to motor, carot and aspartate) were generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6593">
                    <text>superoxide (carot, and permease from DcuB to motor, carot and aspartate) were generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6594">
                    <text>superoxide (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6595">
                    <text>superoxide (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6596">
                    <text>superoxide (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6597">
                    <text>superoxide (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6598">
                    <text>superoxide (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6599">
                    <text>superoxide are generated by NNOS (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6600">
                    <text>superoxide are generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6601">
                    <text>superoxide are generated by nNOS (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6602">
                    <text>superoxide are generated by nNOS .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6603">
                    <text>superoxide are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6604">
                    <text>superoxide can be generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6605">
                    <text>superoxide can be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6606">
                    <text>superoxide is generated by NNOS whose elimination removes the FHL2 link.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6607">
                    <text>superoxide is generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6608">
                    <text>superoxide is generated by NNOS. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6609">
                    <text>superoxide is generated by nNOS whose deletion removes the FHL2 binding.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6610">
                    <text>superoxide is generated by nNOS within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6611">
                    <text>superoxide is generated by nNOS within the recombinant synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6612">
                    <text>superoxide is generated by nNOS. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6613">
                    <text>superoxide was generated by NNOS (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6614">
                    <text>superoxide was generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6615">
                    <text>superoxide was generated by nNOS (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6616">
                    <text>superoxide was generated by nNOS within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6617">
                    <text>superoxide was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6618">
                    <text>superoxide were generated by NNOS (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6619">
                    <text>superoxide were generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6620">
                    <text>superoxide were generated by nNOS (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6621">
                    <text>superoxide were generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6622">
                    <text>superoxide will be generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6623">
                    <text>superoxide will be generated by NNOS. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6624">
                    <text>superoxide will be generated by nNOS. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="6625">
                    <text>superposed sequential defects (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6626">
                    <text>superposed sequential defects (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6627">
                    <text>superposed sequential defects are generated by the TBC method .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6628">
                    <text>superposed sequential defects are generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6629">
                    <text>superposed sequential defects can be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6630">
                    <text>superposed sequential defects is generated by the TBC method whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6631">
                    <text>superposed sequential defects is generated by the TBC method whose elimination removes the FHL2 link.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6632">
                    <text>superposed sequential defects is generated by the TBC method within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6633">
                    <text>superposed sequential defects is generated by the TBC method within the recombinant synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6634">
                    <text>superposed sequential defects is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6635">
                    <text>superposed sequential defects is generated by the TBC method. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6636">
                    <text>superposed sequential defects was generated by the TBC method (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6637">
                    <text>superposed sequential defects was generated by the TBC method within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6638">
                    <text>superposed sequential defects were generated by the TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6639">
                    <text>superposed sequential defects were generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6640">
                    <text>superposed sequential defects will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6641">
                    <text>superposed sequential defects will be generated by the TBC method. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6642">
                    <text>suspected (carot, and permease from DcuB to motor, carot and aspartate) were generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6643">
                    <text>suspected (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6644">
                    <text>suspected (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6645">
                    <text>suspected (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6646">
                    <text>suspected are generated by nNOS (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6647">
                    <text>suspected are generated by nNOS .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6648">
                    <text>suspected are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6649">
                    <text>suspected can be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6650">
                    <text>suspected is generated by nNOS whose deletion removes the FHL2 binding.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6651">
                    <text>suspected is generated by nNOS whose elimination removes the FHL2 link.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6652">
                    <text>suspected is generated by nNOS within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6653">
                    <text>suspected is generated by nNOS within the recombinant synapses.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6654">
                    <text>suspected is generated by nNOS. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6655">
                    <text>suspected was generated by nNOS within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6656">
                    <text>suspected was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6657">
                    <text>suspected were generated by nNOS (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6658">
                    <text>suspected were generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6659">
                    <text>suspected will be generated by nNOS. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="6660">
                    <text>the 21-23 nt of long mature RNAs (carot, and permease from DcuB to motor, carot and aspartate) were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6661">
                    <text>the 21-23 nt of long mature RNAs (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6662">
                    <text>the 21-23 nt of long mature RNAs (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6663">
                    <text>the 21-23 nt of long mature RNAs (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6664">
                    <text>the 21-23 nt of long mature RNAs are generated by The biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6665">
                    <text>the 21-23 nt of long mature RNAs are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6666">
                    <text>the 21-23 nt of long mature RNAs can be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6667">
                    <text>the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer whose deletion removes the FHL2 binding.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6668">
                    <text>the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer whose elimination removes the FHL2 link.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6669">
                    <text>the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6670">
                    <text>the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer within the recombinant synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6671">
                    <text>the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6672">
                    <text>the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6673">
                    <text>the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6674">
                    <text>the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6675">
                    <text>the 21-23 nt of long mature RNAs were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6676">
                    <text>the 21-23 nt of long mature RNAs will be generated by The biceps RNase III Dicer. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="6677">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a (carot, and permease from DcuB to motor, carot and aspartate) were generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6678">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6679">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6680">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a are generated by mino mutant acids EE (437 and 438) to AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6681">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a are generated by mino mutant acids EE (437 and 438) to AA .</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6682">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a are generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6683">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a can be generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6684">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA whose deletion removes the FHL2 binding.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6685">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA whose elimination removes the FHL2 link.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6686">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA within the recombinant synapses.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6687">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6688">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6689">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6690">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA within the recombinant synapse.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6691">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6692">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a were generated by mino mutant acids EE (437 and 438) to AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6693">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a were generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6694">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by mino mutant acids EE (437 and 438) to AA. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="6695">
                    <text>the N-terminal AR can generate a functional interaction surface (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6696">
                    <text>the N-terminal AR can generate a functional interaction surface (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6697">
                    <text>the N-terminal AR can generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6698">
                    <text>the N-terminal AR generated a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6699">
                    <text>the N-terminal AR generated a functional interaction surface (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6700">
                    <text>the N-terminal AR generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6701">
                    <text>the N-terminal AR generated a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6702">
                    <text>the N-terminal AR generated a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6703">
                    <text>the N-terminal AR generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6704">
                    <text>the N-terminal AR generates a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6705">
                    <text>the N-terminal AR generates a functional interaction surface within the recombinant synapses.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6706">
                    <text>the N-terminal AR generates a functional interaction surface-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6707">
                    <text>the N-terminal AR generates a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6708">
                    <text>the N-terminal AR generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6709">
                    <text>the N-terminal AR is able to generate a functional interaction surface .</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6710">
                    <text>the N-terminal AR is able to generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6711">
                    <text>the N-terminal RA are able to generate a functional interaction surface .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6712">
                    <text>the N-terminal RA can generate a functional interaction surface (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6713">
                    <text>the N-terminal RA can generate a functional interaction surface (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6714">
                    <text>the N-terminal RA can generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6715">
                    <text>the N-terminal RA generated a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6716">
                    <text>the N-terminal RA generated a functional interaction surface (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6717">
                    <text>the N-terminal RA generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6718">
                    <text>the N-terminal RA generated a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6719">
                    <text>the N-terminal RA generates a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6720">
                    <text>the N-terminal RA generates a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6721">
                    <text>the N-terminal RA generates a functional interaction surface within the recombinant synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6722">
                    <text>the N-terminal RA generates a functional interaction surface-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6723">
                    <text>the N-terminal RA generates a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6724">
                    <text>the N-terminal RA generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6725">
                    <text>the N-terminal RA has generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6726">
                    <text>the N-terminal RA is able to generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6727">
                    <text>the TBC method are able to generate overlapping sequential fragments .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6728">
                    <text>the TBC method are able to generate superposed sequential defects .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6729">
                    <text>the TBC method can generate overlapping sequential fragments (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6730">
                    <text>the TBC method can generate overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6731">
                    <text>the TBC method can generate superposed sequential defects (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6732">
                    <text>the TBC method can generate superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6733">
                    <text>the TBC method generated overlapping sequential fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6734">
                    <text>the TBC method generated overlapping sequential fragments (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6735">
                    <text>the TBC method generated overlapping sequential fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6736">
                    <text>the TBC method generated overlapping sequential fragments within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6737">
                    <text>the TBC method generated overlapping sequential fragments-G molecules of human leukocytes.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6738">
                    <text>the TBC method generated superposed sequential defects (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6739">
                    <text>the TBC method generated superposed sequential defects (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6740">
                    <text>the TBC method generated superposed sequential defects for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6741">
                    <text>the TBC method generated superposed sequential defects within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6742">
                    <text>the TBC method generated superposed sequential defects-G molecules of human leukocytes.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6743">
                    <text>the TBC method generated superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6744">
                    <text>the TBC method generates overlapping sequential fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6745">
                    <text>the TBC method generates overlapping sequential fragments within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6746">
                    <text>the TBC method generates overlapping sequential fragments within the recombinant synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6747">
                    <text>the TBC method generates overlapping sequential fragments-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6748">
                    <text>the TBC method generates overlapping sequential fragments-G molecules of human leukocytes.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6749">
                    <text>the TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6750">
                    <text>the TBC method generates superposed sequential defects (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6751">
                    <text>the TBC method generates superposed sequential defects (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6752">
                    <text>the TBC method generates superposed sequential defects within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6753">
                    <text>the TBC method generates superposed sequential defects-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6754">
                    <text>the TBC method generates superposed sequential defects-G molecules of human leukocytes.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6755">
                    <text>the TBC method generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6756">
                    <text>the TBC method is able to generate overlapping sequential fragments .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6757">
                    <text>the TBC method is able to generate overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="6758">
                    <text>the TBC method is able to generate superposed sequential defects .</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6759">
                    <text>the TBC method is able to generate superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="6760">
                    <text>the bidentate RNase III Dicer are able to generate mature RNA 21-23 nt .</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6761">
                    <text>the bidentate RNase III Dicer can generate mature RNA 21-23 nt (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6762">
                    <text>the bidentate RNase III Dicer can generate mature RNA 21-23 nt (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6763">
                    <text>the bidentate RNase III Dicer can generate mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6764">
                    <text>the bidentate RNase III Dicer generated mature RNA 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6765">
                    <text>the bidentate RNase III Dicer generated mature RNA 21-23 nt (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6766">
                    <text>the bidentate RNase III Dicer generated mature RNA 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6767">
                    <text>the bidentate RNase III Dicer generated mature RNA 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6768">
                    <text>the bidentate RNase III Dicer generated mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6769">
                    <text>the bidentate RNase III Dicer generates mature RNA 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6770">
                    <text>the bidentate RNase III Dicer generates mature RNA 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6771">
                    <text>the bidentate RNase III Dicer generates mature RNA 21-23 nt within the recombinant synapses.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6772">
                    <text>the bidentate RNase III Dicer generates mature RNA 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6773">
                    <text>the bidentate RNase III Dicer generates mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6774">
                    <text>the bidentate RNase III Dicer has generated mature RNA 21-23 nt for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6775">
                    <text>the bidentate RNase III Dicer is able to generate mature RNA 21-23 nt .</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6776">
                    <text>the bidentate RNase III Dicer is able to generate mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="6777">
                    <text>the correct three-dimensional interaction surface (carot, and permease from DcuB to motor, carot and aspartate) were generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6778">
                    <text>the correct three-dimensional interaction surface (carot, and permease from DcuB to motor, carot and aspartate) were generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6779">
                    <text>the correct three-dimensional interaction surface (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6780">
                    <text>the correct three-dimensional interaction surface (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6781">
                    <text>the correct three-dimensional interaction surface (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6782">
                    <text>the correct three-dimensional interaction surface (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6783">
                    <text>the correct three-dimensional interaction surface (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6784">
                    <text>the correct three-dimensional interaction surface are generated by L723 in H3 (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6785">
                    <text>the correct three-dimensional interaction surface are generated by L723 in H3 .</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6786">
                    <text>the correct three-dimensional interaction surface are generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6787">
                    <text>the correct three-dimensional interaction surface are generated by L723 to H3 (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6788">
                    <text>the correct three-dimensional interaction surface are generated by L723 to H3 .</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6789">
                    <text>the correct three-dimensional interaction surface are generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6790">
                    <text>the correct three-dimensional interaction surface can be generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6791">
                    <text>the correct three-dimensional interaction surface can be generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6792">
                    <text>the correct three-dimensional interaction surface can be generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6793">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3 whose deletion removes the FHL2 binding.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6794">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3 within the recombinant synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6795">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3 within the recombinant synapses.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6796">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6797">
                    <text>the correct three-dimensional interaction surface is generated by L723 to H3 whose deletion removes the FHL2 binding.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6798">
                    <text>the correct three-dimensional interaction surface is generated by L723 to H3 within the recombinant synapse.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6799">
                    <text>the correct three-dimensional interaction surface is generated by L723 to H3 within the recombinant synapses.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6800">
                    <text>the correct three-dimensional interaction surface is generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6801">
                    <text>the correct three-dimensional interaction surface is generated by L723 to H3. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6802">
                    <text>the correct three-dimensional interaction surface was generated by L723 in H3 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6803">
                    <text>the correct three-dimensional interaction surface was generated by L723 in H3 within the recombinant synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6804">
                    <text>the correct three-dimensional interaction surface was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6805">
                    <text>the correct three-dimensional interaction surface was generated by L723 to H3 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6806">
                    <text>the correct three-dimensional interaction surface was generated by L723 to H3 within the recombinant synapse.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6807">
                    <text>the correct three-dimensional interaction surface was generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6808">
                    <text>the correct three-dimensional interaction surface was generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6809">
                    <text>the correct three-dimensional interaction surface were generated by L723 in H3 (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6810">
                    <text>the correct three-dimensional interaction surface were generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6811">
                    <text>the correct three-dimensional interaction surface were generated by L723 to H3 (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6812">
                    <text>the correct three-dimensional interaction surface were generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6813">
                    <text>the correct three-dimensional interaction surface were generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6814">
                    <text>the correct three-dimensional interaction surface will be generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6815">
                    <text>the correct three-dimensional interaction surface will be generated by L723 in H3. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6816">
                    <text>the correct three-dimensional interaction surface will be generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6817">
                    <text>the correct three-dimensional interaction surface will be generated by L723 to H3. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6818">
                    <text>the term N-AR are able to generate a functional interaction surface .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6819">
                    <text>the term N-AR are able to generate a surface of functional interaction .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6820">
                    <text>the term N-AR can generate a functional interaction surface (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6821">
                    <text>the term N-AR can generate a functional interaction surface (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6822">
                    <text>the term N-AR can generate a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6823">
                    <text>the term N-AR can generate a surface of functional interaction (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6824">
                    <text>the term N-AR can generate a surface of functional interaction (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6825">
                    <text>the term N-AR can generate a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6826">
                    <text>the term N-AR generated a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6827">
                    <text>the term N-AR generated a functional interaction surface (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6828">
                    <text>the term N-AR generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6829">
                    <text>the term N-AR generated a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6830">
                    <text>the term N-AR generated a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6831">
                    <text>the term N-AR generated a surface of functional interaction (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6832">
                    <text>the term N-AR generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6833">
                    <text>the term N-AR generated a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6834">
                    <text>the term N-AR generated a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6835">
                    <text>the term N-AR generates a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6836">
                    <text>the term N-AR generates a functional interaction surface (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6837">
                    <text>the term N-AR generates a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6838">
                    <text>the term N-AR generates a functional interaction surface within the recombinant synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6839">
                    <text>the term N-AR generates a functional interaction surface-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6840">
                    <text>the term N-AR generates a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6841">
                    <text>the term N-AR generates a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6842">
                    <text>the term N-AR generates a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6843">
                    <text>the term N-AR generates a surface of functional interaction (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6844">
                    <text>the term N-AR generates a surface of functional interaction within the recombinant synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6845">
                    <text>the term N-AR generates a surface of functional interaction-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6846">
                    <text>the term N-AR generates a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6847">
                    <text>the term N-AR generates a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6848">
                    <text>the term N-AR has generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6849">
                    <text>the term N-AR has generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6850">
                    <text>the term N-AR is able to generate a functional interaction surface .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6851">
                    <text>the term N-AR is able to generate a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="6852">
                    <text>the term N-AR is able to generate a surface of functional interaction .</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6853">
                    <text>the term N-AR is able to generate a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="6854">
                    <text>this binding are able to generate a high-order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6855">
                    <text>this binding are able to generate a higher DNA complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6856">
                    <text>this binding are able to generate a higher DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6857">
                    <text>this binding are able to generate a higher order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6858">
                    <text>this binding are able to generate high-order DNA protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6859">
                    <text>this binding can generate a high-order DNA-protein complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6860">
                    <text>this binding can generate a high-order DNA-protein complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6861">
                    <text>this binding can generate a higher DNA complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6862">
                    <text>this binding can generate a higher DNA complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6863">
                    <text>this binding can generate a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6864">
                    <text>this binding can generate a higher DNA-protein complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6865">
                    <text>this binding can generate a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6866">
                    <text>this binding can generate a higher order DNA-protein complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6867">
                    <text>this binding can generate a higher order DNA-protein complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6868">
                    <text>this binding can generate high-order DNA protein complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6869">
                    <text>this binding can generate high-order DNA protein complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6870">
                    <text>this binding can generate high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6871">
                    <text>this binding can generate high-order DNA-protein complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6872">
                    <text>this binding can generate high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6873">
                    <text>this binding generated a high-order DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6874">
                    <text>this binding generated a high-order DNA-protein complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6875">
                    <text>this binding generated a high-order DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6876">
                    <text>this binding generated a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6877">
                    <text>this binding generated a higher DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6878">
                    <text>this binding generated a higher DNA complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6879">
                    <text>this binding generated a higher DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6880">
                    <text>this binding generated a higher DNA complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6881">
                    <text>this binding generated a higher DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6882">
                    <text>this binding generated a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6883">
                    <text>this binding generated a higher DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6884">
                    <text>this binding generated a higher DNA-protein complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6885">
                    <text>this binding generated a higher DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6886">
                    <text>this binding generated a higher DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6887">
                    <text>this binding generated a higher DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6888">
                    <text>this binding generated a higher order DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6889">
                    <text>this binding generated a higher order DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6890">
                    <text>this binding generated a higher order DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6891">
                    <text>this binding generated a higher order DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6892">
                    <text>this binding generated a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6893">
                    <text>this binding generated high-order DNA protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6894">
                    <text>this binding generated high-order DNA protein complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6895">
                    <text>this binding generated high-order DNA protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6896">
                    <text>this binding generated high-order DNA protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6897">
                    <text>this binding generated high-order DNA protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6898">
                    <text>this binding generated high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6899">
                    <text>this binding generated high-order DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6900">
                    <text>this binding generated high-order DNA-protein complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6901">
                    <text>this binding generated high-order DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6902">
                    <text>this binding generated high-order DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6903">
                    <text>this binding generates a high-order DNA-protein complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6904">
                    <text>this binding generates a high-order DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6905">
                    <text>this binding generates a high-order DNA-protein complex within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6906">
                    <text>this binding generates a high-order DNA-protein complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6907">
                    <text>this binding generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6908">
                    <text>this binding generates a higher DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6909">
                    <text>this binding generates a higher DNA complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6910">
                    <text>this binding generates a higher DNA complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6911">
                    <text>this binding generates a higher DNA complex within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6912">
                    <text>this binding generates a higher DNA complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6913">
                    <text>this binding generates a higher DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6914">
                    <text>this binding generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6915">
                    <text>this binding generates a higher DNA-protein complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6916">
                    <text>this binding generates a higher DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6917">
                    <text>this binding generates a higher DNA-protein complex within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6918">
                    <text>this binding generates a higher DNA-protein complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6919">
                    <text>this binding generates a higher DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6920">
                    <text>this binding generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6921">
                    <text>this binding generates a higher order DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6922">
                    <text>this binding generates a higher order DNA-protein complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6923">
                    <text>this binding generates a higher order DNA-protein complex within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6924">
                    <text>this binding generates a higher order DNA-protein complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6925">
                    <text>this binding generates a higher order DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6926">
                    <text>this binding generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6927">
                    <text>this binding generates high-order DNA protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6928">
                    <text>this binding generates high-order DNA protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6929">
                    <text>this binding generates high-order DNA protein complex within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6930">
                    <text>this binding generates high-order DNA protein complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6931">
                    <text>this binding generates high-order DNA protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6932">
                    <text>this binding generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6933">
                    <text>this binding generates high-order DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6934">
                    <text>this binding generates high-order DNA-protein complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6935">
                    <text>this binding generates high-order DNA-protein complex within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6936">
                    <text>this binding generates high-order DNA-protein complex within the recombinant synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6937">
                    <text>this binding generates high-order DNA-protein complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6938">
                    <text>this binding generates high-order DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6939">
                    <text>this binding generates high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6940">
                    <text>this binding has generated a higher DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6941">
                    <text>this binding has generated high-order DNA protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6942">
                    <text>this binding is able to generate a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6943">
                    <text>this binding is able to generate a higher DNA complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6944">
                    <text>this binding is able to generate a higher DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6945">
                    <text>this binding is able to generate a higher order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6946">
                    <text>this binding is able to generate a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6947">
                    <text>this binding is able to generate high-order DNA protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6948">
                    <text>this binding is able to generate high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6949">
                    <text>this binding is able to generate high-order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6950">
                    <text>this binding is able to generate high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="6951">
                    <text>this junction are able to generate a higher-order protein DNA complex .</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6952">
                    <text>this junction can generate a higher-order protein DNA complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6953">
                    <text>this junction can generate a higher-order protein DNA complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6954">
                    <text>this junction can generate a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6955">
                    <text>this junction generated a higher-order protein DNA complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6956">
                    <text>this junction generated a higher-order protein DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6957">
                    <text>this junction generated a higher-order protein DNA complex within the recombinant synapse.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6958">
                    <text>this junction generated a higher-order protein DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6959">
                    <text>this junction generated a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6960">
                    <text>this junction generates a higher-order protein DNA complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6961">
                    <text>this junction generates a higher-order protein DNA complex within the recombinant synapse.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6962">
                    <text>this junction generates a higher-order protein DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6963">
                    <text>this junction generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6964">
                    <text>this junction has generated a higher-order protein DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6965">
                    <text>this junction is able to generate a higher-order protein DNA complex .</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6966">
                    <text>this junction is able to generate a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6967">
                    <text>this union are able to generate a higher-order protein&#x13;DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6968">
                    <text>this union are able to generate a higher-order protein-DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6969">
                    <text>this union can generate a higher-order protein&#x13;DNA complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6970">
                    <text>this union can generate a higher-order protein&#x13;DNA complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6971">
                    <text>this union can generate a higher-order protein-DNA complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6972">
                    <text>this union can generate a higher-order protein-DNA complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6973">
                    <text>this union can generate a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6974">
                    <text>this union can generate high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6975">
                    <text>this union generated a higher-order protein&#x13;DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6976">
                    <text>this union generated a higher-order protein&#x13;DNA complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6977">
                    <text>this union generated a higher-order protein&#x13;DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6978">
                    <text>this union generated a higher-order protein&#x13;DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6979">
                    <text>this union generated a higher-order protein&#x13;DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6980">
                    <text>this union generated a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6981">
                    <text>this union generated a higher-order protein-DNA complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6982">
                    <text>this union generated a higher-order protein-DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6983">
                    <text>this union generated a higher-order protein-DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6984">
                    <text>this union generated a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6985">
                    <text>this union generated high-order protein-DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6986">
                    <text>this union generated high-order protein-DNA complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6987">
                    <text>this union generated high-order protein-DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6988">
                    <text>this union generated high-order protein-DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6989">
                    <text>this union generated high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6990">
                    <text>this union generates a higher-order protein&#x13;DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6991">
                    <text>this union generates a higher-order protein&#x13;DNA complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6992">
                    <text>this union generates a higher-order protein&#x13;DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6993">
                    <text>this union generates a higher-order protein&#x13;DNA complex within the recombinant synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6994">
                    <text>this union generates a higher-order protein&#x13;DNA complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6995">
                    <text>this union generates a higher-order protein&#x13;DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6996">
                    <text>this union generates a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6997">
                    <text>this union generates a higher-order protein-DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6998">
                    <text>this union generates a higher-order protein-DNA complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="6999">
                    <text>this union generates a higher-order protein-DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7000">
                    <text>this union generates a higher-order protein-DNA complex within the recombinant synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7001">
                    <text>this union generates a higher-order protein-DNA complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7002">
                    <text>this union generates a higher-order protein-DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7003">
                    <text>this union generates a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7004">
                    <text>this union generates high-order protein-DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7005">
                    <text>this union generates high-order protein-DNA complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7006">
                    <text>this union generates high-order protein-DNA complex within the recombinant synapse.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7007">
                    <text>this union generates high-order protein-DNA complex within the recombinant synapses.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7008">
                    <text>this union generates high-order protein-DNA complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7009">
                    <text>this union generates high-order protein-DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7010">
                    <text>this union generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7011">
                    <text>this union has generated a higher-order protein&#x13;DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7012">
                    <text>this union has generated a higher-order protein-DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7013">
                    <text>this union has generated high-order protein-DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7014">
                    <text>this union is able to generate a higher-order protein&#x13;DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7015">
                    <text>this union is able to generate a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7016">
                    <text>this union is able to generate high-order protein-DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7017">
                    <text>this union is able to generate high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="7018">
                    <text>us are able to generate monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7019">
                    <text>us can generate monoclonal antibody against FHL2 (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7020">
                    <text>us can generate monoclonal antibody against FHL2 (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7021">
                    <text>us can generate monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7022">
                    <text>us can generate monoclonal antibody vs. FHL2 (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7023">
                    <text>us can generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7024">
                    <text>us generated monoclonal antibody against FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7025">
                    <text>us generated monoclonal antibody against FHL2 (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7026">
                    <text>us generated monoclonal antibody against FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7027">
                    <text>us generated monoclonal antibody against FHL2 within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7028">
                    <text>us generated monoclonal antibody against FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7029">
                    <text>us generated monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7030">
                    <text>us generated monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7031">
                    <text>us generated monoclonal antibody vs. FHL2 (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7032">
                    <text>us generated monoclonal antibody vs. FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7033">
                    <text>us generated monoclonal antibody vs. FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7034">
                    <text>us generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7035">
                    <text>us generates monoclonal antibody against FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7036">
                    <text>us generates monoclonal antibody against FHL2 (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7037">
                    <text>us generates monoclonal antibody against FHL2 within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7038">
                    <text>us generates monoclonal antibody against FHL2 within the recombinant synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7039">
                    <text>us generates monoclonal antibody against FHL2-G molecules of antigen human leukocytes.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7040">
                    <text>us generates monoclonal antibody against FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7041">
                    <text>us generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7042">
                    <text>us generates monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7043">
                    <text>us generates monoclonal antibody vs. FHL2 (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7044">
                    <text>us generates monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7045">
                    <text>us generates monoclonal antibody vs. FHL2 within the recombinant synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7046">
                    <text>us generates monoclonal antibody vs. FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7047">
                    <text>us generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7048">
                    <text>us has generated monoclonal antibody against FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7049">
                    <text>us has generated monoclonal antibody vs. FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7050">
                    <text>us is able to generate monoclonal antibody against FHL2 .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7051">
                    <text>us is able to generate monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="7052">
                    <text>us is able to generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA was generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA was generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA will be generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HLA will be generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and N-terminal AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and N-terminus AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface was generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface will be generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction was generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction was generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction will be generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction will be generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an alternative splicing of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an alternative splicing of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-ammonia lyase generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon lilase generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon lysase generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon lysis generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon system generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amonylliase generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat was generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat was generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat will be generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat will be generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat will be generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and furama was generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and furama was generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and furama will be generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and intergenic splicing with Prnp generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chemeric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual chemeric transcriptions will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual symmetric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual symmetric transcriptions will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sondes will be generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the N-term AR generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the N-terminal RA generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and N-terminal AR generated a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an alternative splicing of primary gene transcription generated HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and an alternative splicing of primary genetic transcription generated HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-ammonia lyase generated fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon lilase generated fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon lysis generated furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon system generated sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and intergenic splicing with Prnp generated some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and intergenic splicing with Prnp generated some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the N-term AR generated a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA is generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA is generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA was generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA was generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA will be generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and N-terminal AR generated a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and N-terminal AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and N-terminus AR generated a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and N-terminus AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface is generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface was generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction is generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction is generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction was generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction will be generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction will be generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative splicing of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative splicing of primary genetic transcription generated HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative splicing of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-ammonia lyase generated fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-ammonia lyase generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon lilase generated fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon lilase generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon lysase generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon lysis generated furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon lysis generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon system generated sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon system generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amonylliase generated furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amonylliase generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat is generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat is generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat is generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat was generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat was generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat will be generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat will be generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat will be generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and furama is generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and furama was generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and furama was generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and furama will be generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and furama will be generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic splicing with Prnp generated some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic splicing with Prnp generated some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic splicing with Prnp generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic splicing with Prnp generates some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemeric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemeric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual symmetric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual symmetric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sondes is generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sondes was generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sondes will be generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-term AR generated a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-term AR generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-terminal RA generated a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-terminal RA generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HLA has been generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and HLA has been generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface has been generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction has been generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction has been generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and fumat has been generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and fumat has been generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and fumat has been generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and furama has been generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and some unusual chemeric transcriptions has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and some unusual symmetric transcriptions has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and sondes has been generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HLA is generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface is generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction is generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction is generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a surface of functional interaction is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and fumat is generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and furama is generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and furama is generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and some unusual chemeric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and some unusual symmetric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and sondes is generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>A1 is generated by N-terminal AR (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>A1 is generated by N-terminus AR (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>A1 is generated by an alternative splicing of primary gene transcription (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>A1 is generated by an alternative splicing of primary genetic transcription (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>A1 is generated by aspartate-ammonia lyase (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>A1 is generated by aspartate-amon lilase (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>A1 is generated by aspartate-amon lysase (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>A1 is generated by aspartate-amon lysis (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>A1 is generated by aspartate-amon system (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>A1 is generated by aspartate-amonylliase (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>A1 is generated by intergenic splicing with Prnp (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>A1 is generated by the N-terminal RA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HLA has been generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that HLA has been generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that N-terminal AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that N-terminal AR has generated a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that N-terminus AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that N-terminus AR has generated a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a functional interaction surface has been generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a surface of functional interaction has been generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a surface of functional interaction has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative splicing of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative splicing of primary gene transcription has generated HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative splicing of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative splicing of primary genetic transcription has generated HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-ammonia lyase generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-ammonia lyase has generated fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon lilase generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon lilase has generated fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon lysase generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon lysase has generated fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon lysis generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon lysis has generated furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon system generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amon system has generated sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amonylliase generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that aspartate-amonylliase has generated furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat has been generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat has been generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that furama has been generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that furama has been generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic splicing with Prnp generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic splicing with Prnp generates some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic splicing with Prnp has generated some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic splicing with Prnp has generated some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that some unusual chemeric transcriptions has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that sondes has been generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-term AR generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-term AR has generated a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-terminal RA generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the N-terminal RA has generated a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HLA has been generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HLA has been generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that N-terminal AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that N-terminal AR has generated a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that N-terminus AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that N-terminus AR has generated a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a surface of functional interaction has been generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative splicing of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative splicing of primary gene transcription has generated HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative splicing of primary genetic transcription has generated HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-ammonia lyase generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon lilase generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon lilase has generated fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon lysase generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon lysase has generated fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon lysis generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon lysis has generated furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon system generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amon system has generated sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amonylliase generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-amonylliase has generated furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat has been generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat has been generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that furama has been generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that furama has been generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic splicing with Prnp generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic splicing with Prnp generates some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic splicing with Prnp has generated some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that intergenic splicing with Prnp has generated some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that some unusual chemeric transcriptions has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that sondes has been generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-term AR generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-term AR has generated a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-terminal RA generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>HLA (carot, and permease from DcuB to motor, carot and aspartate) were generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>HLA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>HLA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>HLA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>HLA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>HLA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>HLA (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>HLA are generated by an alternative splicing of primary gene transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>HLA are generated by an alternative splicing of primary gene transcription .</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>HLA are generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>HLA are generated by an alternative splicing of primary genetic transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>HLA are generated by an alternative splicing of primary genetic transcription .</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>HLA are generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>HLA can be generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>HLA can be generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>HLA is generated by an alternative splicing of primary gene transcription whose deletion removes the FHL2 binding.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>HLA is generated by an alternative splicing of primary gene transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>HLA is generated by an alternative splicing of primary gene transcription within the recombinant synapses.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>HLA is generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>HLA is generated by an alternative splicing of primary gene transcription. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>HLA is generated by an alternative splicing of primary genetic transcription whose elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>HLA is generated by an alternative splicing of primary genetic transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>HLA is generated by an alternative splicing of primary genetic transcription within the recombinant synapses.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>HLA is generated by an alternative splicing of primary genetic transcription. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>HLA was generated by an alternative splicing of primary gene transcription (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>HLA was generated by an alternative splicing of primary gene transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>HLA was generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>HLA was generated by an alternative splicing of primary genetic transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>HLA was generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>HLA were generated by an alternative splicing of primary gene transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>HLA were generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>HLA were generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>HLA will be generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>HLA will be generated by an alternative splicing of primary genetic transcription. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>In addition, N-terminal AR generates a surface of functional interaction, as its elimination removes the FHL2 link.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>In addition, N-terminal AR, whose elimination removes the FHL2 link, generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>In addition, N-terminus AR generates a surface of functional interaction, as its elimination removes the FHL2 link.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>In addition, N-terminus AR, whose elimination removes the FHL2 link, generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>In addition, an alternative splicing of primary gene transcription generates HLA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>In addition, an alternative splicing of primary genetic transcription generates HLA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>In addition, aspartate-ammonia lyase generates fumat, as its elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>In addition, aspartate-ammonia lyase, whose elimination removes the FHL2 link, generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>In addition, aspartate-amon lilase, whose elimination removes the FHL2 link, generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>In addition, aspartate-amon lysase generates fumat, as its elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>In addition, aspartate-amon lysase, whose elimination removes the FHL2 link, generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>In addition, aspartate-amon lysis generates furama, as its elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>In addition, aspartate-amon lysis, whose elimination removes the FHL2 link, generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>In addition, aspartate-amon system generates sondes, as its elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>In addition, aspartate-amon system, whose elimination removes the FHL2 link, generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>In addition, aspartate-amonylliase generates furama, as its elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>In addition, aspartate-amonylliase, whose elimination removes the FHL2 link, generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>In addition, intergenic splicing with Prnp generates some unusual chemeric transcriptions, as its elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>In addition, intergenic splicing with Prnp generates some unusual symmetric transcriptions, as its elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>In addition, intergenic splicing with Prnp, whose elimination removes the FHL2 link, generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>In addition, intergenic splicing with Prnp, whose elimination removes the FHL2 link, generates some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>In addition, the N-term AR generates a functional interaction surface, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>In addition, the N-term AR, whose elimination removes the FHL2 link, generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>In addition, the N-terminal RA generates a surface of functional interaction, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>In addition, the N-terminal RA, whose elimination removes the FHL2 link, generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, although again the relatively small fraction involved and the possibility that a surface of functional interaction will be generated by no by degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction has no was generated by degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction would be no generated by degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction are not generated by degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction would be not generated by degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, although again the relatively small fraction involved and the possibility that a surface of functional interaction is generated by not for degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, although again the relatively small fraction involved and the possibility that a surface of functional interaction will be generated by no by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction are no generated by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction has no was generated by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, but again the relatively small fraction involved and the possibility that a surface of functional interaction would be no generated by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction are not generated by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction have not has been generated by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction would be not generated by degradation.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminus AR, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, although again the relatively small fraction involved and the possibility that HLA is generated by not for degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, although again the relatively small fraction involved and the possibility that HLA will be generated by no by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, but again the relatively small fraction involved and the possibility that HLA are no generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, but again the relatively small fraction involved and the possibility that HLA would be no generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, though again the relatively small fraction involved and the possibility that HLA are not generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, though again the relatively small fraction involved and the possibility that HLA have not has been generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, though again the relatively small fraction involved and the possibility that HLA would be not generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, although again the relatively small fraction involved and the possibility that HLA is generated by not for degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, but again the relatively small fraction involved and the possibility that HLA are no generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, but again the relatively small fraction involved and the possibility that HLA has no was generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, but again the relatively small fraction involved and the possibility that HLA would be no generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, though again the relatively small fraction involved and the possibility that HLA are not generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, though again the relatively small fraction involved and the possibility that HLA have not has been generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, though again the relatively small fraction involved and the possibility that HLA would be not generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, although again the relatively small fraction involved and the possibility that fumat is generated by not for degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, although again the relatively small fraction involved and the possibility that fumat will be generated by no by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, but again the relatively small fraction involved and the possibility that fumat are no generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, but again the relatively small fraction involved and the possibility that fumat has no was generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, but again the relatively small fraction involved and the possibility that fumat would be no generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, though again the relatively small fraction involved and the possibility that fumat are not generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, though again the relatively small fraction involved and the possibility that fumat have not has been generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-ammonia lyase, though again the relatively small fraction involved and the possibility that fumat would be not generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, although again the relatively small fraction involved and the possibility that fumat will be generated by no by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, but again the relatively small fraction involved and the possibility that fumat are no generated by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, but again the relatively small fraction involved and the possibility that fumat has no was generated by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, but again the relatively small fraction involved and the possibility that fumat would be no generated by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, though again the relatively small fraction involved and the possibility that fumat are not generated by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, though again the relatively small fraction involved and the possibility that fumat have not has been generated by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, though again the relatively small fraction involved and the possibility that fumat would be not generated by degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, although again the relatively small fraction involved and the possibility that fumat is generated by not for degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, although again the relatively small fraction involved and the possibility that fumat will be generated by no by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, but again the relatively small fraction involved and the possibility that fumat are no generated by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, but again the relatively small fraction involved and the possibility that fumat has no was generated by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, but again the relatively small fraction involved and the possibility that fumat would be no generated by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, though again the relatively small fraction involved and the possibility that fumat have not has been generated by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, though again the relatively small fraction involved and the possibility that fumat would be not generated by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, although again the relatively small fraction involved and the possibility that furama is generated by not for degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, although again the relatively small fraction involved and the possibility that furama will be generated by no by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, but again the relatively small fraction involved and the possibility that furama are no generated by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, but again the relatively small fraction involved and the possibility that furama has no was generated by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, but again the relatively small fraction involved and the possibility that furama would be no generated by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, though again the relatively small fraction involved and the possibility that furama are not generated by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, though again the relatively small fraction involved and the possibility that furama would be not generated by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, although again the relatively small fraction involved and the possibility that sondes is generated by not for degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, although again the relatively small fraction involved and the possibility that sondes will be generated by no by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, but again the relatively small fraction involved and the possibility that sondes are no generated by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, but again the relatively small fraction involved and the possibility that sondes has no was generated by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, but again the relatively small fraction involved and the possibility that sondes would be no generated by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, though again the relatively small fraction involved and the possibility that sondes would be not generated by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, although again the relatively small fraction involved and the possibility that furama is generated by not for degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, although again the relatively small fraction involved and the possibility that furama will be generated by no by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, but again the relatively small fraction involved and the possibility that furama are no generated by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, but again the relatively small fraction involved and the possibility that furama has no was generated by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, but again the relatively small fraction involved and the possibility that furama would be no generated by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, though again the relatively small fraction involved and the possibility that furama are not generated by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, though again the relatively small fraction involved and the possibility that furama have not has been generated by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, though again the relatively small fraction involved and the possibility that furama would be not generated by degradation.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions is generated by not for degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions will be generated by no by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions is generated by not for degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions will be generated by no by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions are no generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions has no was generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions would be no generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions are no generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions has no was generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions are not generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions would be not generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions are not generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions would be not generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, although again the relatively small fraction involved and the possibility that a functional interaction surface is generated by not for degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, although again the relatively small fraction involved and the possibility that a functional interaction surface will be generated by no by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, but again the relatively small fraction involved and the possibility that a functional interaction surface has no was generated by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, but again the relatively small fraction involved and the possibility that a functional interaction surface would be no generated by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, though again the relatively small fraction involved and the possibility that a functional interaction surface are not generated by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, though again the relatively small fraction involved and the possibility that a functional interaction surface have not has been generated by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, though again the relatively small fraction involved and the possibility that a functional interaction surface would be not generated by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, although again the relatively small fraction involved and the possibility that a surface of functional interaction is generated by not for degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, although again the relatively small fraction involved and the possibility that a surface of functional interaction will be generated by no by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, but again the relatively small fraction involved and the possibility that a surface of functional interaction are no generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, but again the relatively small fraction involved and the possibility that a surface of functional interaction has no was generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, but again the relatively small fraction involved and the possibility that a surface of functional interaction would be no generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that a surface of functional interaction have not has been generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that a surface of functional interaction would be not generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>In the absence of L-arginine, HLA (O(2)-) has been generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>In the absence of L-arginine, HLA (O(2)-) has been generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>In the absence of L-arginine, HLA (O(2)-) is generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>In the absence of L-arginine, HLA (O(2)-) was generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>In the absence of L-arginine, HLA (O(2)-) will be generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>In the absence of L-arginine, HLA (O(2)-) will be generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>In the absence of L-arginine, N-terminal AR generated a surface of functional interaction (O(2)-).</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>In the absence of L-arginine, N-terminal AR generates a surface of functional interaction (O(2)-).</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>In the absence of L-arginine, N-terminus AR generates a surface of functional interaction (O(2)-).</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) has been generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) is generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) was generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) will be generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) has been generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) has been generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) is generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) is generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) was generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) was generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) will be generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) will be generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>In the absence of L-arginine, a surface of functional interaction (O(2)-) will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>In the absence of L-arginine, an alternative splicing of primary gene transcription generated HLA (O(2)-).</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>In the absence of L-arginine, an alternative splicing of primary gene transcription generates HLA (O(2)-).</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>In the absence of L-arginine, an alternative splicing of primary genetic transcription generated HLA (O(2)-).</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>In the absence of L-arginine, an alternative splicing of primary genetic transcription generates HLA (O(2)-).</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>In the absence of L-arginine, aspartate-ammonia lyase generated fumat (O(2)-).</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>In the absence of L-arginine, aspartate-ammonia lyase generates fumat (O(2)-).</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>In the absence of L-arginine, aspartate-amon lilase generates fumat (O(2)-).</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>In the absence of L-arginine, aspartate-amon lysase generated fumat (O(2)-).</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>In the absence of L-arginine, aspartate-amon lysis generated furama (O(2)-).</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>In the absence of L-arginine, aspartate-amon lysis generates furama (O(2)-).</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>In the absence of L-arginine, aspartate-amon system generated sondes (O(2)-).</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>In the absence of L-arginine, aspartate-amon system generates sondes (O(2)-).</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>In the absence of L-arginine, aspartate-amonylliase generated furama (O(2)-).</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>In the absence of L-arginine, aspartate-amonylliase generates furama (O(2)-).</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>In the absence of L-arginine, fumat (O(2)-) has been generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>In the absence of L-arginine, fumat (O(2)-) has been generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>In the absence of L-arginine, fumat (O(2)-) has been generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>In the absence of L-arginine, fumat (O(2)-) is generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>In the absence of L-arginine, fumat (O(2)-) is generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>In the absence of L-arginine, fumat (O(2)-) is generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>In the absence of L-arginine, fumat (O(2)-) was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>In the absence of L-arginine, fumat (O(2)-) was generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>In the absence of L-arginine, fumat (O(2)-) was generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>In the absence of L-arginine, fumat (O(2)-) will be generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>In the absence of L-arginine, fumat (O(2)-) will be generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>In the absence of L-arginine, fumat (O(2)-) will be generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>In the absence of L-arginine, furama (O(2)-) has been generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>In the absence of L-arginine, furama (O(2)-) is generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>In the absence of L-arginine, furama (O(2)-) is generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>In the absence of L-arginine, furama (O(2)-) was generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>In the absence of L-arginine, furama (O(2)-) was generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>In the absence of L-arginine, furama (O(2)-) will be generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>In the absence of L-arginine, furama (O(2)-) will be generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>In the absence of L-arginine, intergenic splicing with Prnp generated some unusual chemeric transcriptions (O(2)-).</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>In the absence of L-arginine, intergenic splicing with Prnp generated some unusual symmetric transcriptions (O(2)-).</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>In the absence of L-arginine, intergenic splicing with Prnp generates some unusual symmetric transcriptions (O(2)-).</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>In the absence of L-arginine, some unusual chemeric transcriptions (O(2)-) is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>In the absence of L-arginine, some unusual chemeric transcriptions (O(2)-) will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>In the absence of L-arginine, some unusual symmetric transcriptions (O(2)-) has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>In the absence of L-arginine, some unusual symmetric transcriptions (O(2)-) is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>In the absence of L-arginine, some unusual symmetric transcriptions (O(2)-) was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>In the absence of L-arginine, some unusual symmetric transcriptions (O(2)-) will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>In the absence of L-arginine, sondes (O(2)-) has been generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>In the absence of L-arginine, sondes (O(2)-) is generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>In the absence of L-arginine, sondes (O(2)-) was generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>In the absence of L-arginine, sondes (O(2)-) will be generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>In the absence of L-arginine, the N-term AR generated a functional interaction surface (O(2)-).</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>In the absence of L-arginine, the N-term AR generates a functional interaction surface (O(2)-).</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>In the absence of L-arginine, the N-terminal RA generated a surface of functional interaction (O(2)-).</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>In the absence of L-arginine, the N-terminal RA generates a surface of functional interaction (O(2)-).</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>N-terminal AR are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>N-terminal AR are able to generate a surface of functional interaction .</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>N-terminal AR can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>N-terminal AR can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>N-terminal AR can generate a surface of functional interaction (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>N-terminal AR can generate a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>N-terminal AR generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>N-terminal AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>N-terminal AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>N-terminal AR generated a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>N-terminal AR generated a surface of functional interaction (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>N-terminal AR generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>N-terminal AR generated a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>N-terminal AR generated a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>N-terminal AR generated a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>N-terminal AR generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>N-terminal AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>N-terminal AR generates a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>N-terminal AR generates a surface of functional interaction (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>N-terminal AR generates a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>N-terminal AR generates a surface of functional interaction-G molecules of antigen human leukocytes.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>N-terminal AR generates a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>N-terminal AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>N-terminal AR has generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>N-terminal AR is able to generate a surface of functional interaction .</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>N-terminal AR is able to generate a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>N-terminus AR are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>N-terminus AR are able to generate a surface of functional interaction .</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>N-terminus AR can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>N-terminus AR can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>N-terminus AR can generate a surface of functional interaction (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>N-terminus AR can generate a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>N-terminus AR generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>N-terminus AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>N-terminus AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>N-terminus AR generated a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>N-terminus AR generated a surface of functional interaction (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>N-terminus AR generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>N-terminus AR generated a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>N-terminus AR generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>N-terminus AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>N-terminus AR generates a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>N-terminus AR generates a surface of functional interaction (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>N-terminus AR generates a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>N-terminus AR generates a surface of functional interaction within the recombinant synapses.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>N-terminus AR generates a surface of functional interaction-G molecules of antigen human leukocytes.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>N-terminus AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>N-terminus AR has generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>N-terminus AR is able to generate a surface of functional interaction .</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>N-terminus AR is able to generate a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>The HLA of Stat5a has been generated by an alternative splicing of primary gene transcription .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>The HLA of Stat5a will be generated by an alternative splicing of primary genetic transcription.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>The HLA-G molecules are generated by an alternative splicing of primary gene transcription and show a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>The HLA-G molecules of human leukocytes have been generated by an alternative splicing of primary genetic transcription and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative splicing of primary gene transcription and had a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative splicing of primary gene transcription and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative splicing of primary genetic transcription and had a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative splicing of primary genetic transcription and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative splicing of primary genetic transcription and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>The N-terminal AR generated the a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>The N-terminal AR generates the a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>The a functional interaction surface of Stat5a has been generated by the N-term AR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>The a functional interaction surface of Stat5a will be generated by the N-term AR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>The a functional interaction surface-G molecules are generated by the N-term AR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>The a functional interaction surface-G molecules of human leukocytes have been generated by the N-term AR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-term AR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-term AR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-term AR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>The a surface of functional interaction of Stat5a has been generated by N-terminal AR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>The a surface of functional interaction of Stat5a has been generated by N-terminus AR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>The a surface of functional interaction of Stat5a has been generated by the N-terminal RA .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>The a surface of functional interaction of Stat5a will be generated by N-terminal AR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>The a surface of functional interaction of Stat5a will be generated by N-terminus AR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>The a surface of functional interaction of Stat5a will be generated by the N-terminal RA.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>The a surface of functional interaction-G molecules are generated by N-terminal AR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>The a surface of functional interaction-G molecules are generated by N-terminus AR and show a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>The a surface of functional interaction-G molecules of human leukocytes have been generated by N-terminal AR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>The a surface of functional interaction-G molecules of human leukocytes have been generated by N-terminus AR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>The a surface of functional interaction-G molecules of human leukocytes have been generated by the N-terminal RA and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by N-terminal AR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by N-terminal AR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by N-terminal AR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="558">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by N-terminus AR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="559">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by N-terminus AR and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="560">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by the N-terminal RA and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="561">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by the N-terminal RA and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="562">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by the N-terminal RA and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="563">
                    <text>The an alternative splicing of primary gene transcription generated the HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="564">
                    <text>The an alternative splicing of primary gene transcription generates the HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="565">
                    <text>The an alternative splicing of primary genetic transcription generated the HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="566">
                    <text>The an alternative splicing of primary genetic transcription generates the HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="567">
                    <text>The aspartate-ammonia lyase generated the fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="568">
                    <text>The aspartate-ammonia lyase generates the fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="569">
                    <text>The aspartate-amon lilase generated the fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="570">
                    <text>The aspartate-amon lilase generates the fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="571">
                    <text>The aspartate-amon lysase generated the fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="572">
                    <text>The aspartate-amon lysis generated the furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="573">
                    <text>The aspartate-amon system generated the sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="574">
                    <text>The aspartate-amon system generates the sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="575">
                    <text>The aspartate-amonylliase generated the furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="576">
                    <text>The aspartate-amonylliase generates the furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="577">
                    <text>The fumat of Stat5a has been generated by aspartate-ammonia lyase .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="578">
                    <text>The fumat of Stat5a has been generated by aspartate-amon lilase .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="579">
                    <text>The fumat of Stat5a has been generated by aspartate-amon lysase .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="580">
                    <text>The fumat of Stat5a will be generated by aspartate-amon lilase.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="581">
                    <text>The fumat of Stat5a will be generated by aspartate-amon lysase.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="582">
                    <text>The fumat-G molecules are generated by aspartate-ammonia lyase and show a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="583">
                    <text>The fumat-G molecules are generated by aspartate-amon lilase and show a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="584">
                    <text>The fumat-G molecules are generated by aspartate-amon lysase and show a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="585">
                    <text>The fumat-G molecules of human leukocytes have been generated by aspartate-ammonia lyase and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="586">
                    <text>The fumat-G molecules of human leukocytes have been generated by aspartate-amon lilase and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="587">
                    <text>The fumat-G molecules of human leukocytes have been generated by aspartate-amon lysase and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="588">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-ammonia lyase and had a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="589">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-ammonia lyase and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="590">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-amon lilase and had a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="591">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-amon lilase and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="592">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-amon lilase and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="593">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-amon lysase and had a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="594">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-amon lysase and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="595">
                    <text>The furama of Stat5a has been generated by aspartate-amonylliase .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="596">
                    <text>The furama of Stat5a will be generated by aspartate-amonylliase.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="597">
                    <text>The furama-G molecules are generated by aspartate-amonylliase and show a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="598">
                    <text>The furama-G molecules of human leukocytes have been generated by aspartate-amonylliase and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="599">
                    <text>The furama-G molecules of human leukocytes were generated by aspartate-amon lysis and had a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="600">
                    <text>The furama-G molecules of human leukocytes were generated by aspartate-amonylliase and had a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="601">
                    <text>The furama-G molecules of human leukocytes were generated by aspartate-amonylliase and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="602">
                    <text>The furama-G molecules of human leukocytes were generated by aspartate-amonylliase and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="603">
                    <text>The intergenic splicing with Prnp generates the some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="604">
                    <text>The intergenic splicing with Prnp generates the some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="605">
                    <text>The some unusual chemeric transcriptions of Stat5a will be generated by intergenic splicing with Prnp.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="606">
                    <text>The some unusual chemeric transcriptions-G molecules are generated by intergenic splicing with Prnp and show a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="607">
                    <text>The some unusual chemeric transcriptions-G molecules of human leukocytes have been generated by intergenic splicing with Prnp and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="608">
                    <text>The some unusual chemeric transcriptions-G molecules of human leukocytes were generated by intergenic splicing with Prnp and had a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="609">
                    <text>The some unusual chemeric transcriptions-G molecules of human leukocytes were generated by intergenic splicing with Prnp and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="610">
                    <text>The some unusual chemeric transcriptions-G molecules of human leukocytes were generated by intergenic splicing with Prnp and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="611">
                    <text>The some unusual symmetric transcriptions of Stat5a has been generated by intergenic splicing with Prnp .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="612">
                    <text>The some unusual symmetric transcriptions of Stat5a will be generated by intergenic splicing with Prnp.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="613">
                    <text>The some unusual symmetric transcriptions-G molecules are generated by intergenic splicing with Prnp and show a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="614">
                    <text>The some unusual symmetric transcriptions-G molecules of human leukocytes have been generated by intergenic splicing with Prnp and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="615">
                    <text>The some unusual symmetric transcriptions-G molecules of human leukocytes were generated by intergenic splicing with Prnp and had a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="616">
                    <text>The sondes of Stat5a has been generated by aspartate-amon system .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="617">
                    <text>The sondes of Stat5a will be generated by aspartate-amon system.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="618">
                    <text>The sondes-G molecules are generated by aspartate-amon system and show a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="619">
                    <text>The sondes-G molecules of human leukocytes have been generated by aspartate-amon system and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="620">
                    <text>The sondes-G molecules of human leukocytes were generated by aspartate-amon system and had a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="621">
                    <text>The sondes-G molecules of human leukocytes were generated by aspartate-amon system and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="622">
                    <text>The sondes-G molecules of human leukocytes were generated by aspartate-amon system and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="623">
                    <text>The the N-term AR generated the a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="624">
                    <text>The the N-term AR generates the a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="625">
                    <text>The the N-terminal RA generated the a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="626">
                    <text>The the N-terminal RA generates the a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="627">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative splicing of primary gene transcription, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="628">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative splicing of primary genetic transcription, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="629">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative splicing of primary genetic transcription, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="630">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative splicing of primary gene transcription, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="631">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative splicing of primary gene transcription, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="632">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative splicing of primary gene transcription, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="633">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative splicing of primary genetic transcription, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="634">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative splicing of primary genetic transcription, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="635">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the N-term AR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="636">
                    <text>These are a functional interaction surface reductase (coded by the operon of frdABCD), the N-term AR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="637">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-term AR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="638">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), N-terminal AR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="639">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), N-terminus AR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="640">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), N-terminus AR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="641">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), the N-terminal RA, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="642">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), the N-terminal RA, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="643">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), N-terminal AR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="644">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), N-terminal AR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="645">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), N-terminal AR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="646">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), N-terminus AR, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="647">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), N-terminus AR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="648">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), the N-terminal RA, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="649">
                    <text>These are fumat reductase (coded by the operon of frdABCD), aspartate-ammonia lyase, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="650">
                    <text>These are fumat reductase (coded by the operon of frdABCD), aspartate-amon lilase, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="651">
                    <text>These are fumat reductase (coded by the operon of frdABCD), aspartate-amon lilase, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="652">
                    <text>These are fumat reductase (coded by the operon of frdABCD), aspartate-amon lysase, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="653">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-ammonia lyase, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="654">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-ammonia lyase, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="655">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-ammonia lyase, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="656">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-amon lilase, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="657">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-amon lilase, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="658">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-amon lilase, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="659">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-amon lysase, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="660">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-amon lysase, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="661">
                    <text>These are furama reductase (coded by the operon of frdABCD), aspartate-amon lysis, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="662">
                    <text>These are furama reductase (coded by the operon of frdABCD), aspartate-amon lysis, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="663">
                    <text>These are furama reductase (coded by the operon of frdABCD), aspartate-amonylliase, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="664">
                    <text>These are furama reductase (coded by the operon of frdABCD), aspartate-amonylliase, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="665">
                    <text>These are furama reductase (encoded by the operon frdABCD), aspartate-amon lysis, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="666">
                    <text>These are furama reductase (encoded by the operon frdABCD), aspartate-amon lysis, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="667">
                    <text>These are furama reductase (encoded by the operon frdABCD), aspartate-amon lysis, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="668">
                    <text>These are furama reductase (encoded by the operon frdABCD), aspartate-amonylliase, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="669">
                    <text>These are furama reductase (encoded by the operon frdABCD), aspartate-amonylliase, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="670">
                    <text>These are some unusual chemeric transcriptions reductase (coded by the operon of frdABCD), intergenic splicing with Prnp, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="671">
                    <text>These are some unusual chemeric transcriptions reductase (coded by the operon of frdABCD), intergenic splicing with Prnp, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="672">
                    <text>These are some unusual chemeric transcriptions reductase (encoded by the operon frdABCD), intergenic splicing with Prnp, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="673">
                    <text>These are some unusual chemeric transcriptions reductase (encoded by the operon frdABCD), intergenic splicing with Prnp, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="674">
                    <text>These are some unusual symmetric transcriptions reductase (coded by the operon of frdABCD), intergenic splicing with Prnp, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="675">
                    <text>These are some unusual symmetric transcriptions reductase (coded by the operon of frdABCD), intergenic splicing with Prnp, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="676">
                    <text>These are some unusual symmetric transcriptions reductase (encoded by the operon frdABCD), intergenic splicing with Prnp, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="677">
                    <text>These are some unusual symmetric transcriptions reductase (encoded by the operon frdABCD), intergenic splicing with Prnp, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="678">
                    <text>These are sondes reductase (coded by the operon of frdABCD), aspartate-amon system, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="679">
                    <text>These are sondes reductase (encoded by the operon frdABCD), aspartate-amon system, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="680">
                    <text>These are sondes reductase (encoded by the operon frdABCD), aspartate-amon system, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="681">
                    <text>These are sondes reductase (encoded by the operon frdABCD), aspartate-amon system, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="682">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HLA is generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="683">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HLA is generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="684">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a surface of functional interaction is generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="685">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a surface of functional interaction is generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="686">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a surface of functional interaction is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="687">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, fumat is generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="688">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, fumat is generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="689">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, fumat is generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="690">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, furama is generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="691">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, some unusual chemeric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="692">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, some unusual symmetric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="693">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, sondes is generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="694">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HLA is generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="695">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HLA is generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="696">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, N-terminus AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="697">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, N-terminus AR will generate a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="698">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a functional interaction surface is generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="699">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a surface of functional interaction is generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="700">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a surface of functional interaction is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="701">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative splicing of primary gene transcription will generate HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="702">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative splicing of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="703">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative splicing of primary genetic transcription will generate HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="704">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-ammonia lyase generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="705">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-ammonia lyase will generate fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="706">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon lilase generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="707">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon lilase will generate fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="708">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon lysase generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="709">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon lysase will generate fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="710">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon lysis generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="711">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon lysis will generate furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="712">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amonylliase generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="713">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amonylliase will generate furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="714">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat is generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="715">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat is generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="716">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumat is generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="717">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, furama is generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="718">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, furama is generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="719">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic splicing with Prnp generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="720">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic splicing with Prnp generates some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="721">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic splicing with Prnp will generate some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="722">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic splicing with Prnp will generate some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="723">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, some unusual chemeric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="724">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, some unusual symmetric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="725">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-term AR generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="726">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-term AR will generate a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="727">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-terminal RA will generate a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="728">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HLA was generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="729">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HLA was generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="730">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a functional interaction surface was generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="731">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a surface of functional interaction was generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="732">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a surface of functional interaction was generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="733">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a surface of functional interaction was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="734">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, fumat was generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="735">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, furama was generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="736">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, furama was generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="737">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, some unusual chemeric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="738">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, some unusual symmetric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="739">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, sondes was generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="740">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues N-terminal AR can generate a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="741">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues N-terminus AR can generate a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="742">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an alternative splicing of primary gene transcription can generate HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="743">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an alternative splicing of primary genetic transcription can generate HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="744">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues aspartate-amon lilase can generate fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="745">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues aspartate-amon lysase can generate fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="746">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues aspartate-amon lysis can generate furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="747">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues intergenic splicing with Prnp can generate some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="748">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues intergenic splicing with Prnp can generate some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="749">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the N-term AR can generate a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="750">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the N-terminal RA can generate a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="751">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HLA was generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="752">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HLA was generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="753">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, N-terminal AR generates a surface of functional interaction .</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="754">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, N-terminal AR may generate a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="755">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, N-terminal AR will generate a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="756">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, N-terminus AR generates a surface of functional interaction .</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="757">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, N-terminus AR may generate a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="758">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a functional interaction surface was generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="759">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a surface of functional interaction was generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="760">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a surface of functional interaction was generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="761">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a surface of functional interaction was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="762">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative splicing of primary gene transcription generates HLA .</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="763">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative splicing of primary gene transcription may generate HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="764">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative splicing of primary gene transcription will generate HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="765">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative splicing of primary genetic transcription generates HLA .</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="766">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative splicing of primary genetic transcription may generate HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="767">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative splicing of primary genetic transcription will generate HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="768">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-ammonia lyase generates fumat .</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="769">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-ammonia lyase may generate fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="770">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-ammonia lyase will generate fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="771">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lilase generates fumat .</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="772">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lysase generates fumat .</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="773">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lysase may generate fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="774">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lysase will generate fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="775">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lysis may generate furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="776">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lysis will generate furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="777">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon system generates sondes .</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="778">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amonylliase generates furama .</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="779">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amonylliase may generate furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="780">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amonylliase will generate furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="781">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="782">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat was generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="783">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, furama was generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="784">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic splicing with Prnp generates some unusual symmetric transcriptions .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="785">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic splicing with Prnp may generate some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="786">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic splicing with Prnp may generate some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="787">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, some unusual chemeric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="788">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, some unusual symmetric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="789">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, sondes was generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="790">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-term AR may generate a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="791">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-term AR will generate a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="792">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal RA generates a surface of functional interaction .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="793">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal RA may generate a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="794">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-terminal RA will generate a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="795">
                    <text>We believe that N-terminal AR is able to generate a surface of functional interaction within the reombian synapses.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="796">
                    <text>We believe that N-terminal AR is shown to generate a surface of functional interaction within the reombine synapses.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="797">
                    <text>We believe that N-terminus AR is able to generate a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="798">
                    <text>We believe that N-terminus AR is able to generate a surface of functional interaction within the reombian synapses.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="799">
                    <text>We believe that N-terminus AR is shown to generate a surface of functional interaction within the reombine synapses.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="800">
                    <text>We believe that an alternative splicing of primary gene transcription is able to generate HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="801">
                    <text>We believe that an alternative splicing of primary gene transcription is able to generate HLA within the reombian synapses.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="802">
                    <text>We believe that an alternative splicing of primary gene transcription is shown to generate HLA within the reombine synapses.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="803">
                    <text>We believe that an alternative splicing of primary genetic transcription is able to generate HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="804">
                    <text>We believe that an alternative splicing of primary genetic transcription is able to generate HLA within the reombian synapses.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="805">
                    <text>We believe that an alternative splicing of primary genetic transcription is shown to generate HLA within the reombine synapses.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="806">
                    <text>We believe that aspartate-ammonia lyase is able to generate fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="807">
                    <text>We believe that aspartate-ammonia lyase is able to generate fumat within the reombian synapses.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="808">
                    <text>We believe that aspartate-ammonia lyase is shown to generate fumat within the reombine synapses.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="809">
                    <text>We believe that aspartate-amon lilase is able to generate fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="810">
                    <text>We believe that aspartate-amon lilase is shown to generate fumat within the reombine synapses.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="811">
                    <text>We believe that aspartate-amon lysase is able to generate fumat within the reombian synapses.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="812">
                    <text>We believe that aspartate-amon lysase is shown to generate fumat within the reombine synapses.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="813">
                    <text>We believe that aspartate-amon lysis is able to generate furama within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="814">
                    <text>We believe that aspartate-amon lysis is shown to generate furama within the reombine synapses.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="815">
                    <text>We believe that aspartate-amon system is able to generate sondes within the reombian synapses.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="816">
                    <text>We believe that aspartate-amon system is shown to generate sondes within the reombine synapses.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="817">
                    <text>We believe that aspartate-amonylliase is able to generate furama within the recombinant synapse.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="818">
                    <text>We believe that aspartate-amonylliase is able to generate furama within the reombian synapses.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="819">
                    <text>We believe that aspartate-amonylliase is shown to generate furama within the reombine synapses.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="820">
                    <text>We believe that intergenic splicing with Prnp is able to generate some unusual chemeric transcriptions within the reombian synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="821">
                    <text>We believe that intergenic splicing with Prnp is able to generate some unusual symmetric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="822">
                    <text>We believe that intergenic splicing with Prnp is able to generate some unusual symmetric transcriptions within the reombian synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="823">
                    <text>We believe that intergenic splicing with Prnp is shown to generate some unusual chemeric transcriptions within the reombine synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="824">
                    <text>We believe that intergenic splicing with Prnp is shown to generate some unusual symmetric transcriptions within the reombine synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="825">
                    <text>We believe that the N-term AR is able to generate a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="826">
                    <text>We believe that the N-term AR is able to generate a functional interaction surface within the reombian synapses.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="827">
                    <text>We believe that the N-terminal RA is able to generate a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="828">
                    <text>We believe that the N-terminal RA is able to generate a surface of functional interaction within the reombian synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="829">
                    <text>We believe that the N-terminal RA is shown to generate a surface of functional interaction within the reombine synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="830">
                    <text>a functional interaction surface (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="831">
                    <text>a functional interaction surface (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="832">
                    <text>a functional interaction surface are generated by the N-term AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="833">
                    <text>a functional interaction surface are generated by the N-term AR .</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="834">
                    <text>a functional interaction surface are generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="835">
                    <text>a functional interaction surface can be generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="836">
                    <text>a functional interaction surface is generated by the N-term AR within the recombinant synapse.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="837">
                    <text>a functional interaction surface is generated by the N-term AR within the recombinant synapses.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="838">
                    <text>a functional interaction surface is generated by the N-term AR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="839">
                    <text>a functional interaction surface was generated by the N-term AR within the recombinant synapse.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="840">
                    <text>a functional interaction surface was generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="841">
                    <text>a functional interaction surface were generated by the N-term AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="842">
                    <text>a functional interaction surface were generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="843">
                    <text>a functional interaction surface will be generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="844">
                    <text>a functional interaction surface will be generated by the N-term AR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="845">
                    <text>a surface of functional interaction (carot, and permease from DcuB to motor, carot and aspartate) were generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="846">
                    <text>a surface of functional interaction (carot, and permease from DcuB to motor, carot and aspartate) were generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="847">
                    <text>a surface of functional interaction (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="848">
                    <text>a surface of functional interaction (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="849">
                    <text>a surface of functional interaction (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="850">
                    <text>a surface of functional interaction (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="851">
                    <text>a surface of functional interaction (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="852">
                    <text>a surface of functional interaction (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="853">
                    <text>a surface of functional interaction (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="854">
                    <text>a surface of functional interaction (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="855">
                    <text>a surface of functional interaction are generated by N-terminal AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="856">
                    <text>a surface of functional interaction are generated by N-terminal AR .</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="857">
                    <text>a surface of functional interaction are generated by N-terminus AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="858">
                    <text>a surface of functional interaction are generated by N-terminus AR .</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="859">
                    <text>a surface of functional interaction are generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="860">
                    <text>a surface of functional interaction are generated by the N-terminal RA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="861">
                    <text>a surface of functional interaction are generated by the N-terminal RA .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="862">
                    <text>a surface of functional interaction are generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="863">
                    <text>a surface of functional interaction can be generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="864">
                    <text>a surface of functional interaction can be generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="865">
                    <text>a surface of functional interaction can be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="866">
                    <text>a surface of functional interaction is generated by N-terminal AR within the recombinant synapses.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="867">
                    <text>a surface of functional interaction is generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="868">
                    <text>a surface of functional interaction is generated by N-terminal AR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="869">
                    <text>a surface of functional interaction is generated by N-terminus AR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="870">
                    <text>a surface of functional interaction is generated by N-terminus AR whose elimination removes the FHL2 link.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="871">
                    <text>a surface of functional interaction is generated by N-terminus AR within the recombinant synapses.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="872">
                    <text>a surface of functional interaction is generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="873">
                    <text>a surface of functional interaction is generated by the N-terminal RA whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="874">
                    <text>a surface of functional interaction is generated by the N-terminal RA whose elimination removes the FHL2 link.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="875">
                    <text>a surface of functional interaction is generated by the N-terminal RA within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="876">
                    <text>a surface of functional interaction is generated by the N-terminal RA within the recombinant synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="877">
                    <text>a surface of functional interaction is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="878">
                    <text>a surface of functional interaction is generated by the N-terminal RA. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="879">
                    <text>a surface of functional interaction was generated by N-terminal AR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="880">
                    <text>a surface of functional interaction was generated by N-terminal AR within the recombinant synapse.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="881">
                    <text>a surface of functional interaction was generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="882">
                    <text>a surface of functional interaction was generated by N-terminus AR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="883">
                    <text>a surface of functional interaction was generated by N-terminus AR within the recombinant synapse.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="884">
                    <text>a surface of functional interaction was generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="885">
                    <text>a surface of functional interaction was generated by the N-terminal RA within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="886">
                    <text>a surface of functional interaction was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="887">
                    <text>a surface of functional interaction were generated by N-terminal AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="888">
                    <text>a surface of functional interaction were generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="889">
                    <text>a surface of functional interaction were generated by N-terminus AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="890">
                    <text>a surface of functional interaction were generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="891">
                    <text>a surface of functional interaction were generated by the N-terminal RA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="892">
                    <text>a surface of functional interaction were generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="893">
                    <text>a surface of functional interaction will be generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="894">
                    <text>a surface of functional interaction will be generated by N-terminal AR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="895">
                    <text>a surface of functional interaction will be generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="896">
                    <text>a surface of functional interaction will be generated by N-terminus AR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="897">
                    <text>a surface of functional interaction will be generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="898">
                    <text>a surface of functional interaction will be generated by the N-terminal RA. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="899">
                    <text>an alternative splicing of primary gene transcription are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="900">
                    <text>an alternative splicing of primary gene transcription are able to generate HLA .</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="901">
                    <text>an alternative splicing of primary gene transcription can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="902">
                    <text>an alternative splicing of primary gene transcription can generate HLA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="903">
                    <text>an alternative splicing of primary gene transcription can generate HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="904">
                    <text>an alternative splicing of primary gene transcription generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="905">
                    <text>an alternative splicing of primary gene transcription generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="906">
                    <text>an alternative splicing of primary gene transcription generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="907">
                    <text>an alternative splicing of primary gene transcription generated HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="908">
                    <text>an alternative splicing of primary gene transcription generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="909">
                    <text>an alternative splicing of primary gene transcription generated HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="910">
                    <text>an alternative splicing of primary gene transcription generated HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="911">
                    <text>an alternative splicing of primary gene transcription generated HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="912">
                    <text>an alternative splicing of primary gene transcription generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="913">
                    <text>an alternative splicing of primary gene transcription generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="914">
                    <text>an alternative splicing of primary gene transcription generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="915">
                    <text>an alternative splicing of primary gene transcription generates HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="916">
                    <text>an alternative splicing of primary gene transcription generates HLA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="917">
                    <text>an alternative splicing of primary gene transcription generates HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="918">
                    <text>an alternative splicing of primary gene transcription generates HLA within the recombinant synapses.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="919">
                    <text>an alternative splicing of primary gene transcription generates HLA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="920">
                    <text>an alternative splicing of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="921">
                    <text>an alternative splicing of primary gene transcription has generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="922">
                    <text>an alternative splicing of primary gene transcription is able to generate HLA .</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="923">
                    <text>an alternative splicing of primary gene transcription is able to generate HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="924">
                    <text>an alternative splicing of primary genetic transcription are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="925">
                    <text>an alternative splicing of primary genetic transcription are able to generate HLA .</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="926">
                    <text>an alternative splicing of primary genetic transcription can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="927">
                    <text>an alternative splicing of primary genetic transcription can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="928">
                    <text>an alternative splicing of primary genetic transcription can generate HLA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="929">
                    <text>an alternative splicing of primary genetic transcription can generate HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="930">
                    <text>an alternative splicing of primary genetic transcription generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="931">
                    <text>an alternative splicing of primary genetic transcription generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="932">
                    <text>an alternative splicing of primary genetic transcription generated HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="933">
                    <text>an alternative splicing of primary genetic transcription generated HLA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="934">
                    <text>an alternative splicing of primary genetic transcription generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="935">
                    <text>an alternative splicing of primary genetic transcription generated HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="936">
                    <text>an alternative splicing of primary genetic transcription generated HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="937">
                    <text>an alternative splicing of primary genetic transcription generated HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="938">
                    <text>an alternative splicing of primary genetic transcription generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="939">
                    <text>an alternative splicing of primary genetic transcription generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="940">
                    <text>an alternative splicing of primary genetic transcription generates HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="941">
                    <text>an alternative splicing of primary genetic transcription generates HLA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="942">
                    <text>an alternative splicing of primary genetic transcription generates HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="943">
                    <text>an alternative splicing of primary genetic transcription generates HLA within the recombinant synapses.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="944">
                    <text>an alternative splicing of primary genetic transcription generates HLA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="945">
                    <text>an alternative splicing of primary genetic transcription generates HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="946">
                    <text>an alternative splicing of primary genetic transcription has generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="947">
                    <text>an alternative splicing of primary genetic transcription is able to generate HLA .</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="948">
                    <text>an alternative splicing of primary genetic transcription is able to generate HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="949">
                    <text>aspartate-ammonia lyase are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="950">
                    <text>aspartate-ammonia lyase are able to generate fumat .</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="951">
                    <text>aspartate-ammonia lyase can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="952">
                    <text>aspartate-ammonia lyase can generate fumat (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="953">
                    <text>aspartate-ammonia lyase can generate fumat (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="954">
                    <text>aspartate-ammonia lyase can generate fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="955">
                    <text>aspartate-ammonia lyase generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="956">
                    <text>aspartate-ammonia lyase generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="957">
                    <text>aspartate-ammonia lyase generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="958">
                    <text>aspartate-ammonia lyase generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="959">
                    <text>aspartate-ammonia lyase generated fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="960">
                    <text>aspartate-ammonia lyase generated fumat-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="961">
                    <text>aspartate-ammonia lyase generated fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="962">
                    <text>aspartate-ammonia lyase generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="963">
                    <text>aspartate-ammonia lyase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="964">
                    <text>aspartate-ammonia lyase generates fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="965">
                    <text>aspartate-ammonia lyase generates fumat (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="966">
                    <text>aspartate-ammonia lyase generates fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="967">
                    <text>aspartate-ammonia lyase generates fumat within the recombinant synapses.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="968">
                    <text>aspartate-ammonia lyase generates fumat-G molecules of antigen human leukocytes.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="969">
                    <text>aspartate-ammonia lyase generates fumat-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="970">
                    <text>aspartate-ammonia lyase generates fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="971">
                    <text>aspartate-ammonia lyase is able to generate fumat .</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="972">
                    <text>aspartate-ammonia lyase is able to generate fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="973">
                    <text>aspartate-amon lilase are able to generate fumat .</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="974">
                    <text>aspartate-amon lilase can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="975">
                    <text>aspartate-amon lilase can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="976">
                    <text>aspartate-amon lilase can generate fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="977">
                    <text>aspartate-amon lilase generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="978">
                    <text>aspartate-amon lilase generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="979">
                    <text>aspartate-amon lilase generated fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="980">
                    <text>aspartate-amon lilase generated fumat (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="981">
                    <text>aspartate-amon lilase generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="982">
                    <text>aspartate-amon lilase generated fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="983">
                    <text>aspartate-amon lilase generated fumat-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="984">
                    <text>aspartate-amon lilase generated fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="985">
                    <text>aspartate-amon lilase generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="986">
                    <text>aspartate-amon lilase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="987">
                    <text>aspartate-amon lilase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="988">
                    <text>aspartate-amon lilase generates fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="989">
                    <text>aspartate-amon lilase generates fumat within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="990">
                    <text>aspartate-amon lilase generates fumat-G molecules of antigen human leukocytes.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="991">
                    <text>aspartate-amon lilase generates fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="992">
                    <text>aspartate-amon lilase has generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="993">
                    <text>aspartate-amon lilase is able to generate fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="994">
                    <text>aspartate-amon lysase are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="995">
                    <text>aspartate-amon lysase are able to generate fumat .</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="996">
                    <text>aspartate-amon lysase can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="997">
                    <text>aspartate-amon lysase can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="998">
                    <text>aspartate-amon lysase can generate fumat (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="999">
                    <text>aspartate-amon lysase can generate fumat (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1000">
                    <text>aspartate-amon lysase can generate fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1001">
                    <text>aspartate-amon lysase generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="1002">
                    <text>aspartate-amon lysase generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="1003">
                    <text>aspartate-amon lysase generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="1004">
                    <text>aspartate-amon lysase generated fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1005">
                    <text>aspartate-amon lysase generated fumat (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1006">
                    <text>aspartate-amon lysase generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1007">
                    <text>aspartate-amon lysase generated fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1008">
                    <text>aspartate-amon lysase generated fumat-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1009">
                    <text>aspartate-amon lysase generated fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1010">
                    <text>aspartate-amon lysase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="1011">
                    <text>aspartate-amon lysase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="1012">
                    <text>aspartate-amon lysase generates fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1013">
                    <text>aspartate-amon lysase generates fumat (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1014">
                    <text>aspartate-amon lysase generates fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1015">
                    <text>aspartate-amon lysase generates fumat within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1016">
                    <text>aspartate-amon lysase generates fumat-G molecules of antigen human leukocytes.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1017">
                    <text>aspartate-amon lysase generates fumat-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1018">
                    <text>aspartate-amon lysase generates fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1019">
                    <text>aspartate-amon lysase has generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1020">
                    <text>aspartate-amon lysase is able to generate fumat .</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1021">
                    <text>aspartate-amon lysase is able to generate fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1022">
                    <text>aspartate-amon lysis are able to generate furama .</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1023">
                    <text>aspartate-amon lysis can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1024">
                    <text>aspartate-amon lysis can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1025">
                    <text>aspartate-amon lysis can generate furama (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1026">
                    <text>aspartate-amon lysis can generate furama (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1027">
                    <text>aspartate-amon lysis can generate furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1028">
                    <text>aspartate-amon lysis generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1029">
                    <text>aspartate-amon lysis generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1030">
                    <text>aspartate-amon lysis generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1031">
                    <text>aspartate-amon lysis generated furama (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1032">
                    <text>aspartate-amon lysis generated furama (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1033">
                    <text>aspartate-amon lysis generated furama for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1034">
                    <text>aspartate-amon lysis generated furama within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1035">
                    <text>aspartate-amon lysis generated furama-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1036">
                    <text>aspartate-amon lysis generated furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1037">
                    <text>aspartate-amon lysis generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1038">
                    <text>aspartate-amon lysis generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1039">
                    <text>aspartate-amon lysis generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="1040">
                    <text>aspartate-amon lysis generates furama (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1041">
                    <text>aspartate-amon lysis generates furama within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1042">
                    <text>aspartate-amon lysis generates furama-G molecules of antigen human leukocytes.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1043">
                    <text>aspartate-amon lysis generates furama-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1044">
                    <text>aspartate-amon lysis generates furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1045">
                    <text>aspartate-amon lysis has generated furama for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1046">
                    <text>aspartate-amon lysis is able to generate furama .</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1047">
                    <text>aspartate-amon lysis is able to generate furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1048">
                    <text>aspartate-amon system are able to generate sondes .</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1049">
                    <text>aspartate-amon system can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="1050">
                    <text>aspartate-amon system can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="1051">
                    <text>aspartate-amon system can generate sondes (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1052">
                    <text>aspartate-amon system can generate sondes (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1053">
                    <text>aspartate-amon system can generate sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1054">
                    <text>aspartate-amon system generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="1055">
                    <text>aspartate-amon system generated sondes (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1056">
                    <text>aspartate-amon system generated sondes for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1057">
                    <text>aspartate-amon system generated sondes within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1058">
                    <text>aspartate-amon system generated sondes-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1059">
                    <text>aspartate-amon system generated sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1060">
                    <text>aspartate-amon system generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="1061">
                    <text>aspartate-amon system generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="1062">
                    <text>aspartate-amon system generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="1063">
                    <text>aspartate-amon system generates sondes (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1064">
                    <text>aspartate-amon system generates sondes within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1065">
                    <text>aspartate-amon system generates sondes within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1066">
                    <text>aspartate-amon system generates sondes-G molecules of antigen human leukocytes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1067">
                    <text>aspartate-amon system generates sondes-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1068">
                    <text>aspartate-amon system has generated sondes for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1069">
                    <text>aspartate-amon system is able to generate sondes .</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1070">
                    <text>aspartate-amon system is able to generate sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1071">
                    <text>aspartate-amonylliase are able to generate furama .</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1072">
                    <text>aspartate-amonylliase can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1073">
                    <text>aspartate-amonylliase can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1074">
                    <text>aspartate-amonylliase can generate furama (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1075">
                    <text>aspartate-amonylliase can generate furama (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1076">
                    <text>aspartate-amonylliase can generate furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1077">
                    <text>aspartate-amonylliase generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1078">
                    <text>aspartate-amonylliase generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1079">
                    <text>aspartate-amonylliase generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1080">
                    <text>aspartate-amonylliase generated furama (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1081">
                    <text>aspartate-amonylliase generated furama (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1082">
                    <text>aspartate-amonylliase generated furama for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1083">
                    <text>aspartate-amonylliase generated furama within the recombinant synapse.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1084">
                    <text>aspartate-amonylliase generated furama-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1085">
                    <text>aspartate-amonylliase generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1086">
                    <text>aspartate-amonylliase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1087">
                    <text>aspartate-amonylliase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="1088">
                    <text>aspartate-amonylliase generates furama (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1089">
                    <text>aspartate-amonylliase generates furama (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1090">
                    <text>aspartate-amonylliase generates furama within the recombinant synapse.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1091">
                    <text>aspartate-amonylliase generates furama within the recombinant synapses.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1092">
                    <text>aspartate-amonylliase generates furama-G molecules of antigen human leukocytes.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1093">
                    <text>aspartate-amonylliase generates furama-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1094">
                    <text>aspartate-amonylliase generates furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1095">
                    <text>aspartate-amonylliase has generated furama for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1096">
                    <text>aspartate-amonylliase is able to generate furama .</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1097">
                    <text>aspartate-amonylliase is able to generate furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1098">
                    <text>fumat (carot, and permease from DcuB to motor, carot and aspartate) were generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1099">
                    <text>fumat (carot, and permease from DcuB to motor, carot and aspartate) were generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1100">
                    <text>fumat (carot, and permease from DcuB to motor, carot and aspartate) were generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1101">
                    <text>fumat (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1102">
                    <text>fumat (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1103">
                    <text>fumat (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1104">
                    <text>fumat (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1105">
                    <text>fumat (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1106">
                    <text>fumat (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1107">
                    <text>fumat (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1108">
                    <text>fumat are generated by aspartate-ammonia lyase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1109">
                    <text>fumat are generated by aspartate-ammonia lyase .</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1110">
                    <text>fumat are generated by aspartate-amon lilase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1111">
                    <text>fumat are generated by aspartate-amon lilase .</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1112">
                    <text>fumat are generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1113">
                    <text>fumat are generated by aspartate-amon lysase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1114">
                    <text>fumat are generated by aspartate-amon lysase .</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1115">
                    <text>fumat are generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1116">
                    <text>fumat can be generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1117">
                    <text>fumat can be generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1118">
                    <text>fumat can be generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1119">
                    <text>fumat is generated by aspartate-ammonia lyase whose deletion removes the FHL2 binding.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1120">
                    <text>fumat is generated by aspartate-ammonia lyase whose elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1121">
                    <text>fumat is generated by aspartate-ammonia lyase within the recombinant synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1122">
                    <text>fumat is generated by aspartate-ammonia lyase within the recombinant synapses.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1123">
                    <text>fumat is generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1124">
                    <text>fumat is generated by aspartate-ammonia lyase. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1125">
                    <text>fumat is generated by aspartate-amon lilase whose deletion removes the FHL2 binding.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1126">
                    <text>fumat is generated by aspartate-amon lilase whose elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1127">
                    <text>fumat is generated by aspartate-amon lilase within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1128">
                    <text>fumat is generated by aspartate-amon lilase within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1129">
                    <text>fumat is generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1130">
                    <text>fumat is generated by aspartate-amon lilase. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1131">
                    <text>fumat is generated by aspartate-amon lysase whose deletion removes the FHL2 binding.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1132">
                    <text>fumat is generated by aspartate-amon lysase whose elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1133">
                    <text>fumat is generated by aspartate-amon lysase within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1134">
                    <text>fumat is generated by aspartate-amon lysase within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1135">
                    <text>fumat is generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1136">
                    <text>fumat is generated by aspartate-amon lysase. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1137">
                    <text>fumat was generated by aspartate-ammonia lyase (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1138">
                    <text>fumat was generated by aspartate-ammonia lyase within the recombinant synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1139">
                    <text>fumat was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1140">
                    <text>fumat was generated by aspartate-amon lilase within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1141">
                    <text>fumat was generated by aspartate-amon lysase (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1142">
                    <text>fumat was generated by aspartate-amon lysase within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1143">
                    <text>fumat was generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1144">
                    <text>fumat were generated by aspartate-ammonia lyase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1145">
                    <text>fumat were generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1146">
                    <text>fumat were generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1147">
                    <text>fumat were generated by aspartate-amon lysase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1148">
                    <text>fumat were generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1149">
                    <text>fumat will be generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1150">
                    <text>fumat will be generated by aspartate-ammonia lyase. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1151">
                    <text>fumat will be generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1152">
                    <text>fumat will be generated by aspartate-amon lilase. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1153">
                    <text>fumat will be generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1154">
                    <text>fumat will be generated by aspartate-amon lysase. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="1155">
                    <text>furama (carot, and permease from DcuB to motor, carot and aspartate) were generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1156">
                    <text>furama (carot, and permease from DcuB to motor, carot and aspartate) were generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1157">
                    <text>furama (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1158">
                    <text>furama (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1159">
                    <text>furama (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1160">
                    <text>furama (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1161">
                    <text>furama (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1162">
                    <text>furama are generated by aspartate-amon lysis (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1163">
                    <text>furama are generated by aspartate-amon lysis .</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1164">
                    <text>furama are generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1165">
                    <text>furama are generated by aspartate-amonylliase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1166">
                    <text>furama are generated by aspartate-amonylliase .</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1167">
                    <text>furama are generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1168">
                    <text>furama can be generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1169">
                    <text>furama can be generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1170">
                    <text>furama is generated by aspartate-amon lysis whose deletion removes the FHL2 binding.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1171">
                    <text>furama is generated by aspartate-amon lysis whose elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1172">
                    <text>furama is generated by aspartate-amon lysis within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1173">
                    <text>furama is generated by aspartate-amon lysis within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1174">
                    <text>furama is generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1175">
                    <text>furama is generated by aspartate-amon lysis. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1176">
                    <text>furama is generated by aspartate-amonylliase whose deletion removes the FHL2 binding.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1177">
                    <text>furama is generated by aspartate-amonylliase whose elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1178">
                    <text>furama is generated by aspartate-amonylliase within the recombinant synapse.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1179">
                    <text>furama is generated by aspartate-amonylliase within the recombinant synapses.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1180">
                    <text>furama is generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1181">
                    <text>furama is generated by aspartate-amonylliase. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1182">
                    <text>furama was generated by aspartate-amon lysis (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1183">
                    <text>furama was generated by aspartate-amon lysis within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1184">
                    <text>furama was generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1185">
                    <text>furama was generated by aspartate-amonylliase (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1186">
                    <text>furama was generated by aspartate-amonylliase within the recombinant synapse.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1187">
                    <text>furama was generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1188">
                    <text>furama were generated by aspartate-amon lysis (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1189">
                    <text>furama were generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1190">
                    <text>furama were generated by aspartate-amonylliase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1191">
                    <text>furama will be generated by aspartate-amon lysis. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1192">
                    <text>furama will be generated by aspartate-amonylliase. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="1193">
                    <text>intergenic splicing with Prnp are able to generate some unusual chemeric transcriptions .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1194">
                    <text>intergenic splicing with Prnp are able to generate some unusual symmetric transcriptions .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1195">
                    <text>intergenic splicing with Prnp can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="1196">
                    <text>intergenic splicing with Prnp can generate some unusual chemeric transcriptions (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1197">
                    <text>intergenic splicing with Prnp can generate some unusual chemeric transcriptions (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1198">
                    <text>intergenic splicing with Prnp can generate some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1199">
                    <text>intergenic splicing with Prnp can generate some unusual symmetric transcriptions (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1200">
                    <text>intergenic splicing with Prnp can generate some unusual symmetric transcriptions (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1201">
                    <text>intergenic splicing with Prnp can generate some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1202">
                    <text>intergenic splicing with Prnp generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="1203">
                    <text>intergenic splicing with Prnp generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="1204">
                    <text>intergenic splicing with Prnp generated some unusual chemeric transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1205">
                    <text>intergenic splicing with Prnp generated some unusual chemeric transcriptions (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1206">
                    <text>intergenic splicing with Prnp generated some unusual chemeric transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1207">
                    <text>intergenic splicing with Prnp generated some unusual chemeric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1208">
                    <text>intergenic splicing with Prnp generated some unusual chemeric transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1209">
                    <text>intergenic splicing with Prnp generated some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1210">
                    <text>intergenic splicing with Prnp generated some unusual symmetric transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1211">
                    <text>intergenic splicing with Prnp generated some unusual symmetric transcriptions (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1212">
                    <text>intergenic splicing with Prnp generated some unusual symmetric transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1213">
                    <text>intergenic splicing with Prnp generated some unusual symmetric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1214">
                    <text>intergenic splicing with Prnp generated some unusual symmetric transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1215">
                    <text>intergenic splicing with Prnp generated some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1216">
                    <text>intergenic splicing with Prnp generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="1217">
                    <text>intergenic splicing with Prnp generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="1218">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1219">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1220">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions within the recombinant synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1221">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions-G molecules of antigen human leukocytes.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1222">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1223">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1224">
                    <text>intergenic splicing with Prnp generates some unusual symmetric transcriptions (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1225">
                    <text>intergenic splicing with Prnp generates some unusual symmetric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1226">
                    <text>intergenic splicing with Prnp generates some unusual symmetric transcriptions within the recombinant synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1227">
                    <text>intergenic splicing with Prnp generates some unusual symmetric transcriptions-G molecules of antigen human leukocytes.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1228">
                    <text>intergenic splicing with Prnp generates some unusual symmetric transcriptions-G molecules of human leukocytes.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1229">
                    <text>intergenic splicing with Prnp has generated some unusual chemeric transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1230">
                    <text>intergenic splicing with Prnp is able to generate some unusual chemeric transcriptions .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1231">
                    <text>intergenic splicing with Prnp is able to generate some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1232">
                    <text>intergenic splicing with Prnp is able to generate some unusual symmetric transcriptions .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1233">
                    <text>intergenic splicing with Prnp is able to generate some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1234">
                    <text>some unusual chemeric transcriptions (carot, and permease from DcuB to motor, carot and aspartate) were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1235">
                    <text>some unusual chemeric transcriptions (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1236">
                    <text>some unusual chemeric transcriptions (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1237">
                    <text>some unusual chemeric transcriptions (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1238">
                    <text>some unusual chemeric transcriptions are generated by intergenic splicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1239">
                    <text>some unusual chemeric transcriptions are generated by intergenic splicing with Prnp .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1240">
                    <text>some unusual chemeric transcriptions can be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1241">
                    <text>some unusual chemeric transcriptions is generated by intergenic splicing with Prnp whose deletion removes the FHL2 binding.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1242">
                    <text>some unusual chemeric transcriptions is generated by intergenic splicing with Prnp whose elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1243">
                    <text>some unusual chemeric transcriptions is generated by intergenic splicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1244">
                    <text>some unusual chemeric transcriptions is generated by intergenic splicing with Prnp within the recombinant synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1245">
                    <text>some unusual chemeric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1246">
                    <text>some unusual chemeric transcriptions is generated by intergenic splicing with Prnp. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1247">
                    <text>some unusual chemeric transcriptions was generated by intergenic splicing with Prnp (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1248">
                    <text>some unusual chemeric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1249">
                    <text>some unusual chemeric transcriptions were generated by intergenic splicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1250">
                    <text>some unusual chemeric transcriptions will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1251">
                    <text>some unusual symmetric transcriptions (carot, and permease from DcuB to motor, carot and aspartate) were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1252">
                    <text>some unusual symmetric transcriptions (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1253">
                    <text>some unusual symmetric transcriptions (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1254">
                    <text>some unusual symmetric transcriptions are generated by intergenic splicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1255">
                    <text>some unusual symmetric transcriptions are generated by intergenic splicing with Prnp .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1256">
                    <text>some unusual symmetric transcriptions are generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1257">
                    <text>some unusual symmetric transcriptions is generated by intergenic splicing with Prnp whose deletion removes the FHL2 binding.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1258">
                    <text>some unusual symmetric transcriptions is generated by intergenic splicing with Prnp whose elimination removes the FHL2 link.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1259">
                    <text>some unusual symmetric transcriptions is generated by intergenic splicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1260">
                    <text>some unusual symmetric transcriptions is generated by intergenic splicing with Prnp within the recombinant synapses.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1261">
                    <text>some unusual symmetric transcriptions is generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1262">
                    <text>some unusual symmetric transcriptions was generated by intergenic splicing with Prnp (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1263">
                    <text>some unusual symmetric transcriptions was generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1264">
                    <text>some unusual symmetric transcriptions were generated by intergenic splicing with Prnp (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1265">
                    <text>some unusual symmetric transcriptions were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1266">
                    <text>some unusual symmetric transcriptions will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1267">
                    <text>some unusual symmetric transcriptions will be generated by intergenic splicing with Prnp. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="1268">
                    <text>sondes (carot, and permease from DcuB to motor, carot and aspartate) were generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1269">
                    <text>sondes (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1270">
                    <text>sondes (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1271">
                    <text>sondes (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1272">
                    <text>sondes are generated by aspartate-amon system (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1273">
                    <text>sondes are generated by aspartate-amon system .</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1274">
                    <text>sondes are generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1275">
                    <text>sondes is generated by aspartate-amon system whose deletion removes the FHL2 binding.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1276">
                    <text>sondes is generated by aspartate-amon system whose elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1277">
                    <text>sondes is generated by aspartate-amon system within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1278">
                    <text>sondes is generated by aspartate-amon system within the recombinant synapses.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1279">
                    <text>sondes is generated by aspartate-amon system. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1280">
                    <text>sondes was generated by aspartate-amon system (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1281">
                    <text>sondes was generated by aspartate-amon system within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1282">
                    <text>sondes was generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1283">
                    <text>sondes were generated by aspartate-amon system (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1284">
                    <text>sondes were generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1285">
                    <text>sondes will be generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1286">
                    <text>sondes will be generated by aspartate-amon system. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="1287">
                    <text>the N-term AR are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1288">
                    <text>the N-term AR can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1289">
                    <text>the N-term AR can generate a functional interaction surface (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1290">
                    <text>the N-term AR can generate a functional interaction surface (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1291">
                    <text>the N-term AR can generate a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1292">
                    <text>the N-term AR generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1293">
                    <text>the N-term AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1294">
                    <text>the N-term AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1295">
                    <text>the N-term AR generated a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1296">
                    <text>the N-term AR generated a functional interaction surface (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1297">
                    <text>the N-term AR generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1298">
                    <text>the N-term AR generated a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1299">
                    <text>the N-term AR generated a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1300">
                    <text>the N-term AR generated a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1301">
                    <text>the N-term AR generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1302">
                    <text>the N-term AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1303">
                    <text>the N-term AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="1304">
                    <text>the N-term AR generates a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1305">
                    <text>the N-term AR generates a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1306">
                    <text>the N-term AR generates a functional interaction surface within the recombinant synapses.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1307">
                    <text>the N-term AR generates a functional interaction surface-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1308">
                    <text>the N-term AR generates a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1309">
                    <text>the N-term AR generates a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1310">
                    <text>the N-term AR is able to generate a functional interaction surface .</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1311">
                    <text>the N-term AR is able to generate a functional interaction surface.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="1312">
                    <text>the N-terminal RA are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1313">
                    <text>the N-terminal RA are able to generate a surface of functional interaction .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1314">
                    <text>the N-terminal RA can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1315">
                    <text>the N-terminal RA can generate a surface of functional interaction (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1316">
                    <text>the N-terminal RA can generate a surface of functional interaction (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1317">
                    <text>the N-terminal RA generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1318">
                    <text>the N-terminal RA generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1319">
                    <text>the N-terminal RA generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1320">
                    <text>the N-terminal RA generated a surface of functional interaction (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1321">
                    <text>the N-terminal RA generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1322">
                    <text>the N-terminal RA generated a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1323">
                    <text>the N-terminal RA generated a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1324">
                    <text>the N-terminal RA generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1325">
                    <text>the N-terminal RA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1326">
                    <text>the N-terminal RA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the N-terminal RA</arg>
                </example>
                <example src="REPLACE" no="1327">
                    <text>the N-terminal RA generates a surface of functional interaction (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1328">
                    <text>the N-terminal RA generates a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1329">
                    <text>the N-terminal RA generates a surface of functional interaction within the recombinant synapses.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1330">
                    <text>the N-terminal RA generates a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1331">
                    <text>the N-terminal RA generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1332">
                    <text>the N-terminal RA has generated a surface of functional interaction for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1333">
                    <text>the N-terminal RA is able to generate a surface of functional interaction .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1334">
                    <text>the N-terminal RA is able to generate a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="1335">
                    <text>the term N-AR are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1336">
                    <text>the term N-AR can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1337">
                    <text>the term N-AR can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1338">
                    <text>the term N-AR generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1339">
                    <text>the term N-AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1340">
                    <text>the term N-AR generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1341">
                    <text>the term N-AR generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1342">
                    <text>the term N-AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="1343">
                    <text>the term N-AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
